{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1182.311",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2019-11-11T01:00:18.000-05:00"
  },
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \u003ch2\u003eComplications of Care\u003c/h2\u003e\n      \u003cp\u003eThis value set includes codes from the following code systems:\u003c/p\u003e\n      \u003cul\u003e\n        \u003cli\u003eInclude these codes as defined in \n          \u003ccode\u003ehttp://hl7.org/fhir/sid/icd-10-cm\u003c/code\u003e\n          \u003ctable class\u003d\"none\"\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e\n                \u003cb\u003eCode\u003c/b\u003e\n              \u003c/td\u003e\n              \u003ctd\u003e\n                \u003cb\u003eDisplay\u003c/b\u003e\n              \u003c/td\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA36.81\u003c/td\u003e\n              \u003ctd\u003eDiphtheritic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA38.1\u003c/td\u003e\n              \u003ctd\u003eScarlet fever with myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.50\u003c/td\u003e\n              \u003ctd\u003eMeningococcal carditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.51\u003c/td\u003e\n              \u003ctd\u003eMeningococcal endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.52\u003c/td\u003e\n              \u003ctd\u003eMeningococcal myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.53\u003c/td\u003e\n              \u003ctd\u003eMeningococcal pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB26.82\u003c/td\u003e\n              \u003ctd\u003eMumps myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.20\u003c/td\u003e\n              \u003ctd\u003eViral carditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.21\u003c/td\u003e\n              \u003ctd\u003eViral endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.22\u003c/td\u003e\n              \u003ctd\u003eViral myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.23\u003c/td\u003e\n              \u003ctd\u003eViral pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.24\u003c/td\u003e\n              \u003ctd\u003eViral cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB37.6\u003c/td\u003e\n              \u003ctd\u003eCandidal endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB44.81\u003c/td\u003e\n              \u003ctd\u003eAllergic bronchopulmonary aspergillosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB58.81\u003c/td\u003e\n              \u003ctd\u003eToxoplasma myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external upper lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external lower lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lip, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lip, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lip, unspecified, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of commissure of lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of base of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of dorsal surface of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of border of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ventral surface of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior two-thirds of tongue, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lingual tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tongue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper gum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower gum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of gum, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of floor of mouth, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hard palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of soft palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uvula\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of palate, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cheek mucosa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vestibule of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of retromolar area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.89\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of other parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mouth, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC07\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parotid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of submandibular gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sublingual gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of major salivary gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsillar fossa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsillar pillar (anterior) (posterior)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsil, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vallecula\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior surface of epiglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of branchial cleft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of oropharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of superior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nasopharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pyriform sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of postcricoid region\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of aryepiglottic fold, hypopharyngeal aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hypopharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of Waldeyer\u0027s ring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of lip, oral cavity and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of esophagus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of fundus of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pyloric antrum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pylorus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lesser curvature of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of greater curvature of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.3\u003c/td\u003e\n              \u003ctd\u003eMeckel\u0027s diverticulum, malignant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of small intestine, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hepatic flexure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of splenic flexure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of colon, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC19\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cloacogenic zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of rectum, anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.0\u003c/td\u003e\n              \u003ctd\u003eLiver cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.1\u003c/td\u003e\n              \u003ctd\u003eIntrahepatic bile duct carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.2\u003c/td\u003e\n              \u003ctd\u003eHepatoblastoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.3\u003c/td\u003e\n              \u003ctd\u003eAngiosarcoma of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.4\u003c/td\u003e\n              \u003ctd\u003eOther sarcomas of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.7\u003c/td\u003e\n              \u003ctd\u003eOther specified carcinomas of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of liver, primary, unspecified as to type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of liver, not specified as primary or secondary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC23\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of gallbladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of extrahepatic bile duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ampulla of Vater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of biliary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of biliary tract, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of head of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tail of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pancreatic duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocrine pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other parts of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pancreas, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of intestinal tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ill-defined sites within the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC30.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nasal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC30.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle ear\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of maxillary sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ethmoidal sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of frontal sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sphenoid sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of accessory sinus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of glottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of supraglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of subglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of laryngeal cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of larynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC33\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle lobe, bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC37\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mediastinum, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of heart, mediastinum and pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC39.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper respiratory tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC39.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower respiratory tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of right limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of left limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of right limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of left limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bones of skull and face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mandible\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vertebral column\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ribs, sternum and clavicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pelvic bones, sacrum and coccyx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bone and articular cartilage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.0\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.10\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.11\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.111\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.112\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.12\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.121\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.122\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.20\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.21\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.22\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.30\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.31\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.39\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.4\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.51\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.52\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.59\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.60\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.61\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.62\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.70\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.71\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.72\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.8\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.9\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.00\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.01\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.02\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.09\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.101\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.102\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1021\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1022\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.109\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1091\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1092\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.111\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.112\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1121\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1122\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.119\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1191\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1192\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.121\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.122\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1221\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1222\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.129\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1291\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1292\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.131\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1321\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1322\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1391\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1392\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.191\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.192\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1921\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1922\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.199\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1991\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1992\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.201\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.202\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.209\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.211\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.212\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.219\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.221\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.222\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.229\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.291\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.292\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.299\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.300\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.301\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.309\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.310\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.311\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.319\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.320\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.321\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.329\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.390\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.391\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.399\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.41\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.42\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.49\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.500\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.501\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.509\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.510\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.511\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.519\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.520\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.521\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.529\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.590\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.591\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.599\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.601\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.602\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.609\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.611\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.612\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.619\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.621\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.622\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.629\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.691\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.692\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.699\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.701\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.702\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.709\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.711\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.712\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.719\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.721\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.722\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.729\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.791\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.792\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.799\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.80\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.81\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.82\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.89\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.91\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.92\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.99\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.0\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.1\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.2\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of pericardium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.7\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.9\u003c/td\u003e\n              \u003ctd\u003eMesothelioma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.0\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.1\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.2\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.3\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.4\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of gastrointestinal sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.50\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of unspecified lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.51\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of right lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.52\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of left lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.7\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.9\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves and autonomic nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of specified parts of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peritoneum, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of retroperitoneum and peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of connective and soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A0\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A1\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A2\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A3\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A4\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A5\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A9\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.0\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.10\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.11\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.111\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.112\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.12\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.121\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.122\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.20\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.21\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.22\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.30\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.31\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.39\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.4\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.51\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.52\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.59\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.60\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.61\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.62\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.70\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.71\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.72\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.8\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of overlapping sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.9\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.011\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.012\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.019\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.021\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.022\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.029\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.111\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.112\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.119\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.121\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.122\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.129\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.211\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.212\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.219\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.221\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.222\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.229\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.311\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.312\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.319\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.321\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.322\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.329\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.411\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.412\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.419\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.421\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.422\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.429\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.511\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.512\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.519\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.521\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.522\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.529\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.611\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.612\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.619\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.621\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.622\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.629\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.811\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.812\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.819\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.821\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.822\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.829\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.911\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.912\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.919\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.921\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.922\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.929\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of labium majus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of labium minus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of clitoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vulva, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of exocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cervix uteri, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of isthmus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of myometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of fundus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of corpus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of corpus uteri, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC55\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uterus, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parametrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uterine adnexa, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC58\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of prepuce\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of glans penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of penis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC61\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified undescended testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of undescended right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of undescended left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified descended testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descended right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descended left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of trigone of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of dome of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bladder neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ureteric orifice\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urachus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bladder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of paraurethral glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urinary organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.51\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.60\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.61\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.62\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebrum, except lobes and ventricles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of frontal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of temporal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parietal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of occipital lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebral ventricle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebellum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of brain stem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cauda equina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified cranial nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.59\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC73\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm with pluriglandular involvement, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocrine gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.51\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified ill-defined sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.0\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph nodes of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.1\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.2\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.3\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.4\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.5\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.8\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph nodes of multiple regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.9\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph node, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.00\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.01\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.02\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.1\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.2\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.30\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified respiratory organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.39\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.4\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.5\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of large intestine and rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.6\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of retroperitoneum and peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.7\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of liver and intrahepatic bile duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.80\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified digestive organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.89\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.00\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.01\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.02\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.10\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.11\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.19\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.2\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.31\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.32\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.40\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified part of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.49\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other parts of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.51\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.52\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bone marrow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.60\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.61\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.62\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.70\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.71\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.72\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.81\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.82\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.89\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.9\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.00\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.010\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.011\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.012\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.019\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the small intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.020\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.021\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.022\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.023\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.024\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.025\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.026\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.029\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the large intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.090\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.091\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.092\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.093\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.094\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the foregut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.095\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the midgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.096\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the hindgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.098\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.1\u003c/td\u003e\n              \u003ctd\u003eMalignant poorly differentiated neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.8\u003c/td\u003e\n              \u003ctd\u003eOther malignant neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.00\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.01\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of distant lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.02\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.03\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.04\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.09\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.1\u003c/td\u003e\n              \u003ctd\u003eSecondary Merkel cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.8\u003c/td\u003e\n              \u003ctd\u003eOther secondary neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.0\u003c/td\u003e\n              \u003ctd\u003eDisseminated malignant neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.1\u003c/td\u003e\n              \u003ctd\u003eMalignant (primary) neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm associated with transplanted organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.00\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.01\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.02\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.03\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.04\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.05\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.06\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.07\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.08\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.09\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.10\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.11\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.12\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.13\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.14\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.15\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.16\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.17\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.18\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.19\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.20\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.21\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.22\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.23\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.24\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.25\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.26\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.27\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.28\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.29\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.30\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.31\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.32\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.33\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.34\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.35\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.36\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.37\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.38\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.39\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.40\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.41\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.42\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.43\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.44\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.45\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.46\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.47\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.48\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.49\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.70\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.71\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.72\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.73\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.74\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.75\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.76\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.77\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.78\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.79\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.90\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.91\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.92\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.93\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.94\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.95\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.96\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.97\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.98\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.99\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.00\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.01\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.02\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.03\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.04\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.05\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.06\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.07\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.08\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.09\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.10\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.11\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.12\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.13\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.14\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.15\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.16\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.17\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.18\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.19\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.20\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.21\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.22\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.23\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.24\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.25\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.26\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.27\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.28\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.29\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.30\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.31\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.32\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.33\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.34\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.35\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.36\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.37\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.38\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.39\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.40\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.41\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.42\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.43\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.44\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.45\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.46\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.47\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.48\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.49\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.50\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.51\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.52\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.53\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.54\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.55\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.56\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.57\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.58\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.59\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.60\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.61\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.62\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.63\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.64\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.65\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.66\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.67\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.68\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.69\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.80\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.81\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.82\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.83\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.84\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.85\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.86\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.87\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.88\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.89\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.90\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.91\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.92\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.93\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.94\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.95\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.96\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.97\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.98\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.99\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.00\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.01\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.02\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.03\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.04\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.05\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.06\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.07\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.08\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.09\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.10\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.11\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.12\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.13\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.14\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.15\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.16\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.17\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.18\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.19\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.30\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.31\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.32\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.33\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.34\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.35\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.36\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.37\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.38\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.39\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.50\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.51\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.52\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.53\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.54\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.55\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.56\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.57\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.58\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.59\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.70\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.71\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.72\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.73\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.74\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.75\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.76\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.77\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.78\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.79\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.80\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.81\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.82\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.83\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.84\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.85\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.86\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.87\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.88\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.89\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.90\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.91\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.92\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.93\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.94\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.95\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.96\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.97\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.98\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.99\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.00\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.01\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.02\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.03\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.04\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.05\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.06\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.07\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.08\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.09\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.10\u003c/td\u003e\n              \u003ctd\u003eSzary disease, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.11\u003c/td\u003e\n              \u003ctd\u003eSzary disease, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.12\u003c/td\u003e\n              \u003ctd\u003eSzary disease, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.13\u003c/td\u003e\n              \u003ctd\u003eSzary disease, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.14\u003c/td\u003e\n              \u003ctd\u003eSzary disease, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.15\u003c/td\u003e\n              \u003ctd\u003eSzary disease, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.16\u003c/td\u003e\n              \u003ctd\u003eSzary disease, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.17\u003c/td\u003e\n              \u003ctd\u003eSzary disease, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.18\u003c/td\u003e\n              \u003ctd\u003eSzary disease, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.19\u003c/td\u003e\n              \u003ctd\u003eSzary disease, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.40\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.41\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.42\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.43\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.44\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.45\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.46\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.47\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.48\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.49\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.60\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.61\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.62\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.63\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.64\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.65\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.66\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.67\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.68\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.69\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.70\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.71\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.72\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.73\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.74\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.75\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.76\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.77\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.78\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.79\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.90\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.91\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.92\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.93\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.94\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.95\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.96\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.97\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.98\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.99\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A0\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A1\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A2\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A3\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A4\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A5\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A6\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A7\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A8\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A9\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z0\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z1\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z2\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z3\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z4\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z5\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z6\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z7\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z8\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z9\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.11\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.12\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.13\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.14\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.15\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.16\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.17\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.18\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.19\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.20\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.21\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.22\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.23\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.24\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.25\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.26\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.27\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.28\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.29\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.80\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.81\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.82\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.83\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.84\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.85\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.86\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.87\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.88\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.89\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.90\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.91\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.92\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.93\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.94\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.95\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.96\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.97\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.98\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.99\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.0\u003c/td\u003e\n              \u003ctd\u003eExtranodal NK/T-cell lymphoma, nasal type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.1\u003c/td\u003e\n              \u003ctd\u003eHepatosplenic T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.2\u003c/td\u003e\n              \u003ctd\u003eEnteropathy-type (intestinal) T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.3\u003c/td\u003e\n              \u003ctd\u003eSubcutaneous panniculitis-like T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.4\u003c/td\u003e\n              \u003ctd\u003eBlastic NK-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.5\u003c/td\u003e\n              \u003ctd\u003eAngioimmunoblastic T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.6\u003c/td\u003e\n              \u003ctd\u003ePrimary cutaneous CD30-positive T-cell proliferations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.0\u003c/td\u003e\n              \u003ctd\u003eWaldenstrm macroglobulinemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.2\u003c/td\u003e\n              \u003ctd\u003eHeavy chain disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.3\u003c/td\u003e\n              \u003ctd\u003eImmunoproliferative small intestinal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.4\u003c/td\u003e\n              \u003ctd\u003eExtranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.8\u003c/td\u003e\n              \u003ctd\u003eOther malignant immunoproliferative diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.9\u003c/td\u003e\n              \u003ctd\u003eMalignant immunoproliferative disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.00\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.01\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.02\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.10\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.11\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.12\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.20\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.21\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.22\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.30\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.31\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.32\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.00\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.01\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.02\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.10\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.11\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.12\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.30\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.31\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.32\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.40\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.41\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.42\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.50\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.51\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated), in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.52\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.60\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.61\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.62\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.90\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.91\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.92\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A0\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A1\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A2\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z0\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z1\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z2\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.00\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.01\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.02\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.10\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.11\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.12\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.20\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.21\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.22\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.30\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.31\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.32\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.40\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.41\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.42\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.50\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.51\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.52\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.60\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.61\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.62\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.90\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.91\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.92\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A0\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A1\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A2\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z0\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z1\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z2\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.00\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.01\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.02\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.10\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.11\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.12\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.30\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.31\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.32\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.90\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.91\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.92\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z0\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z1\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z2\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.00\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.01\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.02\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.20\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.21\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.22\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.30\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.31\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.32\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.40\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.41\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.42\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.6\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic disease, not classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.80\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.81\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.82\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.00\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.01\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.02\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.10\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.11\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.12\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.90\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.91\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.92\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.0\u003c/td\u003e\n              \u003ctd\u003eMultifocal and multisystemic (disseminated) Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.2\u003c/td\u003e\n              \u003ctd\u003eMalignant mast cell neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.20\u003c/td\u003e\n              \u003ctd\u003eMalignant mast cell neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.21\u003c/td\u003e\n              \u003ctd\u003eAggressive systemic mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.22\u003c/td\u003e\n              \u003ctd\u003eMast cell sarcoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.29\u003c/td\u003e\n              \u003ctd\u003eOther malignant mast cell neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.4\u003c/td\u003e\n              \u003ctd\u003eSarcoma of dendritic cells (accessory cells)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.5\u003c/td\u003e\n              \u003ctd\u003eMultifocal and unisystemic Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.6\u003c/td\u003e\n              \u003ctd\u003eUnifocal Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.A\u003c/td\u003e\n              \u003ctd\u003eHistiocytic sarcoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.Z\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasms of lymphoid, hematopoietic and related tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.00\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of oral cavity, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.01\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of labial mucosa and vermilion border\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.02\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of buccal mucosa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.03\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of gingiva and edentulous alveolar ridge\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.04\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of soft palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.05\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of hard palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.06\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.07\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.08\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.40\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified part of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.49\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of liver, gallbladder and bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.7\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other specified digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of digestive organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of respiratory system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.0\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.10\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.11\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.111\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.112\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.12\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.121\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.122\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.20\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.21\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.22\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.30\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.39\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.4\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.51\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.52\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of breast (skin) (soft tissue)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.59\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.60\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.61\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.62\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.70\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.71\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.72\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.8\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.9\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.10\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.11\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.111\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.112\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.12\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.121\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.122\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.30\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.39\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.60\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.61\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.62\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.70\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.71\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.72\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.8\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.00\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.01\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.02\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.10\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.11\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.12\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.80\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.81\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.82\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.91\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.92\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of endocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of exocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.7\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of cervix, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of endometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.30\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.39\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.60\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.61\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.69\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.10\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified urinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.19\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of thyroid and other endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.8\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.39\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of parotid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other major salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of major salivary gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of colon, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.39\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of extrahepatic bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of endocrine pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ill-defined sites within the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of middle ear, nasal cavity and accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of respiratory system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of intrathoracic organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bones of skull and face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lower jaw bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vertebral column\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ribs, sternum and clavicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pelvic bones, sacrum and coccyx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bone and articular cartilage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.0\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.1\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.20\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.21\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of right arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.22\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of left arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.23\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.24\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.30\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.39\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.4\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.5\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of intra-abdominal organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.6\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.71\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.72\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of other genitourinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.79\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.9\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.00\u003c/td\u003e\n              \u003ctd\u003eHemangioma unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.01\u003c/td\u003e\n              \u003ctd\u003eHemangioma of skin and subcutaneous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.02\u003c/td\u003e\n              \u003ctd\u003eHemangioma of intracranial structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.03\u003c/td\u003e\n              \u003ctd\u003eHemangioma of intra-abdominal structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.09\u003c/td\u003e\n              \u003ctd\u003eHemangioma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.1\u003c/td\u003e\n              \u003ctd\u003eLymphangioma, any site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD20.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of soft tissue of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD20.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of soft tissue of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.0\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.10\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.11\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.111\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.112\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.12\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.121\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.122\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.20\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.21\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.22\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.30\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.39\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.4\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.5\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.60\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.61\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.62\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.70\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.71\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.72\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.9\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.0\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.10\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.11\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.111\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.112\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.12\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.121\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.122\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.20\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.21\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.22\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.30\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.39\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.4\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.5\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.60\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.61\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.62\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.70\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.71\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.72\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.9\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.0\u003c/td\u003e\n              \u003ctd\u003eSubmucous leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.1\u003c/td\u003e\n              \u003ctd\u003eIntramural leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.2\u003c/td\u003e\n              \u003ctd\u003eSubserosal leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.9\u003c/td\u003e\n              \u003ctd\u003eLeiomyoma of uterus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.0\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.1\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of corpus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.7\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of other parts of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.9\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of uterus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of uterine tubes and ligaments\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of urinary organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.40\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.41\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.42\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.50\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.51\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.52\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.60\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of unspecified orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.61\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of right orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.62\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of left orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.90\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.91\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.92\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, supratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, infratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified parts of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD34\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of endocrine gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.13\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.14\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.15\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.16\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.17\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.01\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.02\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.030\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the parotid salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.031\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the sublingual salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.032\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the submandibular salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.039\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the major salivary glands, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.04\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the minor salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.05\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.09\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified sites of the oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of liver, gallbladder and bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of digestive organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of trachea, bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of respiratory organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.00\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.010\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.011\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.012\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.019\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the small intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.020\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.021\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.022\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.023\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.024\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.025\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.026\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.029\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the large intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.090\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.091\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.092\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.093\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.094\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the foregut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.095\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the midgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.096\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the hindgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.098\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.8\u003c/td\u003e\n              \u003ctd\u003eOther benign neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.00\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.01\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.02\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.20\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.21\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.22\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified urinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, supratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, infratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified parts of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified endocrine gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD45\u003c/td\u003e\n              \u003ctd\u003ePolycythemia vera\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.0\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia without ring sideroblasts, so stated\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.1\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with ring sideroblasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.20\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.21\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.22\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.4\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.9\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic syndrome, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.A\u003c/td\u003e\n              \u003ctd\u003eRefractory cytopenia with multilineage dysplasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.B\u003c/td\u003e\n              \u003ctd\u003eRefractory cytopenia with multilineage dysplasia and ring sideroblasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.C\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic syndrome with isolated del(5q) chromosomal abnormality\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.Z\u003c/td\u003e\n              \u003ctd\u003eOther myelodysplastic syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.0\u003c/td\u003e\n              \u003ctd\u003eMast cell neoplasms of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.01\u003c/td\u003e\n              \u003ctd\u003eCutaneous mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.02\u003c/td\u003e\n              \u003ctd\u003eSystemic mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.09\u003c/td\u003e\n              \u003ctd\u003eOther mast cell neoplasms of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.1\u003c/td\u003e\n              \u003ctd\u003eChronic myeloproliferative disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.2\u003c/td\u003e\n              \u003ctd\u003eMonoclonal gammopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.3\u003c/td\u003e\n              \u003ctd\u003eEssential (hemorrhagic) thrombocythemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.4\u003c/td\u003e\n              \u003ctd\u003eOsteomyelofibrosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z1\u003c/td\u003e\n              \u003ctd\u003ePost-transplant lymphoproliferative disorder (PTLD)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z2\u003c/td\u003e\n              \u003ctd\u003eCastleman disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z9\u003c/td\u003e\n              \u003ctd\u003eOther specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of bone and articular cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of connective and other soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of peripheral nerves and autonomic nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.60\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.61\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.62\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of bone, soft tissue, and skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other genitourinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.511\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.512\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.519\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.59\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other genitourinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of endocrine glands and other parts of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.81\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of retina and choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.89\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eE31.22\u003c/td\u003e\n              \u003ctd\u003eMultiple endocrine neoplasia [MEN] type IIA\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eE31.23\u003c/td\u003e\n              \u003ctd\u003eMultiple endocrine neoplasia [MEN] type IIB\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.601\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, not intractable, with status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.609\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, not intractable, without status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.611\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, intractable, with status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.619\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, intractable, without status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.0\u003c/td\u003e\n              \u003ctd\u003eVertebro-basilar artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.1\u003c/td\u003e\n              \u003ctd\u003eCarotid artery syndrome (hemispheric)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.2\u003c/td\u003e\n              \u003ctd\u003eMultiple and bilateral precerebral artery syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.3\u003c/td\u003e\n              \u003ctd\u003eAmaurosis fugax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.4\u003c/td\u003e\n              \u003ctd\u003eTransient global amnesia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.8\u003c/td\u003e\n              \u003ctd\u003eOther transient cerebral ischemic attacks and related syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.9\u003c/td\u003e\n              \u003ctd\u003eTransient cerebral ischemic attack, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.0\u003c/td\u003e\n              \u003ctd\u003eMiddle cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.1\u003c/td\u003e\n              \u003ctd\u003eAnterior cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.2\u003c/td\u003e\n              \u003ctd\u003ePosterior cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.3\u003c/td\u003e\n              \u003ctd\u003eBrain stem stroke syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.4\u003c/td\u003e\n              \u003ctd\u003eCerebellar stroke syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.5\u003c/td\u003e\n              \u003ctd\u003ePure motor lacunar syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.6\u003c/td\u003e\n              \u003ctd\u003ePure sensory lacunar syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.7\u003c/td\u003e\n              \u003ctd\u003eOther lacunar syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.8\u003c/td\u003e\n              \u003ctd\u003eOther vascular syndromes of brain in cerebrovascular diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG93.3\u003c/td\u003e\n              \u003ctd\u003ePostviral fatigue syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.0\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.1\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.2\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.8\u003c/td\u003e\n              \u003ctd\u003eOther acute rheumatic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.9\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI02.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic chorea with heart involvement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic mitral valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic aortic valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid stenosis and insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic tricuspid valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both mitral and aortic valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both mitral and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both aortic and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.3\u003c/td\u003e\n              \u003ctd\u003eCombined rheumatic disorders of mitral, aortic and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic multiple valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic multiple valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic diseases of endocardium, valve unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.2\u003c/td\u003e\n              \u003ctd\u003eChronic rheumatic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.81\u003c/td\u003e\n              \u003ctd\u003eRheumatic heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.89\u003c/td\u003e\n              \u003ctd\u003eOther specified rheumatic heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI10\u003c/td\u003e\n              \u003ctd\u003eEssential (primary) hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI11.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart disease with heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI11.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart disease without heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI12.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI12.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.10\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.11\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.2\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.0\u003c/td\u003e\n              \u003ctd\u003eRenovascular hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.1\u003c/td\u003e\n              \u003ctd\u003eHypertension secondary to other renal disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.2\u003c/td\u003e\n              \u003ctd\u003eHypertension secondary to endocrine disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.8\u003c/td\u003e\n              \u003ctd\u003eOther secondary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.9\u003c/td\u003e\n              \u003ctd\u003eSecondary hypertension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive urgency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.1\u003c/td\u003e\n              \u003ctd\u003eHypertensive emergency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive crisis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.0\u003c/td\u003e\n              \u003ctd\u003eUnstable angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.1\u003c/td\u003e\n              \u003ctd\u003eAngina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.9\u003c/td\u003e\n              \u003ctd\u003eAngina pectoris, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.01\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left main coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.02\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.09\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.11\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving right coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.19\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.21\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left circumflex coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.29\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.3\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.4\u003c/td\u003e\n              \u003ctd\u003eNon-ST elevation (NSTEMI) myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.9\u003c/td\u003e\n              \u003ctd\u003eAcute myocardial infarction, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.A1\u003c/td\u003e\n              \u003ctd\u003eMyocardial infarction type 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.A9\u003c/td\u003e\n              \u003ctd\u003eOther myocardial infarction type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.0\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of anterior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.1\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of inferior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.2\u003c/td\u003e\n              \u003ctd\u003eSubsequent non-ST elevation (NSTEMI) myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.8\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.9\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.0\u003c/td\u003e\n              \u003ctd\u003eHemopericardium as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.1\u003c/td\u003e\n              \u003ctd\u003eAtrial septal defect as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.2\u003c/td\u003e\n              \u003ctd\u003eVentricular septal defect as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.3\u003c/td\u003e\n              \u003ctd\u003eRupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.4\u003c/td\u003e\n              \u003ctd\u003eRupture of chordae tendineae as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.5\u003c/td\u003e\n              \u003ctd\u003eRupture of papillary muscle as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.6\u003c/td\u003e\n              \u003ctd\u003eThrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.7\u003c/td\u003e\n              \u003ctd\u003ePostinfarction angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.8\u003c/td\u003e\n              \u003ctd\u003eOther current complications following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.0\u003c/td\u003e\n              \u003ctd\u003eAcute coronary thrombosis not resulting in myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.1\u003c/td\u003e\n              \u003ctd\u003eDressler\u0027s syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of acute ischemic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.9\u003c/td\u003e\n              \u003ctd\u003eAcute ischemic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.10\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery without angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.110\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with unstable angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.111\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.118\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with other forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.119\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with unspecified angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.2\u003c/td\u003e\n              \u003ctd\u003eOld myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.3\u003c/td\u003e\n              \u003ctd\u003eAneurysm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.41\u003c/td\u003e\n              \u003ctd\u003eCoronary artery aneurysm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.42\u003c/td\u003e\n              \u003ctd\u003eCoronary artery dissection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.5\u003c/td\u003e\n              \u003ctd\u003eIschemic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.6\u003c/td\u003e\n              \u003ctd\u003eSilent myocardial ischemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.750\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with unstable angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.751\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.758\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.759\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.811\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart without angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.82\u003c/td\u003e\n              \u003ctd\u003eChronic total occlusion of coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.83\u003c/td\u003e\n              \u003ctd\u003eCoronary atherosclerosis due to lipid rich plaque\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.84\u003c/td\u003e\n              \u003ctd\u003eCoronary atherosclerosis due to calcified coronary lesion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.89\u003c/td\u003e\n              \u003ctd\u003eOther forms of chronic ischemic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.9\u003c/td\u003e\n              \u003ctd\u003eChronic ischemic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.01\u003c/td\u003e\n              \u003ctd\u003eSeptic pulmonary embolism with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.02\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of pulmonary artery with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.09\u003c/td\u003e\n              \u003ctd\u003eOther pulmonary embolism with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.90\u003c/td\u003e\n              \u003ctd\u003eSeptic pulmonary embolism without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.92\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of pulmonary artery without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.99\u003c/td\u003e\n              \u003ctd\u003eOther pulmonary embolism without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.0\u003c/td\u003e\n              \u003ctd\u003ePrimary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.1\u003c/td\u003e\n              \u003ctd\u003eKyphoscoliotic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.2\u003c/td\u003e\n              \u003ctd\u003eOther secondary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.20\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.21\u003c/td\u003e\n              \u003ctd\u003eSecondary pulmonary arterial hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.22\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension due to left heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.23\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension due to lung diseases and hypoxia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.24\u003c/td\u003e\n              \u003ctd\u003eChronic thromboembolic pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.29\u003c/td\u003e\n              \u003ctd\u003eOther secondary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.81\u003c/td\u003e\n              \u003ctd\u003eCor pulmonale (chronic)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.82\u003c/td\u003e\n              \u003ctd\u003eChronic pulmonary embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.83\u003c/td\u003e\n              \u003ctd\u003eEisenmenger\u0027s syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.89\u003c/td\u003e\n              \u003ctd\u003eOther specified pulmonary heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.9\u003c/td\u003e\n              \u003ctd\u003ePulmonary heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.0\u003c/td\u003e\n              \u003ctd\u003eArteriovenous fistula of pulmonary vessels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.1\u003c/td\u003e\n              \u003ctd\u003eAneurysm of pulmonary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.8\u003c/td\u003e\n              \u003ctd\u003eOther diseases of pulmonary vessels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.9\u003c/td\u003e\n              \u003ctd\u003eDisease of pulmonary vessels, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.0\u003c/td\u003e\n              \u003ctd\u003eAcute nonspecific idiopathic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.1\u003c/td\u003e\n              \u003ctd\u003eInfective pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of acute pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.9\u003c/td\u003e\n              \u003ctd\u003eAcute pericarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.0\u003c/td\u003e\n              \u003ctd\u003eChronic adhesive pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.1\u003c/td\u003e\n              \u003ctd\u003eChronic constrictive pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.2\u003c/td\u003e\n              \u003ctd\u003eHemopericardium, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.3\u003c/td\u003e\n              \u003ctd\u003ePericardial effusion (noninflammatory)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.4\u003c/td\u003e\n              \u003ctd\u003eCardiac tamponade\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.8\u003c/td\u003e\n              \u003ctd\u003eOther specified diseases of pericardium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.9\u003c/td\u003e\n              \u003ctd\u003eDisease of pericardium, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI32\u003c/td\u003e\n              \u003ctd\u003ePericarditis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI33.0\u003c/td\u003e\n              \u003ctd\u003eAcute and subacute infective endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI33.9\u003c/td\u003e\n              \u003ctd\u003eAcute and subacute endocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) prolapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic mitral valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic aortic valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic tricuspid valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic pulmonary valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI38\u003c/td\u003e\n              \u003ctd\u003eEndocarditis, valve unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI39\u003c/td\u003e\n              \u003ctd\u003eEndocarditis and heart valve disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.0\u003c/td\u003e\n              \u003ctd\u003eInfective myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.1\u003c/td\u003e\n              \u003ctd\u003eIsolated myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.8\u003c/td\u003e\n              \u003ctd\u003eOther acute myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.9\u003c/td\u003e\n              \u003ctd\u003eAcute myocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI41\u003c/td\u003e\n              \u003ctd\u003eMyocarditis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.0\u003c/td\u003e\n              \u003ctd\u003eDilated cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.1\u003c/td\u003e\n              \u003ctd\u003eObstructive hypertrophic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.2\u003c/td\u003e\n              \u003ctd\u003eOther hypertrophic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.3\u003c/td\u003e\n              \u003ctd\u003eEndomyocardial (eosinophilic) disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.4\u003c/td\u003e\n              \u003ctd\u003eEndocardial fibroelastosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.5\u003c/td\u003e\n              \u003ctd\u003eOther restrictive cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.7\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy due to drug and external agent\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.8\u003c/td\u003e\n              \u003ctd\u003eOther cardiomyopathies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.9\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI43\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.0\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, first degree\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.1\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, second degree\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.2\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, complete\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrioventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.39\u003c/td\u003e\n              \u003ctd\u003eOther atrioventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.4\u003c/td\u003e\n              \u003ctd\u003eLeft anterior fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.5\u003c/td\u003e\n              \u003ctd\u003eLeft posterior fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.60\u003c/td\u003e\n              \u003ctd\u003eUnspecified fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.69\u003c/td\u003e\n              \u003ctd\u003eOther fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.7\u003c/td\u003e\n              \u003ctd\u003eLeft bundle-branch block, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.0\u003c/td\u003e\n              \u003ctd\u003eRight fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified right bundle-branch block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.19\u003c/td\u003e\n              \u003ctd\u003eOther right bundle-branch block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.2\u003c/td\u003e\n              \u003ctd\u003eBifascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.3\u003c/td\u003e\n              \u003ctd\u003eTrifascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.4\u003c/td\u003e\n              \u003ctd\u003eNonspecific intraventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.5\u003c/td\u003e\n              \u003ctd\u003eOther specified heart block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.6\u003c/td\u003e\n              \u003ctd\u003ePre-excitation syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.81\u003c/td\u003e\n              \u003ctd\u003eLong QT syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.89\u003c/td\u003e\n              \u003ctd\u003eOther specified conduction disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.9\u003c/td\u003e\n              \u003ctd\u003eConduction disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.2\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest due to underlying cardiac condition\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.8\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest due to other underlying condition\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.9\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest, cause unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.0\u003c/td\u003e\n              \u003ctd\u003eRe-entry ventricular arrhythmia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.1\u003c/td\u003e\n              \u003ctd\u003eSupraventricular tachycardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.2\u003c/td\u003e\n              \u003ctd\u003eVentricular tachycardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.9\u003c/td\u003e\n              \u003ctd\u003eParoxysmal tachycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.0\u003c/td\u003e\n              \u003ctd\u003eParoxysmal atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.1\u003c/td\u003e\n              \u003ctd\u003ePersistent atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.2\u003c/td\u003e\n              \u003ctd\u003eChronic atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.3\u003c/td\u003e\n              \u003ctd\u003eTypical atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.4\u003c/td\u003e\n              \u003ctd\u003eAtypical atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.91\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.92\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.01\u003c/td\u003e\n              \u003ctd\u003eVentricular fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.02\u003c/td\u003e\n              \u003ctd\u003eVentricular flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.1\u003c/td\u003e\n              \u003ctd\u003eAtrial premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.2\u003c/td\u003e\n              \u003ctd\u003eJunctional premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.3\u003c/td\u003e\n              \u003ctd\u003eVentricular premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.49\u003c/td\u003e\n              \u003ctd\u003eOther premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.5\u003c/td\u003e\n              \u003ctd\u003eSick sinus syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.8\u003c/td\u003e\n              \u003ctd\u003eOther specified cardiac arrhythmias\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.9\u003c/td\u003e\n              \u003ctd\u003eCardiac arrhythmia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.1\u003c/td\u003e\n              \u003ctd\u003eLeft ventricular failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.20\u003c/td\u003e\n              \u003ctd\u003eUnspecified systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.21\u003c/td\u003e\n              \u003ctd\u003eAcute systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.22\u003c/td\u003e\n              \u003ctd\u003eChronic systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.23\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.31\u003c/td\u003e\n              \u003ctd\u003eAcute diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.32\u003c/td\u003e\n              \u003ctd\u003eChronic diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.33\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.41\u003c/td\u003e\n              \u003ctd\u003eAcute combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.42\u003c/td\u003e\n              \u003ctd\u003eChronic combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.43\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.810\u003c/td\u003e\n              \u003ctd\u003eRight heart failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.811\u003c/td\u003e\n              \u003ctd\u003eAcute right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.812\u003c/td\u003e\n              \u003ctd\u003eChronic right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.813\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.814\u003c/td\u003e\n              \u003ctd\u003eRight heart failure due to left heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.82\u003c/td\u003e\n              \u003ctd\u003eBiventricular heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.83\u003c/td\u003e\n              \u003ctd\u003eHigh output heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.84\u003c/td\u003e\n              \u003ctd\u003eEnd stage heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.89\u003c/td\u003e\n              \u003ctd\u003eOther heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.9\u003c/td\u003e\n              \u003ctd\u003eHeart failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.0\u003c/td\u003e\n              \u003ctd\u003eCardiac septal defect, acquired\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.1\u003c/td\u003e\n              \u003ctd\u003eRupture of chordae tendineae, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.2\u003c/td\u003e\n              \u003ctd\u003eRupture of papillary muscle, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.3\u003c/td\u003e\n              \u003ctd\u003eIntracardiac thrombosis, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.4\u003c/td\u003e\n              \u003ctd\u003eMyocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.5\u003c/td\u003e\n              \u003ctd\u003eMyocardial degeneration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.7\u003c/td\u003e\n              \u003ctd\u003eCardiomegaly\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.81\u003c/td\u003e\n              \u003ctd\u003eTakotsubo syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.89\u003c/td\u003e\n              \u003ctd\u003eOther ill-defined heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.9\u003c/td\u003e\n              \u003ctd\u003eHeart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI52\u003c/td\u003e\n              \u003ctd\u003eOther heart disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.00\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.01\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.02\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.10\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.11\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.12\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.2\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from anterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.30\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.31\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.32\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.4\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.50\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.51\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.52\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.6\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from other intracranial arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.7\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified intracranial artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.8\u003c/td\u003e\n              \u003ctd\u003eOther nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.0\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, subcortical\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.1\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, cortical\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.2\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.3\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in brain stem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.4\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in cerebellum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.5\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, intraventricular\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.6\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, multiple localized\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.8\u003c/td\u003e\n              \u003ctd\u003eOther nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.00\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subdural hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.01\u003c/td\u003e\n              \u003ctd\u003eNontraumatic acute subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.02\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subacute subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.03\u003c/td\u003e\n              \u003ctd\u003eNontraumatic chronic subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.1\u003c/td\u003e\n              \u003ctd\u003eNontraumatic extradural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracranial hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.00\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.011\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.012\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.013\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.019\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.02\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.031\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.032\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.033\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.039\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.09\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of other precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.10\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.111\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.112\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.113\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.119\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.12\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.131\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.132\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.133\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.139\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.19\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of other precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.20\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.211\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.212\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.213\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.219\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.22\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.231\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.232\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.233\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.239\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.29\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.30\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.311\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.312\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.313\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.319\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.321\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.322\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.323\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.329\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.331\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.332\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.333\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.339\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.341\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.342\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.343\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.349\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.39\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.40\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.411\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.412\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.413\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.419\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.421\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.422\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.423\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.429\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.431\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.432\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.433\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.439\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.441\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.442\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.443\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.449\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.49\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.50\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.511\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.512\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.513\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.519\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.521\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.522\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.523\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.529\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.531\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.532\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.533\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.539\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.541\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.542\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.543\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.549\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.59\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.6\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to cerebral venous thrombosis, nonpyogenic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.8\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.81\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction due to occlusion or stenosis of small artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.89\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.9\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.01\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.02\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.03\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.09\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.1\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.21\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.22\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.23\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.29\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.8\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.9\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.01\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.02\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.03\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.09\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.11\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.12\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.13\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.19\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.21\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.22\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.23\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.29\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.3\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.8\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of other cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.9\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.0\u003c/td\u003e\n              \u003ctd\u003eDissection of cerebral arteries, nonruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.1\u003c/td\u003e\n              \u003ctd\u003eCerebral aneurysm, nonruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.2\u003c/td\u003e\n              \u003ctd\u003eCerebral atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.4\u003c/td\u003e\n              \u003ctd\u003eHypertensive encephalopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.5\u003c/td\u003e\n              \u003ctd\u003eMoyamoya disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.6\u003c/td\u003e\n              \u003ctd\u003eNonpyogenic thrombosis of intracranial venous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.7\u003c/td\u003e\n              \u003ctd\u003eCerebral arteritis, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.81\u003c/td\u003e\n              \u003ctd\u003eAcute cerebrovascular insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.82\u003c/td\u003e\n              \u003ctd\u003eCerebral ischemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.83\u003c/td\u003e\n              \u003ctd\u003ePosterior reversible encephalopathy syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.841\u003c/td\u003e\n              \u003ctd\u003eReversible cerebrovascular vasoconstriction syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.848\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular vasospasm and vasoconstriction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.850\u003c/td\u003e\n              \u003ctd\u003eCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.858\u003c/td\u003e\n              \u003ctd\u003eOther hereditary cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.89\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.9\u003c/td\u003e\n              \u003ctd\u003eCerebrovascular disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.0\u003c/td\u003e\n              \u003ctd\u003eCerebral amyloid angiopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.2\u003c/td\u003e\n              \u003ctd\u003eCerebral arteritis in other diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.8\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.00\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.01\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.010\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.011\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.012\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.013\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.014\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.015\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.018\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.019\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.020\u003c/td\u003e\n              \u003ctd\u003eAphasia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.021\u003c/td\u003e\n              \u003ctd\u003eDysphasia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.022\u003c/td\u003e\n              \u003ctd\u003eDysarthria following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.023\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.028\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.031\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.032\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.033\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.034\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.039\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.041\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.042\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.043\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.044\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.049\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.051\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.052\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.053\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.054\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.059\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.061\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.062\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.063\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.064\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.065\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.069\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.090\u003c/td\u003e\n              \u003ctd\u003eApraxia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.091\u003c/td\u003e\n              \u003ctd\u003eDysphagia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.092\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.093\u003c/td\u003e\n              \u003ctd\u003eAtaxia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.098\u003c/td\u003e\n              \u003ctd\u003eOther sequelae following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.11\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.110\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.111\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.112\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.113\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.114\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.115\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.118\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.119\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.120\u003c/td\u003e\n              \u003ctd\u003eAphasia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.121\u003c/td\u003e\n              \u003ctd\u003eDysphasia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.122\u003c/td\u003e\n              \u003ctd\u003eDysarthria following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.123\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.128\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.131\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.132\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.133\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.134\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.139\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.141\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.142\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.143\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.144\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.149\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.151\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.152\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.153\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.154\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.159\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.161\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.162\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.163\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.164\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.165\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.169\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.190\u003c/td\u003e\n              \u003ctd\u003eApraxia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.191\u003c/td\u003e\n              \u003ctd\u003eDysphagia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.192\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.193\u003c/td\u003e\n              \u003ctd\u003eAtaxia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.198\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.20\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.21\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.210\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.211\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.212\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.213\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.214\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.215\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.218\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.219\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.220\u003c/td\u003e\n              \u003ctd\u003eAphasia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.221\u003c/td\u003e\n              \u003ctd\u003eDysphasia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.222\u003c/td\u003e\n              \u003ctd\u003eDysarthria following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.223\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.228\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.231\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.232\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.233\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.234\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.239\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.241\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.242\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.243\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.244\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.249\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.251\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.252\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.253\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.254\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.259\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.261\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.262\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.263\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.264\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.265\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.269\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.290\u003c/td\u003e\n              \u003ctd\u003eApraxia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.291\u003c/td\u003e\n              \u003ctd\u003eDysphagia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.292\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.293\u003c/td\u003e\n              \u003ctd\u003eAtaxia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.298\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.31\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.310\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.311\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.312\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.313\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.314\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.315\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.318\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.319\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.320\u003c/td\u003e\n              \u003ctd\u003eAphasia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.321\u003c/td\u003e\n              \u003ctd\u003eDysphasia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.322\u003c/td\u003e\n              \u003ctd\u003eDysarthria following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.323\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.328\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.331\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.332\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.333\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.334\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.339\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.341\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.342\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.343\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.344\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.349\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.351\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.352\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.353\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.354\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.359\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.361\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.362\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.363\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.364\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.365\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.369\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.390\u003c/td\u003e\n              \u003ctd\u003eApraxia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.391\u003c/td\u003e\n              \u003ctd\u003eDysphagia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.392\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.393\u003c/td\u003e\n              \u003ctd\u003eAtaxia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.398\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.80\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.81\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.810\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.811\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.812\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.813\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.814\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.815\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.818\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.819\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.820\u003c/td\u003e\n              \u003ctd\u003eAphasia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.821\u003c/td\u003e\n              \u003ctd\u003eDysphasia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.822\u003c/td\u003e\n              \u003ctd\u003eDysarthria following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.823\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.828\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.831\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.832\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.833\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.834\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.839\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.841\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.842\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.843\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.844\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.849\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.851\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.852\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.853\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.854\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.859\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.861\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.862\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.863\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.864\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.865\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.869\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.890\u003c/td\u003e\n              \u003ctd\u003eApraxia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.891\u003c/td\u003e\n              \u003ctd\u003eDysphagia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.892\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.893\u003c/td\u003e\n              \u003ctd\u003eAtaxia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.898\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.91\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.910\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.911\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.912\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.913\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.914\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.915\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.918\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.919\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.920\u003c/td\u003e\n              \u003ctd\u003eAphasia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.921\u003c/td\u003e\n              \u003ctd\u003eDysphasia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.922\u003c/td\u003e\n              \u003ctd\u003eDysarthria following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.923\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.928\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.931\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.932\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.933\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.934\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.939\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.941\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.942\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.943\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.944\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.949\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.951\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.952\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.953\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.954\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.959\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.961\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.962\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.963\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.964\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.965\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.969\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.990\u003c/td\u003e\n              \u003ctd\u003eApraxia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.991\u003c/td\u003e\n              \u003ctd\u003eDysphagia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.992\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.993\u003c/td\u003e\n              \u003ctd\u003eAtaxia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.998\u003c/td\u003e\n              \u003ctd\u003eOther sequelae following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.0\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.1\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.201\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.202\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.203\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.208\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.209\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.211\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.212\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.213\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.218\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.219\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.221\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.222\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.223\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.228\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.229\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.231\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.232\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.233\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.234\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.235\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.238\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.239\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.241\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.242\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.243\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.244\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.245\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.248\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.249\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.25\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of other extremities with ulceration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.261\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.262\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.263\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.268\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.269\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.291\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.292\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.293\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.298\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.299\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.8\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of other arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.91\u003c/td\u003e\n              \u003ctd\u003eGeneralized atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.92\u003c/td\u003e\n              \u003ctd\u003eChronic total occlusion of artery of the extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.00\u003c/td\u003e\n              \u003ctd\u003eDissection of unspecified site of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.01\u003c/td\u003e\n              \u003ctd\u003eDissection of thoracic aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.02\u003c/td\u003e\n              \u003ctd\u003eDissection of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.03\u003c/td\u003e\n              \u003ctd\u003eDissection of thoracoabdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.1\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.2\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.3\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.4\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.5\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.6\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.8\u003c/td\u003e\n              \u003ctd\u003eAortic aneurysm of unspecified site, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.9\u003c/td\u003e\n              \u003ctd\u003eAortic aneurysm of unspecified site, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.0\u003c/td\u003e\n              \u003ctd\u003eAneurysm of carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.1\u003c/td\u003e\n              \u003ctd\u003eAneurysm of artery of upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.2\u003c/td\u003e\n              \u003ctd\u003eAneurysm of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.3\u003c/td\u003e\n              \u003ctd\u003eAneurysm of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.4\u003c/td\u003e\n              \u003ctd\u003eAneurysm of artery of lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.5\u003c/td\u003e\n              \u003ctd\u003eAneurysm of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.6\u003c/td\u003e\n              \u003ctd\u003eAneurysm of vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.8\u003c/td\u003e\n              \u003ctd\u003eAneurysm of other specified arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.9\u003c/td\u003e\n              \u003ctd\u003eAneurysm of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.00\u003c/td\u003e\n              \u003ctd\u003eRaynaud\u0027s syndrome without gangrene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.01\u003c/td\u003e\n              \u003ctd\u003eRaynaud\u0027s syndrome with gangrene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.1\u003c/td\u003e\n              \u003ctd\u003eThromboangiitis obliterans [Buerger\u0027s disease]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.81\u003c/td\u003e\n              \u003ctd\u003eErythromelalgia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.89\u003c/td\u003e\n              \u003ctd\u003eOther specified peripheral vascular diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.9\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.01\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.09\u003c/td\u003e\n              \u003ctd\u003eOther arterial embolism and thrombosis of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.10\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of unspecified parts of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.11\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of thoracic aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.19\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of other parts of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.2\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of the upper extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.3\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of the lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.4\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of extremities, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.5\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.8\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of other arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.9\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of unspecified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.011\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.012\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.013\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of bilateral upper extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.019\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.021\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.022\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.023\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of bilateral lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.029\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.81\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.89\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of other site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.0\u003c/td\u003e\n              \u003ctd\u003eArteriovenous fistula, acquired\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.1\u003c/td\u003e\n              \u003ctd\u003eStricture of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.2\u003c/td\u003e\n              \u003ctd\u003eRupture of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.3\u003c/td\u003e\n              \u003ctd\u003eArterial fibromuscular dysplasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.4\u003c/td\u003e\n              \u003ctd\u003eCeliac artery compression syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.5\u003c/td\u003e\n              \u003ctd\u003eNecrosis of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.6\u003c/td\u003e\n              \u003ctd\u003eArteritis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.70\u003c/td\u003e\n              \u003ctd\u003eDissection of unspecified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.71\u003c/td\u003e\n              \u003ctd\u003eDissection of carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.72\u003c/td\u003e\n              \u003ctd\u003eDissection of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.73\u003c/td\u003e\n              \u003ctd\u003eDissection of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.74\u003c/td\u003e\n              \u003ctd\u003eDissection of vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.75\u003c/td\u003e\n              \u003ctd\u003eDissection of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.76\u003c/td\u003e\n              \u003ctd\u003eDissection of artery of upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.77\u003c/td\u003e\n              \u003ctd\u003eDissection of artery of lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.79\u003c/td\u003e\n              \u003ctd\u003eDissection of other specified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.810\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.811\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.812\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.819\u003c/td\u003e\n              \u003ctd\u003eAortic ectasia, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.89\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of arteries and arterioles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of arteries and arterioles, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.0\u003c/td\u003e\n              \u003ctd\u003eHereditary hemorrhagic telangiectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.1\u003c/td\u003e\n              \u003ctd\u003eNevus, non-neoplastic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.8\u003c/td\u003e\n              \u003ctd\u003eOther diseases of capillaries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.9\u003c/td\u003e\n              \u003ctd\u003eDisease of capillaries, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.0\u003c/td\u003e\n              \u003ctd\u003eAneurysm of aorta in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.1\u003c/td\u003e\n              \u003ctd\u003eAortitis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.8\u003c/td\u003e\n              \u003ctd\u003eOther disorders of arteries, arterioles and capillaries in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.00\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.01\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.02\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.03\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.10\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.11\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.12\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.13\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.201\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.202\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.203\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.209\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.211\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.212\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.213\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.219\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.221\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.222\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.223\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.229\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.231\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.232\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.233\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.239\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.291\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.292\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.293\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.299\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.3\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of lower extremities, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.8\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.9\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI81\u003c/td\u003e\n              \u003ctd\u003ePortal vein thrombosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.0\u003c/td\u003e\n              \u003ctd\u003eBudd-Chiari syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.1\u003c/td\u003e\n              \u003ctd\u003eThrombophlebitis migrans\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.210\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.211\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.220\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of inferior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.221\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of inferior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.290\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other thoracic veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.291\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other thoracic veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.3\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of renal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.401\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.402\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.403\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.409\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.411\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.412\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.413\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.419\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.421\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.422\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.423\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.429\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.431\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.432\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.433\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.439\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.441\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.442\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.443\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.449\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.491\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.492\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.493\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.499\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y1\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y2\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y3\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y9\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z1\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z2\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z3\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z9\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.501\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.502\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.503\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.509\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.511\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.512\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.513\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.519\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.521\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.522\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.523\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.529\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.531\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.532\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.533\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.539\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.541\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.542\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.543\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.549\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.591\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.592\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.593\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.599\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y1\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y2\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y3\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y9\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z1\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z2\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z3\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z9\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.601\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.602\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.603\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.609\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.611\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.612\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.613\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.619\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.621\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.622\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.623\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.629\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.701\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.702\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.703\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.709\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.711\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.712\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.713\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.719\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.721\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.722\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.723\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.729\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.811\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.812\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.813\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.819\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.890\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.891\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.90\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.91\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of axillary vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of axillary vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of subclavian vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of subclavian vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of internal jugular vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of internal jugular vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.001\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.002\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.003\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.004\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.005\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.008\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.009\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.011\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.012\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.013\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.014\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.015\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.018\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.019\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.021\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.022\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.023\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.024\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.025\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.028\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.029\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.10\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.11\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.12\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.201\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.202\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.203\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.204\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.205\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.208\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.209\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.211\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.212\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.213\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.214\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.215\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.218\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.219\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.221\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.222\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.223\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.224\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.225\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.228\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.229\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.811\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.812\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.813\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of bilateral lower extremities with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.819\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.891\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.892\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.893\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of bilateral lower extremities with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.899\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.90\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.91\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.92\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.93\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of bilateral lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.0\u003c/td\u003e\n              \u003ctd\u003eSublingual varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.1\u003c/td\u003e\n              \u003ctd\u003eScrotal varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.2\u003c/td\u003e\n              \u003ctd\u003ePelvic varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.3\u003c/td\u003e\n              \u003ctd\u003eVulval varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.4\u003c/td\u003e\n              \u003ctd\u003eGastric varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.8\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.001\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.002\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.003\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.009\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.011\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.012\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.013\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.019\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.021\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.022\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.023\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.029\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.031\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.032\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.033\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.039\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.091\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.092\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.093\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.099\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.1\u003c/td\u003e\n              \u003ctd\u003eCompression of vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.2\u003c/td\u003e\n              \u003ctd\u003eVenous insufficiency (chronic) (peripheral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.301\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.302\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.303\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.309\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.311\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.312\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.313\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.319\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.321\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.322\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.323\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.329\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.331\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.332\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.333\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.339\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.391\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.392\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.393\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.399\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.8\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of vein, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.0\u003c/td\u003e\n              \u003ctd\u003eNonspecific mesenteric lymphadenitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.1\u003c/td\u003e\n              \u003ctd\u003eChronic lymphadenitis, except mesenteric\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.8\u003c/td\u003e\n              \u003ctd\u003eOther nonspecific lymphadenitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.9\u003c/td\u003e\n              \u003ctd\u003eNonspecific lymphadenitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.0\u003c/td\u003e\n              \u003ctd\u003eLymphedema, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.1\u003c/td\u003e\n              \u003ctd\u003eLymphangitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.8\u003c/td\u003e\n              \u003ctd\u003eOther specified noninfective disorders of lymphatic vessels and lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.9\u003c/td\u003e\n              \u003ctd\u003eNoninfective disorder of lymphatic vessels and lymph nodes, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.0\u003c/td\u003e\n              \u003ctd\u003eIdiopathic hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.1\u003c/td\u003e\n              \u003ctd\u003eOrthostatic hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.89\u003c/td\u003e\n              \u003ctd\u003eOther hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.9\u003c/td\u003e\n              \u003ctd\u003eHypotension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI96\u003c/td\u003e\n              \u003ctd\u003eGangrene, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI99.8\u003c/td\u003e\n              \u003ctd\u003eOther disorder of circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI99.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified disorder of circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ10.82\u003c/td\u003e\n              \u003ctd\u003eInfluenza due to other identified influenza virus with myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ30.5\u003c/td\u003e\n              \u003ctd\u003eAllergic rhinitis due to food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ85.0\u003c/td\u003e\n              \u003ctd\u003eGangrene and necrosis of lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ91.0\u003c/td\u003e\n              \u003ctd\u003eMalignant pleural effusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK31.7\u003c/td\u003e\n              \u003ctd\u003ePolyp of stomach and duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.2\u003c/td\u003e\n              \u003ctd\u003eAllergic and dietetic gastroenteritis and colitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.21\u003c/td\u003e\n              \u003ctd\u003eFood protein-induced enterocolitis syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.22\u003c/td\u003e\n              \u003ctd\u003eFood protein-induced enteropathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.29\u003c/td\u003e\n              \u003ctd\u003eOther allergic and dietetic gastroenteritis and colitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.0\u003c/td\u003e\n              \u003ctd\u003eAcute vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.011\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.012\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.019\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of small intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.021\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.022\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.029\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of small intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.031\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.032\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.039\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of large intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.041\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.042\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.049\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of large intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.051\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.052\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.059\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of intestine, part and extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.061\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.062\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.069\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of intestine, part and extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.1\u003c/td\u003e\n              \u003ctd\u003eChronic vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.8\u003c/td\u003e\n              \u003ctd\u003eOther vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.9\u003c/td\u003e\n              \u003ctd\u003eVascular disorder of intestine, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK63.5\u003c/td\u003e\n              \u003ctd\u003ePolyp of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.0\u003c/td\u003e\n              \u003ctd\u003eFirst degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.1\u003c/td\u003e\n              \u003ctd\u003eSecond degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.2\u003c/td\u003e\n              \u003ctd\u003eThird degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.3\u003c/td\u003e\n              \u003ctd\u003eFourth degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.4\u003c/td\u003e\n              \u003ctd\u003eResidual hemorrhoidal skin tags\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.5\u003c/td\u003e\n              \u003ctd\u003ePerianal venous thrombosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.8\u003c/td\u003e\n              \u003ctd\u003eOther hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK90.41\u003c/td\u003e\n              \u003ctd\u003eNon-celiac gluten sensitivity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.0\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of face, head and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.1\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.2\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.3\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.8\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.9\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.0\u003c/td\u003e\n              \u003ctd\u003eBesnier\u0027s prurigo\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.81\u003c/td\u003e\n              \u003ctd\u003eAtopic neurodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.82\u003c/td\u003e\n              \u003ctd\u003eFlexural eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.83\u003c/td\u003e\n              \u003ctd\u003eInfantile (acute) (chronic) eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.84\u003c/td\u003e\n              \u003ctd\u003eIntrinsic (allergic) eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.89\u003c/td\u003e\n              \u003ctd\u003eOther atopic dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.9\u003c/td\u003e\n              \u003ctd\u003eAtopic dermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL22\u003c/td\u003e\n              \u003ctd\u003eDiaper dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.0\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to metals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.1\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to adhesives\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.2\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.3\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.4\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to dyes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.5\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.6\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to food in contact with the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.7\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.81\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to animal (cat) (dog) dander\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.89\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.9\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.0\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to detergents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.1\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to oils and greases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.2\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to solvents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.3\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.4\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.5\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.6\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to food in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.7\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.81\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to metals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.89\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.9\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.0\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.1\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.2\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to dyes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.3\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.4\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to food in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.5\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.8\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.0\u003c/td\u003e\n              \u003ctd\u003eGeneralized skin eruption due to drugs and medicaments taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.1\u003c/td\u003e\n              \u003ctd\u003eLocalized skin eruption due to drugs and medicaments taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.2\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to ingested food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.8\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to other substances taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.9\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to unspecified substance taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.0\u003c/td\u003e\n              \u003ctd\u003eNummular dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.2\u003c/td\u003e\n              \u003ctd\u003eCutaneous autosensitization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.8\u003c/td\u003e\n              \u003ctd\u003eOther specified dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.9\u003c/td\u003e\n              \u003ctd\u003eDermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.0\u003c/td\u003e\n              \u003ctd\u003eAllergic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.1\u003c/td\u003e\n              \u003ctd\u003eIdiopathic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.2\u003c/td\u003e\n              \u003ctd\u003eUrticaria due to cold and heat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.3\u003c/td\u003e\n              \u003ctd\u003eDermatographic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.4\u003c/td\u003e\n              \u003ctd\u003eVibratory urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.5\u003c/td\u003e\n              \u003ctd\u003eCholinergic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.6\u003c/td\u003e\n              \u003ctd\u003eContact urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.8\u003c/td\u003e\n              \u003ctd\u003eOther urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.9\u003c/td\u003e\n              \u003ctd\u003eUrticaria, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.0\u003c/td\u003e\n              \u003ctd\u003eDrug phototoxic response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.1\u003c/td\u003e\n              \u003ctd\u003eDrug photoallergic response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.2\u003c/td\u003e\n              \u003ctd\u003ePhotocontact dermatitis [berloque dermatitis]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.3\u003c/td\u003e\n              \u003ctd\u003eSolar urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.4\u003c/td\u003e\n              \u003ctd\u003ePolymorphous light eruption\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.8\u003c/td\u003e\n              \u003ctd\u003eOther specified acute skin changes due to ultraviolet radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.9\u003c/td\u003e\n              \u003ctd\u003eAcute skin change due to ultraviolet radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL57.8\u003c/td\u003e\n              \u003ctd\u003eOther skin changes due to chronic exposure to nonionizing radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL57.9\u003c/td\u003e\n              \u003ctd\u003eSkin changes due to chronic exposure to nonionizing radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.0\u003c/td\u003e\n              \u003ctd\u003eAcute radiodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.1\u003c/td\u003e\n              \u003ctd\u003eChronic radiodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.9\u003c/td\u003e\n              \u003ctd\u003eRadiodermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.0\u003c/td\u003e\n              \u003ctd\u003eErythema ab igne [dermatitis ab igne]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.8\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of the skin and subcutaneous tissue related to radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of the skin and subcutaneous tissue related to radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eM31.0\u003c/td\u003e\n              \u003ctd\u003eHypersensitivity angiitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eN26.2\u003c/td\u003e\n              \u003ctd\u003ePage kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.0\u003c/td\u003e\n              \u003ctd\u003eTachycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.1\u003c/td\u003e\n              \u003ctd\u003eBradycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.2\u003c/td\u003e\n              \u003ctd\u003ePalpitations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormalities of heart beat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormalities of heart beat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.0\u003c/td\u003e\n              \u003ctd\u003eBenign and innocent cardiac murmurs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.1\u003c/td\u003e\n              \u003ctd\u003eCardiac murmur, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.2\u003c/td\u003e\n              \u003ctd\u003eOther cardiac sounds\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR03.0\u003c/td\u003e\n              \u003ctd\u003eElevated blood-pressure reading, without diagnosis of hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR03.1\u003c/td\u003e\n              \u003ctd\u003eNonspecific low blood-pressure reading\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.2\u003c/td\u003e\n              \u003ctd\u003ePrecordial pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.82\u003c/td\u003e\n              \u003ctd\u003eIntercostal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.89\u003c/td\u003e\n              \u003ctd\u003eOther chest pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.9\u003c/td\u003e\n              \u003ctd\u003eChest pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR09.89\u003c/td\u003e\n              \u003ctd\u003eOther specified symptoms and signs involving the circulatory and respiratory systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.0\u003c/td\u003e\n              \u003ctd\u003eAcute abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.10\u003c/td\u003e\n              \u003ctd\u003eUpper abdominal pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.11\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.12\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.13\u003c/td\u003e\n              \u003ctd\u003eEpigastric pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.2\u003c/td\u003e\n              \u003ctd\u003ePelvic and perineal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.30\u003c/td\u003e\n              \u003ctd\u003eLower abdominal pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.31\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.32\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.33\u003c/td\u003e\n              \u003ctd\u003ePeriumbilical pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.811\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.812\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.813\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.814\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.815\u003c/td\u003e\n              \u003ctd\u003ePeriumbilic abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.816\u003c/td\u003e\n              \u003ctd\u003eEpigastric abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.817\u003c/td\u003e\n              \u003ctd\u003eGeneralized abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.819\u003c/td\u003e\n              \u003ctd\u003eAbdominal tenderness, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.821\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.822\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.823\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.824\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.825\u003c/td\u003e\n              \u003ctd\u003ePeriumbilic rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.826\u003c/td\u003e\n              \u003ctd\u003eEpigastric rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.827\u003c/td\u003e\n              \u003ctd\u003eGeneralized rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.829\u003c/td\u003e\n              \u003ctd\u003eRebound abdominal tenderness, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.84\u003c/td\u003e\n              \u003ctd\u003eGeneralized abdominal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abdominal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.0\u003c/td\u003e\n              \u003ctd\u003eNausea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.10\u003c/td\u003e\n              \u003ctd\u003eVomiting, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.11\u003c/td\u003e\n              \u003ctd\u003eVomiting without nausea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.12\u003c/td\u003e\n              \u003ctd\u003eProjectile vomiting\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.14\u003c/td\u003e\n              \u003ctd\u003eBilious vomiting\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.2\u003c/td\u003e\n              \u003ctd\u003eNausea with vomiting, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR18.0\u003c/td\u003e\n              \u003ctd\u003eMalignant ascites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.700\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 0\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.701\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.702\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.703\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 3\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.704\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 4\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.705\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 5\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.706\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.707\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 7\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.708\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 8\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.709\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 9\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.710\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 10\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.711\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 11\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.712\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.713\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 13\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.714\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 14\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.715\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 15\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.716\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 16\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.717\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 17\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.718\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 18\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.719\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 19\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.720\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 20\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.721\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 21\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.722\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 22\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.723\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 23\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.724\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 24\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.725\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 25\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.726\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 26\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.727\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 27\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.728\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 28\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.729\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 29\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.730\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 30\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.731\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 31\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.732\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 32\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.733\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 33\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.734\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 34\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.735\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 35\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.736\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 36\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.737\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 37\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.738\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 38\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.739\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 39\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.740\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 40\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.741\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 41\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.742\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 42\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR50.81\u003c/td\u003e\n              \u003ctd\u003eFever presenting with conditions classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR50.9\u003c/td\u003e\n              \u003ctd\u003eFever, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.0\u003c/td\u003e\n              \u003ctd\u003eNeoplastic (malignant) related fatigue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.1\u003c/td\u003e\n              \u003ctd\u003eWeakness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.81\u003c/td\u003e\n              \u003ctd\u003eOther malaise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.82\u003c/td\u003e\n              \u003ctd\u003eChronic fatigue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.83\u003c/td\u003e\n              \u003ctd\u003eOther fatigue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR55\u003c/td\u003e\n              \u003ctd\u003eSyncope and collapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.0\u003c/td\u003e\n              \u003ctd\u003eCardiogenic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.1\u003c/td\u003e\n              \u003ctd\u003eHypovolemic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.8\u003c/td\u003e\n              \u003ctd\u003eOther shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.9\u003c/td\u003e\n              \u003ctd\u003eShock, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR58\u003c/td\u003e\n              \u003ctd\u003eHemorrhage, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.0\u003c/td\u003e\n              \u003ctd\u003eLocalized enlarged lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.1\u003c/td\u003e\n              \u003ctd\u003eGeneralized enlarged lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.9\u003c/td\u003e\n              \u003ctd\u003eEnlarged lymph nodes, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR65.21\u003c/td\u003e\n              \u003ctd\u003eSevere sepsis with septic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.71\u003c/td\u003e\n              \u003ctd\u003eAbnormal lead level in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.79\u003c/td\u003e\n              \u003ctd\u003eFinding of abnormal level of heavy metals in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.89\u003c/td\u003e\n              \u003ctd\u003eFinding of other specified substances, not normally found in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.9\u003c/td\u003e\n              \u003ctd\u003eFinding of unspecified substance, not normally found in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of blood mineral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal coagulation profile\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.81\u003c/td\u003e\n              \u003ctd\u003eAbnormal blood-gas level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.82\u003c/td\u003e\n              \u003ctd\u003eElevated C-reactive protein (CRP)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.89\u003c/td\u003e\n              \u003ctd\u003eOther specified abnormal findings of blood chemistry\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.9\u003c/td\u003e\n              \u003ctd\u003eAbnormal finding of blood chemistry, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.610\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.611\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.612\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.613\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.614\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.615\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.616\u003c/td\u003e\n              \u003ctd\u003eSatisfactory anal smear but lacking transformation zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.618\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.619\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.69\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.610\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.611\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.612\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.613\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.614\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.615\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.616\u003c/td\u003e\n              \u003ctd\u003eSatisfactory cervical smear but lacking transformation zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.618\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.619\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.620\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.621\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.622\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.623\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.624\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.625\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.628\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.629\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.69\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR88.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings in other body fluids and substances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR90.81\u003c/td\u003e\n              \u003ctd\u003eAbnormal echoencephalogram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR90.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings on diagnostic imaging of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR92.2\u003c/td\u003e\n              \u003ctd\u003eInconclusive mammogram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR92.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal and inconclusive findings on diagnostic imaging of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of skull and head, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of heart and coronary circulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of liver and biliary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other parts of digestive tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.41\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.421\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.422\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.429\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.49\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of limbs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other parts of musculoskeletal system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other specified body structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.811\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of right testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.812\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of left testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.813\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of testicles, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.819\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of unspecified testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.89\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other specified body structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.9\u003c/td\u003e\n              \u003ctd\u003eDiagnostic imaging inconclusive due to excess body fat of patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.01\u003c/td\u003e\n              \u003ctd\u003eAbnormal electroencephalogram [EEG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.02\u003c/td\u003e\n              \u003ctd\u003eAbnormal brain scan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.09\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.110\u003c/td\u003e\n              \u003ctd\u003eAbnormal electro-oculogram [EOG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.111\u003c/td\u003e\n              \u003ctd\u003eAbnormal electroretinogram [ERG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.112\u003c/td\u003e\n              \u003ctd\u003eAbnormal visually evoked potential [VEP]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.113\u003c/td\u003e\n              \u003ctd\u003eAbnormal oculomotor study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.118\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.120\u003c/td\u003e\n              \u003ctd\u003eAbnormal auditory function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.121\u003c/td\u003e\n              \u003ctd\u003eAbnormal vestibular function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.128\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of ear and other special senses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.130\u003c/td\u003e\n              \u003ctd\u003eAbnormal response to nerve stimulation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.131\u003c/td\u003e\n              \u003ctd\u003eAbnormal electromyogram [EMG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.138\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of peripheral nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of pulmonary function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.30\u003c/td\u003e\n              \u003ctd\u003eAbnormal result of cardiovascular function study, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.31\u003c/td\u003e\n              \u003ctd\u003eAbnormal electrocardiogram [ECG] [EKG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.39\u003c/td\u003e\n              \u003ctd\u003eAbnormal result of other cardiovascular function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of kidney function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of liver function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of thyroid function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other endocrine function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of function studies of other organs and systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.0\u003c/td\u003e\n              \u003ctd\u003eElevated carcinoembryonic antigen [CEA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.1\u003c/td\u003e\n              \u003ctd\u003eElevated cancer antigen 125 [CA 125]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.2\u003c/td\u003e\n              \u003ctd\u003eElevated prostate specific antigen [PSA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.20\u003c/td\u003e\n              \u003ctd\u003eElevated prostate specific antigen [PSA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.21\u003c/td\u003e\n              \u003ctd\u003eRising PSA following treatment for malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal tumor markers\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXA\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXD\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXS\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.2XXA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic shock, unspecified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.40XA\u003c/td\u003e\n              \u003ctd\u003eAllergy, unspecified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.49XA\u003c/td\u003e\n              \u003ctd\u003eOther allergy, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for general adult medical examination without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for general adult medical examination with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.110\u003c/td\u003e\n              \u003ctd\u003eHealth examination for newborn under 8 days old\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.111\u003c/td\u003e\n              \u003ctd\u003eHealth examination for newborn 8 to 28 days old\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.121\u003c/td\u003e\n              \u003ctd\u003eEncounter for routine child health examination with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.129\u003c/td\u003e\n              \u003ctd\u003eEncounter for routine child health examination without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of rapid growth in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for adolescent development state\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of potential donor of organ and tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for normal comparison and control in clinical research program\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.70\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of delayed growth in childhood without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of delayed growth in childhood with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for other general examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of eyes and vision without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of eyes and vision with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.10\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of ears and hearing without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.110\u003c/td\u003e\n              \u003ctd\u003eEncounter for hearing examination following failed hearing screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.118\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of ears and hearing with other abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for hearing conservation and treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.20\u003c/td\u003e\n              \u003ctd\u003eEncounter for dental examination and cleaning without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for dental examination and cleaning with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.30\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of blood pressure without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of blood pressure with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.411\u003c/td\u003e\n              \u003ctd\u003eEncounter for gynecological examination (general) (routine) with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.419\u003c/td\u003e\n              \u003ctd\u003eEncounter for gynecological examination (general) (routine) without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural cardiovascular examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural respiratory examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural laboratory examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.818\u003c/td\u003e\n              \u003ctd\u003eEncounter for other preprocedural examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for allergy testing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for blood typing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for antibody response examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified special examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for admission to educational institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for pre-employment examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for admission to residential institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for recruitment to armed forces\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for driving license\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for participation in sport\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for insurance purposes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for disability determination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for issue of other medical certificate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for paternity testing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for adoption services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for blood-alcohol and blood-drug test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other administrative examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for administrative examinations, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for observation for suspected toxic effect from ingested substance ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected problem with amniotic cavity and membrane ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected placental problem ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.73\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected fetal anomaly ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.74\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected problem with fetal growth ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.75\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected cervical shortening ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for other suspected maternal and fetal conditions ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for observation for other suspected diseases and conditions ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.41\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged adult rape\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged child rape\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged adult physical abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged child physical abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for other specified reasons\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation of victim following forced sexual exploitation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation of victim following forced labor exploitation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for other specified reasons\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for unspecified reason\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.0\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected cardiac condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.2\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected neurological condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.3\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected respiratory condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.41\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected genetic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.42\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected metabolic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.43\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected immunologic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.5\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected gastrointestinal condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.6\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected genitourinary condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.71\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.72\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected musculoskeletal condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.73\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected connective tissue condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.8\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for other specified suspected condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.9\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for unspecified suspected condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ08\u003c/td\u003e\n              \u003ctd\u003eEncounter for follow-up examination after completed treatment for malignant neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ09\u003c/td\u003e\n              \u003ctd\u003eEncounter for follow-up examination after completed treatment for conditions other than malignant neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.10\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of intestinal tract, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.13\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening mammogram for malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.39\u003c/td\u003e\n              \u003ctd\u003eEncounter for other screening for malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.73\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of other genitourinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm, site unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for diabetes mellitus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for nutritional disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.220\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for lipoid disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.228\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other metabolic disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.29\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other suspected endocrine disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for eye and ear disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for cardiovascular disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for nonprocreative screening for genetic disease carrier status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for other screening for genetic and chromosomal anomalies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for upper gastrointestinal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for lower gastrointestinal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.818\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other digestive system disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.820\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for osteoporosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.828\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other musculoskeletal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for respiratory disorder NEC\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for dental disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.850\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for traumatic brain injury\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.858\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other nervous system disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.88\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for disorder due to exposure to contaminants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for pregnancy test, result unknown\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for pregnancy test, result negative\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for childbirth instruction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for childcare instruction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening of mother\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for chromosomal anomalies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for raised alphafetoprotein level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for other antenatal screening follow-up\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for malformations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal growth retardation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for isoimmunization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for hydrops fetalis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for nuchal translucency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for fetal screening for congenital cardiac abnormalities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal lung maturity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.85\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for Streptococcus B\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.86\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for cervical length\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.87\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for uncertain dates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.88\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal macrosomia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified antenatal screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.8A\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for other genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ42.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for breast reconstruction following mastectomy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ42.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for other plastic and reconstructive surgery following medical procedure or healed injury\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ43.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for attention to other artificial openings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ43.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for attention to unspecified artificial opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.001\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified right artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.002\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified left artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.009\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.011\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete right artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.012\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete left artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.019\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.021\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial right arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.022\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial left arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.029\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.101\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified right artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.102\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified left artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.109\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.111\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete right artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.112\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete left artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.119\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.121\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.122\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.129\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.30\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external breast prosthesis, unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external right breast prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.32\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external left breast prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of other external prosthetic devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified external prosthetic device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.010\u003c/td\u003e\n              \u003ctd\u003eEncounter for checking and testing of cardiac pacemaker pulse generator [battery]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.018\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other part of cardiac pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of automatic implantable cardiac defibrillator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.09\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other cardiac device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of infusion pump\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of vascular access device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of implanted visual substitution device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.320\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of bone conduction device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.321\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of cochlear device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.328\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted hearing device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.41\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of cerebrospinal fluid drainage device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of neurostimulator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.49\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted nervous system device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of right breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of left breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.819\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of unspecified breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of myringotomy device (stent) (tube)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of unspecified implanted device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of non-vascular catheter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of other specified devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.1\u003c/td\u003e\n              \u003ctd\u003eAftercare following joint replacement surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for removal of internal fixation device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.31\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of shoulder joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.32\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of hip joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.33\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of knee joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for orthopedic aftercare following surgical amputation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for orthopedic aftercare following scoliosis surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other orthopedic aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of nonsurgical wound dressing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of surgical wound dressing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for removal of sutures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.03\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of drains\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for planned postprocedural wound closure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following heart transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.22\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following kidney transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.23\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following liver transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.24\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following lung transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.280\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following heart-lung transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.288\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following multiple organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.290\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following bone marrow transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.298\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following other organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.3\u003c/td\u003e\n              \u003ctd\u003eAftercare following surgery for neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the sense organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.813\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.814\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the teeth or oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.815\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.816\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the genitourinary system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.817\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the skin and subcutaneous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified surgical aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic chemotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for palliative care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for desensitization to allergens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for therapeutic drug level monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.0\u003c/td\u003e\n              \u003ctd\u003eIlliteracy and low-level literacy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.1\u003c/td\u003e\n              \u003ctd\u003eSchooling unavailable and unattainable\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.2\u003c/td\u003e\n              \u003ctd\u003eFailed school examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.3\u003c/td\u003e\n              \u003ctd\u003eUnderachievement in school\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.4\u003c/td\u003e\n              \u003ctd\u003eEducational maladjustment and discord with teachers and classmates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to education and literacy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.9\u003c/td\u003e\n              \u003ctd\u003eProblems related to education and literacy, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.0\u003c/td\u003e\n              \u003ctd\u003eUnemployment, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.1\u003c/td\u003e\n              \u003ctd\u003eChange of job\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.2\u003c/td\u003e\n              \u003ctd\u003eThreat of job loss\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.3\u003c/td\u003e\n              \u003ctd\u003eStressful work schedule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.4\u003c/td\u003e\n              \u003ctd\u003eDiscord with boss and workmates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.5\u003c/td\u003e\n              \u003ctd\u003eUncongenial work environment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.6\u003c/td\u003e\n              \u003ctd\u003eOther physical and mental strain related to work\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.81\u003c/td\u003e\n              \u003ctd\u003eSexual harassment on the job\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.82\u003c/td\u003e\n              \u003ctd\u003eMilitary deployment status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.89\u003c/td\u003e\n              \u003ctd\u003eOther problems related to employment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified problems related to employment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.0\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to noise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.1\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.2\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to dust\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.31\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to environmental tobacco smoke\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.39\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to other air contaminants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.4\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to toxic agents in agriculture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.5\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to toxic agents in other industries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.6\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to extreme temperature\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.7\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to vibration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.8\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to other risk factors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.9\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to unspecified risk factor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.0\u003c/td\u003e\n              \u003ctd\u003eHomelessness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.1\u003c/td\u003e\n              \u003ctd\u003eInadequate housing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.2\u003c/td\u003e\n              \u003ctd\u003eDiscord with neighbors, lodgers and landlord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.3\u003c/td\u003e\n              \u003ctd\u003eProblems related to living in residential institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.4\u003c/td\u003e\n              \u003ctd\u003eLack of adequate food and safe drinking water\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.5\u003c/td\u003e\n              \u003ctd\u003eExtreme poverty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.6\u003c/td\u003e\n              \u003ctd\u003eLow income\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.7\u003c/td\u003e\n              \u003ctd\u003eInsufficient social insurance and welfare support\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to housing and economic circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to housing and economic circumstances, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.0\u003c/td\u003e\n              \u003ctd\u003eProblems of adjustment to life-cycle transitions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.2\u003c/td\u003e\n              \u003ctd\u003eProblems related to living alone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.3\u003c/td\u003e\n              \u003ctd\u003eAcculturation difficulty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.4\u003c/td\u003e\n              \u003ctd\u003eSocial exclusion and rejection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.5\u003c/td\u003e\n              \u003ctd\u003eTarget of (perceived) adverse discrimination and persecution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to social environment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to social environment, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.0\u003c/td\u003e\n              \u003ctd\u003eInadequate parental supervision and control\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.1\u003c/td\u003e\n              \u003ctd\u003eParental overprotection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.21\u003c/td\u003e\n              \u003ctd\u003eChild in welfare custody\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.22\u003c/td\u003e\n              \u003ctd\u003eInstitutional upbringing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.29\u003c/td\u003e\n              \u003ctd\u003eOther upbringing away from parents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.3\u003c/td\u003e\n              \u003ctd\u003eHostility towards and scapegoating of child\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.6\u003c/td\u003e\n              \u003ctd\u003eInappropriate (excessive) parental pressure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.810\u003c/td\u003e\n              \u003ctd\u003ePersonal history of physical and sexual abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.811\u003c/td\u003e\n              \u003ctd\u003ePersonal history of psychological abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.812\u003c/td\u003e\n              \u003ctd\u003ePersonal history of neglect in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.813\u003c/td\u003e\n              \u003ctd\u003ePersonal history of forced labor or sexual exploitation in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.819\u003c/td\u003e\n              \u003ctd\u003ePersonal history of unspecified abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.820\u003c/td\u003e\n              \u003ctd\u003eParent-biological child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.821\u003c/td\u003e\n              \u003ctd\u003eParent-adopted child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.822\u003c/td\u003e\n              \u003ctd\u003eParent-foster child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.890\u003c/td\u003e\n              \u003ctd\u003eParent-child estrangement NEC\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.891\u003c/td\u003e\n              \u003ctd\u003eSibling rivalry\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.898\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to upbringing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to upbringing, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.0\u003c/td\u003e\n              \u003ctd\u003eProblems in relationship with spouse or partner\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.1\u003c/td\u003e\n              \u003ctd\u003eProblems in relationship with in-laws\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.31\u003c/td\u003e\n              \u003ctd\u003eAbsence of family member due to military deployment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.32\u003c/td\u003e\n              \u003ctd\u003eOther absence of family member\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.4\u003c/td\u003e\n              \u003ctd\u003eDisappearance and death of family member\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.5\u003c/td\u003e\n              \u003ctd\u003eDisruption of family by separation and divorce\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.6\u003c/td\u003e\n              \u003ctd\u003eDependent relative needing care at home\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.71\u003c/td\u003e\n              \u003ctd\u003eStress on family due to return of family member from military deployment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.72\u003c/td\u003e\n              \u003ctd\u003eAlcoholism and drug addiction in family\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.79\u003c/td\u003e\n              \u003ctd\u003eOther stressful life events affecting family and household\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.8\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to primary support group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to primary support group, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.0\u003c/td\u003e\n              \u003ctd\u003eProblems related to unwanted pregnancy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.1\u003c/td\u003e\n              \u003ctd\u003eProblems related to multiparity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.4\u003c/td\u003e\n              \u003ctd\u003eDiscord with counselors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.0\u003c/td\u003e\n              \u003ctd\u003eConviction in civil and criminal proceedings without imprisonment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.1\u003c/td\u003e\n              \u003ctd\u003eImprisonment and other incarceration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.2\u003c/td\u003e\n              \u003ctd\u003eProblems related to release from prison\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.3\u003c/td\u003e\n              \u003ctd\u003eProblems related to other legal circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.4\u003c/td\u003e\n              \u003ctd\u003eVictim of crime and terrorism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.5\u003c/td\u003e\n              \u003ctd\u003eExposure to disaster, war and other hostilities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.8\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to psychosocial circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to unspecified psychosocial circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.010\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.011\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.020\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of non-parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.021\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of non-parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of spousal or partner abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of spousal or partner abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of other abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of other abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.0\u003c/td\u003e\n              \u003ctd\u003eCounseling related to sexual attitude\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.1\u003c/td\u003e\n              \u003ctd\u003eCounseling related to patient\u0027s sexual behavior and orientation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.2\u003c/td\u003e\n              \u003ctd\u003eCounseling related to sexual behavior and orientation of third party\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.3\u003c/td\u003e\n              \u003ctd\u003eCounseling related to combined concerns regarding sexual attitude, behavior and orientation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.8\u003c/td\u003e\n              \u003ctd\u003eOther sex counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.9\u003c/td\u003e\n              \u003ctd\u003eSex counseling, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.0\u003c/td\u003e\n              \u003ctd\u003ePerson encountering health services to consult on behalf of another person\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.1\u003c/td\u003e\n              \u003ctd\u003ePerson with feared health complaint in whom no diagnosis is made\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.2\u003c/td\u003e\n              \u003ctd\u003ePerson consulting for explanation of examination or test findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.3\u003c/td\u003e\n              \u003ctd\u003eDietary counseling and surveillance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.41\u003c/td\u003e\n              \u003ctd\u003eAlcohol abuse counseling and surveillance of alcoholic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.42\u003c/td\u003e\n              \u003ctd\u003eCounseling for family member of alcoholic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.51\u003c/td\u003e\n              \u003ctd\u003eDrug abuse counseling and surveillance of drug abuser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.52\u003c/td\u003e\n              \u003ctd\u003eCounseling for family member of drug abuser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.6\u003c/td\u003e\n              \u003ctd\u003eTobacco abuse counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.7\u003c/td\u003e\n              \u003ctd\u003eHuman immunodeficiency virus [HIV] counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.81\u003c/td\u003e\n              \u003ctd\u003eSpiritual or religious counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.82\u003c/td\u003e\n              \u003ctd\u003eExercise counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for nonprocreative genetic counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.89\u003c/td\u003e\n              \u003ctd\u003eOther specified counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.9\u003c/td\u003e\n              \u003ctd\u003eCounseling, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.0\u003c/td\u003e\n              \u003ctd\u003eBurn-out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.1\u003c/td\u003e\n              \u003ctd\u003eType A behavior pattern\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.2\u003c/td\u003e\n              \u003ctd\u003eLack of relaxation and leisure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.3\u003c/td\u003e\n              \u003ctd\u003eStress, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.4\u003c/td\u003e\n              \u003ctd\u003eInadequate social skills, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.5\u003c/td\u003e\n              \u003ctd\u003eSocial role conflict, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.6\u003c/td\u003e\n              \u003ctd\u003eLimitation of activities due to disability\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.810\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, sleep-onset association type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.811\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, limit setting type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.812\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, combined type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.819\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, unspecified type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.89\u003c/td\u003e\n              \u003ctd\u003eOther problems related to life management difficulty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to life management difficulty, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.01\u003c/td\u003e\n              \u003ctd\u003eBed confinement status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.09\u003c/td\u003e\n              \u003ctd\u003eOther reduced mobility\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.1\u003c/td\u003e\n              \u003ctd\u003eNeed for assistance with personal care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.2\u003c/td\u003e\n              \u003ctd\u003eNeed for assistance at home and no other household member able to render care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.3\u003c/td\u003e\n              \u003ctd\u003eNeed for continuous supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to care provider dependency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to care provider dependency, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.0\u003c/td\u003e\n              \u003ctd\u003eMedical services not available in home\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.1\u003c/td\u003e\n              \u003ctd\u003ePerson awaiting admission to adequate facility elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.2\u003c/td\u003e\n              \u003ctd\u003eOther waiting period for investigation and treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.3\u003c/td\u003e\n              \u003ctd\u003eUnavailability and inaccessibility of health-care facilities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.4\u003c/td\u003e\n              \u003ctd\u003eUnavailability and inaccessibility of other helping agencies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.5\u003c/td\u003e\n              \u003ctd\u003eHoliday relief care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to medical facilities and other health care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified problem related to medical facilities and other health care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for issue of repeat prescription\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for health supervision and care of foundling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for health supervision and care of other healthy infant and child\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.3\u003c/td\u003e\n              \u003ctd\u003eHealthy person accompanying sick person\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.4\u003c/td\u003e\n              \u003ctd\u003eOther boarder to healthcare facility\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.5\u003c/td\u003e\n              \u003ctd\u003eMalingerer [conscious simulation]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.81\u003c/td\u003e\n              \u003ctd\u003eExpectant parent(s) prebirth pediatrician visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.89\u003c/td\u003e\n              \u003ctd\u003ePersons encountering health services in other specified circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.01\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of anticoagulants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.02\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of antithrombotics/antiplatelets\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.1\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of non-steroidal anti-inflammatories (NSAID)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.2\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of antibiotics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.3\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of hormonal contraceptives\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.4\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of insulin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.51\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of inhaled steroids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.52\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of systemic steroids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.810\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of selective estrogen receptor modulators (SERMs)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.811\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of aromatase inhibitors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.818\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of other agents affecting estrogen receptors and estrogen levels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.82\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of aspirin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.83\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of bisphosphonates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.84\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of oral hypoglycemic drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.891\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of opiate analgesic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.899\u003c/td\u003e\n              \u003ctd\u003eOther long term (current) drug therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.00\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified digestive organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.01\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.020\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.028\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.030\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.038\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.040\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.048\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.05\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.060\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.068\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.07\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.09\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.110\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.118\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.12\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.20\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified respiratory organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.21\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.22\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.230\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.238\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.29\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other respiratory and intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.3\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.40\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified female genital organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.41\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.42\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other parts of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.43\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.44\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.45\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified male genital organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.46\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.47\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.48\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.49\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.50\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified urinary tract organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.51\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.520\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.528\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.53\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.54\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.59\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other urinary tract organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.6\u003c/td\u003e\n              \u003ctd\u003ePersonal history of leukemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.71\u003c/td\u003e\n              \u003ctd\u003ePersonal history of Hodgkin lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.72\u003c/td\u003e\n              \u003ctd\u003ePersonal history of non-Hodgkin lymphomas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.79\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.810\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.818\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.819\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.820\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant melanoma of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.821\u003c/td\u003e\n              \u003ctd\u003ePersonal history of Merkel cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.828\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.830\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.831\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.840\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.841\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.848\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other parts of nervous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.850\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of thyroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.858\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.89\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other organs and systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.9\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.000\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.001\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.008\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of other site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.010\u003c/td\u003e\n              \u003ctd\u003ePersonal history of colonic polyps\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.012\u003c/td\u003e\n              \u003ctd\u003ePersonal history of benign carcinoid tumor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.018\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other benign neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.03\u003c/td\u003e\n              \u003ctd\u003ePersonal history of neoplasm of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.711\u003c/td\u003e\n              \u003ctd\u003ePersonal history of pulmonary embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.718\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other venous thrombosis and embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.72\u003c/td\u003e\n              \u003ctd\u003ePersonal history of thrombophlebitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.73\u003c/td\u003e\n              \u003ctd\u003ePersonal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.74\u003c/td\u003e\n              \u003ctd\u003ePersonal history of sudden cardiac arrest\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.79\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other diseases of the circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ87.892\u003c/td\u003e\n              \u003ctd\u003ePersonal history of anaphylaxis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.0\u003c/td\u003e\n              \u003ctd\u003eAllergy status to penicillin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.1\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other antibiotic agents status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.2\u003c/td\u003e\n              \u003ctd\u003eAllergy status to sulfonamides status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.3\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other anti-infective agents status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.4\u003c/td\u003e\n              \u003ctd\u003eAllergy status to anesthetic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.5\u003c/td\u003e\n              \u003ctd\u003eAllergy status to narcotic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.6\u003c/td\u003e\n              \u003ctd\u003eAllergy status to analgesic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.7\u003c/td\u003e\n              \u003ctd\u003eAllergy status to serum and vaccine status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.8\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other drugs, medicaments and biological substances status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.9\u003c/td\u003e\n              \u003ctd\u003eAllergy status to unspecified drugs, medicaments and biological substances status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.010\u003c/td\u003e\n              \u003ctd\u003eAllergy to peanuts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.011\u003c/td\u003e\n              \u003ctd\u003eAllergy to milk products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.012\u003c/td\u003e\n              \u003ctd\u003eAllergy to eggs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.013\u003c/td\u003e\n              \u003ctd\u003eAllergy to seafood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.018\u003c/td\u003e\n              \u003ctd\u003eAllergy to other foods\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.02\u003c/td\u003e\n              \u003ctd\u003eFood additives allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.030\u003c/td\u003e\n              \u003ctd\u003eBee allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.038\u003c/td\u003e\n              \u003ctd\u003eOther insect allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.040\u003c/td\u003e\n              \u003ctd\u003eLatex allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.041\u003c/td\u003e\n              \u003ctd\u003eRadiographic dye allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.048\u003c/td\u003e\n              \u003ctd\u003eOther nonmedicinal substance allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.09\u003c/td\u003e\n              \u003ctd\u003eOther allergy status, other than to drugs and biological substances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ94.1\u003c/td\u003e\n              \u003ctd\u003eHeart transplant status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ94.3\u003c/td\u003e\n              \u003ctd\u003eHeart and lungs transplant status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.0\u003c/td\u003e\n              \u003ctd\u003ePresence of cardiac pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.1\u003c/td\u003e\n              \u003ctd\u003ePresence of aortocoronary bypass graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.2\u003c/td\u003e\n              \u003ctd\u003ePresence of prosthetic heart valve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.3\u003c/td\u003e\n              \u003ctd\u003ePresence of xenogenic heart valve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.4\u003c/td\u003e\n              \u003ctd\u003ePresence of other heart-valve replacement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.5\u003c/td\u003e\n              \u003ctd\u003ePresence of coronary angioplasty implant and graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.810\u003c/td\u003e\n              \u003ctd\u003ePresence of automatic (implantable) cardiac defibrillator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.811\u003c/td\u003e\n              \u003ctd\u003ePresence of heart assist device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.812\u003c/td\u003e\n              \u003ctd\u003ePresence of fully implantable artificial heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.818\u003c/td\u003e\n              \u003ctd\u003ePresence of other cardiac implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.820\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular angioplasty status with implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.828\u003c/td\u003e\n              \u003ctd\u003ePresence of other vascular implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.9\u003c/td\u003e\n              \u003ctd\u003ePresence of cardiac and vascular implant and graft, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ98.61\u003c/td\u003e\n              \u003ctd\u003eCoronary angioplasty status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ98.62\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular angioplasty status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n          \u003c/table\u003e\n        \u003c/li\u003e\n      \u003c/ul\u003e\n    \u003c/div\u003e"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.311",
  "version": "20191111",
  "name": "Complications of Care",
  "status": "active",
  "date": "2019-11-11T01:00:18-05:00",
  "publisher": "Change Healthcare Steward",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/sid/icd-10-cm",
        "concept": [
          {
            "code": "A36.81",
            "display": "Diphtheritic cardiomyopathy"
          },
          {
            "code": "A38.1",
            "display": "Scarlet fever with myocarditis"
          },
          {
            "code": "A39.50",
            "display": "Meningococcal carditis, unspecified"
          },
          {
            "code": "A39.51",
            "display": "Meningococcal endocarditis"
          },
          {
            "code": "A39.52",
            "display": "Meningococcal myocarditis"
          },
          {
            "code": "A39.53",
            "display": "Meningococcal pericarditis"
          },
          {
            "code": "B26.82",
            "display": "Mumps myocarditis"
          },
          {
            "code": "B33.20",
            "display": "Viral carditis, unspecified"
          },
          {
            "code": "B33.21",
            "display": "Viral endocarditis"
          },
          {
            "code": "B33.22",
            "display": "Viral myocarditis"
          },
          {
            "code": "B33.23",
            "display": "Viral pericarditis"
          },
          {
            "code": "B33.24",
            "display": "Viral cardiomyopathy"
          },
          {
            "code": "B37.6",
            "display": "Candidal endocarditis"
          },
          {
            "code": "B44.81",
            "display": "Allergic bronchopulmonary aspergillosis"
          },
          {
            "code": "B58.81",
            "display": "Toxoplasma myocarditis"
          },
          {
            "code": "C00.0",
            "display": "Malignant neoplasm of external upper lip"
          },
          {
            "code": "C00.1",
            "display": "Malignant neoplasm of external lower lip"
          },
          {
            "code": "C00.2",
            "display": "Malignant neoplasm of external lip, unspecified"
          },
          {
            "code": "C00.3",
            "display": "Malignant neoplasm of upper lip, inner aspect"
          },
          {
            "code": "C00.4",
            "display": "Malignant neoplasm of lower lip, inner aspect"
          },
          {
            "code": "C00.5",
            "display": "Malignant neoplasm of lip, unspecified, inner aspect"
          },
          {
            "code": "C00.6",
            "display": "Malignant neoplasm of commissure of lip, unspecified"
          },
          {
            "code": "C00.8",
            "display": "Malignant neoplasm of overlapping sites of lip"
          },
          {
            "code": "C00.9",
            "display": "Malignant neoplasm of lip, unspecified"
          },
          {
            "code": "C01",
            "display": "Malignant neoplasm of base of tongue"
          },
          {
            "code": "C02.0",
            "display": "Malignant neoplasm of dorsal surface of tongue"
          },
          {
            "code": "C02.1",
            "display": "Malignant neoplasm of border of tongue"
          },
          {
            "code": "C02.2",
            "display": "Malignant neoplasm of ventral surface of tongue"
          },
          {
            "code": "C02.3",
            "display": "Malignant neoplasm of anterior two-thirds of tongue, part unspecified"
          },
          {
            "code": "C02.4",
            "display": "Malignant neoplasm of lingual tonsil"
          },
          {
            "code": "C02.8",
            "display": "Malignant neoplasm of overlapping sites of tongue"
          },
          {
            "code": "C02.9",
            "display": "Malignant neoplasm of tongue, unspecified"
          },
          {
            "code": "C03.0",
            "display": "Malignant neoplasm of upper gum"
          },
          {
            "code": "C03.1",
            "display": "Malignant neoplasm of lower gum"
          },
          {
            "code": "C03.9",
            "display": "Malignant neoplasm of gum, unspecified"
          },
          {
            "code": "C04.0",
            "display": "Malignant neoplasm of anterior floor of mouth"
          },
          {
            "code": "C04.1",
            "display": "Malignant neoplasm of lateral floor of mouth"
          },
          {
            "code": "C04.8",
            "display": "Malignant neoplasm of overlapping sites of floor of mouth"
          },
          {
            "code": "C04.9",
            "display": "Malignant neoplasm of floor of mouth, unspecified"
          },
          {
            "code": "C05.0",
            "display": "Malignant neoplasm of hard palate"
          },
          {
            "code": "C05.1",
            "display": "Malignant neoplasm of soft palate"
          },
          {
            "code": "C05.2",
            "display": "Malignant neoplasm of uvula"
          },
          {
            "code": "C05.8",
            "display": "Malignant neoplasm of overlapping sites of palate"
          },
          {
            "code": "C05.9",
            "display": "Malignant neoplasm of palate, unspecified"
          },
          {
            "code": "C06.0",
            "display": "Malignant neoplasm of cheek mucosa"
          },
          {
            "code": "C06.1",
            "display": "Malignant neoplasm of vestibule of mouth"
          },
          {
            "code": "C06.2",
            "display": "Malignant neoplasm of retromolar area"
          },
          {
            "code": "C06.80",
            "display": "Malignant neoplasm of overlapping sites of unspecified parts of mouth"
          },
          {
            "code": "C06.89",
            "display": "Malignant neoplasm of overlapping sites of other parts of mouth"
          },
          {
            "code": "C06.9",
            "display": "Malignant neoplasm of mouth, unspecified"
          },
          {
            "code": "C07",
            "display": "Malignant neoplasm of parotid gland"
          },
          {
            "code": "C08.0",
            "display": "Malignant neoplasm of submandibular gland"
          },
          {
            "code": "C08.1",
            "display": "Malignant neoplasm of sublingual gland"
          },
          {
            "code": "C08.9",
            "display": "Malignant neoplasm of major salivary gland, unspecified"
          },
          {
            "code": "C09.0",
            "display": "Malignant neoplasm of tonsillar fossa"
          },
          {
            "code": "C09.1",
            "display": "Malignant neoplasm of tonsillar pillar (anterior) (posterior)"
          },
          {
            "code": "C09.8",
            "display": "Malignant neoplasm of overlapping sites of tonsil"
          },
          {
            "code": "C09.9",
            "display": "Malignant neoplasm of tonsil, unspecified"
          },
          {
            "code": "C10.0",
            "display": "Malignant neoplasm of vallecula"
          },
          {
            "code": "C10.1",
            "display": "Malignant neoplasm of anterior surface of epiglottis"
          },
          {
            "code": "C10.2",
            "display": "Malignant neoplasm of lateral wall of oropharynx"
          },
          {
            "code": "C10.3",
            "display": "Malignant neoplasm of posterior wall of oropharynx"
          },
          {
            "code": "C10.4",
            "display": "Malignant neoplasm of branchial cleft"
          },
          {
            "code": "C10.8",
            "display": "Malignant neoplasm of overlapping sites of oropharynx"
          },
          {
            "code": "C10.9",
            "display": "Malignant neoplasm of oropharynx, unspecified"
          },
          {
            "code": "C11.0",
            "display": "Malignant neoplasm of superior wall of nasopharynx"
          },
          {
            "code": "C11.1",
            "display": "Malignant neoplasm of posterior wall of nasopharynx"
          },
          {
            "code": "C11.2",
            "display": "Malignant neoplasm of lateral wall of nasopharynx"
          },
          {
            "code": "C11.3",
            "display": "Malignant neoplasm of anterior wall of nasopharynx"
          },
          {
            "code": "C11.8",
            "display": "Malignant neoplasm of overlapping sites of nasopharynx"
          },
          {
            "code": "C11.9",
            "display": "Malignant neoplasm of nasopharynx, unspecified"
          },
          {
            "code": "C12",
            "display": "Malignant neoplasm of pyriform sinus"
          },
          {
            "code": "C13.0",
            "display": "Malignant neoplasm of postcricoid region"
          },
          {
            "code": "C13.1",
            "display": "Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect"
          },
          {
            "code": "C13.2",
            "display": "Malignant neoplasm of posterior wall of hypopharynx"
          },
          {
            "code": "C13.8",
            "display": "Malignant neoplasm of overlapping sites of hypopharynx"
          },
          {
            "code": "C13.9",
            "display": "Malignant neoplasm of hypopharynx, unspecified"
          },
          {
            "code": "C14.0",
            "display": "Malignant neoplasm of pharynx, unspecified"
          },
          {
            "code": "C14.2",
            "display": "Malignant neoplasm of Waldeyer\u0027s ring"
          },
          {
            "code": "C14.8",
            "display": "Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx"
          },
          {
            "code": "C15.3",
            "display": "Malignant neoplasm of upper third of esophagus"
          },
          {
            "code": "C15.4",
            "display": "Malignant neoplasm of middle third of esophagus"
          },
          {
            "code": "C15.5",
            "display": "Malignant neoplasm of lower third of esophagus"
          },
          {
            "code": "C15.8",
            "display": "Malignant neoplasm of overlapping sites of esophagus"
          },
          {
            "code": "C15.9",
            "display": "Malignant neoplasm of esophagus, unspecified"
          },
          {
            "code": "C16.0",
            "display": "Malignant neoplasm of cardia"
          },
          {
            "code": "C16.1",
            "display": "Malignant neoplasm of fundus of stomach"
          },
          {
            "code": "C16.2",
            "display": "Malignant neoplasm of body of stomach"
          },
          {
            "code": "C16.3",
            "display": "Malignant neoplasm of pyloric antrum"
          },
          {
            "code": "C16.4",
            "display": "Malignant neoplasm of pylorus"
          },
          {
            "code": "C16.5",
            "display": "Malignant neoplasm of lesser curvature of stomach, unspecified"
          },
          {
            "code": "C16.6",
            "display": "Malignant neoplasm of greater curvature of stomach, unspecified"
          },
          {
            "code": "C16.8",
            "display": "Malignant neoplasm of overlapping sites of stomach"
          },
          {
            "code": "C16.9",
            "display": "Malignant neoplasm of stomach, unspecified"
          },
          {
            "code": "C17.0",
            "display": "Malignant neoplasm of duodenum"
          },
          {
            "code": "C17.1",
            "display": "Malignant neoplasm of jejunum"
          },
          {
            "code": "C17.2",
            "display": "Malignant neoplasm of ileum"
          },
          {
            "code": "C17.3",
            "display": "Meckel\u0027s diverticulum, malignant"
          },
          {
            "code": "C17.8",
            "display": "Malignant neoplasm of overlapping sites of small intestine"
          },
          {
            "code": "C17.9",
            "display": "Malignant neoplasm of small intestine, unspecified"
          },
          {
            "code": "C18.0",
            "display": "Malignant neoplasm of cecum"
          },
          {
            "code": "C18.1",
            "display": "Malignant neoplasm of appendix"
          },
          {
            "code": "C18.2",
            "display": "Malignant neoplasm of ascending colon"
          },
          {
            "code": "C18.3",
            "display": "Malignant neoplasm of hepatic flexure"
          },
          {
            "code": "C18.4",
            "display": "Malignant neoplasm of transverse colon"
          },
          {
            "code": "C18.5",
            "display": "Malignant neoplasm of splenic flexure"
          },
          {
            "code": "C18.6",
            "display": "Malignant neoplasm of descending colon"
          },
          {
            "code": "C18.7",
            "display": "Malignant neoplasm of sigmoid colon"
          },
          {
            "code": "C18.8",
            "display": "Malignant neoplasm of overlapping sites of colon"
          },
          {
            "code": "C18.9",
            "display": "Malignant neoplasm of colon, unspecified"
          },
          {
            "code": "C19",
            "display": "Malignant neoplasm of rectosigmoid junction"
          },
          {
            "code": "C20",
            "display": "Malignant neoplasm of rectum"
          },
          {
            "code": "C21.0",
            "display": "Malignant neoplasm of anus, unspecified"
          },
          {
            "code": "C21.1",
            "display": "Malignant neoplasm of anal canal"
          },
          {
            "code": "C21.2",
            "display": "Malignant neoplasm of cloacogenic zone"
          },
          {
            "code": "C21.8",
            "display": "Malignant neoplasm of overlapping sites of rectum, anus and anal canal"
          },
          {
            "code": "C22.0",
            "display": "Liver cell carcinoma"
          },
          {
            "code": "C22.1",
            "display": "Intrahepatic bile duct carcinoma"
          },
          {
            "code": "C22.2",
            "display": "Hepatoblastoma"
          },
          {
            "code": "C22.3",
            "display": "Angiosarcoma of liver"
          },
          {
            "code": "C22.4",
            "display": "Other sarcomas of liver"
          },
          {
            "code": "C22.7",
            "display": "Other specified carcinomas of liver"
          },
          {
            "code": "C22.8",
            "display": "Malignant neoplasm of liver, primary, unspecified as to type"
          },
          {
            "code": "C22.9",
            "display": "Malignant neoplasm of liver, not specified as primary or secondary"
          },
          {
            "code": "C23",
            "display": "Malignant neoplasm of gallbladder"
          },
          {
            "code": "C24.0",
            "display": "Malignant neoplasm of extrahepatic bile duct"
          },
          {
            "code": "C24.1",
            "display": "Malignant neoplasm of ampulla of Vater"
          },
          {
            "code": "C24.8",
            "display": "Malignant neoplasm of overlapping sites of biliary tract"
          },
          {
            "code": "C24.9",
            "display": "Malignant neoplasm of biliary tract, unspecified"
          },
          {
            "code": "C25.0",
            "display": "Malignant neoplasm of head of pancreas"
          },
          {
            "code": "C25.1",
            "display": "Malignant neoplasm of body of pancreas"
          },
          {
            "code": "C25.2",
            "display": "Malignant neoplasm of tail of pancreas"
          },
          {
            "code": "C25.3",
            "display": "Malignant neoplasm of pancreatic duct"
          },
          {
            "code": "C25.4",
            "display": "Malignant neoplasm of endocrine pancreas"
          },
          {
            "code": "C25.7",
            "display": "Malignant neoplasm of other parts of pancreas"
          },
          {
            "code": "C25.8",
            "display": "Malignant neoplasm of overlapping sites of pancreas"
          },
          {
            "code": "C25.9",
            "display": "Malignant neoplasm of pancreas, unspecified"
          },
          {
            "code": "C26.0",
            "display": "Malignant neoplasm of intestinal tract, part unspecified"
          },
          {
            "code": "C26.1",
            "display": "Malignant neoplasm of spleen"
          },
          {
            "code": "C26.9",
            "display": "Malignant neoplasm of ill-defined sites within the digestive system"
          },
          {
            "code": "C30.0",
            "display": "Malignant neoplasm of nasal cavity"
          },
          {
            "code": "C30.1",
            "display": "Malignant neoplasm of middle ear"
          },
          {
            "code": "C31.0",
            "display": "Malignant neoplasm of maxillary sinus"
          },
          {
            "code": "C31.1",
            "display": "Malignant neoplasm of ethmoidal sinus"
          },
          {
            "code": "C31.2",
            "display": "Malignant neoplasm of frontal sinus"
          },
          {
            "code": "C31.3",
            "display": "Malignant neoplasm of sphenoid sinus"
          },
          {
            "code": "C31.8",
            "display": "Malignant neoplasm of overlapping sites of accessory sinuses"
          },
          {
            "code": "C31.9",
            "display": "Malignant neoplasm of accessory sinus, unspecified"
          },
          {
            "code": "C32.0",
            "display": "Malignant neoplasm of glottis"
          },
          {
            "code": "C32.1",
            "display": "Malignant neoplasm of supraglottis"
          },
          {
            "code": "C32.2",
            "display": "Malignant neoplasm of subglottis"
          },
          {
            "code": "C32.3",
            "display": "Malignant neoplasm of laryngeal cartilage"
          },
          {
            "code": "C32.8",
            "display": "Malignant neoplasm of overlapping sites of larynx"
          },
          {
            "code": "C32.9",
            "display": "Malignant neoplasm of larynx, unspecified"
          },
          {
            "code": "C33",
            "display": "Malignant neoplasm of trachea"
          },
          {
            "code": "C34.00",
            "display": "Malignant neoplasm of unspecified main bronchus"
          },
          {
            "code": "C34.01",
            "display": "Malignant neoplasm of right main bronchus"
          },
          {
            "code": "C34.02",
            "display": "Malignant neoplasm of left main bronchus"
          },
          {
            "code": "C34.10",
            "display": "Malignant neoplasm of upper lobe, unspecified bronchus or lung"
          },
          {
            "code": "C34.11",
            "display": "Malignant neoplasm of upper lobe, right bronchus or lung"
          },
          {
            "code": "C34.12",
            "display": "Malignant neoplasm of upper lobe, left bronchus or lung"
          },
          {
            "code": "C34.2",
            "display": "Malignant neoplasm of middle lobe, bronchus or lung"
          },
          {
            "code": "C34.30",
            "display": "Malignant neoplasm of lower lobe, unspecified bronchus or lung"
          },
          {
            "code": "C34.31",
            "display": "Malignant neoplasm of lower lobe, right bronchus or lung"
          },
          {
            "code": "C34.32",
            "display": "Malignant neoplasm of lower lobe, left bronchus or lung"
          },
          {
            "code": "C34.80",
            "display": "Malignant neoplasm of overlapping sites of unspecified bronchus and lung"
          },
          {
            "code": "C34.81",
            "display": "Malignant neoplasm of overlapping sites of right bronchus and lung"
          },
          {
            "code": "C34.82",
            "display": "Malignant neoplasm of overlapping sites of left bronchus and lung"
          },
          {
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of unspecified bronchus or lung"
          },
          {
            "code": "C34.91",
            "display": "Malignant neoplasm of unspecified part of right bronchus or lung"
          },
          {
            "code": "C34.92",
            "display": "Malignant neoplasm of unspecified part of left bronchus or lung"
          },
          {
            "code": "C37",
            "display": "Malignant neoplasm of thymus"
          },
          {
            "code": "C38.0",
            "display": "Malignant neoplasm of heart"
          },
          {
            "code": "C38.1",
            "display": "Malignant neoplasm of anterior mediastinum"
          },
          {
            "code": "C38.2",
            "display": "Malignant neoplasm of posterior mediastinum"
          },
          {
            "code": "C38.3",
            "display": "Malignant neoplasm of mediastinum, part unspecified"
          },
          {
            "code": "C38.4",
            "display": "Malignant neoplasm of pleura"
          },
          {
            "code": "C38.8",
            "display": "Malignant neoplasm of overlapping sites of heart, mediastinum and pleura"
          },
          {
            "code": "C39.0",
            "display": "Malignant neoplasm of upper respiratory tract, part unspecified"
          },
          {
            "code": "C39.9",
            "display": "Malignant neoplasm of lower respiratory tract, part unspecified"
          },
          {
            "code": "C40.00",
            "display": "Malignant neoplasm of scapula and long bones of unspecified upper limb"
          },
          {
            "code": "C40.01",
            "display": "Malignant neoplasm of scapula and long bones of right upper limb"
          },
          {
            "code": "C40.02",
            "display": "Malignant neoplasm of scapula and long bones of left upper limb"
          },
          {
            "code": "C40.10",
            "display": "Malignant neoplasm of short bones of unspecified upper limb"
          },
          {
            "code": "C40.11",
            "display": "Malignant neoplasm of short bones of right upper limb"
          },
          {
            "code": "C40.12",
            "display": "Malignant neoplasm of short bones of left upper limb"
          },
          {
            "code": "C40.20",
            "display": "Malignant neoplasm of long bones of unspecified lower limb"
          },
          {
            "code": "C40.21",
            "display": "Malignant neoplasm of long bones of right lower limb"
          },
          {
            "code": "C40.22",
            "display": "Malignant neoplasm of long bones of left lower limb"
          },
          {
            "code": "C40.30",
            "display": "Malignant neoplasm of short bones of unspecified lower limb"
          },
          {
            "code": "C40.31",
            "display": "Malignant neoplasm of short bones of right lower limb"
          },
          {
            "code": "C40.32",
            "display": "Malignant neoplasm of short bones of left lower limb"
          },
          {
            "code": "C40.80",
            "display": "Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb"
          },
          {
            "code": "C40.81",
            "display": "Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb"
          },
          {
            "code": "C40.82",
            "display": "Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb"
          },
          {
            "code": "C40.90",
            "display": "Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb"
          },
          {
            "code": "C40.91",
            "display": "Malignant neoplasm of unspecified bones and articular cartilage of right limb"
          },
          {
            "code": "C40.92",
            "display": "Malignant neoplasm of unspecified bones and articular cartilage of left limb"
          },
          {
            "code": "C41.0",
            "display": "Malignant neoplasm of bones of skull and face"
          },
          {
            "code": "C41.1",
            "display": "Malignant neoplasm of mandible"
          },
          {
            "code": "C41.2",
            "display": "Malignant neoplasm of vertebral column"
          },
          {
            "code": "C41.3",
            "display": "Malignant neoplasm of ribs, sternum and clavicle"
          },
          {
            "code": "C41.4",
            "display": "Malignant neoplasm of pelvic bones, sacrum and coccyx"
          },
          {
            "code": "C41.9",
            "display": "Malignant neoplasm of bone and articular cartilage, unspecified"
          },
          {
            "code": "C43.0",
            "display": "Malignant melanoma of lip"
          },
          {
            "code": "C43.10",
            "display": "Malignant melanoma of unspecified eyelid, including canthus"
          },
          {
            "code": "C43.11",
            "display": "Malignant melanoma of right eyelid, including canthus"
          },
          {
            "code": "C43.111",
            "display": "Malignant melanoma of right upper eyelid, including canthus"
          },
          {
            "code": "C43.112",
            "display": "Malignant melanoma of right lower eyelid, including canthus"
          },
          {
            "code": "C43.12",
            "display": "Malignant melanoma of left eyelid, including canthus"
          },
          {
            "code": "C43.121",
            "display": "Malignant melanoma of left upper eyelid, including canthus"
          },
          {
            "code": "C43.122",
            "display": "Malignant melanoma of left lower eyelid, including canthus"
          },
          {
            "code": "C43.20",
            "display": "Malignant melanoma of unspecified ear and external auricular canal"
          },
          {
            "code": "C43.21",
            "display": "Malignant melanoma of right ear and external auricular canal"
          },
          {
            "code": "C43.22",
            "display": "Malignant melanoma of left ear and external auricular canal"
          },
          {
            "code": "C43.30",
            "display": "Malignant melanoma of unspecified part of face"
          },
          {
            "code": "C43.31",
            "display": "Malignant melanoma of nose"
          },
          {
            "code": "C43.39",
            "display": "Malignant melanoma of other parts of face"
          },
          {
            "code": "C43.4",
            "display": "Malignant melanoma of scalp and neck"
          },
          {
            "code": "C43.51",
            "display": "Malignant melanoma of anal skin"
          },
          {
            "code": "C43.52",
            "display": "Malignant melanoma of skin of breast"
          },
          {
            "code": "C43.59",
            "display": "Malignant melanoma of other part of trunk"
          },
          {
            "code": "C43.60",
            "display": "Malignant melanoma of unspecified upper limb, including shoulder"
          },
          {
            "code": "C43.61",
            "display": "Malignant melanoma of right upper limb, including shoulder"
          },
          {
            "code": "C43.62",
            "display": "Malignant melanoma of left upper limb, including shoulder"
          },
          {
            "code": "C43.70",
            "display": "Malignant melanoma of unspecified lower limb, including hip"
          },
          {
            "code": "C43.71",
            "display": "Malignant melanoma of right lower limb, including hip"
          },
          {
            "code": "C43.72",
            "display": "Malignant melanoma of left lower limb, including hip"
          },
          {
            "code": "C43.8",
            "display": "Malignant melanoma of overlapping sites of skin"
          },
          {
            "code": "C43.9",
            "display": "Malignant melanoma of skin, unspecified"
          },
          {
            "code": "C44.00",
            "display": "Unspecified malignant neoplasm of skin of lip"
          },
          {
            "code": "C44.01",
            "display": "Basal cell carcinoma of skin of lip"
          },
          {
            "code": "C44.02",
            "display": "Squamous cell carcinoma of skin of lip"
          },
          {
            "code": "C44.09",
            "display": "Other specified malignant neoplasm of skin of lip"
          },
          {
            "code": "C44.101",
            "display": "Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "C44.102",
            "display": "Unspecified malignant neoplasm of skin of right eyelid, including canthus"
          },
          {
            "code": "C44.1021",
            "display": "Unspecified malignant neoplasm of skin of right upper eyelid, including canthus"
          },
          {
            "code": "C44.1022",
            "display": "Unspecified malignant neoplasm of skin of right lower eyelid, including canthus"
          },
          {
            "code": "C44.109",
            "display": "Unspecified malignant neoplasm of skin of left eyelid, including canthus"
          },
          {
            "code": "C44.1091",
            "display": "Unspecified malignant neoplasm of skin of left upper eyelid, including canthus"
          },
          {
            "code": "C44.1092",
            "display": "Unspecified malignant neoplasm of skin of left lower eyelid, including canthus"
          },
          {
            "code": "C44.111",
            "display": "Basal cell carcinoma of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "C44.112",
            "display": "Basal cell carcinoma of skin of right eyelid, including canthus"
          },
          {
            "code": "C44.1121",
            "display": "Basal cell carcinoma of skin of right upper eyelid, including canthus"
          },
          {
            "code": "C44.1122",
            "display": "Basal cell carcinoma of skin of right lower eyelid, including canthus"
          },
          {
            "code": "C44.119",
            "display": "Basal cell carcinoma of skin of left eyelid, including canthus"
          },
          {
            "code": "C44.1191",
            "display": "Basal cell carcinoma of skin of left upper eyelid, including canthus"
          },
          {
            "code": "C44.1192",
            "display": "Basal cell carcinoma of skin of left lower eyelid, including canthus"
          },
          {
            "code": "C44.121",
            "display": "Squamous cell carcinoma of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "C44.122",
            "display": "Squamous cell carcinoma of skin of right eyelid, including canthus"
          },
          {
            "code": "C44.1221",
            "display": "Squamous cell carcinoma of skin of right upper eyelid, including canthus"
          },
          {
            "code": "C44.1222",
            "display": "Squamous cell carcinoma of skin of right lower eyelid, including canthus"
          },
          {
            "code": "C44.129",
            "display": "Squamous cell carcinoma of skin of left eyelid, including canthus"
          },
          {
            "code": "C44.1291",
            "display": "Squamous cell carcinoma of skin of left upper eyelid, including canthus"
          },
          {
            "code": "C44.1292",
            "display": "Squamous cell carcinoma of skin of left lower eyelid, including canthus"
          },
          {
            "code": "C44.131",
            "display": "Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "C44.1321",
            "display": "Sebaceous cell carcinoma of skin of right upper eyelid, including canthus"
          },
          {
            "code": "C44.1322",
            "display": "Sebaceous cell carcinoma of skin of right lower eyelid, including canthus"
          },
          {
            "code": "C44.1391",
            "display": "Sebaceous cell carcinoma of skin of left upper eyelid, including canthus"
          },
          {
            "code": "C44.1392",
            "display": "Sebaceous cell carcinoma of skin of left lower eyelid, including canthus"
          },
          {
            "code": "C44.191",
            "display": "Other specified malignant neoplasm of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "C44.192",
            "display": "Other specified malignant neoplasm of skin of right eyelid, including canthus"
          },
          {
            "code": "C44.1921",
            "display": "Other specified malignant neoplasm of skin of right upper eyelid, including canthus"
          },
          {
            "code": "C44.1922",
            "display": "Other specified malignant neoplasm of skin of right lower eyelid, including canthus"
          },
          {
            "code": "C44.199",
            "display": "Other specified malignant neoplasm of skin of left eyelid, including canthus"
          },
          {
            "code": "C44.1991",
            "display": "Other specified malignant neoplasm of skin of left upper eyelid, including canthus"
          },
          {
            "code": "C44.1992",
            "display": "Other specified malignant neoplasm of skin of left lower eyelid, including canthus"
          },
          {
            "code": "C44.201",
            "display": "Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "C44.202",
            "display": "Unspecified malignant neoplasm of skin of right ear and external auricular canal"
          },
          {
            "code": "C44.209",
            "display": "Unspecified malignant neoplasm of skin of left ear and external auricular canal"
          },
          {
            "code": "C44.211",
            "display": "Basal cell carcinoma of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "C44.212",
            "display": "Basal cell carcinoma of skin of right ear and external auricular canal"
          },
          {
            "code": "C44.219",
            "display": "Basal cell carcinoma of skin of left ear and external auricular canal"
          },
          {
            "code": "C44.221",
            "display": "Squamous cell carcinoma of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "C44.222",
            "display": "Squamous cell carcinoma of skin of right ear and external auricular canal"
          },
          {
            "code": "C44.229",
            "display": "Squamous cell carcinoma of skin of left ear and external auricular canal"
          },
          {
            "code": "C44.291",
            "display": "Other specified malignant neoplasm of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "C44.292",
            "display": "Other specified malignant neoplasm of skin of right ear and external auricular canal"
          },
          {
            "code": "C44.299",
            "display": "Other specified malignant neoplasm of skin of left ear and external auricular canal"
          },
          {
            "code": "C44.300",
            "display": "Unspecified malignant neoplasm of skin of unspecified part of face"
          },
          {
            "code": "C44.301",
            "display": "Unspecified malignant neoplasm of skin of nose"
          },
          {
            "code": "C44.309",
            "display": "Unspecified malignant neoplasm of skin of other parts of face"
          },
          {
            "code": "C44.310",
            "display": "Basal cell carcinoma of skin of unspecified parts of face"
          },
          {
            "code": "C44.311",
            "display": "Basal cell carcinoma of skin of nose"
          },
          {
            "code": "C44.319",
            "display": "Basal cell carcinoma of skin of other parts of face"
          },
          {
            "code": "C44.320",
            "display": "Squamous cell carcinoma of skin of unspecified parts of face"
          },
          {
            "code": "C44.321",
            "display": "Squamous cell carcinoma of skin of nose"
          },
          {
            "code": "C44.329",
            "display": "Squamous cell carcinoma of skin of other parts of face"
          },
          {
            "code": "C44.390",
            "display": "Other specified malignant neoplasm of skin of unspecified parts of face"
          },
          {
            "code": "C44.391",
            "display": "Other specified malignant neoplasm of skin of nose"
          },
          {
            "code": "C44.399",
            "display": "Other specified malignant neoplasm of skin of other parts of face"
          },
          {
            "code": "C44.40",
            "display": "Unspecified malignant neoplasm of skin of scalp and neck"
          },
          {
            "code": "C44.41",
            "display": "Basal cell carcinoma of skin of scalp and neck"
          },
          {
            "code": "C44.42",
            "display": "Squamous cell carcinoma of skin of scalp and neck"
          },
          {
            "code": "C44.49",
            "display": "Other specified malignant neoplasm of skin of scalp and neck"
          },
          {
            "code": "C44.500",
            "display": "Unspecified malignant neoplasm of anal skin"
          },
          {
            "code": "C44.501",
            "display": "Unspecified malignant neoplasm of skin of breast"
          },
          {
            "code": "C44.509",
            "display": "Unspecified malignant neoplasm of skin of other part of trunk"
          },
          {
            "code": "C44.510",
            "display": "Basal cell carcinoma of anal skin"
          },
          {
            "code": "C44.511",
            "display": "Basal cell carcinoma of skin of breast"
          },
          {
            "code": "C44.519",
            "display": "Basal cell carcinoma of skin of other part of trunk"
          },
          {
            "code": "C44.520",
            "display": "Squamous cell carcinoma of anal skin"
          },
          {
            "code": "C44.521",
            "display": "Squamous cell carcinoma of skin of breast"
          },
          {
            "code": "C44.529",
            "display": "Squamous cell carcinoma of skin of other part of trunk"
          },
          {
            "code": "C44.590",
            "display": "Other specified malignant neoplasm of anal skin"
          },
          {
            "code": "C44.591",
            "display": "Other specified malignant neoplasm of skin of breast"
          },
          {
            "code": "C44.599",
            "display": "Other specified malignant neoplasm of skin of other part of trunk"
          },
          {
            "code": "C44.601",
            "display": "Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "C44.602",
            "display": "Unspecified malignant neoplasm of skin of right upper limb, including shoulder"
          },
          {
            "code": "C44.609",
            "display": "Unspecified malignant neoplasm of skin of left upper limb, including shoulder"
          },
          {
            "code": "C44.611",
            "display": "Basal cell carcinoma of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "C44.612",
            "display": "Basal cell carcinoma of skin of right upper limb, including shoulder"
          },
          {
            "code": "C44.619",
            "display": "Basal cell carcinoma of skin of left upper limb, including shoulder"
          },
          {
            "code": "C44.621",
            "display": "Squamous cell carcinoma of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "C44.622",
            "display": "Squamous cell carcinoma of skin of right upper limb, including shoulder"
          },
          {
            "code": "C44.629",
            "display": "Squamous cell carcinoma of skin of left upper limb, including shoulder"
          },
          {
            "code": "C44.691",
            "display": "Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "C44.692",
            "display": "Other specified malignant neoplasm of skin of right upper limb, including shoulder"
          },
          {
            "code": "C44.699",
            "display": "Other specified malignant neoplasm of skin of left upper limb, including shoulder"
          },
          {
            "code": "C44.701",
            "display": "Unspecified malignant neoplasm of skin of unspecified lower limb, including hip"
          },
          {
            "code": "C44.702",
            "display": "Unspecified malignant neoplasm of skin of right lower limb, including hip"
          },
          {
            "code": "C44.709",
            "display": "Unspecified malignant neoplasm of skin of left lower limb, including hip"
          },
          {
            "code": "C44.711",
            "display": "Basal cell carcinoma of skin of unspecified lower limb, including hip"
          },
          {
            "code": "C44.712",
            "display": "Basal cell carcinoma of skin of right lower limb, including hip"
          },
          {
            "code": "C44.719",
            "display": "Basal cell carcinoma of skin of left lower limb, including hip"
          },
          {
            "code": "C44.721",
            "display": "Squamous cell carcinoma of skin of unspecified lower limb, including hip"
          },
          {
            "code": "C44.722",
            "display": "Squamous cell carcinoma of skin of right lower limb, including hip"
          },
          {
            "code": "C44.729",
            "display": "Squamous cell carcinoma of skin of left lower limb, including hip"
          },
          {
            "code": "C44.791",
            "display": "Other specified malignant neoplasm of skin of unspecified lower limb, including hip"
          },
          {
            "code": "C44.792",
            "display": "Other specified malignant neoplasm of skin of right lower limb, including hip"
          },
          {
            "code": "C44.799",
            "display": "Other specified malignant neoplasm of skin of left lower limb, including hip"
          },
          {
            "code": "C44.80",
            "display": "Unspecified malignant neoplasm of overlapping sites of skin"
          },
          {
            "code": "C44.81",
            "display": "Basal cell carcinoma of overlapping sites of skin"
          },
          {
            "code": "C44.82",
            "display": "Squamous cell carcinoma of overlapping sites of skin"
          },
          {
            "code": "C44.89",
            "display": "Other specified malignant neoplasm of overlapping sites of skin"
          },
          {
            "code": "C44.90",
            "display": "Unspecified malignant neoplasm of skin, unspecified"
          },
          {
            "code": "C44.91",
            "display": "Basal cell carcinoma of skin, unspecified"
          },
          {
            "code": "C44.92",
            "display": "Squamous cell carcinoma of skin, unspecified"
          },
          {
            "code": "C44.99",
            "display": "Other specified malignant neoplasm of skin, unspecified"
          },
          {
            "code": "C45.0",
            "display": "Mesothelioma of pleura"
          },
          {
            "code": "C45.1",
            "display": "Mesothelioma of peritoneum"
          },
          {
            "code": "C45.2",
            "display": "Mesothelioma of pericardium"
          },
          {
            "code": "C45.7",
            "display": "Mesothelioma of other sites"
          },
          {
            "code": "C45.9",
            "display": "Mesothelioma, unspecified"
          },
          {
            "code": "C46.0",
            "display": "Kaposi\u0027s sarcoma of skin"
          },
          {
            "code": "C46.1",
            "display": "Kaposi\u0027s sarcoma of soft tissue"
          },
          {
            "code": "C46.2",
            "display": "Kaposi\u0027s sarcoma of palate"
          },
          {
            "code": "C46.3",
            "display": "Kaposi\u0027s sarcoma of lymph nodes"
          },
          {
            "code": "C46.4",
            "display": "Kaposi\u0027s sarcoma of gastrointestinal sites"
          },
          {
            "code": "C46.50",
            "display": "Kaposi\u0027s sarcoma of unspecified lung"
          },
          {
            "code": "C46.51",
            "display": "Kaposi\u0027s sarcoma of right lung"
          },
          {
            "code": "C46.52",
            "display": "Kaposi\u0027s sarcoma of left lung"
          },
          {
            "code": "C46.7",
            "display": "Kaposi\u0027s sarcoma of other sites"
          },
          {
            "code": "C46.9",
            "display": "Kaposi\u0027s sarcoma, unspecified"
          },
          {
            "code": "C47.0",
            "display": "Malignant neoplasm of peripheral nerves of head, face and neck"
          },
          {
            "code": "C47.10",
            "display": "Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder"
          },
          {
            "code": "C47.11",
            "display": "Malignant neoplasm of peripheral nerves of right upper limb, including shoulder"
          },
          {
            "code": "C47.12",
            "display": "Malignant neoplasm of peripheral nerves of left upper limb, including shoulder"
          },
          {
            "code": "C47.20",
            "display": "Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip"
          },
          {
            "code": "C47.21",
            "display": "Malignant neoplasm of peripheral nerves of right lower limb, including hip"
          },
          {
            "code": "C47.22",
            "display": "Malignant neoplasm of peripheral nerves of left lower limb, including hip"
          },
          {
            "code": "C47.3",
            "display": "Malignant neoplasm of peripheral nerves of thorax"
          },
          {
            "code": "C47.4",
            "display": "Malignant neoplasm of peripheral nerves of abdomen"
          },
          {
            "code": "C47.5",
            "display": "Malignant neoplasm of peripheral nerves of pelvis"
          },
          {
            "code": "C47.6",
            "display": "Malignant neoplasm of peripheral nerves of trunk, unspecified"
          },
          {
            "code": "C47.8",
            "display": "Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system"
          },
          {
            "code": "C47.9",
            "display": "Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified"
          },
          {
            "code": "C48.0",
            "display": "Malignant neoplasm of retroperitoneum"
          },
          {
            "code": "C48.1",
            "display": "Malignant neoplasm of specified parts of peritoneum"
          },
          {
            "code": "C48.2",
            "display": "Malignant neoplasm of peritoneum, unspecified"
          },
          {
            "code": "C48.8",
            "display": "Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum"
          },
          {
            "code": "C49.0",
            "display": "Malignant neoplasm of connective and soft tissue of head, face and neck"
          },
          {
            "code": "C49.10",
            "display": "Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder"
          },
          {
            "code": "C49.11",
            "display": "Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder"
          },
          {
            "code": "C49.12",
            "display": "Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder"
          },
          {
            "code": "C49.20",
            "display": "Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip"
          },
          {
            "code": "C49.21",
            "display": "Malignant neoplasm of connective and soft tissue of right lower limb, including hip"
          },
          {
            "code": "C49.22",
            "display": "Malignant neoplasm of connective and soft tissue of left lower limb, including hip"
          },
          {
            "code": "C49.3",
            "display": "Malignant neoplasm of connective and soft tissue of thorax"
          },
          {
            "code": "C49.4",
            "display": "Malignant neoplasm of connective and soft tissue of abdomen"
          },
          {
            "code": "C49.5",
            "display": "Malignant neoplasm of connective and soft tissue of pelvis"
          },
          {
            "code": "C49.6",
            "display": "Malignant neoplasm of connective and soft tissue of trunk, unspecified"
          },
          {
            "code": "C49.8",
            "display": "Malignant neoplasm of overlapping sites of connective and soft tissue"
          },
          {
            "code": "C49.9",
            "display": "Malignant neoplasm of connective and soft tissue, unspecified"
          },
          {
            "code": "C49.A0",
            "display": "Gastrointestinal stromal tumor, unspecified site"
          },
          {
            "code": "C49.A1",
            "display": "Gastrointestinal stromal tumor of esophagus"
          },
          {
            "code": "C49.A2",
            "display": "Gastrointestinal stromal tumor of stomach"
          },
          {
            "code": "C49.A3",
            "display": "Gastrointestinal stromal tumor of small intestine"
          },
          {
            "code": "C49.A4",
            "display": "Gastrointestinal stromal tumor of large intestine"
          },
          {
            "code": "C49.A5",
            "display": "Gastrointestinal stromal tumor of rectum"
          },
          {
            "code": "C49.A9",
            "display": "Gastrointestinal stromal tumor of other sites"
          },
          {
            "code": "C4A.0",
            "display": "Merkel cell carcinoma of lip"
          },
          {
            "code": "C4A.10",
            "display": "Merkel cell carcinoma of unspecified eyelid, including canthus"
          },
          {
            "code": "C4A.11",
            "display": "Merkel cell carcinoma of right eyelid, including canthus"
          },
          {
            "code": "C4A.111",
            "display": "Merkel cell carcinoma of right upper eyelid, including canthus"
          },
          {
            "code": "C4A.112",
            "display": "Merkel cell carcinoma of right lower eyelid, including canthus"
          },
          {
            "code": "C4A.12",
            "display": "Merkel cell carcinoma of left eyelid, including canthus"
          },
          {
            "code": "C4A.121",
            "display": "Merkel cell carcinoma of left upper eyelid, including canthus"
          },
          {
            "code": "C4A.122",
            "display": "Merkel cell carcinoma of left lower eyelid, including canthus"
          },
          {
            "code": "C4A.20",
            "display": "Merkel cell carcinoma of unspecified ear and external auricular canal"
          },
          {
            "code": "C4A.21",
            "display": "Merkel cell carcinoma of right ear and external auricular canal"
          },
          {
            "code": "C4A.22",
            "display": "Merkel cell carcinoma of left ear and external auricular canal"
          },
          {
            "code": "C4A.30",
            "display": "Merkel cell carcinoma of unspecified part of face"
          },
          {
            "code": "C4A.31",
            "display": "Merkel cell carcinoma of nose"
          },
          {
            "code": "C4A.39",
            "display": "Merkel cell carcinoma of other parts of face"
          },
          {
            "code": "C4A.4",
            "display": "Merkel cell carcinoma of scalp and neck"
          },
          {
            "code": "C4A.51",
            "display": "Merkel cell carcinoma of anal skin"
          },
          {
            "code": "C4A.52",
            "display": "Merkel cell carcinoma of skin of breast"
          },
          {
            "code": "C4A.59",
            "display": "Merkel cell carcinoma of other part of trunk"
          },
          {
            "code": "C4A.60",
            "display": "Merkel cell carcinoma of unspecified upper limb, including shoulder"
          },
          {
            "code": "C4A.61",
            "display": "Merkel cell carcinoma of right upper limb, including shoulder"
          },
          {
            "code": "C4A.62",
            "display": "Merkel cell carcinoma of left upper limb, including shoulder"
          },
          {
            "code": "C4A.70",
            "display": "Merkel cell carcinoma of unspecified lower limb, including hip"
          },
          {
            "code": "C4A.71",
            "display": "Merkel cell carcinoma of right lower limb, including hip"
          },
          {
            "code": "C4A.72",
            "display": "Merkel cell carcinoma of left lower limb, including hip"
          },
          {
            "code": "C4A.8",
            "display": "Merkel cell carcinoma of overlapping sites"
          },
          {
            "code": "C4A.9",
            "display": "Merkel cell carcinoma, unspecified"
          },
          {
            "code": "C50.011",
            "display": "Malignant neoplasm of nipple and areola, right female breast"
          },
          {
            "code": "C50.012",
            "display": "Malignant neoplasm of nipple and areola, left female breast"
          },
          {
            "code": "C50.019",
            "display": "Malignant neoplasm of nipple and areola, unspecified female breast"
          },
          {
            "code": "C50.021",
            "display": "Malignant neoplasm of nipple and areola, right male breast"
          },
          {
            "code": "C50.022",
            "display": "Malignant neoplasm of nipple and areola, left male breast"
          },
          {
            "code": "C50.029",
            "display": "Malignant neoplasm of nipple and areola, unspecified male breast"
          },
          {
            "code": "C50.111",
            "display": "Malignant neoplasm of central portion of right female breast"
          },
          {
            "code": "C50.112",
            "display": "Malignant neoplasm of central portion of left female breast"
          },
          {
            "code": "C50.119",
            "display": "Malignant neoplasm of central portion of unspecified female breast"
          },
          {
            "code": "C50.121",
            "display": "Malignant neoplasm of central portion of right male breast"
          },
          {
            "code": "C50.122",
            "display": "Malignant neoplasm of central portion of left male breast"
          },
          {
            "code": "C50.129",
            "display": "Malignant neoplasm of central portion of unspecified male breast"
          },
          {
            "code": "C50.211",
            "display": "Malignant neoplasm of upper-inner quadrant of right female breast"
          },
          {
            "code": "C50.212",
            "display": "Malignant neoplasm of upper-inner quadrant of left female breast"
          },
          {
            "code": "C50.219",
            "display": "Malignant neoplasm of upper-inner quadrant of unspecified female breast"
          },
          {
            "code": "C50.221",
            "display": "Malignant neoplasm of upper-inner quadrant of right male breast"
          },
          {
            "code": "C50.222",
            "display": "Malignant neoplasm of upper-inner quadrant of left male breast"
          },
          {
            "code": "C50.229",
            "display": "Malignant neoplasm of upper-inner quadrant of unspecified male breast"
          },
          {
            "code": "C50.311",
            "display": "Malignant neoplasm of lower-inner quadrant of right female breast"
          },
          {
            "code": "C50.312",
            "display": "Malignant neoplasm of lower-inner quadrant of left female breast"
          },
          {
            "code": "C50.319",
            "display": "Malignant neoplasm of lower-inner quadrant of unspecified female breast"
          },
          {
            "code": "C50.321",
            "display": "Malignant neoplasm of lower-inner quadrant of right male breast"
          },
          {
            "code": "C50.322",
            "display": "Malignant neoplasm of lower-inner quadrant of left male breast"
          },
          {
            "code": "C50.329",
            "display": "Malignant neoplasm of lower-inner quadrant of unspecified male breast"
          },
          {
            "code": "C50.411",
            "display": "Malignant neoplasm of upper-outer quadrant of right female breast"
          },
          {
            "code": "C50.412",
            "display": "Malignant neoplasm of upper-outer quadrant of left female breast"
          },
          {
            "code": "C50.419",
            "display": "Malignant neoplasm of upper-outer quadrant of unspecified female breast"
          },
          {
            "code": "C50.421",
            "display": "Malignant neoplasm of upper-outer quadrant of right male breast"
          },
          {
            "code": "C50.422",
            "display": "Malignant neoplasm of upper-outer quadrant of left male breast"
          },
          {
            "code": "C50.429",
            "display": "Malignant neoplasm of upper-outer quadrant of unspecified male breast"
          },
          {
            "code": "C50.511",
            "display": "Malignant neoplasm of lower-outer quadrant of right female breast"
          },
          {
            "code": "C50.512",
            "display": "Malignant neoplasm of lower-outer quadrant of left female breast"
          },
          {
            "code": "C50.519",
            "display": "Malignant neoplasm of lower-outer quadrant of unspecified female breast"
          },
          {
            "code": "C50.521",
            "display": "Malignant neoplasm of lower-outer quadrant of right male breast"
          },
          {
            "code": "C50.522",
            "display": "Malignant neoplasm of lower-outer quadrant of left male breast"
          },
          {
            "code": "C50.529",
            "display": "Malignant neoplasm of lower-outer quadrant of unspecified male breast"
          },
          {
            "code": "C50.611",
            "display": "Malignant neoplasm of axillary tail of right female breast"
          },
          {
            "code": "C50.612",
            "display": "Malignant neoplasm of axillary tail of left female breast"
          },
          {
            "code": "C50.619",
            "display": "Malignant neoplasm of axillary tail of unspecified female breast"
          },
          {
            "code": "C50.621",
            "display": "Malignant neoplasm of axillary tail of right male breast"
          },
          {
            "code": "C50.622",
            "display": "Malignant neoplasm of axillary tail of left male breast"
          },
          {
            "code": "C50.629",
            "display": "Malignant neoplasm of axillary tail of unspecified male breast"
          },
          {
            "code": "C50.811",
            "display": "Malignant neoplasm of overlapping sites of right female breast"
          },
          {
            "code": "C50.812",
            "display": "Malignant neoplasm of overlapping sites of left female breast"
          },
          {
            "code": "C50.819",
            "display": "Malignant neoplasm of overlapping sites of unspecified female breast"
          },
          {
            "code": "C50.821",
            "display": "Malignant neoplasm of overlapping sites of right male breast"
          },
          {
            "code": "C50.822",
            "display": "Malignant neoplasm of overlapping sites of left male breast"
          },
          {
            "code": "C50.829",
            "display": "Malignant neoplasm of overlapping sites of unspecified male breast"
          },
          {
            "code": "C50.911",
            "display": "Malignant neoplasm of unspecified site of right female breast"
          },
          {
            "code": "C50.912",
            "display": "Malignant neoplasm of unspecified site of left female breast"
          },
          {
            "code": "C50.919",
            "display": "Malignant neoplasm of unspecified site of unspecified female breast"
          },
          {
            "code": "C50.921",
            "display": "Malignant neoplasm of unspecified site of right male breast"
          },
          {
            "code": "C50.922",
            "display": "Malignant neoplasm of unspecified site of left male breast"
          },
          {
            "code": "C50.929",
            "display": "Malignant neoplasm of unspecified site of unspecified male breast"
          },
          {
            "code": "C51.0",
            "display": "Malignant neoplasm of labium majus"
          },
          {
            "code": "C51.1",
            "display": "Malignant neoplasm of labium minus"
          },
          {
            "code": "C51.2",
            "display": "Malignant neoplasm of clitoris"
          },
          {
            "code": "C51.8",
            "display": "Malignant neoplasm of overlapping sites of vulva"
          },
          {
            "code": "C51.9",
            "display": "Malignant neoplasm of vulva, unspecified"
          },
          {
            "code": "C52",
            "display": "Malignant neoplasm of vagina"
          },
          {
            "code": "C53.0",
            "display": "Malignant neoplasm of endocervix"
          },
          {
            "code": "C53.1",
            "display": "Malignant neoplasm of exocervix"
          },
          {
            "code": "C53.8",
            "display": "Malignant neoplasm of overlapping sites of cervix uteri"
          },
          {
            "code": "C53.9",
            "display": "Malignant neoplasm of cervix uteri, unspecified"
          },
          {
            "code": "C54.0",
            "display": "Malignant neoplasm of isthmus uteri"
          },
          {
            "code": "C54.1",
            "display": "Malignant neoplasm of endometrium"
          },
          {
            "code": "C54.2",
            "display": "Malignant neoplasm of myometrium"
          },
          {
            "code": "C54.3",
            "display": "Malignant neoplasm of fundus uteri"
          },
          {
            "code": "C54.8",
            "display": "Malignant neoplasm of overlapping sites of corpus uteri"
          },
          {
            "code": "C54.9",
            "display": "Malignant neoplasm of corpus uteri, unspecified"
          },
          {
            "code": "C55",
            "display": "Malignant neoplasm of uterus, part unspecified"
          },
          {
            "code": "C56.1",
            "display": "Malignant neoplasm of right ovary"
          },
          {
            "code": "C56.2",
            "display": "Malignant neoplasm of left ovary"
          },
          {
            "code": "C56.9",
            "display": "Malignant neoplasm of unspecified ovary"
          },
          {
            "code": "C57.00",
            "display": "Malignant neoplasm of unspecified fallopian tube"
          },
          {
            "code": "C57.01",
            "display": "Malignant neoplasm of right fallopian tube"
          },
          {
            "code": "C57.02",
            "display": "Malignant neoplasm of left fallopian tube"
          },
          {
            "code": "C57.10",
            "display": "Malignant neoplasm of unspecified broad ligament"
          },
          {
            "code": "C57.11",
            "display": "Malignant neoplasm of right broad ligament"
          },
          {
            "code": "C57.12",
            "display": "Malignant neoplasm of left broad ligament"
          },
          {
            "code": "C57.20",
            "display": "Malignant neoplasm of unspecified round ligament"
          },
          {
            "code": "C57.21",
            "display": "Malignant neoplasm of right round ligament"
          },
          {
            "code": "C57.22",
            "display": "Malignant neoplasm of left round ligament"
          },
          {
            "code": "C57.3",
            "display": "Malignant neoplasm of parametrium"
          },
          {
            "code": "C57.4",
            "display": "Malignant neoplasm of uterine adnexa, unspecified"
          },
          {
            "code": "C57.7",
            "display": "Malignant neoplasm of other specified female genital organs"
          },
          {
            "code": "C57.8",
            "display": "Malignant neoplasm of overlapping sites of female genital organs"
          },
          {
            "code": "C57.9",
            "display": "Malignant neoplasm of female genital organ, unspecified"
          },
          {
            "code": "C58",
            "display": "Malignant neoplasm of placenta"
          },
          {
            "code": "C60.0",
            "display": "Malignant neoplasm of prepuce"
          },
          {
            "code": "C60.1",
            "display": "Malignant neoplasm of glans penis"
          },
          {
            "code": "C60.2",
            "display": "Malignant neoplasm of body of penis"
          },
          {
            "code": "C60.8",
            "display": "Malignant neoplasm of overlapping sites of penis"
          },
          {
            "code": "C60.9",
            "display": "Malignant neoplasm of penis, unspecified"
          },
          {
            "code": "C61",
            "display": "Malignant neoplasm of prostate"
          },
          {
            "code": "C62.00",
            "display": "Malignant neoplasm of unspecified undescended testis"
          },
          {
            "code": "C62.01",
            "display": "Malignant neoplasm of undescended right testis"
          },
          {
            "code": "C62.02",
            "display": "Malignant neoplasm of undescended left testis"
          },
          {
            "code": "C62.10",
            "display": "Malignant neoplasm of unspecified descended testis"
          },
          {
            "code": "C62.11",
            "display": "Malignant neoplasm of descended right testis"
          },
          {
            "code": "C62.12",
            "display": "Malignant neoplasm of descended left testis"
          },
          {
            "code": "C62.90",
            "display": "Malignant neoplasm of unspecified testis, unspecified whether descended or undescended"
          },
          {
            "code": "C62.91",
            "display": "Malignant neoplasm of right testis, unspecified whether descended or undescended"
          },
          {
            "code": "C62.92",
            "display": "Malignant neoplasm of left testis, unspecified whether descended or undescended"
          },
          {
            "code": "C63.00",
            "display": "Malignant neoplasm of unspecified epididymis"
          },
          {
            "code": "C63.01",
            "display": "Malignant neoplasm of right epididymis"
          },
          {
            "code": "C63.02",
            "display": "Malignant neoplasm of left epididymis"
          },
          {
            "code": "C63.10",
            "display": "Malignant neoplasm of unspecified spermatic cord"
          },
          {
            "code": "C63.11",
            "display": "Malignant neoplasm of right spermatic cord"
          },
          {
            "code": "C63.12",
            "display": "Malignant neoplasm of left spermatic cord"
          },
          {
            "code": "C63.2",
            "display": "Malignant neoplasm of scrotum"
          },
          {
            "code": "C63.7",
            "display": "Malignant neoplasm of other specified male genital organs"
          },
          {
            "code": "C63.8",
            "display": "Malignant neoplasm of overlapping sites of male genital organs"
          },
          {
            "code": "C63.9",
            "display": "Malignant neoplasm of male genital organ, unspecified"
          },
          {
            "code": "C64.1",
            "display": "Malignant neoplasm of right kidney, except renal pelvis"
          },
          {
            "code": "C64.2",
            "display": "Malignant neoplasm of left kidney, except renal pelvis"
          },
          {
            "code": "C64.9",
            "display": "Malignant neoplasm of unspecified kidney, except renal pelvis"
          },
          {
            "code": "C65.1",
            "display": "Malignant neoplasm of right renal pelvis"
          },
          {
            "code": "C65.2",
            "display": "Malignant neoplasm of left renal pelvis"
          },
          {
            "code": "C65.9",
            "display": "Malignant neoplasm of unspecified renal pelvis"
          },
          {
            "code": "C66.1",
            "display": "Malignant neoplasm of right ureter"
          },
          {
            "code": "C66.2",
            "display": "Malignant neoplasm of left ureter"
          },
          {
            "code": "C66.9",
            "display": "Malignant neoplasm of unspecified ureter"
          },
          {
            "code": "C67.0",
            "display": "Malignant neoplasm of trigone of bladder"
          },
          {
            "code": "C67.1",
            "display": "Malignant neoplasm of dome of bladder"
          },
          {
            "code": "C67.2",
            "display": "Malignant neoplasm of lateral wall of bladder"
          },
          {
            "code": "C67.3",
            "display": "Malignant neoplasm of anterior wall of bladder"
          },
          {
            "code": "C67.4",
            "display": "Malignant neoplasm of posterior wall of bladder"
          },
          {
            "code": "C67.5",
            "display": "Malignant neoplasm of bladder neck"
          },
          {
            "code": "C67.6",
            "display": "Malignant neoplasm of ureteric orifice"
          },
          {
            "code": "C67.7",
            "display": "Malignant neoplasm of urachus"
          },
          {
            "code": "C67.8",
            "display": "Malignant neoplasm of overlapping sites of bladder"
          },
          {
            "code": "C67.9",
            "display": "Malignant neoplasm of bladder, unspecified"
          },
          {
            "code": "C68.0",
            "display": "Malignant neoplasm of urethra"
          },
          {
            "code": "C68.1",
            "display": "Malignant neoplasm of paraurethral glands"
          },
          {
            "code": "C68.8",
            "display": "Malignant neoplasm of overlapping sites of urinary organs"
          },
          {
            "code": "C68.9",
            "display": "Malignant neoplasm of urinary organ, unspecified"
          },
          {
            "code": "C69.00",
            "display": "Malignant neoplasm of unspecified conjunctiva"
          },
          {
            "code": "C69.01",
            "display": "Malignant neoplasm of right conjunctiva"
          },
          {
            "code": "C69.02",
            "display": "Malignant neoplasm of left conjunctiva"
          },
          {
            "code": "C69.10",
            "display": "Malignant neoplasm of unspecified cornea"
          },
          {
            "code": "C69.11",
            "display": "Malignant neoplasm of right cornea"
          },
          {
            "code": "C69.12",
            "display": "Malignant neoplasm of left cornea"
          },
          {
            "code": "C69.20",
            "display": "Malignant neoplasm of unspecified retina"
          },
          {
            "code": "C69.21",
            "display": "Malignant neoplasm of right retina"
          },
          {
            "code": "C69.22",
            "display": "Malignant neoplasm of left retina"
          },
          {
            "code": "C69.30",
            "display": "Malignant neoplasm of unspecified choroid"
          },
          {
            "code": "C69.31",
            "display": "Malignant neoplasm of right choroid"
          },
          {
            "code": "C69.32",
            "display": "Malignant neoplasm of left choroid"
          },
          {
            "code": "C69.40",
            "display": "Malignant neoplasm of unspecified ciliary body"
          },
          {
            "code": "C69.41",
            "display": "Malignant neoplasm of right ciliary body"
          },
          {
            "code": "C69.42",
            "display": "Malignant neoplasm of left ciliary body"
          },
          {
            "code": "C69.50",
            "display": "Malignant neoplasm of unspecified lacrimal gland and duct"
          },
          {
            "code": "C69.51",
            "display": "Malignant neoplasm of right lacrimal gland and duct"
          },
          {
            "code": "C69.52",
            "display": "Malignant neoplasm of left lacrimal gland and duct"
          },
          {
            "code": "C69.60",
            "display": "Malignant neoplasm of unspecified orbit"
          },
          {
            "code": "C69.61",
            "display": "Malignant neoplasm of right orbit"
          },
          {
            "code": "C69.62",
            "display": "Malignant neoplasm of left orbit"
          },
          {
            "code": "C69.80",
            "display": "Malignant neoplasm of overlapping sites of unspecified eye and adnexa"
          },
          {
            "code": "C69.81",
            "display": "Malignant neoplasm of overlapping sites of right eye and adnexa"
          },
          {
            "code": "C69.82",
            "display": "Malignant neoplasm of overlapping sites of left eye and adnexa"
          },
          {
            "code": "C69.90",
            "display": "Malignant neoplasm of unspecified site of unspecified eye"
          },
          {
            "code": "C69.91",
            "display": "Malignant neoplasm of unspecified site of right eye"
          },
          {
            "code": "C69.92",
            "display": "Malignant neoplasm of unspecified site of left eye"
          },
          {
            "code": "C70.0",
            "display": "Malignant neoplasm of cerebral meninges"
          },
          {
            "code": "C70.1",
            "display": "Malignant neoplasm of spinal meninges"
          },
          {
            "code": "C70.9",
            "display": "Malignant neoplasm of meninges, unspecified"
          },
          {
            "code": "C71.0",
            "display": "Malignant neoplasm of cerebrum, except lobes and ventricles"
          },
          {
            "code": "C71.1",
            "display": "Malignant neoplasm of frontal lobe"
          },
          {
            "code": "C71.2",
            "display": "Malignant neoplasm of temporal lobe"
          },
          {
            "code": "C71.3",
            "display": "Malignant neoplasm of parietal lobe"
          },
          {
            "code": "C71.4",
            "display": "Malignant neoplasm of occipital lobe"
          },
          {
            "code": "C71.5",
            "display": "Malignant neoplasm of cerebral ventricle"
          },
          {
            "code": "C71.6",
            "display": "Malignant neoplasm of cerebellum"
          },
          {
            "code": "C71.7",
            "display": "Malignant neoplasm of brain stem"
          },
          {
            "code": "C71.8",
            "display": "Malignant neoplasm of overlapping sites of brain"
          },
          {
            "code": "C71.9",
            "display": "Malignant neoplasm of brain, unspecified"
          },
          {
            "code": "C72.0",
            "display": "Malignant neoplasm of spinal cord"
          },
          {
            "code": "C72.1",
            "display": "Malignant neoplasm of cauda equina"
          },
          {
            "code": "C72.20",
            "display": "Malignant neoplasm of unspecified olfactory nerve"
          },
          {
            "code": "C72.21",
            "display": "Malignant neoplasm of right olfactory nerve"
          },
          {
            "code": "C72.22",
            "display": "Malignant neoplasm of left olfactory nerve"
          },
          {
            "code": "C72.30",
            "display": "Malignant neoplasm of unspecified optic nerve"
          },
          {
            "code": "C72.31",
            "display": "Malignant neoplasm of right optic nerve"
          },
          {
            "code": "C72.32",
            "display": "Malignant neoplasm of left optic nerve"
          },
          {
            "code": "C72.40",
            "display": "Malignant neoplasm of unspecified acoustic nerve"
          },
          {
            "code": "C72.41",
            "display": "Malignant neoplasm of right acoustic nerve"
          },
          {
            "code": "C72.42",
            "display": "Malignant neoplasm of left acoustic nerve"
          },
          {
            "code": "C72.50",
            "display": "Malignant neoplasm of unspecified cranial nerve"
          },
          {
            "code": "C72.59",
            "display": "Malignant neoplasm of other cranial nerves"
          },
          {
            "code": "C72.9",
            "display": "Malignant neoplasm of central nervous system, unspecified"
          },
          {
            "code": "C73",
            "display": "Malignant neoplasm of thyroid gland"
          },
          {
            "code": "C74.00",
            "display": "Malignant neoplasm of cortex of unspecified adrenal gland"
          },
          {
            "code": "C74.01",
            "display": "Malignant neoplasm of cortex of right adrenal gland"
          },
          {
            "code": "C74.02",
            "display": "Malignant neoplasm of cortex of left adrenal gland"
          },
          {
            "code": "C74.10",
            "display": "Malignant neoplasm of medulla of unspecified adrenal gland"
          },
          {
            "code": "C74.11",
            "display": "Malignant neoplasm of medulla of right adrenal gland"
          },
          {
            "code": "C74.12",
            "display": "Malignant neoplasm of medulla of left adrenal gland"
          },
          {
            "code": "C74.90",
            "display": "Malignant neoplasm of unspecified part of unspecified adrenal gland"
          },
          {
            "code": "C74.91",
            "display": "Malignant neoplasm of unspecified part of right adrenal gland"
          },
          {
            "code": "C74.92",
            "display": "Malignant neoplasm of unspecified part of left adrenal gland"
          },
          {
            "code": "C75.0",
            "display": "Malignant neoplasm of parathyroid gland"
          },
          {
            "code": "C75.1",
            "display": "Malignant neoplasm of pituitary gland"
          },
          {
            "code": "C75.2",
            "display": "Malignant neoplasm of craniopharyngeal duct"
          },
          {
            "code": "C75.3",
            "display": "Malignant neoplasm of pineal gland"
          },
          {
            "code": "C75.4",
            "display": "Malignant neoplasm of carotid body"
          },
          {
            "code": "C75.5",
            "display": "Malignant neoplasm of aortic body and other paraganglia"
          },
          {
            "code": "C75.8",
            "display": "Malignant neoplasm with pluriglandular involvement, unspecified"
          },
          {
            "code": "C75.9",
            "display": "Malignant neoplasm of endocrine gland, unspecified"
          },
          {
            "code": "C76.0",
            "display": "Malignant neoplasm of head, face and neck"
          },
          {
            "code": "C76.1",
            "display": "Malignant neoplasm of thorax"
          },
          {
            "code": "C76.2",
            "display": "Malignant neoplasm of abdomen"
          },
          {
            "code": "C76.3",
            "display": "Malignant neoplasm of pelvis"
          },
          {
            "code": "C76.40",
            "display": "Malignant neoplasm of unspecified upper limb"
          },
          {
            "code": "C76.41",
            "display": "Malignant neoplasm of right upper limb"
          },
          {
            "code": "C76.42",
            "display": "Malignant neoplasm of left upper limb"
          },
          {
            "code": "C76.50",
            "display": "Malignant neoplasm of unspecified lower limb"
          },
          {
            "code": "C76.51",
            "display": "Malignant neoplasm of right lower limb"
          },
          {
            "code": "C76.52",
            "display": "Malignant neoplasm of left lower limb"
          },
          {
            "code": "C76.8",
            "display": "Malignant neoplasm of other specified ill-defined sites"
          },
          {
            "code": "C77.0",
            "display": "Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck"
          },
          {
            "code": "C77.1",
            "display": "Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes"
          },
          {
            "code": "C77.2",
            "display": "Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes"
          },
          {
            "code": "C77.3",
            "display": "Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes"
          },
          {
            "code": "C77.4",
            "display": "Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes"
          },
          {
            "code": "C77.5",
            "display": "Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes"
          },
          {
            "code": "C77.8",
            "display": "Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"
          },
          {
            "code": "C77.9",
            "display": "Secondary and unspecified malignant neoplasm of lymph node, unspecified"
          },
          {
            "code": "C78.00",
            "display": "Secondary malignant neoplasm of unspecified lung"
          },
          {
            "code": "C78.01",
            "display": "Secondary malignant neoplasm of right lung"
          },
          {
            "code": "C78.02",
            "display": "Secondary malignant neoplasm of left lung"
          },
          {
            "code": "C78.1",
            "display": "Secondary malignant neoplasm of mediastinum"
          },
          {
            "code": "C78.2",
            "display": "Secondary malignant neoplasm of pleura"
          },
          {
            "code": "C78.30",
            "display": "Secondary malignant neoplasm of unspecified respiratory organ"
          },
          {
            "code": "C78.39",
            "display": "Secondary malignant neoplasm of other respiratory organs"
          },
          {
            "code": "C78.4",
            "display": "Secondary malignant neoplasm of small intestine"
          },
          {
            "code": "C78.5",
            "display": "Secondary malignant neoplasm of large intestine and rectum"
          },
          {
            "code": "C78.6",
            "display": "Secondary malignant neoplasm of retroperitoneum and peritoneum"
          },
          {
            "code": "C78.7",
            "display": "Secondary malignant neoplasm of liver and intrahepatic bile duct"
          },
          {
            "code": "C78.80",
            "display": "Secondary malignant neoplasm of unspecified digestive organ"
          },
          {
            "code": "C78.89",
            "display": "Secondary malignant neoplasm of other digestive organs"
          },
          {
            "code": "C79.00",
            "display": "Secondary malignant neoplasm of unspecified kidney and renal pelvis"
          },
          {
            "code": "C79.01",
            "display": "Secondary malignant neoplasm of right kidney and renal pelvis"
          },
          {
            "code": "C79.02",
            "display": "Secondary malignant neoplasm of left kidney and renal pelvis"
          },
          {
            "code": "C79.10",
            "display": "Secondary malignant neoplasm of unspecified urinary organs"
          },
          {
            "code": "C79.11",
            "display": "Secondary malignant neoplasm of bladder"
          },
          {
            "code": "C79.19",
            "display": "Secondary malignant neoplasm of other urinary organs"
          },
          {
            "code": "C79.2",
            "display": "Secondary malignant neoplasm of skin"
          },
          {
            "code": "C79.31",
            "display": "Secondary malignant neoplasm of brain"
          },
          {
            "code": "C79.32",
            "display": "Secondary malignant neoplasm of cerebral meninges"
          },
          {
            "code": "C79.40",
            "display": "Secondary malignant neoplasm of unspecified part of nervous system"
          },
          {
            "code": "C79.49",
            "display": "Secondary malignant neoplasm of other parts of nervous system"
          },
          {
            "code": "C79.51",
            "display": "Secondary malignant neoplasm of bone"
          },
          {
            "code": "C79.52",
            "display": "Secondary malignant neoplasm of bone marrow"
          },
          {
            "code": "C79.60",
            "display": "Secondary malignant neoplasm of unspecified ovary"
          },
          {
            "code": "C79.61",
            "display": "Secondary malignant neoplasm of right ovary"
          },
          {
            "code": "C79.62",
            "display": "Secondary malignant neoplasm of left ovary"
          },
          {
            "code": "C79.70",
            "display": "Secondary malignant neoplasm of unspecified adrenal gland"
          },
          {
            "code": "C79.71",
            "display": "Secondary malignant neoplasm of right adrenal gland"
          },
          {
            "code": "C79.72",
            "display": "Secondary malignant neoplasm of left adrenal gland"
          },
          {
            "code": "C79.81",
            "display": "Secondary malignant neoplasm of breast"
          },
          {
            "code": "C79.82",
            "display": "Secondary malignant neoplasm of genital organs"
          },
          {
            "code": "C79.89",
            "display": "Secondary malignant neoplasm of other specified sites"
          },
          {
            "code": "C79.9",
            "display": "Secondary malignant neoplasm of unspecified site"
          },
          {
            "code": "C7A.00",
            "display": "Malignant carcinoid tumor of unspecified site"
          },
          {
            "code": "C7A.010",
            "display": "Malignant carcinoid tumor of the duodenum"
          },
          {
            "code": "C7A.011",
            "display": "Malignant carcinoid tumor of the jejunum"
          },
          {
            "code": "C7A.012",
            "display": "Malignant carcinoid tumor of the ileum"
          },
          {
            "code": "C7A.019",
            "display": "Malignant carcinoid tumor of the small intestine, unspecified portion"
          },
          {
            "code": "C7A.020",
            "display": "Malignant carcinoid tumor of the appendix"
          },
          {
            "code": "C7A.021",
            "display": "Malignant carcinoid tumor of the cecum"
          },
          {
            "code": "C7A.022",
            "display": "Malignant carcinoid tumor of the ascending colon"
          },
          {
            "code": "C7A.023",
            "display": "Malignant carcinoid tumor of the transverse colon"
          },
          {
            "code": "C7A.024",
            "display": "Malignant carcinoid tumor of the descending colon"
          },
          {
            "code": "C7A.025",
            "display": "Malignant carcinoid tumor of the sigmoid colon"
          },
          {
            "code": "C7A.026",
            "display": "Malignant carcinoid tumor of the rectum"
          },
          {
            "code": "C7A.029",
            "display": "Malignant carcinoid tumor of the large intestine, unspecified portion"
          },
          {
            "code": "C7A.090",
            "display": "Malignant carcinoid tumor of the bronchus and lung"
          },
          {
            "code": "C7A.091",
            "display": "Malignant carcinoid tumor of the thymus"
          },
          {
            "code": "C7A.092",
            "display": "Malignant carcinoid tumor of the stomach"
          },
          {
            "code": "C7A.093",
            "display": "Malignant carcinoid tumor of the kidney"
          },
          {
            "code": "C7A.094",
            "display": "Malignant carcinoid tumor of the foregut, unspecified"
          },
          {
            "code": "C7A.095",
            "display": "Malignant carcinoid tumor of the midgut, unspecified"
          },
          {
            "code": "C7A.096",
            "display": "Malignant carcinoid tumor of the hindgut, unspecified"
          },
          {
            "code": "C7A.098",
            "display": "Malignant carcinoid tumors of other sites"
          },
          {
            "code": "C7A.1",
            "display": "Malignant poorly differentiated neuroendocrine tumors"
          },
          {
            "code": "C7A.8",
            "display": "Other malignant neuroendocrine tumors"
          },
          {
            "code": "C7B.00",
            "display": "Secondary carcinoid tumors, unspecified site"
          },
          {
            "code": "C7B.01",
            "display": "Secondary carcinoid tumors of distant lymph nodes"
          },
          {
            "code": "C7B.02",
            "display": "Secondary carcinoid tumors of liver"
          },
          {
            "code": "C7B.03",
            "display": "Secondary carcinoid tumors of bone"
          },
          {
            "code": "C7B.04",
            "display": "Secondary carcinoid tumors of peritoneum"
          },
          {
            "code": "C7B.09",
            "display": "Secondary carcinoid tumors of other sites"
          },
          {
            "code": "C7B.1",
            "display": "Secondary Merkel cell carcinoma"
          },
          {
            "code": "C7B.8",
            "display": "Other secondary neuroendocrine tumors"
          },
          {
            "code": "C80.0",
            "display": "Disseminated malignant neoplasm, unspecified"
          },
          {
            "code": "C80.1",
            "display": "Malignant (primary) neoplasm, unspecified"
          },
          {
            "code": "C80.2",
            "display": "Malignant neoplasm associated with transplanted organ"
          },
          {
            "code": "C81.00",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.01",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.02",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.03",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.04",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.05",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.06",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.07",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.08",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.09",
            "display": "Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.10",
            "display": "Nodular sclerosis Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.11",
            "display": "Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.12",
            "display": "Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.13",
            "display": "Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.14",
            "display": "Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.15",
            "display": "Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.16",
            "display": "Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.17",
            "display": "Nodular sclerosis Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.18",
            "display": "Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.19",
            "display": "Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.20",
            "display": "Mixed cellularity Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.21",
            "display": "Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.22",
            "display": "Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.23",
            "display": "Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.24",
            "display": "Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.25",
            "display": "Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.26",
            "display": "Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.27",
            "display": "Mixed cellularity Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.28",
            "display": "Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.29",
            "display": "Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.30",
            "display": "Lymphocyte depleted Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.31",
            "display": "Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.32",
            "display": "Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.33",
            "display": "Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.34",
            "display": "Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.35",
            "display": "Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.36",
            "display": "Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.37",
            "display": "Lymphocyte depleted Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.38",
            "display": "Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.39",
            "display": "Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.40",
            "display": "Lymphocyte-rich Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.41",
            "display": "Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.42",
            "display": "Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.43",
            "display": "Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.44",
            "display": "Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.45",
            "display": "Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.46",
            "display": "Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.47",
            "display": "Lymphocyte-rich Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.48",
            "display": "Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.49",
            "display": "Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.70",
            "display": "Other Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C81.71",
            "display": "Other Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.72",
            "display": "Other Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C81.73",
            "display": "Other Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.74",
            "display": "Other Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.75",
            "display": "Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.76",
            "display": "Other Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C81.77",
            "display": "Other Hodgkin lymphoma, spleen"
          },
          {
            "code": "C81.78",
            "display": "Other Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C81.79",
            "display": "Other Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C81.90",
            "display": "Hodgkin lymphoma, unspecified, unspecified site"
          },
          {
            "code": "C81.91",
            "display": "Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C81.92",
            "display": "Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C81.93",
            "display": "Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C81.94",
            "display": "Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C81.95",
            "display": "Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C81.96",
            "display": "Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C81.97",
            "display": "Hodgkin lymphoma, unspecified, spleen"
          },
          {
            "code": "C81.98",
            "display": "Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C81.99",
            "display": "Hodgkin lymphoma, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C82.00",
            "display": "Follicular lymphoma grade I, unspecified site"
          },
          {
            "code": "C82.01",
            "display": "Follicular lymphoma grade I, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.02",
            "display": "Follicular lymphoma grade I, intrathoracic lymph nodes"
          },
          {
            "code": "C82.03",
            "display": "Follicular lymphoma grade I, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.04",
            "display": "Follicular lymphoma grade I, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.05",
            "display": "Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.06",
            "display": "Follicular lymphoma grade I, intrapelvic lymph nodes"
          },
          {
            "code": "C82.07",
            "display": "Follicular lymphoma grade I, spleen"
          },
          {
            "code": "C82.08",
            "display": "Follicular lymphoma grade I, lymph nodes of multiple sites"
          },
          {
            "code": "C82.09",
            "display": "Follicular lymphoma grade I, extranodal and solid organ sites"
          },
          {
            "code": "C82.10",
            "display": "Follicular lymphoma grade II, unspecified site"
          },
          {
            "code": "C82.11",
            "display": "Follicular lymphoma grade II, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.12",
            "display": "Follicular lymphoma grade II, intrathoracic lymph nodes"
          },
          {
            "code": "C82.13",
            "display": "Follicular lymphoma grade II, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.14",
            "display": "Follicular lymphoma grade II, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.15",
            "display": "Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.16",
            "display": "Follicular lymphoma grade II, intrapelvic lymph nodes"
          },
          {
            "code": "C82.17",
            "display": "Follicular lymphoma grade II, spleen"
          },
          {
            "code": "C82.18",
            "display": "Follicular lymphoma grade II, lymph nodes of multiple sites"
          },
          {
            "code": "C82.19",
            "display": "Follicular lymphoma grade II, extranodal and solid organ sites"
          },
          {
            "code": "C82.20",
            "display": "Follicular lymphoma grade III, unspecified, unspecified site"
          },
          {
            "code": "C82.21",
            "display": "Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.22",
            "display": "Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C82.23",
            "display": "Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.24",
            "display": "Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.25",
            "display": "Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.26",
            "display": "Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C82.27",
            "display": "Follicular lymphoma grade III, unspecified, spleen"
          },
          {
            "code": "C82.28",
            "display": "Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C82.29",
            "display": "Follicular lymphoma grade III, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C82.30",
            "display": "Follicular lymphoma grade IIIa, unspecified site"
          },
          {
            "code": "C82.31",
            "display": "Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.32",
            "display": "Follicular lymphoma grade IIIa, intrathoracic lymph nodes"
          },
          {
            "code": "C82.33",
            "display": "Follicular lymphoma grade IIIa, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.34",
            "display": "Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.35",
            "display": "Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.36",
            "display": "Follicular lymphoma grade IIIa, intrapelvic lymph nodes"
          },
          {
            "code": "C82.37",
            "display": "Follicular lymphoma grade IIIa, spleen"
          },
          {
            "code": "C82.38",
            "display": "Follicular lymphoma grade IIIa, lymph nodes of multiple sites"
          },
          {
            "code": "C82.39",
            "display": "Follicular lymphoma grade IIIa, extranodal and solid organ sites"
          },
          {
            "code": "C82.40",
            "display": "Follicular lymphoma grade IIIb, unspecified site"
          },
          {
            "code": "C82.41",
            "display": "Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.42",
            "display": "Follicular lymphoma grade IIIb, intrathoracic lymph nodes"
          },
          {
            "code": "C82.43",
            "display": "Follicular lymphoma grade IIIb, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.44",
            "display": "Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.45",
            "display": "Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.46",
            "display": "Follicular lymphoma grade IIIb, intrapelvic lymph nodes"
          },
          {
            "code": "C82.47",
            "display": "Follicular lymphoma grade IIIb, spleen"
          },
          {
            "code": "C82.48",
            "display": "Follicular lymphoma grade IIIb, lymph nodes of multiple sites"
          },
          {
            "code": "C82.49",
            "display": "Follicular lymphoma grade IIIb, extranodal and solid organ sites"
          },
          {
            "code": "C82.50",
            "display": "Diffuse follicle center lymphoma, unspecified site"
          },
          {
            "code": "C82.51",
            "display": "Diffuse follicle center lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.52",
            "display": "Diffuse follicle center lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C82.53",
            "display": "Diffuse follicle center lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.54",
            "display": "Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.55",
            "display": "Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.56",
            "display": "Diffuse follicle center lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C82.57",
            "display": "Diffuse follicle center lymphoma, spleen"
          },
          {
            "code": "C82.58",
            "display": "Diffuse follicle center lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C82.59",
            "display": "Diffuse follicle center lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C82.60",
            "display": "Cutaneous follicle center lymphoma, unspecified site"
          },
          {
            "code": "C82.61",
            "display": "Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.62",
            "display": "Cutaneous follicle center lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C82.63",
            "display": "Cutaneous follicle center lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.64",
            "display": "Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.65",
            "display": "Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.66",
            "display": "Cutaneous follicle center lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C82.67",
            "display": "Cutaneous follicle center lymphoma, spleen"
          },
          {
            "code": "C82.68",
            "display": "Cutaneous follicle center lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C82.69",
            "display": "Cutaneous follicle center lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C82.80",
            "display": "Other types of follicular lymphoma, unspecified site"
          },
          {
            "code": "C82.81",
            "display": "Other types of follicular lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.82",
            "display": "Other types of follicular lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C82.83",
            "display": "Other types of follicular lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.84",
            "display": "Other types of follicular lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.85",
            "display": "Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.86",
            "display": "Other types of follicular lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C82.87",
            "display": "Other types of follicular lymphoma, spleen"
          },
          {
            "code": "C82.88",
            "display": "Other types of follicular lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C82.89",
            "display": "Other types of follicular lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C82.90",
            "display": "Follicular lymphoma, unspecified, unspecified site"
          },
          {
            "code": "C82.91",
            "display": "Follicular lymphoma, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C82.92",
            "display": "Follicular lymphoma, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C82.93",
            "display": "Follicular lymphoma, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C82.94",
            "display": "Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C82.95",
            "display": "Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C82.96",
            "display": "Follicular lymphoma, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C82.97",
            "display": "Follicular lymphoma, unspecified, spleen"
          },
          {
            "code": "C82.98",
            "display": "Follicular lymphoma, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C82.99",
            "display": "Follicular lymphoma, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C83.00",
            "display": "Small cell B-cell lymphoma, unspecified site"
          },
          {
            "code": "C83.01",
            "display": "Small cell B-cell lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.02",
            "display": "Small cell B-cell lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.03",
            "display": "Small cell B-cell lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.04",
            "display": "Small cell B-cell lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.05",
            "display": "Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.06",
            "display": "Small cell B-cell lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.07",
            "display": "Small cell B-cell lymphoma, spleen"
          },
          {
            "code": "C83.08",
            "display": "Small cell B-cell lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.09",
            "display": "Small cell B-cell lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.10",
            "display": "Mantle cell lymphoma, unspecified site"
          },
          {
            "code": "C83.11",
            "display": "Mantle cell lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.12",
            "display": "Mantle cell lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.13",
            "display": "Mantle cell lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.14",
            "display": "Mantle cell lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.15",
            "display": "Mantle cell lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.16",
            "display": "Mantle cell lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.17",
            "display": "Mantle cell lymphoma, spleen"
          },
          {
            "code": "C83.18",
            "display": "Mantle cell lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.19",
            "display": "Mantle cell lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.30",
            "display": "Diffuse large B-cell lymphoma, unspecified site"
          },
          {
            "code": "C83.31",
            "display": "Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.32",
            "display": "Diffuse large B-cell lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.33",
            "display": "Diffuse large B-cell lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.34",
            "display": "Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.35",
            "display": "Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.36",
            "display": "Diffuse large B-cell lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.37",
            "display": "Diffuse large B-cell lymphoma, spleen"
          },
          {
            "code": "C83.38",
            "display": "Diffuse large B-cell lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.39",
            "display": "Diffuse large B-cell lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.50",
            "display": "Lymphoblastic (diffuse) lymphoma, unspecified site"
          },
          {
            "code": "C83.51",
            "display": "Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.52",
            "display": "Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.53",
            "display": "Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.54",
            "display": "Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.55",
            "display": "Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.56",
            "display": "Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.57",
            "display": "Lymphoblastic (diffuse) lymphoma, spleen"
          },
          {
            "code": "C83.58",
            "display": "Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.59",
            "display": "Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.70",
            "display": "Burkitt lymphoma, unspecified site"
          },
          {
            "code": "C83.71",
            "display": "Burkitt lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.72",
            "display": "Burkitt lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.73",
            "display": "Burkitt lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.74",
            "display": "Burkitt lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.75",
            "display": "Burkitt lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.76",
            "display": "Burkitt lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.77",
            "display": "Burkitt lymphoma, spleen"
          },
          {
            "code": "C83.78",
            "display": "Burkitt lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.79",
            "display": "Burkitt lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.80",
            "display": "Other non-follicular lymphoma, unspecified site"
          },
          {
            "code": "C83.81",
            "display": "Other non-follicular lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.82",
            "display": "Other non-follicular lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C83.83",
            "display": "Other non-follicular lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.84",
            "display": "Other non-follicular lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.85",
            "display": "Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.86",
            "display": "Other non-follicular lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C83.87",
            "display": "Other non-follicular lymphoma, spleen"
          },
          {
            "code": "C83.88",
            "display": "Other non-follicular lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C83.89",
            "display": "Other non-follicular lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C83.90",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, unspecified site"
          },
          {
            "code": "C83.91",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C83.92",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C83.93",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C83.94",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C83.95",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C83.96",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C83.97",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, spleen"
          },
          {
            "code": "C83.98",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C83.99",
            "display": "Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C84.00",
            "display": "Mycosis fungoides, unspecified site"
          },
          {
            "code": "C84.01",
            "display": "Mycosis fungoides, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.02",
            "display": "Mycosis fungoides, intrathoracic lymph nodes"
          },
          {
            "code": "C84.03",
            "display": "Mycosis fungoides, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.04",
            "display": "Mycosis fungoides, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.05",
            "display": "Mycosis fungoides, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.06",
            "display": "Mycosis fungoides, intrapelvic lymph nodes"
          },
          {
            "code": "C84.07",
            "display": "Mycosis fungoides, spleen"
          },
          {
            "code": "C84.08",
            "display": "Mycosis fungoides, lymph nodes of multiple sites"
          },
          {
            "code": "C84.09",
            "display": "Mycosis fungoides, extranodal and solid organ sites"
          },
          {
            "code": "C84.10",
            "display": "Szary disease, unspecified site"
          },
          {
            "code": "C84.11",
            "display": "Szary disease, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.12",
            "display": "Szary disease, intrathoracic lymph nodes"
          },
          {
            "code": "C84.13",
            "display": "Szary disease, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.14",
            "display": "Szary disease, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.15",
            "display": "Szary disease, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.16",
            "display": "Szary disease, intrapelvic lymph nodes"
          },
          {
            "code": "C84.17",
            "display": "Szary disease, spleen"
          },
          {
            "code": "C84.18",
            "display": "Szary disease, lymph nodes of multiple sites"
          },
          {
            "code": "C84.19",
            "display": "Szary disease, extranodal and solid organ sites"
          },
          {
            "code": "C84.40",
            "display": "Peripheral T-cell lymphoma, not classified, unspecified site"
          },
          {
            "code": "C84.41",
            "display": "Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.42",
            "display": "Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes"
          },
          {
            "code": "C84.43",
            "display": "Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.44",
            "display": "Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.45",
            "display": "Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.46",
            "display": "Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes"
          },
          {
            "code": "C84.47",
            "display": "Peripheral T-cell lymphoma, not classified, spleen"
          },
          {
            "code": "C84.48",
            "display": "Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites"
          },
          {
            "code": "C84.49",
            "display": "Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites"
          },
          {
            "code": "C84.60",
            "display": "Anaplastic large cell lymphoma, ALK-positive, unspecified site"
          },
          {
            "code": "C84.61",
            "display": "Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.62",
            "display": "Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes"
          },
          {
            "code": "C84.63",
            "display": "Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.64",
            "display": "Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.65",
            "display": "Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.66",
            "display": "Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes"
          },
          {
            "code": "C84.67",
            "display": "Anaplastic large cell lymphoma, ALK-positive, spleen"
          },
          {
            "code": "C84.68",
            "display": "Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites"
          },
          {
            "code": "C84.69",
            "display": "Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites"
          },
          {
            "code": "C84.70",
            "display": "Anaplastic large cell lymphoma, ALK-negative, unspecified site"
          },
          {
            "code": "C84.71",
            "display": "Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.72",
            "display": "Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes"
          },
          {
            "code": "C84.73",
            "display": "Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.74",
            "display": "Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.75",
            "display": "Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.76",
            "display": "Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes"
          },
          {
            "code": "C84.77",
            "display": "Anaplastic large cell lymphoma, ALK-negative, spleen"
          },
          {
            "code": "C84.78",
            "display": "Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites"
          },
          {
            "code": "C84.79",
            "display": "Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites"
          },
          {
            "code": "C84.90",
            "display": "Mature T/NK-cell lymphomas, unspecified, unspecified site"
          },
          {
            "code": "C84.91",
            "display": "Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.92",
            "display": "Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C84.93",
            "display": "Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.94",
            "display": "Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.95",
            "display": "Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.96",
            "display": "Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C84.97",
            "display": "Mature T/NK-cell lymphomas, unspecified, spleen"
          },
          {
            "code": "C84.98",
            "display": "Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C84.99",
            "display": "Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C84.A0",
            "display": "Cutaneous T-cell lymphoma, unspecified, unspecified site"
          },
          {
            "code": "C84.A1",
            "display": "Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.A2",
            "display": "Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C84.A3",
            "display": "Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.A4",
            "display": "Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.A5",
            "display": "Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.A6",
            "display": "Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C84.A7",
            "display": "Cutaneous T-cell lymphoma, unspecified, spleen"
          },
          {
            "code": "C84.A8",
            "display": "Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C84.A9",
            "display": "Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C84.Z0",
            "display": "Other mature T/NK-cell lymphomas, unspecified site"
          },
          {
            "code": "C84.Z1",
            "display": "Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck"
          },
          {
            "code": "C84.Z2",
            "display": "Other mature T/NK-cell lymphomas, intrathoracic lymph nodes"
          },
          {
            "code": "C84.Z3",
            "display": "Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes"
          },
          {
            "code": "C84.Z4",
            "display": "Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C84.Z5",
            "display": "Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C84.Z6",
            "display": "Other mature T/NK-cell lymphomas, intrapelvic lymph nodes"
          },
          {
            "code": "C84.Z7",
            "display": "Other mature T/NK-cell lymphomas, spleen"
          },
          {
            "code": "C84.Z8",
            "display": "Other mature T/NK-cell lymphomas, lymph nodes of multiple sites"
          },
          {
            "code": "C84.Z9",
            "display": "Other mature T/NK-cell lymphomas, extranodal and solid organ sites"
          },
          {
            "code": "C85.10",
            "display": "Unspecified B-cell lymphoma, unspecified site"
          },
          {
            "code": "C85.11",
            "display": "Unspecified B-cell lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C85.12",
            "display": "Unspecified B-cell lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C85.13",
            "display": "Unspecified B-cell lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C85.14",
            "display": "Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C85.15",
            "display": "Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C85.16",
            "display": "Unspecified B-cell lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C85.17",
            "display": "Unspecified B-cell lymphoma, spleen"
          },
          {
            "code": "C85.18",
            "display": "Unspecified B-cell lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C85.19",
            "display": "Unspecified B-cell lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C85.20",
            "display": "Mediastinal (thymic) large B-cell lymphoma, unspecified site"
          },
          {
            "code": "C85.21",
            "display": "Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C85.22",
            "display": "Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C85.23",
            "display": "Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C85.24",
            "display": "Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C85.25",
            "display": "Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C85.26",
            "display": "Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C85.27",
            "display": "Mediastinal (thymic) large B-cell lymphoma, spleen"
          },
          {
            "code": "C85.28",
            "display": "Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C85.29",
            "display": "Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C85.80",
            "display": "Other specified types of non-Hodgkin lymphoma, unspecified site"
          },
          {
            "code": "C85.81",
            "display": "Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck"
          },
          {
            "code": "C85.82",
            "display": "Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes"
          },
          {
            "code": "C85.83",
            "display": "Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes"
          },
          {
            "code": "C85.84",
            "display": "Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C85.85",
            "display": "Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C85.86",
            "display": "Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes"
          },
          {
            "code": "C85.87",
            "display": "Other specified types of non-Hodgkin lymphoma, spleen"
          },
          {
            "code": "C85.88",
            "display": "Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites"
          },
          {
            "code": "C85.89",
            "display": "Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites"
          },
          {
            "code": "C85.90",
            "display": "Non-Hodgkin lymphoma, unspecified, unspecified site"
          },
          {
            "code": "C85.91",
            "display": "Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"
          },
          {
            "code": "C85.92",
            "display": "Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"
          },
          {
            "code": "C85.93",
            "display": "Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"
          },
          {
            "code": "C85.94",
            "display": "Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"
          },
          {
            "code": "C85.95",
            "display": "Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"
          },
          {
            "code": "C85.96",
            "display": "Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"
          },
          {
            "code": "C85.97",
            "display": "Non-Hodgkin lymphoma, unspecified, spleen"
          },
          {
            "code": "C85.98",
            "display": "Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"
          },
          {
            "code": "C85.99",
            "display": "Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites"
          },
          {
            "code": "C86.0",
            "display": "Extranodal NK/T-cell lymphoma, nasal type"
          },
          {
            "code": "C86.1",
            "display": "Hepatosplenic T-cell lymphoma"
          },
          {
            "code": "C86.2",
            "display": "Enteropathy-type (intestinal) T-cell lymphoma"
          },
          {
            "code": "C86.3",
            "display": "Subcutaneous panniculitis-like T-cell lymphoma"
          },
          {
            "code": "C86.4",
            "display": "Blastic NK-cell lymphoma"
          },
          {
            "code": "C86.5",
            "display": "Angioimmunoblastic T-cell lymphoma"
          },
          {
            "code": "C86.6",
            "display": "Primary cutaneous CD30-positive T-cell proliferations"
          },
          {
            "code": "C88.0",
            "display": "Waldenstrm macroglobulinemia"
          },
          {
            "code": "C88.2",
            "display": "Heavy chain disease"
          },
          {
            "code": "C88.3",
            "display": "Immunoproliferative small intestinal disease"
          },
          {
            "code": "C88.4",
            "display": "Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]"
          },
          {
            "code": "C88.8",
            "display": "Other malignant immunoproliferative diseases"
          },
          {
            "code": "C88.9",
            "display": "Malignant immunoproliferative disease, unspecified"
          },
          {
            "code": "C90.00",
            "display": "Multiple myeloma not having achieved remission"
          },
          {
            "code": "C90.01",
            "display": "Multiple myeloma in remission"
          },
          {
            "code": "C90.02",
            "display": "Multiple myeloma in relapse"
          },
          {
            "code": "C90.10",
            "display": "Plasma cell leukemia not having achieved remission"
          },
          {
            "code": "C90.11",
            "display": "Plasma cell leukemia in remission"
          },
          {
            "code": "C90.12",
            "display": "Plasma cell leukemia in relapse"
          },
          {
            "code": "C90.20",
            "display": "Extramedullary plasmacytoma not having achieved remission"
          },
          {
            "code": "C90.21",
            "display": "Extramedullary plasmacytoma in remission"
          },
          {
            "code": "C90.22",
            "display": "Extramedullary plasmacytoma in relapse"
          },
          {
            "code": "C90.30",
            "display": "Solitary plasmacytoma not having achieved remission"
          },
          {
            "code": "C90.31",
            "display": "Solitary plasmacytoma in remission"
          },
          {
            "code": "C90.32",
            "display": "Solitary plasmacytoma in relapse"
          },
          {
            "code": "C91.00",
            "display": "Acute lymphoblastic leukemia not having achieved remission"
          },
          {
            "code": "C91.01",
            "display": "Acute lymphoblastic leukemia, in remission"
          },
          {
            "code": "C91.02",
            "display": "Acute lymphoblastic leukemia, in relapse"
          },
          {
            "code": "C91.10",
            "display": "Chronic lymphocytic leukemia of B-cell type not having achieved remission"
          },
          {
            "code": "C91.11",
            "display": "Chronic lymphocytic leukemia of B-cell type in remission"
          },
          {
            "code": "C91.12",
            "display": "Chronic lymphocytic leukemia of B-cell type in relapse"
          },
          {
            "code": "C91.30",
            "display": "Prolymphocytic leukemia of B-cell type not having achieved remission"
          },
          {
            "code": "C91.31",
            "display": "Prolymphocytic leukemia of B-cell type, in remission"
          },
          {
            "code": "C91.32",
            "display": "Prolymphocytic leukemia of B-cell type, in relapse"
          },
          {
            "code": "C91.40",
            "display": "Hairy cell leukemia not having achieved remission"
          },
          {
            "code": "C91.41",
            "display": "Hairy cell leukemia, in remission"
          },
          {
            "code": "C91.42",
            "display": "Hairy cell leukemia, in relapse"
          },
          {
            "code": "C91.50",
            "display": "Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission"
          },
          {
            "code": "C91.51",
            "display": "Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission"
          },
          {
            "code": "C91.52",
            "display": "Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse"
          },
          {
            "code": "C91.60",
            "display": "Prolymphocytic leukemia of T-cell type not having achieved remission"
          },
          {
            "code": "C91.61",
            "display": "Prolymphocytic leukemia of T-cell type, in remission"
          },
          {
            "code": "C91.62",
            "display": "Prolymphocytic leukemia of T-cell type, in relapse"
          },
          {
            "code": "C91.90",
            "display": "Lymphoid leukemia, unspecified not having achieved remission"
          },
          {
            "code": "C91.91",
            "display": "Lymphoid leukemia, unspecified, in remission"
          },
          {
            "code": "C91.92",
            "display": "Lymphoid leukemia, unspecified, in relapse"
          },
          {
            "code": "C91.A0",
            "display": "Mature B-cell leukemia Burkitt-type not having achieved remission"
          },
          {
            "code": "C91.A1",
            "display": "Mature B-cell leukemia Burkitt-type, in remission"
          },
          {
            "code": "C91.A2",
            "display": "Mature B-cell leukemia Burkitt-type, in relapse"
          },
          {
            "code": "C91.Z0",
            "display": "Other lymphoid leukemia not having achieved remission"
          },
          {
            "code": "C91.Z1",
            "display": "Other lymphoid leukemia, in remission"
          },
          {
            "code": "C91.Z2",
            "display": "Other lymphoid leukemia, in relapse"
          },
          {
            "code": "C92.00",
            "display": "Acute myeloblastic leukemia, not having achieved remission"
          },
          {
            "code": "C92.01",
            "display": "Acute myeloblastic leukemia, in remission"
          },
          {
            "code": "C92.02",
            "display": "Acute myeloblastic leukemia, in relapse"
          },
          {
            "code": "C92.10",
            "display": "Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission"
          },
          {
            "code": "C92.11",
            "display": "Chronic myeloid leukemia, BCR/ABL-positive, in remission"
          },
          {
            "code": "C92.12",
            "display": "Chronic myeloid leukemia, BCR/ABL-positive, in relapse"
          },
          {
            "code": "C92.20",
            "display": "Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission"
          },
          {
            "code": "C92.21",
            "display": "Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission"
          },
          {
            "code": "C92.22",
            "display": "Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse"
          },
          {
            "code": "C92.30",
            "display": "Myeloid sarcoma, not having achieved remission"
          },
          {
            "code": "C92.31",
            "display": "Myeloid sarcoma, in remission"
          },
          {
            "code": "C92.32",
            "display": "Myeloid sarcoma, in relapse"
          },
          {
            "code": "C92.40",
            "display": "Acute promyelocytic leukemia, not having achieved remission"
          },
          {
            "code": "C92.41",
            "display": "Acute promyelocytic leukemia, in remission"
          },
          {
            "code": "C92.42",
            "display": "Acute promyelocytic leukemia, in relapse"
          },
          {
            "code": "C92.50",
            "display": "Acute myelomonocytic leukemia, not having achieved remission"
          },
          {
            "code": "C92.51",
            "display": "Acute myelomonocytic leukemia, in remission"
          },
          {
            "code": "C92.52",
            "display": "Acute myelomonocytic leukemia, in relapse"
          },
          {
            "code": "C92.60",
            "display": "Acute myeloid leukemia with 11q23-abnormality not having achieved remission"
          },
          {
            "code": "C92.61",
            "display": "Acute myeloid leukemia with 11q23-abnormality in remission"
          },
          {
            "code": "C92.62",
            "display": "Acute myeloid leukemia with 11q23-abnormality in relapse"
          },
          {
            "code": "C92.90",
            "display": "Myeloid leukemia, unspecified, not having achieved remission"
          },
          {
            "code": "C92.91",
            "display": "Myeloid leukemia, unspecified in remission"
          },
          {
            "code": "C92.92",
            "display": "Myeloid leukemia, unspecified in relapse"
          },
          {
            "code": "C92.A0",
            "display": "Acute myeloid leukemia with multilineage dysplasia, not having achieved remission"
          },
          {
            "code": "C92.A1",
            "display": "Acute myeloid leukemia with multilineage dysplasia, in remission"
          },
          {
            "code": "C92.A2",
            "display": "Acute myeloid leukemia with multilineage dysplasia, in relapse"
          },
          {
            "code": "C92.Z0",
            "display": "Other myeloid leukemia not having achieved remission"
          },
          {
            "code": "C92.Z1",
            "display": "Other myeloid leukemia, in remission"
          },
          {
            "code": "C92.Z2",
            "display": "Other myeloid leukemia, in relapse"
          },
          {
            "code": "C93.00",
            "display": "Acute monoblastic/monocytic leukemia, not having achieved remission"
          },
          {
            "code": "C93.01",
            "display": "Acute monoblastic/monocytic leukemia, in remission"
          },
          {
            "code": "C93.02",
            "display": "Acute monoblastic/monocytic leukemia, in relapse"
          },
          {
            "code": "C93.10",
            "display": "Chronic myelomonocytic leukemia not having achieved remission"
          },
          {
            "code": "C93.11",
            "display": "Chronic myelomonocytic leukemia, in remission"
          },
          {
            "code": "C93.12",
            "display": "Chronic myelomonocytic leukemia, in relapse"
          },
          {
            "code": "C93.30",
            "display": "Juvenile myelomonocytic leukemia, not having achieved remission"
          },
          {
            "code": "C93.31",
            "display": "Juvenile myelomonocytic leukemia, in remission"
          },
          {
            "code": "C93.32",
            "display": "Juvenile myelomonocytic leukemia, in relapse"
          },
          {
            "code": "C93.90",
            "display": "Monocytic leukemia, unspecified, not having achieved remission"
          },
          {
            "code": "C93.91",
            "display": "Monocytic leukemia, unspecified in remission"
          },
          {
            "code": "C93.92",
            "display": "Monocytic leukemia, unspecified in relapse"
          },
          {
            "code": "C93.Z0",
            "display": "Other monocytic leukemia, not having achieved remission"
          },
          {
            "code": "C93.Z1",
            "display": "Other monocytic leukemia, in remission"
          },
          {
            "code": "C93.Z2",
            "display": "Other monocytic leukemia, in relapse"
          },
          {
            "code": "C94.00",
            "display": "Acute erythroid leukemia, not having achieved remission"
          },
          {
            "code": "C94.01",
            "display": "Acute erythroid leukemia, in remission"
          },
          {
            "code": "C94.02",
            "display": "Acute erythroid leukemia, in relapse"
          },
          {
            "code": "C94.20",
            "display": "Acute megakaryoblastic leukemia not having achieved remission"
          },
          {
            "code": "C94.21",
            "display": "Acute megakaryoblastic leukemia, in remission"
          },
          {
            "code": "C94.22",
            "display": "Acute megakaryoblastic leukemia, in relapse"
          },
          {
            "code": "C94.30",
            "display": "Mast cell leukemia not having achieved remission"
          },
          {
            "code": "C94.31",
            "display": "Mast cell leukemia, in remission"
          },
          {
            "code": "C94.32",
            "display": "Mast cell leukemia, in relapse"
          },
          {
            "code": "C94.40",
            "display": "Acute panmyelosis with myelofibrosis not having achieved remission"
          },
          {
            "code": "C94.41",
            "display": "Acute panmyelosis with myelofibrosis, in remission"
          },
          {
            "code": "C94.42",
            "display": "Acute panmyelosis with myelofibrosis, in relapse"
          },
          {
            "code": "C94.6",
            "display": "Myelodysplastic disease, not classified"
          },
          {
            "code": "C94.80",
            "display": "Other specified leukemias not having achieved remission"
          },
          {
            "code": "C94.81",
            "display": "Other specified leukemias, in remission"
          },
          {
            "code": "C94.82",
            "display": "Other specified leukemias, in relapse"
          },
          {
            "code": "C95.00",
            "display": "Acute leukemia of unspecified cell type not having achieved remission"
          },
          {
            "code": "C95.01",
            "display": "Acute leukemia of unspecified cell type, in remission"
          },
          {
            "code": "C95.02",
            "display": "Acute leukemia of unspecified cell type, in relapse"
          },
          {
            "code": "C95.10",
            "display": "Chronic leukemia of unspecified cell type not having achieved remission"
          },
          {
            "code": "C95.11",
            "display": "Chronic leukemia of unspecified cell type, in remission"
          },
          {
            "code": "C95.12",
            "display": "Chronic leukemia of unspecified cell type, in relapse"
          },
          {
            "code": "C95.90",
            "display": "Leukemia, unspecified not having achieved remission"
          },
          {
            "code": "C95.91",
            "display": "Leukemia, unspecified, in remission"
          },
          {
            "code": "C95.92",
            "display": "Leukemia, unspecified, in relapse"
          },
          {
            "code": "C96.0",
            "display": "Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis"
          },
          {
            "code": "C96.2",
            "display": "Malignant mast cell neoplasm"
          },
          {
            "code": "C96.20",
            "display": "Malignant mast cell neoplasm, unspecified"
          },
          {
            "code": "C96.21",
            "display": "Aggressive systemic mastocytosis"
          },
          {
            "code": "C96.22",
            "display": "Mast cell sarcoma"
          },
          {
            "code": "C96.29",
            "display": "Other malignant mast cell neoplasm"
          },
          {
            "code": "C96.4",
            "display": "Sarcoma of dendritic cells (accessory cells)"
          },
          {
            "code": "C96.5",
            "display": "Multifocal and unisystemic Langerhans-cell histiocytosis"
          },
          {
            "code": "C96.6",
            "display": "Unifocal Langerhans-cell histiocytosis"
          },
          {
            "code": "C96.9",
            "display": "Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified"
          },
          {
            "code": "C96.A",
            "display": "Histiocytic sarcoma"
          },
          {
            "code": "C96.Z",
            "display": "Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue"
          },
          {
            "code": "D00.00",
            "display": "Carcinoma in situ of oral cavity, unspecified site"
          },
          {
            "code": "D00.01",
            "display": "Carcinoma in situ of labial mucosa and vermilion border"
          },
          {
            "code": "D00.02",
            "display": "Carcinoma in situ of buccal mucosa"
          },
          {
            "code": "D00.03",
            "display": "Carcinoma in situ of gingiva and edentulous alveolar ridge"
          },
          {
            "code": "D00.04",
            "display": "Carcinoma in situ of soft palate"
          },
          {
            "code": "D00.05",
            "display": "Carcinoma in situ of hard palate"
          },
          {
            "code": "D00.06",
            "display": "Carcinoma in situ of floor of mouth"
          },
          {
            "code": "D00.07",
            "display": "Carcinoma in situ of tongue"
          },
          {
            "code": "D00.08",
            "display": "Carcinoma in situ of pharynx"
          },
          {
            "code": "D00.1",
            "display": "Carcinoma in situ of esophagus"
          },
          {
            "code": "D00.2",
            "display": "Carcinoma in situ of stomach"
          },
          {
            "code": "D01.0",
            "display": "Carcinoma in situ of colon"
          },
          {
            "code": "D01.1",
            "display": "Carcinoma in situ of rectosigmoid junction"
          },
          {
            "code": "D01.2",
            "display": "Carcinoma in situ of rectum"
          },
          {
            "code": "D01.3",
            "display": "Carcinoma in situ of anus and anal canal"
          },
          {
            "code": "D01.40",
            "display": "Carcinoma in situ of unspecified part of intestine"
          },
          {
            "code": "D01.49",
            "display": "Carcinoma in situ of other parts of intestine"
          },
          {
            "code": "D01.5",
            "display": "Carcinoma in situ of liver, gallbladder and bile ducts"
          },
          {
            "code": "D01.7",
            "display": "Carcinoma in situ of other specified digestive organs"
          },
          {
            "code": "D01.9",
            "display": "Carcinoma in situ of digestive organ, unspecified"
          },
          {
            "code": "D02.0",
            "display": "Carcinoma in situ of larynx"
          },
          {
            "code": "D02.1",
            "display": "Carcinoma in situ of trachea"
          },
          {
            "code": "D02.20",
            "display": "Carcinoma in situ of unspecified bronchus and lung"
          },
          {
            "code": "D02.21",
            "display": "Carcinoma in situ of right bronchus and lung"
          },
          {
            "code": "D02.22",
            "display": "Carcinoma in situ of left bronchus and lung"
          },
          {
            "code": "D02.3",
            "display": "Carcinoma in situ of other parts of respiratory system"
          },
          {
            "code": "D02.4",
            "display": "Carcinoma in situ of respiratory system, unspecified"
          },
          {
            "code": "D03.0",
            "display": "Melanoma in situ of lip"
          },
          {
            "code": "D03.10",
            "display": "Melanoma in situ of unspecified eyelid, including canthus"
          },
          {
            "code": "D03.11",
            "display": "Melanoma in situ of right eyelid, including canthus"
          },
          {
            "code": "D03.111",
            "display": "Melanoma in situ of right upper eyelid, including canthus"
          },
          {
            "code": "D03.112",
            "display": "Melanoma in situ of right lower eyelid, including canthus"
          },
          {
            "code": "D03.12",
            "display": "Melanoma in situ of left eyelid, including canthus"
          },
          {
            "code": "D03.121",
            "display": "Melanoma in situ of left upper eyelid, including canthus"
          },
          {
            "code": "D03.122",
            "display": "Melanoma in situ of left lower eyelid, including canthus"
          },
          {
            "code": "D03.20",
            "display": "Melanoma in situ of unspecified ear and external auricular canal"
          },
          {
            "code": "D03.21",
            "display": "Melanoma in situ of right ear and external auricular canal"
          },
          {
            "code": "D03.22",
            "display": "Melanoma in situ of left ear and external auricular canal"
          },
          {
            "code": "D03.30",
            "display": "Melanoma in situ of unspecified part of face"
          },
          {
            "code": "D03.39",
            "display": "Melanoma in situ of other parts of face"
          },
          {
            "code": "D03.4",
            "display": "Melanoma in situ of scalp and neck"
          },
          {
            "code": "D03.51",
            "display": "Melanoma in situ of anal skin"
          },
          {
            "code": "D03.52",
            "display": "Melanoma in situ of breast (skin) (soft tissue)"
          },
          {
            "code": "D03.59",
            "display": "Melanoma in situ of other part of trunk"
          },
          {
            "code": "D03.60",
            "display": "Melanoma in situ of unspecified upper limb, including shoulder"
          },
          {
            "code": "D03.61",
            "display": "Melanoma in situ of right upper limb, including shoulder"
          },
          {
            "code": "D03.62",
            "display": "Melanoma in situ of left upper limb, including shoulder"
          },
          {
            "code": "D03.70",
            "display": "Melanoma in situ of unspecified lower limb, including hip"
          },
          {
            "code": "D03.71",
            "display": "Melanoma in situ of right lower limb, including hip"
          },
          {
            "code": "D03.72",
            "display": "Melanoma in situ of left lower limb, including hip"
          },
          {
            "code": "D03.8",
            "display": "Melanoma in situ of other sites"
          },
          {
            "code": "D03.9",
            "display": "Melanoma in situ, unspecified"
          },
          {
            "code": "D04.0",
            "display": "Carcinoma in situ of skin of lip"
          },
          {
            "code": "D04.10",
            "display": "Carcinoma in situ of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "D04.11",
            "display": "Carcinoma in situ of skin of right eyelid, including canthus"
          },
          {
            "code": "D04.111",
            "display": "Carcinoma in situ of skin of right upper eyelid, including canthus"
          },
          {
            "code": "D04.112",
            "display": "Carcinoma in situ of skin of right lower eyelid, including canthus"
          },
          {
            "code": "D04.12",
            "display": "Carcinoma in situ of skin of left eyelid, including canthus"
          },
          {
            "code": "D04.121",
            "display": "Carcinoma in situ of skin of left upper eyelid, including canthus"
          },
          {
            "code": "D04.122",
            "display": "Carcinoma in situ of skin of left lower eyelid, including canthus"
          },
          {
            "code": "D04.20",
            "display": "Carcinoma in situ of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "D04.21",
            "display": "Carcinoma in situ of skin of right ear and external auricular canal"
          },
          {
            "code": "D04.22",
            "display": "Carcinoma in situ of skin of left ear and external auricular canal"
          },
          {
            "code": "D04.30",
            "display": "Carcinoma in situ of skin of unspecified part of face"
          },
          {
            "code": "D04.39",
            "display": "Carcinoma in situ of skin of other parts of face"
          },
          {
            "code": "D04.4",
            "display": "Carcinoma in situ of skin of scalp and neck"
          },
          {
            "code": "D04.5",
            "display": "Carcinoma in situ of skin of trunk"
          },
          {
            "code": "D04.60",
            "display": "Carcinoma in situ of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "D04.61",
            "display": "Carcinoma in situ of skin of right upper limb, including shoulder"
          },
          {
            "code": "D04.62",
            "display": "Carcinoma in situ of skin of left upper limb, including shoulder"
          },
          {
            "code": "D04.70",
            "display": "Carcinoma in situ of skin of unspecified lower limb, including hip"
          },
          {
            "code": "D04.71",
            "display": "Carcinoma in situ of skin of right lower limb, including hip"
          },
          {
            "code": "D04.72",
            "display": "Carcinoma in situ of skin of left lower limb, including hip"
          },
          {
            "code": "D04.8",
            "display": "Carcinoma in situ of skin of other sites"
          },
          {
            "code": "D04.9",
            "display": "Carcinoma in situ of skin, unspecified"
          },
          {
            "code": "D05.00",
            "display": "Lobular carcinoma in situ of unspecified breast"
          },
          {
            "code": "D05.01",
            "display": "Lobular carcinoma in situ of right breast"
          },
          {
            "code": "D05.02",
            "display": "Lobular carcinoma in situ of left breast"
          },
          {
            "code": "D05.10",
            "display": "Intraductal carcinoma in situ of unspecified breast"
          },
          {
            "code": "D05.11",
            "display": "Intraductal carcinoma in situ of right breast"
          },
          {
            "code": "D05.12",
            "display": "Intraductal carcinoma in situ of left breast"
          },
          {
            "code": "D05.80",
            "display": "Other specified type of carcinoma in situ of unspecified breast"
          },
          {
            "code": "D05.81",
            "display": "Other specified type of carcinoma in situ of right breast"
          },
          {
            "code": "D05.82",
            "display": "Other specified type of carcinoma in situ of left breast"
          },
          {
            "code": "D05.90",
            "display": "Unspecified type of carcinoma in situ of unspecified breast"
          },
          {
            "code": "D05.91",
            "display": "Unspecified type of carcinoma in situ of right breast"
          },
          {
            "code": "D05.92",
            "display": "Unspecified type of carcinoma in situ of left breast"
          },
          {
            "code": "D06.0",
            "display": "Carcinoma in situ of endocervix"
          },
          {
            "code": "D06.1",
            "display": "Carcinoma in situ of exocervix"
          },
          {
            "code": "D06.7",
            "display": "Carcinoma in situ of other parts of cervix"
          },
          {
            "code": "D06.9",
            "display": "Carcinoma in situ of cervix, unspecified"
          },
          {
            "code": "D07.0",
            "display": "Carcinoma in situ of endometrium"
          },
          {
            "code": "D07.1",
            "display": "Carcinoma in situ of vulva"
          },
          {
            "code": "D07.2",
            "display": "Carcinoma in situ of vagina"
          },
          {
            "code": "D07.30",
            "display": "Carcinoma in situ of unspecified female genital organs"
          },
          {
            "code": "D07.39",
            "display": "Carcinoma in situ of other female genital organs"
          },
          {
            "code": "D07.4",
            "display": "Carcinoma in situ of penis"
          },
          {
            "code": "D07.5",
            "display": "Carcinoma in situ of prostate"
          },
          {
            "code": "D07.60",
            "display": "Carcinoma in situ of unspecified male genital organs"
          },
          {
            "code": "D07.61",
            "display": "Carcinoma in situ of scrotum"
          },
          {
            "code": "D07.69",
            "display": "Carcinoma in situ of other male genital organs"
          },
          {
            "code": "D09.0",
            "display": "Carcinoma in situ of bladder"
          },
          {
            "code": "D09.10",
            "display": "Carcinoma in situ of unspecified urinary organ"
          },
          {
            "code": "D09.19",
            "display": "Carcinoma in situ of other urinary organs"
          },
          {
            "code": "D09.20",
            "display": "Carcinoma in situ of unspecified eye"
          },
          {
            "code": "D09.21",
            "display": "Carcinoma in situ of right eye"
          },
          {
            "code": "D09.22",
            "display": "Carcinoma in situ of left eye"
          },
          {
            "code": "D09.3",
            "display": "Carcinoma in situ of thyroid and other endocrine glands"
          },
          {
            "code": "D09.8",
            "display": "Carcinoma in situ of other specified sites"
          },
          {
            "code": "D09.9",
            "display": "Carcinoma in situ, unspecified"
          },
          {
            "code": "D10.0",
            "display": "Benign neoplasm of lip"
          },
          {
            "code": "D10.1",
            "display": "Benign neoplasm of tongue"
          },
          {
            "code": "D10.2",
            "display": "Benign neoplasm of floor of mouth"
          },
          {
            "code": "D10.30",
            "display": "Benign neoplasm of unspecified part of mouth"
          },
          {
            "code": "D10.39",
            "display": "Benign neoplasm of other parts of mouth"
          },
          {
            "code": "D10.4",
            "display": "Benign neoplasm of tonsil"
          },
          {
            "code": "D10.5",
            "display": "Benign neoplasm of other parts of oropharynx"
          },
          {
            "code": "D10.6",
            "display": "Benign neoplasm of nasopharynx"
          },
          {
            "code": "D10.7",
            "display": "Benign neoplasm of hypopharynx"
          },
          {
            "code": "D10.9",
            "display": "Benign neoplasm of pharynx, unspecified"
          },
          {
            "code": "D11.0",
            "display": "Benign neoplasm of parotid gland"
          },
          {
            "code": "D11.7",
            "display": "Benign neoplasm of other major salivary glands"
          },
          {
            "code": "D11.9",
            "display": "Benign neoplasm of major salivary gland, unspecified"
          },
          {
            "code": "D12.0",
            "display": "Benign neoplasm of cecum"
          },
          {
            "code": "D12.1",
            "display": "Benign neoplasm of appendix"
          },
          {
            "code": "D12.2",
            "display": "Benign neoplasm of ascending colon"
          },
          {
            "code": "D12.3",
            "display": "Benign neoplasm of transverse colon"
          },
          {
            "code": "D12.4",
            "display": "Benign neoplasm of descending colon"
          },
          {
            "code": "D12.5",
            "display": "Benign neoplasm of sigmoid colon"
          },
          {
            "code": "D12.6",
            "display": "Benign neoplasm of colon, unspecified"
          },
          {
            "code": "D12.7",
            "display": "Benign neoplasm of rectosigmoid junction"
          },
          {
            "code": "D12.8",
            "display": "Benign neoplasm of rectum"
          },
          {
            "code": "D12.9",
            "display": "Benign neoplasm of anus and anal canal"
          },
          {
            "code": "D13.0",
            "display": "Benign neoplasm of esophagus"
          },
          {
            "code": "D13.1",
            "display": "Benign neoplasm of stomach"
          },
          {
            "code": "D13.2",
            "display": "Benign neoplasm of duodenum"
          },
          {
            "code": "D13.30",
            "display": "Benign neoplasm of unspecified part of small intestine"
          },
          {
            "code": "D13.39",
            "display": "Benign neoplasm of other parts of small intestine"
          },
          {
            "code": "D13.4",
            "display": "Benign neoplasm of liver"
          },
          {
            "code": "D13.5",
            "display": "Benign neoplasm of extrahepatic bile ducts"
          },
          {
            "code": "D13.6",
            "display": "Benign neoplasm of pancreas"
          },
          {
            "code": "D13.7",
            "display": "Benign neoplasm of endocrine pancreas"
          },
          {
            "code": "D13.9",
            "display": "Benign neoplasm of ill-defined sites within the digestive system"
          },
          {
            "code": "D14.0",
            "display": "Benign neoplasm of middle ear, nasal cavity and accessory sinuses"
          },
          {
            "code": "D14.1",
            "display": "Benign neoplasm of larynx"
          },
          {
            "code": "D14.2",
            "display": "Benign neoplasm of trachea"
          },
          {
            "code": "D14.30",
            "display": "Benign neoplasm of unspecified bronchus and lung"
          },
          {
            "code": "D14.31",
            "display": "Benign neoplasm of right bronchus and lung"
          },
          {
            "code": "D14.32",
            "display": "Benign neoplasm of left bronchus and lung"
          },
          {
            "code": "D14.4",
            "display": "Benign neoplasm of respiratory system, unspecified"
          },
          {
            "code": "D15.0",
            "display": "Benign neoplasm of thymus"
          },
          {
            "code": "D15.1",
            "display": "Benign neoplasm of heart"
          },
          {
            "code": "D15.2",
            "display": "Benign neoplasm of mediastinum"
          },
          {
            "code": "D15.7",
            "display": "Benign neoplasm of other specified intrathoracic organs"
          },
          {
            "code": "D15.9",
            "display": "Benign neoplasm of intrathoracic organ, unspecified"
          },
          {
            "code": "D16.00",
            "display": "Benign neoplasm of scapula and long bones of unspecified upper limb"
          },
          {
            "code": "D16.01",
            "display": "Benign neoplasm of scapula and long bones of right upper limb"
          },
          {
            "code": "D16.02",
            "display": "Benign neoplasm of scapula and long bones of left upper limb"
          },
          {
            "code": "D16.10",
            "display": "Benign neoplasm of short bones of unspecified upper limb"
          },
          {
            "code": "D16.11",
            "display": "Benign neoplasm of short bones of right upper limb"
          },
          {
            "code": "D16.12",
            "display": "Benign neoplasm of short bones of left upper limb"
          },
          {
            "code": "D16.20",
            "display": "Benign neoplasm of long bones of unspecified lower limb"
          },
          {
            "code": "D16.21",
            "display": "Benign neoplasm of long bones of right lower limb"
          },
          {
            "code": "D16.22",
            "display": "Benign neoplasm of long bones of left lower limb"
          },
          {
            "code": "D16.30",
            "display": "Benign neoplasm of short bones of unspecified lower limb"
          },
          {
            "code": "D16.31",
            "display": "Benign neoplasm of short bones of right lower limb"
          },
          {
            "code": "D16.32",
            "display": "Benign neoplasm of short bones of left lower limb"
          },
          {
            "code": "D16.4",
            "display": "Benign neoplasm of bones of skull and face"
          },
          {
            "code": "D16.5",
            "display": "Benign neoplasm of lower jaw bone"
          },
          {
            "code": "D16.6",
            "display": "Benign neoplasm of vertebral column"
          },
          {
            "code": "D16.7",
            "display": "Benign neoplasm of ribs, sternum and clavicle"
          },
          {
            "code": "D16.8",
            "display": "Benign neoplasm of pelvic bones, sacrum and coccyx"
          },
          {
            "code": "D16.9",
            "display": "Benign neoplasm of bone and articular cartilage, unspecified"
          },
          {
            "code": "D17.0",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck"
          },
          {
            "code": "D17.1",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk"
          },
          {
            "code": "D17.20",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb"
          },
          {
            "code": "D17.21",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of right arm"
          },
          {
            "code": "D17.22",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of left arm"
          },
          {
            "code": "D17.23",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of right leg"
          },
          {
            "code": "D17.24",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of left leg"
          },
          {
            "code": "D17.30",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites"
          },
          {
            "code": "D17.39",
            "display": "Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites"
          },
          {
            "code": "D17.4",
            "display": "Benign lipomatous neoplasm of intrathoracic organs"
          },
          {
            "code": "D17.5",
            "display": "Benign lipomatous neoplasm of intra-abdominal organs"
          },
          {
            "code": "D17.6",
            "display": "Benign lipomatous neoplasm of spermatic cord"
          },
          {
            "code": "D17.71",
            "display": "Benign lipomatous neoplasm of kidney"
          },
          {
            "code": "D17.72",
            "display": "Benign lipomatous neoplasm of other genitourinary organ"
          },
          {
            "code": "D17.79",
            "display": "Benign lipomatous neoplasm of other sites"
          },
          {
            "code": "D17.9",
            "display": "Benign lipomatous neoplasm, unspecified"
          },
          {
            "code": "D18.00",
            "display": "Hemangioma unspecified site"
          },
          {
            "code": "D18.01",
            "display": "Hemangioma of skin and subcutaneous tissue"
          },
          {
            "code": "D18.02",
            "display": "Hemangioma of intracranial structures"
          },
          {
            "code": "D18.03",
            "display": "Hemangioma of intra-abdominal structures"
          },
          {
            "code": "D18.09",
            "display": "Hemangioma of other sites"
          },
          {
            "code": "D18.1",
            "display": "Lymphangioma, any site"
          },
          {
            "code": "D19.0",
            "display": "Benign neoplasm of mesothelial tissue of pleura"
          },
          {
            "code": "D19.1",
            "display": "Benign neoplasm of mesothelial tissue of peritoneum"
          },
          {
            "code": "D19.7",
            "display": "Benign neoplasm of mesothelial tissue of other sites"
          },
          {
            "code": "D19.9",
            "display": "Benign neoplasm of mesothelial tissue, unspecified"
          },
          {
            "code": "D20.0",
            "display": "Benign neoplasm of soft tissue of retroperitoneum"
          },
          {
            "code": "D20.1",
            "display": "Benign neoplasm of soft tissue of peritoneum"
          },
          {
            "code": "D21.0",
            "display": "Benign neoplasm of connective and other soft tissue of head, face and neck"
          },
          {
            "code": "D21.10",
            "display": "Benign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder"
          },
          {
            "code": "D21.11",
            "display": "Benign neoplasm of connective and other soft tissue of right upper limb, including shoulder"
          },
          {
            "code": "D21.12",
            "display": "Benign neoplasm of connective and other soft tissue of left upper limb, including shoulder"
          },
          {
            "code": "D21.20",
            "display": "Benign neoplasm of connective and other soft tissue of unspecified lower limb, including hip"
          },
          {
            "code": "D21.21",
            "display": "Benign neoplasm of connective and other soft tissue of right lower limb, including hip"
          },
          {
            "code": "D21.22",
            "display": "Benign neoplasm of connective and other soft tissue of left lower limb, including hip"
          },
          {
            "code": "D21.3",
            "display": "Benign neoplasm of connective and other soft tissue of thorax"
          },
          {
            "code": "D21.4",
            "display": "Benign neoplasm of connective and other soft tissue of abdomen"
          },
          {
            "code": "D21.5",
            "display": "Benign neoplasm of connective and other soft tissue of pelvis"
          },
          {
            "code": "D21.6",
            "display": "Benign neoplasm of connective and other soft tissue of trunk, unspecified"
          },
          {
            "code": "D21.9",
            "display": "Benign neoplasm of connective and other soft tissue, unspecified"
          },
          {
            "code": "D22.0",
            "display": "Melanocytic nevi of lip"
          },
          {
            "code": "D22.10",
            "display": "Melanocytic nevi of unspecified eyelid, including canthus"
          },
          {
            "code": "D22.11",
            "display": "Melanocytic nevi of right eyelid, including canthus"
          },
          {
            "code": "D22.111",
            "display": "Melanocytic nevi of right upper eyelid, including canthus"
          },
          {
            "code": "D22.112",
            "display": "Melanocytic nevi of right lower eyelid, including canthus"
          },
          {
            "code": "D22.12",
            "display": "Melanocytic nevi of left eyelid, including canthus"
          },
          {
            "code": "D22.121",
            "display": "Melanocytic nevi of left upper eyelid, including canthus"
          },
          {
            "code": "D22.122",
            "display": "Melanocytic nevi of left lower eyelid, including canthus"
          },
          {
            "code": "D22.20",
            "display": "Melanocytic nevi of unspecified ear and external auricular canal"
          },
          {
            "code": "D22.21",
            "display": "Melanocytic nevi of right ear and external auricular canal"
          },
          {
            "code": "D22.22",
            "display": "Melanocytic nevi of left ear and external auricular canal"
          },
          {
            "code": "D22.30",
            "display": "Melanocytic nevi of unspecified part of face"
          },
          {
            "code": "D22.39",
            "display": "Melanocytic nevi of other parts of face"
          },
          {
            "code": "D22.4",
            "display": "Melanocytic nevi of scalp and neck"
          },
          {
            "code": "D22.5",
            "display": "Melanocytic nevi of trunk"
          },
          {
            "code": "D22.60",
            "display": "Melanocytic nevi of unspecified upper limb, including shoulder"
          },
          {
            "code": "D22.61",
            "display": "Melanocytic nevi of right upper limb, including shoulder"
          },
          {
            "code": "D22.62",
            "display": "Melanocytic nevi of left upper limb, including shoulder"
          },
          {
            "code": "D22.70",
            "display": "Melanocytic nevi of unspecified lower limb, including hip"
          },
          {
            "code": "D22.71",
            "display": "Melanocytic nevi of right lower limb, including hip"
          },
          {
            "code": "D22.72",
            "display": "Melanocytic nevi of left lower limb, including hip"
          },
          {
            "code": "D22.9",
            "display": "Melanocytic nevi, unspecified"
          },
          {
            "code": "D23.0",
            "display": "Other benign neoplasm of skin of lip"
          },
          {
            "code": "D23.10",
            "display": "Other benign neoplasm of skin of unspecified eyelid, including canthus"
          },
          {
            "code": "D23.11",
            "display": "Other benign neoplasm of skin of right eyelid, including canthus"
          },
          {
            "code": "D23.111",
            "display": "Other benign neoplasm of skin of right upper eyelid, including canthus"
          },
          {
            "code": "D23.112",
            "display": "Other benign neoplasm of skin of right lower eyelid, including canthus"
          },
          {
            "code": "D23.12",
            "display": "Other benign neoplasm of skin of left eyelid, including canthus"
          },
          {
            "code": "D23.121",
            "display": "Other benign neoplasm of skin of left upper eyelid, including canthus"
          },
          {
            "code": "D23.122",
            "display": "Other benign neoplasm of skin of left lower eyelid, including canthus"
          },
          {
            "code": "D23.20",
            "display": "Other benign neoplasm of skin of unspecified ear and external auricular canal"
          },
          {
            "code": "D23.21",
            "display": "Other benign neoplasm of skin of right ear and external auricular canal"
          },
          {
            "code": "D23.22",
            "display": "Other benign neoplasm of skin of left ear and external auricular canal"
          },
          {
            "code": "D23.30",
            "display": "Other benign neoplasm of skin of unspecified part of face"
          },
          {
            "code": "D23.39",
            "display": "Other benign neoplasm of skin of other parts of face"
          },
          {
            "code": "D23.4",
            "display": "Other benign neoplasm of skin of scalp and neck"
          },
          {
            "code": "D23.5",
            "display": "Other benign neoplasm of skin of trunk"
          },
          {
            "code": "D23.60",
            "display": "Other benign neoplasm of skin of unspecified upper limb, including shoulder"
          },
          {
            "code": "D23.61",
            "display": "Other benign neoplasm of skin of right upper limb, including shoulder"
          },
          {
            "code": "D23.62",
            "display": "Other benign neoplasm of skin of left upper limb, including shoulder"
          },
          {
            "code": "D23.70",
            "display": "Other benign neoplasm of skin of unspecified lower limb, including hip"
          },
          {
            "code": "D23.71",
            "display": "Other benign neoplasm of skin of right lower limb, including hip"
          },
          {
            "code": "D23.72",
            "display": "Other benign neoplasm of skin of left lower limb, including hip"
          },
          {
            "code": "D23.9",
            "display": "Other benign neoplasm of skin, unspecified"
          },
          {
            "code": "D24.1",
            "display": "Benign neoplasm of right breast"
          },
          {
            "code": "D24.2",
            "display": "Benign neoplasm of left breast"
          },
          {
            "code": "D24.9",
            "display": "Benign neoplasm of unspecified breast"
          },
          {
            "code": "D25.0",
            "display": "Submucous leiomyoma of uterus"
          },
          {
            "code": "D25.1",
            "display": "Intramural leiomyoma of uterus"
          },
          {
            "code": "D25.2",
            "display": "Subserosal leiomyoma of uterus"
          },
          {
            "code": "D25.9",
            "display": "Leiomyoma of uterus, unspecified"
          },
          {
            "code": "D26.0",
            "display": "Other benign neoplasm of cervix uteri"
          },
          {
            "code": "D26.1",
            "display": "Other benign neoplasm of corpus uteri"
          },
          {
            "code": "D26.7",
            "display": "Other benign neoplasm of other parts of uterus"
          },
          {
            "code": "D26.9",
            "display": "Other benign neoplasm of uterus, unspecified"
          },
          {
            "code": "D27.0",
            "display": "Benign neoplasm of right ovary"
          },
          {
            "code": "D27.1",
            "display": "Benign neoplasm of left ovary"
          },
          {
            "code": "D27.9",
            "display": "Benign neoplasm of unspecified ovary"
          },
          {
            "code": "D28.0",
            "display": "Benign neoplasm of vulva"
          },
          {
            "code": "D28.1",
            "display": "Benign neoplasm of vagina"
          },
          {
            "code": "D28.2",
            "display": "Benign neoplasm of uterine tubes and ligaments"
          },
          {
            "code": "D28.7",
            "display": "Benign neoplasm of other specified female genital organs"
          },
          {
            "code": "D28.9",
            "display": "Benign neoplasm of female genital organ, unspecified"
          },
          {
            "code": "D29.0",
            "display": "Benign neoplasm of penis"
          },
          {
            "code": "D29.1",
            "display": "Benign neoplasm of prostate"
          },
          {
            "code": "D29.20",
            "display": "Benign neoplasm of unspecified testis"
          },
          {
            "code": "D29.21",
            "display": "Benign neoplasm of right testis"
          },
          {
            "code": "D29.22",
            "display": "Benign neoplasm of left testis"
          },
          {
            "code": "D29.30",
            "display": "Benign neoplasm of unspecified epididymis"
          },
          {
            "code": "D29.31",
            "display": "Benign neoplasm of right epididymis"
          },
          {
            "code": "D29.32",
            "display": "Benign neoplasm of left epididymis"
          },
          {
            "code": "D29.4",
            "display": "Benign neoplasm of scrotum"
          },
          {
            "code": "D29.8",
            "display": "Benign neoplasm of other specified male genital organs"
          },
          {
            "code": "D29.9",
            "display": "Benign neoplasm of male genital organ, unspecified"
          },
          {
            "code": "D30.00",
            "display": "Benign neoplasm of unspecified kidney"
          },
          {
            "code": "D30.01",
            "display": "Benign neoplasm of right kidney"
          },
          {
            "code": "D30.02",
            "display": "Benign neoplasm of left kidney"
          },
          {
            "code": "D30.10",
            "display": "Benign neoplasm of unspecified renal pelvis"
          },
          {
            "code": "D30.11",
            "display": "Benign neoplasm of right renal pelvis"
          },
          {
            "code": "D30.12",
            "display": "Benign neoplasm of left renal pelvis"
          },
          {
            "code": "D30.20",
            "display": "Benign neoplasm of unspecified ureter"
          },
          {
            "code": "D30.21",
            "display": "Benign neoplasm of right ureter"
          },
          {
            "code": "D30.22",
            "display": "Benign neoplasm of left ureter"
          },
          {
            "code": "D30.3",
            "display": "Benign neoplasm of bladder"
          },
          {
            "code": "D30.4",
            "display": "Benign neoplasm of urethra"
          },
          {
            "code": "D30.8",
            "display": "Benign neoplasm of other specified urinary organs"
          },
          {
            "code": "D30.9",
            "display": "Benign neoplasm of urinary organ, unspecified"
          },
          {
            "code": "D31.00",
            "display": "Benign neoplasm of unspecified conjunctiva"
          },
          {
            "code": "D31.01",
            "display": "Benign neoplasm of right conjunctiva"
          },
          {
            "code": "D31.02",
            "display": "Benign neoplasm of left conjunctiva"
          },
          {
            "code": "D31.10",
            "display": "Benign neoplasm of unspecified cornea"
          },
          {
            "code": "D31.11",
            "display": "Benign neoplasm of right cornea"
          },
          {
            "code": "D31.12",
            "display": "Benign neoplasm of left cornea"
          },
          {
            "code": "D31.20",
            "display": "Benign neoplasm of unspecified retina"
          },
          {
            "code": "D31.21",
            "display": "Benign neoplasm of right retina"
          },
          {
            "code": "D31.22",
            "display": "Benign neoplasm of left retina"
          },
          {
            "code": "D31.30",
            "display": "Benign neoplasm of unspecified choroid"
          },
          {
            "code": "D31.31",
            "display": "Benign neoplasm of right choroid"
          },
          {
            "code": "D31.32",
            "display": "Benign neoplasm of left choroid"
          },
          {
            "code": "D31.40",
            "display": "Benign neoplasm of unspecified ciliary body"
          },
          {
            "code": "D31.41",
            "display": "Benign neoplasm of right ciliary body"
          },
          {
            "code": "D31.42",
            "display": "Benign neoplasm of left ciliary body"
          },
          {
            "code": "D31.50",
            "display": "Benign neoplasm of unspecified lacrimal gland and duct"
          },
          {
            "code": "D31.51",
            "display": "Benign neoplasm of right lacrimal gland and duct"
          },
          {
            "code": "D31.52",
            "display": "Benign neoplasm of left lacrimal gland and duct"
          },
          {
            "code": "D31.60",
            "display": "Benign neoplasm of unspecified site of unspecified orbit"
          },
          {
            "code": "D31.61",
            "display": "Benign neoplasm of unspecified site of right orbit"
          },
          {
            "code": "D31.62",
            "display": "Benign neoplasm of unspecified site of left orbit"
          },
          {
            "code": "D31.90",
            "display": "Benign neoplasm of unspecified part of unspecified eye"
          },
          {
            "code": "D31.91",
            "display": "Benign neoplasm of unspecified part of right eye"
          },
          {
            "code": "D31.92",
            "display": "Benign neoplasm of unspecified part of left eye"
          },
          {
            "code": "D32.0",
            "display": "Benign neoplasm of cerebral meninges"
          },
          {
            "code": "D32.1",
            "display": "Benign neoplasm of spinal meninges"
          },
          {
            "code": "D32.9",
            "display": "Benign neoplasm of meninges, unspecified"
          },
          {
            "code": "D33.0",
            "display": "Benign neoplasm of brain, supratentorial"
          },
          {
            "code": "D33.1",
            "display": "Benign neoplasm of brain, infratentorial"
          },
          {
            "code": "D33.2",
            "display": "Benign neoplasm of brain, unspecified"
          },
          {
            "code": "D33.3",
            "display": "Benign neoplasm of cranial nerves"
          },
          {
            "code": "D33.4",
            "display": "Benign neoplasm of spinal cord"
          },
          {
            "code": "D33.7",
            "display": "Benign neoplasm of other specified parts of central nervous system"
          },
          {
            "code": "D33.9",
            "display": "Benign neoplasm of central nervous system, unspecified"
          },
          {
            "code": "D34",
            "display": "Benign neoplasm of thyroid gland"
          },
          {
            "code": "D35.00",
            "display": "Benign neoplasm of unspecified adrenal gland"
          },
          {
            "code": "D35.01",
            "display": "Benign neoplasm of right adrenal gland"
          },
          {
            "code": "D35.02",
            "display": "Benign neoplasm of left adrenal gland"
          },
          {
            "code": "D35.1",
            "display": "Benign neoplasm of parathyroid gland"
          },
          {
            "code": "D35.2",
            "display": "Benign neoplasm of pituitary gland"
          },
          {
            "code": "D35.3",
            "display": "Benign neoplasm of craniopharyngeal duct"
          },
          {
            "code": "D35.4",
            "display": "Benign neoplasm of pineal gland"
          },
          {
            "code": "D35.5",
            "display": "Benign neoplasm of carotid body"
          },
          {
            "code": "D35.6",
            "display": "Benign neoplasm of aortic body and other paraganglia"
          },
          {
            "code": "D35.7",
            "display": "Benign neoplasm of other specified endocrine glands"
          },
          {
            "code": "D35.9",
            "display": "Benign neoplasm of endocrine gland, unspecified"
          },
          {
            "code": "D36.0",
            "display": "Benign neoplasm of lymph nodes"
          },
          {
            "code": "D36.10",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified"
          },
          {
            "code": "D36.11",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck"
          },
          {
            "code": "D36.12",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder"
          },
          {
            "code": "D36.13",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip"
          },
          {
            "code": "D36.14",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of thorax"
          },
          {
            "code": "D36.15",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of abdomen"
          },
          {
            "code": "D36.16",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of pelvis"
          },
          {
            "code": "D36.17",
            "display": "Benign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified"
          },
          {
            "code": "D36.7",
            "display": "Benign neoplasm of other specified sites"
          },
          {
            "code": "D36.9",
            "display": "Benign neoplasm, unspecified site"
          },
          {
            "code": "D37.01",
            "display": "Neoplasm of uncertain behavior of lip"
          },
          {
            "code": "D37.02",
            "display": "Neoplasm of uncertain behavior of tongue"
          },
          {
            "code": "D37.030",
            "display": "Neoplasm of uncertain behavior of the parotid salivary glands"
          },
          {
            "code": "D37.031",
            "display": "Neoplasm of uncertain behavior of the sublingual salivary glands"
          },
          {
            "code": "D37.032",
            "display": "Neoplasm of uncertain behavior of the submandibular salivary glands"
          },
          {
            "code": "D37.039",
            "display": "Neoplasm of uncertain behavior of the major salivary glands, unspecified"
          },
          {
            "code": "D37.04",
            "display": "Neoplasm of uncertain behavior of the minor salivary glands"
          },
          {
            "code": "D37.05",
            "display": "Neoplasm of uncertain behavior of pharynx"
          },
          {
            "code": "D37.09",
            "display": "Neoplasm of uncertain behavior of other specified sites of the oral cavity"
          },
          {
            "code": "D37.1",
            "display": "Neoplasm of uncertain behavior of stomach"
          },
          {
            "code": "D37.2",
            "display": "Neoplasm of uncertain behavior of small intestine"
          },
          {
            "code": "D37.3",
            "display": "Neoplasm of uncertain behavior of appendix"
          },
          {
            "code": "D37.4",
            "display": "Neoplasm of uncertain behavior of colon"
          },
          {
            "code": "D37.5",
            "display": "Neoplasm of uncertain behavior of rectum"
          },
          {
            "code": "D37.6",
            "display": "Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"
          },
          {
            "code": "D37.8",
            "display": "Neoplasm of uncertain behavior of other specified digestive organs"
          },
          {
            "code": "D37.9",
            "display": "Neoplasm of uncertain behavior of digestive organ, unspecified"
          },
          {
            "code": "D38.0",
            "display": "Neoplasm of uncertain behavior of larynx"
          },
          {
            "code": "D38.1",
            "display": "Neoplasm of uncertain behavior of trachea, bronchus and lung"
          },
          {
            "code": "D38.2",
            "display": "Neoplasm of uncertain behavior of pleura"
          },
          {
            "code": "D38.3",
            "display": "Neoplasm of uncertain behavior of mediastinum"
          },
          {
            "code": "D38.4",
            "display": "Neoplasm of uncertain behavior of thymus"
          },
          {
            "code": "D38.5",
            "display": "Neoplasm of uncertain behavior of other respiratory organs"
          },
          {
            "code": "D38.6",
            "display": "Neoplasm of uncertain behavior of respiratory organ, unspecified"
          },
          {
            "code": "D39.0",
            "display": "Neoplasm of uncertain behavior of uterus"
          },
          {
            "code": "D39.10",
            "display": "Neoplasm of uncertain behavior of unspecified ovary"
          },
          {
            "code": "D39.11",
            "display": "Neoplasm of uncertain behavior of right ovary"
          },
          {
            "code": "D39.12",
            "display": "Neoplasm of uncertain behavior of left ovary"
          },
          {
            "code": "D39.2",
            "display": "Neoplasm of uncertain behavior of placenta"
          },
          {
            "code": "D39.8",
            "display": "Neoplasm of uncertain behavior of other specified female genital organs"
          },
          {
            "code": "D39.9",
            "display": "Neoplasm of uncertain behavior of female genital organ, unspecified"
          },
          {
            "code": "D3A.00",
            "display": "Benign carcinoid tumor of unspecified site"
          },
          {
            "code": "D3A.010",
            "display": "Benign carcinoid tumor of the duodenum"
          },
          {
            "code": "D3A.011",
            "display": "Benign carcinoid tumor of the jejunum"
          },
          {
            "code": "D3A.012",
            "display": "Benign carcinoid tumor of the ileum"
          },
          {
            "code": "D3A.019",
            "display": "Benign carcinoid tumor of the small intestine, unspecified portion"
          },
          {
            "code": "D3A.020",
            "display": "Benign carcinoid tumor of the appendix"
          },
          {
            "code": "D3A.021",
            "display": "Benign carcinoid tumor of the cecum"
          },
          {
            "code": "D3A.022",
            "display": "Benign carcinoid tumor of the ascending colon"
          },
          {
            "code": "D3A.023",
            "display": "Benign carcinoid tumor of the transverse colon"
          },
          {
            "code": "D3A.024",
            "display": "Benign carcinoid tumor of the descending colon"
          },
          {
            "code": "D3A.025",
            "display": "Benign carcinoid tumor of the sigmoid colon"
          },
          {
            "code": "D3A.026",
            "display": "Benign carcinoid tumor of the rectum"
          },
          {
            "code": "D3A.029",
            "display": "Benign carcinoid tumor of the large intestine, unspecified portion"
          },
          {
            "code": "D3A.090",
            "display": "Benign carcinoid tumor of the bronchus and lung"
          },
          {
            "code": "D3A.091",
            "display": "Benign carcinoid tumor of the thymus"
          },
          {
            "code": "D3A.092",
            "display": "Benign carcinoid tumor of the stomach"
          },
          {
            "code": "D3A.093",
            "display": "Benign carcinoid tumor of the kidney"
          },
          {
            "code": "D3A.094",
            "display": "Benign carcinoid tumor of the foregut, unspecified"
          },
          {
            "code": "D3A.095",
            "display": "Benign carcinoid tumor of the midgut, unspecified"
          },
          {
            "code": "D3A.096",
            "display": "Benign carcinoid tumor of the hindgut, unspecified"
          },
          {
            "code": "D3A.098",
            "display": "Benign carcinoid tumors of other sites"
          },
          {
            "code": "D3A.8",
            "display": "Other benign neuroendocrine tumors"
          },
          {
            "code": "D40.0",
            "display": "Neoplasm of uncertain behavior of prostate"
          },
          {
            "code": "D40.10",
            "display": "Neoplasm of uncertain behavior of unspecified testis"
          },
          {
            "code": "D40.11",
            "display": "Neoplasm of uncertain behavior of right testis"
          },
          {
            "code": "D40.12",
            "display": "Neoplasm of uncertain behavior of left testis"
          },
          {
            "code": "D40.8",
            "display": "Neoplasm of uncertain behavior of other specified male genital organs"
          },
          {
            "code": "D40.9",
            "display": "Neoplasm of uncertain behavior of male genital organ, unspecified"
          },
          {
            "code": "D41.00",
            "display": "Neoplasm of uncertain behavior of unspecified kidney"
          },
          {
            "code": "D41.01",
            "display": "Neoplasm of uncertain behavior of right kidney"
          },
          {
            "code": "D41.02",
            "display": "Neoplasm of uncertain behavior of left kidney"
          },
          {
            "code": "D41.10",
            "display": "Neoplasm of uncertain behavior of unspecified renal pelvis"
          },
          {
            "code": "D41.11",
            "display": "Neoplasm of uncertain behavior of right renal pelvis"
          },
          {
            "code": "D41.12",
            "display": "Neoplasm of uncertain behavior of left renal pelvis"
          },
          {
            "code": "D41.20",
            "display": "Neoplasm of uncertain behavior of unspecified ureter"
          },
          {
            "code": "D41.21",
            "display": "Neoplasm of uncertain behavior of right ureter"
          },
          {
            "code": "D41.22",
            "display": "Neoplasm of uncertain behavior of left ureter"
          },
          {
            "code": "D41.3",
            "display": "Neoplasm of uncertain behavior of urethra"
          },
          {
            "code": "D41.4",
            "display": "Neoplasm of uncertain behavior of bladder"
          },
          {
            "code": "D41.8",
            "display": "Neoplasm of uncertain behavior of other specified urinary organs"
          },
          {
            "code": "D41.9",
            "display": "Neoplasm of uncertain behavior of unspecified urinary organ"
          },
          {
            "code": "D42.0",
            "display": "Neoplasm of uncertain behavior of cerebral meninges"
          },
          {
            "code": "D42.1",
            "display": "Neoplasm of uncertain behavior of spinal meninges"
          },
          {
            "code": "D42.9",
            "display": "Neoplasm of uncertain behavior of meninges, unspecified"
          },
          {
            "code": "D43.0",
            "display": "Neoplasm of uncertain behavior of brain, supratentorial"
          },
          {
            "code": "D43.1",
            "display": "Neoplasm of uncertain behavior of brain, infratentorial"
          },
          {
            "code": "D43.2",
            "display": "Neoplasm of uncertain behavior of brain, unspecified"
          },
          {
            "code": "D43.3",
            "display": "Neoplasm of uncertain behavior of cranial nerves"
          },
          {
            "code": "D43.4",
            "display": "Neoplasm of uncertain behavior of spinal cord"
          },
          {
            "code": "D43.8",
            "display": "Neoplasm of uncertain behavior of other specified parts of central nervous system"
          },
          {
            "code": "D43.9",
            "display": "Neoplasm of uncertain behavior of central nervous system, unspecified"
          },
          {
            "code": "D44.0",
            "display": "Neoplasm of uncertain behavior of thyroid gland"
          },
          {
            "code": "D44.10",
            "display": "Neoplasm of uncertain behavior of unspecified adrenal gland"
          },
          {
            "code": "D44.11",
            "display": "Neoplasm of uncertain behavior of right adrenal gland"
          },
          {
            "code": "D44.12",
            "display": "Neoplasm of uncertain behavior of left adrenal gland"
          },
          {
            "code": "D44.2",
            "display": "Neoplasm of uncertain behavior of parathyroid gland"
          },
          {
            "code": "D44.3",
            "display": "Neoplasm of uncertain behavior of pituitary gland"
          },
          {
            "code": "D44.4",
            "display": "Neoplasm of uncertain behavior of craniopharyngeal duct"
          },
          {
            "code": "D44.5",
            "display": "Neoplasm of uncertain behavior of pineal gland"
          },
          {
            "code": "D44.6",
            "display": "Neoplasm of uncertain behavior of carotid body"
          },
          {
            "code": "D44.7",
            "display": "Neoplasm of uncertain behavior of aortic body and other paraganglia"
          },
          {
            "code": "D44.9",
            "display": "Neoplasm of uncertain behavior of unspecified endocrine gland"
          },
          {
            "code": "D45",
            "display": "Polycythemia vera"
          },
          {
            "code": "D46.0",
            "display": "Refractory anemia without ring sideroblasts, so stated"
          },
          {
            "code": "D46.1",
            "display": "Refractory anemia with ring sideroblasts"
          },
          {
            "code": "D46.20",
            "display": "Refractory anemia with excess of blasts, unspecified"
          },
          {
            "code": "D46.21",
            "display": "Refractory anemia with excess of blasts 1"
          },
          {
            "code": "D46.22",
            "display": "Refractory anemia with excess of blasts 2"
          },
          {
            "code": "D46.4",
            "display": "Refractory anemia, unspecified"
          },
          {
            "code": "D46.9",
            "display": "Myelodysplastic syndrome, unspecified"
          },
          {
            "code": "D46.A",
            "display": "Refractory cytopenia with multilineage dysplasia"
          },
          {
            "code": "D46.B",
            "display": "Refractory cytopenia with multilineage dysplasia and ring sideroblasts"
          },
          {
            "code": "D46.C",
            "display": "Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality"
          },
          {
            "code": "D46.Z",
            "display": "Other myelodysplastic syndromes"
          },
          {
            "code": "D47.0",
            "display": "Mast cell neoplasms of uncertain behavior"
          },
          {
            "code": "D47.01",
            "display": "Cutaneous mastocytosis"
          },
          {
            "code": "D47.02",
            "display": "Systemic mastocytosis"
          },
          {
            "code": "D47.09",
            "display": "Other mast cell neoplasms of uncertain behavior"
          },
          {
            "code": "D47.1",
            "display": "Chronic myeloproliferative disease"
          },
          {
            "code": "D47.2",
            "display": "Monoclonal gammopathy"
          },
          {
            "code": "D47.3",
            "display": "Essential (hemorrhagic) thrombocythemia"
          },
          {
            "code": "D47.4",
            "display": "Osteomyelofibrosis"
          },
          {
            "code": "D47.9",
            "display": "Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified"
          },
          {
            "code": "D47.Z1",
            "display": "Post-transplant lymphoproliferative disorder (PTLD)"
          },
          {
            "code": "D47.Z2",
            "display": "Castleman disease"
          },
          {
            "code": "D47.Z9",
            "display": "Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue"
          },
          {
            "code": "D48.0",
            "display": "Neoplasm of uncertain behavior of bone and articular cartilage"
          },
          {
            "code": "D48.1",
            "display": "Neoplasm of uncertain behavior of connective and other soft tissue"
          },
          {
            "code": "D48.2",
            "display": "Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system"
          },
          {
            "code": "D48.3",
            "display": "Neoplasm of uncertain behavior of retroperitoneum"
          },
          {
            "code": "D48.4",
            "display": "Neoplasm of uncertain behavior of peritoneum"
          },
          {
            "code": "D48.5",
            "display": "Neoplasm of uncertain behavior of skin"
          },
          {
            "code": "D48.60",
            "display": "Neoplasm of uncertain behavior of unspecified breast"
          },
          {
            "code": "D48.61",
            "display": "Neoplasm of uncertain behavior of right breast"
          },
          {
            "code": "D48.62",
            "display": "Neoplasm of uncertain behavior of left breast"
          },
          {
            "code": "D48.7",
            "display": "Neoplasm of uncertain behavior of other specified sites"
          },
          {
            "code": "D48.9",
            "display": "Neoplasm of uncertain behavior, unspecified"
          },
          {
            "code": "D49.0",
            "display": "Neoplasm of unspecified behavior of digestive system"
          },
          {
            "code": "D49.1",
            "display": "Neoplasm of unspecified behavior of respiratory system"
          },
          {
            "code": "D49.2",
            "display": "Neoplasm of unspecified behavior of bone, soft tissue, and skin"
          },
          {
            "code": "D49.3",
            "display": "Neoplasm of unspecified behavior of breast"
          },
          {
            "code": "D49.4",
            "display": "Neoplasm of unspecified behavior of bladder"
          },
          {
            "code": "D49.5",
            "display": "Neoplasm of unspecified behavior of other genitourinary organs"
          },
          {
            "code": "D49.511",
            "display": "Neoplasm of unspecified behavior of right kidney"
          },
          {
            "code": "D49.512",
            "display": "Neoplasm of unspecified behavior of left kidney"
          },
          {
            "code": "D49.519",
            "display": "Neoplasm of unspecified behavior of unspecified kidney"
          },
          {
            "code": "D49.59",
            "display": "Neoplasm of unspecified behavior of other genitourinary organ"
          },
          {
            "code": "D49.6",
            "display": "Neoplasm of unspecified behavior of brain"
          },
          {
            "code": "D49.7",
            "display": "Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system"
          },
          {
            "code": "D49.81",
            "display": "Neoplasm of unspecified behavior of retina and choroid"
          },
          {
            "code": "D49.89",
            "display": "Neoplasm of unspecified behavior of other specified sites"
          },
          {
            "code": "D49.9",
            "display": "Neoplasm of unspecified behavior of unspecified site"
          },
          {
            "code": "E31.22",
            "display": "Multiple endocrine neoplasia [MEN] type IIA"
          },
          {
            "code": "E31.23",
            "display": "Multiple endocrine neoplasia [MEN] type IIB"
          },
          {
            "code": "G43.601",
            "display": "Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus"
          },
          {
            "code": "G43.609",
            "display": "Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus"
          },
          {
            "code": "G43.611",
            "display": "Persistent migraine aura with cerebral infarction, intractable, with status migrainosus"
          },
          {
            "code": "G43.619",
            "display": "Persistent migraine aura with cerebral infarction, intractable, without status migrainosus"
          },
          {
            "code": "G45.0",
            "display": "Vertebro-basilar artery syndrome"
          },
          {
            "code": "G45.1",
            "display": "Carotid artery syndrome (hemispheric)"
          },
          {
            "code": "G45.2",
            "display": "Multiple and bilateral precerebral artery syndromes"
          },
          {
            "code": "G45.3",
            "display": "Amaurosis fugax"
          },
          {
            "code": "G45.4",
            "display": "Transient global amnesia"
          },
          {
            "code": "G45.8",
            "display": "Other transient cerebral ischemic attacks and related syndromes"
          },
          {
            "code": "G45.9",
            "display": "Transient cerebral ischemic attack, unspecified"
          },
          {
            "code": "G46.0",
            "display": "Middle cerebral artery syndrome"
          },
          {
            "code": "G46.1",
            "display": "Anterior cerebral artery syndrome"
          },
          {
            "code": "G46.2",
            "display": "Posterior cerebral artery syndrome"
          },
          {
            "code": "G46.3",
            "display": "Brain stem stroke syndrome"
          },
          {
            "code": "G46.4",
            "display": "Cerebellar stroke syndrome"
          },
          {
            "code": "G46.5",
            "display": "Pure motor lacunar syndrome"
          },
          {
            "code": "G46.6",
            "display": "Pure sensory lacunar syndrome"
          },
          {
            "code": "G46.7",
            "display": "Other lacunar syndromes"
          },
          {
            "code": "G46.8",
            "display": "Other vascular syndromes of brain in cerebrovascular diseases"
          },
          {
            "code": "G93.3",
            "display": "Postviral fatigue syndrome"
          },
          {
            "code": "I01.0",
            "display": "Acute rheumatic pericarditis"
          },
          {
            "code": "I01.1",
            "display": "Acute rheumatic endocarditis"
          },
          {
            "code": "I01.2",
            "display": "Acute rheumatic myocarditis"
          },
          {
            "code": "I01.8",
            "display": "Other acute rheumatic heart disease"
          },
          {
            "code": "I01.9",
            "display": "Acute rheumatic heart disease, unspecified"
          },
          {
            "code": "I02.0",
            "display": "Rheumatic chorea with heart involvement"
          },
          {
            "code": "I05.0",
            "display": "Rheumatic mitral stenosis"
          },
          {
            "code": "I05.1",
            "display": "Rheumatic mitral insufficiency"
          },
          {
            "code": "I05.2",
            "display": "Rheumatic mitral stenosis with insufficiency"
          },
          {
            "code": "I05.8",
            "display": "Other rheumatic mitral valve diseases"
          },
          {
            "code": "I05.9",
            "display": "Rheumatic mitral valve disease, unspecified"
          },
          {
            "code": "I06.0",
            "display": "Rheumatic aortic stenosis"
          },
          {
            "code": "I06.1",
            "display": "Rheumatic aortic insufficiency"
          },
          {
            "code": "I06.2",
            "display": "Rheumatic aortic stenosis with insufficiency"
          },
          {
            "code": "I06.8",
            "display": "Other rheumatic aortic valve diseases"
          },
          {
            "code": "I06.9",
            "display": "Rheumatic aortic valve disease, unspecified"
          },
          {
            "code": "I07.0",
            "display": "Rheumatic tricuspid stenosis"
          },
          {
            "code": "I07.1",
            "display": "Rheumatic tricuspid insufficiency"
          },
          {
            "code": "I07.2",
            "display": "Rheumatic tricuspid stenosis and insufficiency"
          },
          {
            "code": "I07.8",
            "display": "Other rheumatic tricuspid valve diseases"
          },
          {
            "code": "I07.9",
            "display": "Rheumatic tricuspid valve disease, unspecified"
          },
          {
            "code": "I08.0",
            "display": "Rheumatic disorders of both mitral and aortic valves"
          },
          {
            "code": "I08.1",
            "display": "Rheumatic disorders of both mitral and tricuspid valves"
          },
          {
            "code": "I08.2",
            "display": "Rheumatic disorders of both aortic and tricuspid valves"
          },
          {
            "code": "I08.3",
            "display": "Combined rheumatic disorders of mitral, aortic and tricuspid valves"
          },
          {
            "code": "I08.8",
            "display": "Other rheumatic multiple valve diseases"
          },
          {
            "code": "I08.9",
            "display": "Rheumatic multiple valve disease, unspecified"
          },
          {
            "code": "I09.0",
            "display": "Rheumatic myocarditis"
          },
          {
            "code": "I09.1",
            "display": "Rheumatic diseases of endocardium, valve unspecified"
          },
          {
            "code": "I09.2",
            "display": "Chronic rheumatic pericarditis"
          },
          {
            "code": "I09.81",
            "display": "Rheumatic heart failure"
          },
          {
            "code": "I09.89",
            "display": "Other specified rheumatic heart diseases"
          },
          {
            "code": "I09.9",
            "display": "Rheumatic heart disease, unspecified"
          },
          {
            "code": "I10",
            "display": "Essential (primary) hypertension"
          },
          {
            "code": "I11.0",
            "display": "Hypertensive heart disease with heart failure"
          },
          {
            "code": "I11.9",
            "display": "Hypertensive heart disease without heart failure"
          },
          {
            "code": "I12.0",
            "display": "Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease"
          },
          {
            "code": "I12.9",
            "display": "Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"
          },
          {
            "code": "I13.0",
            "display": "Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"
          },
          {
            "code": "I13.10",
            "display": "Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"
          },
          {
            "code": "I13.11",
            "display": "Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease"
          },
          {
            "code": "I13.2",
            "display": "Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease"
          },
          {
            "code": "I15.0",
            "display": "Renovascular hypertension"
          },
          {
            "code": "I15.1",
            "display": "Hypertension secondary to other renal disorders"
          },
          {
            "code": "I15.2",
            "display": "Hypertension secondary to endocrine disorders"
          },
          {
            "code": "I15.8",
            "display": "Other secondary hypertension"
          },
          {
            "code": "I15.9",
            "display": "Secondary hypertension, unspecified"
          },
          {
            "code": "I16.0",
            "display": "Hypertensive urgency"
          },
          {
            "code": "I16.1",
            "display": "Hypertensive emergency"
          },
          {
            "code": "I16.9",
            "display": "Hypertensive crisis, unspecified"
          },
          {
            "code": "I20.0",
            "display": "Unstable angina"
          },
          {
            "code": "I20.1",
            "display": "Angina pectoris with documented spasm"
          },
          {
            "code": "I20.8",
            "display": "Other forms of angina pectoris"
          },
          {
            "code": "I20.9",
            "display": "Angina pectoris, unspecified"
          },
          {
            "code": "I21.01",
            "display": "ST elevation (STEMI) myocardial infarction involving left main coronary artery"
          },
          {
            "code": "I21.02",
            "display": "ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery"
          },
          {
            "code": "I21.09",
            "display": "ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall"
          },
          {
            "code": "I21.11",
            "display": "ST elevation (STEMI) myocardial infarction involving right coronary artery"
          },
          {
            "code": "I21.19",
            "display": "ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall"
          },
          {
            "code": "I21.21",
            "display": "ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery"
          },
          {
            "code": "I21.29",
            "display": "ST elevation (STEMI) myocardial infarction involving other sites"
          },
          {
            "code": "I21.3",
            "display": "ST elevation (STEMI) myocardial infarction of unspecified site"
          },
          {
            "code": "I21.4",
            "display": "Non-ST elevation (NSTEMI) myocardial infarction"
          },
          {
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          },
          {
            "code": "I21.A1",
            "display": "Myocardial infarction type 2"
          },
          {
            "code": "I21.A9",
            "display": "Other myocardial infarction type"
          },
          {
            "code": "I22.0",
            "display": "Subsequent ST elevation (STEMI) myocardial infarction of anterior wall"
          },
          {
            "code": "I22.1",
            "display": "Subsequent ST elevation (STEMI) myocardial infarction of inferior wall"
          },
          {
            "code": "I22.2",
            "display": "Subsequent non-ST elevation (NSTEMI) myocardial infarction"
          },
          {
            "code": "I22.8",
            "display": "Subsequent ST elevation (STEMI) myocardial infarction of other sites"
          },
          {
            "code": "I22.9",
            "display": "Subsequent ST elevation (STEMI) myocardial infarction of unspecified site"
          },
          {
            "code": "I23.0",
            "display": "Hemopericardium as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.1",
            "display": "Atrial septal defect as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.2",
            "display": "Ventricular septal defect as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.3",
            "display": "Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.4",
            "display": "Rupture of chordae tendineae as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.5",
            "display": "Rupture of papillary muscle as current complication following acute myocardial infarction"
          },
          {
            "code": "I23.6",
            "display": "Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction"
          },
          {
            "code": "I23.7",
            "display": "Postinfarction angina"
          },
          {
            "code": "I23.8",
            "display": "Other current complications following acute myocardial infarction"
          },
          {
            "code": "I24.0",
            "display": "Acute coronary thrombosis not resulting in myocardial infarction"
          },
          {
            "code": "I24.1",
            "display": "Dressler\u0027s syndrome"
          },
          {
            "code": "I24.8",
            "display": "Other forms of acute ischemic heart disease"
          },
          {
            "code": "I24.9",
            "display": "Acute ischemic heart disease, unspecified"
          },
          {
            "code": "I25.10",
            "display": "Atherosclerotic heart disease of native coronary artery without angina pectoris"
          },
          {
            "code": "I25.110",
            "display": "Atherosclerotic heart disease of native coronary artery with unstable angina pectoris"
          },
          {
            "code": "I25.111",
            "display": "Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm"
          },
          {
            "code": "I25.118",
            "display": "Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris"
          },
          {
            "code": "I25.119",
            "display": "Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris"
          },
          {
            "code": "I25.2",
            "display": "Old myocardial infarction"
          },
          {
            "code": "I25.3",
            "display": "Aneurysm of heart"
          },
          {
            "code": "I25.41",
            "display": "Coronary artery aneurysm"
          },
          {
            "code": "I25.42",
            "display": "Coronary artery dissection"
          },
          {
            "code": "I25.5",
            "display": "Ischemic cardiomyopathy"
          },
          {
            "code": "I25.6",
            "display": "Silent myocardial ischemia"
          },
          {
            "code": "I25.750",
            "display": "Atherosclerosis of native coronary artery of transplanted heart with unstable angina"
          },
          {
            "code": "I25.751",
            "display": "Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm"
          },
          {
            "code": "I25.758",
            "display": "Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris"
          },
          {
            "code": "I25.759",
            "display": "Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris"
          },
          {
            "code": "I25.811",
            "display": "Atherosclerosis of native coronary artery of transplanted heart without angina pectoris"
          },
          {
            "code": "I25.82",
            "display": "Chronic total occlusion of coronary artery"
          },
          {
            "code": "I25.83",
            "display": "Coronary atherosclerosis due to lipid rich plaque"
          },
          {
            "code": "I25.84",
            "display": "Coronary atherosclerosis due to calcified coronary lesion"
          },
          {
            "code": "I25.89",
            "display": "Other forms of chronic ischemic heart disease"
          },
          {
            "code": "I25.9",
            "display": "Chronic ischemic heart disease, unspecified"
          },
          {
            "code": "I26.01",
            "display": "Septic pulmonary embolism with acute cor pulmonale"
          },
          {
            "code": "I26.02",
            "display": "Saddle embolus of pulmonary artery with acute cor pulmonale"
          },
          {
            "code": "I26.09",
            "display": "Other pulmonary embolism with acute cor pulmonale"
          },
          {
            "code": "I26.90",
            "display": "Septic pulmonary embolism without acute cor pulmonale"
          },
          {
            "code": "I26.92",
            "display": "Saddle embolus of pulmonary artery without acute cor pulmonale"
          },
          {
            "code": "I26.99",
            "display": "Other pulmonary embolism without acute cor pulmonale"
          },
          {
            "code": "I27.0",
            "display": "Primary pulmonary hypertension"
          },
          {
            "code": "I27.1",
            "display": "Kyphoscoliotic heart disease"
          },
          {
            "code": "I27.2",
            "display": "Other secondary pulmonary hypertension"
          },
          {
            "code": "I27.20",
            "display": "Pulmonary hypertension, unspecified"
          },
          {
            "code": "I27.21",
            "display": "Secondary pulmonary arterial hypertension"
          },
          {
            "code": "I27.22",
            "display": "Pulmonary hypertension due to left heart disease"
          },
          {
            "code": "I27.23",
            "display": "Pulmonary hypertension due to lung diseases and hypoxia"
          },
          {
            "code": "I27.24",
            "display": "Chronic thromboembolic pulmonary hypertension"
          },
          {
            "code": "I27.29",
            "display": "Other secondary pulmonary hypertension"
          },
          {
            "code": "I27.81",
            "display": "Cor pulmonale (chronic)"
          },
          {
            "code": "I27.82",
            "display": "Chronic pulmonary embolism"
          },
          {
            "code": "I27.83",
            "display": "Eisenmenger\u0027s syndrome"
          },
          {
            "code": "I27.89",
            "display": "Other specified pulmonary heart diseases"
          },
          {
            "code": "I27.9",
            "display": "Pulmonary heart disease, unspecified"
          },
          {
            "code": "I28.0",
            "display": "Arteriovenous fistula of pulmonary vessels"
          },
          {
            "code": "I28.1",
            "display": "Aneurysm of pulmonary artery"
          },
          {
            "code": "I28.8",
            "display": "Other diseases of pulmonary vessels"
          },
          {
            "code": "I28.9",
            "display": "Disease of pulmonary vessels, unspecified"
          },
          {
            "code": "I30.0",
            "display": "Acute nonspecific idiopathic pericarditis"
          },
          {
            "code": "I30.1",
            "display": "Infective pericarditis"
          },
          {
            "code": "I30.8",
            "display": "Other forms of acute pericarditis"
          },
          {
            "code": "I30.9",
            "display": "Acute pericarditis, unspecified"
          },
          {
            "code": "I31.0",
            "display": "Chronic adhesive pericarditis"
          },
          {
            "code": "I31.1",
            "display": "Chronic constrictive pericarditis"
          },
          {
            "code": "I31.2",
            "display": "Hemopericardium, not elsewhere classified"
          },
          {
            "code": "I31.3",
            "display": "Pericardial effusion (noninflammatory)"
          },
          {
            "code": "I31.4",
            "display": "Cardiac tamponade"
          },
          {
            "code": "I31.8",
            "display": "Other specified diseases of pericardium"
          },
          {
            "code": "I31.9",
            "display": "Disease of pericardium, unspecified"
          },
          {
            "code": "I32",
            "display": "Pericarditis in diseases classified elsewhere"
          },
          {
            "code": "I33.0",
            "display": "Acute and subacute infective endocarditis"
          },
          {
            "code": "I33.9",
            "display": "Acute and subacute endocarditis, unspecified"
          },
          {
            "code": "I34.0",
            "display": "Nonrheumatic mitral (valve) insufficiency"
          },
          {
            "code": "I34.1",
            "display": "Nonrheumatic mitral (valve) prolapse"
          },
          {
            "code": "I34.2",
            "display": "Nonrheumatic mitral (valve) stenosis"
          },
          {
            "code": "I34.8",
            "display": "Other nonrheumatic mitral valve disorders"
          },
          {
            "code": "I34.9",
            "display": "Nonrheumatic mitral valve disorder, unspecified"
          },
          {
            "code": "I35.0",
            "display": "Nonrheumatic aortic (valve) stenosis"
          },
          {
            "code": "I35.1",
            "display": "Nonrheumatic aortic (valve) insufficiency"
          },
          {
            "code": "I35.2",
            "display": "Nonrheumatic aortic (valve) stenosis with insufficiency"
          },
          {
            "code": "I35.8",
            "display": "Other nonrheumatic aortic valve disorders"
          },
          {
            "code": "I35.9",
            "display": "Nonrheumatic aortic valve disorder, unspecified"
          },
          {
            "code": "I36.0",
            "display": "Nonrheumatic tricuspid (valve) stenosis"
          },
          {
            "code": "I36.1",
            "display": "Nonrheumatic tricuspid (valve) insufficiency"
          },
          {
            "code": "I36.2",
            "display": "Nonrheumatic tricuspid (valve) stenosis with insufficiency"
          },
          {
            "code": "I36.8",
            "display": "Other nonrheumatic tricuspid valve disorders"
          },
          {
            "code": "I36.9",
            "display": "Nonrheumatic tricuspid valve disorder, unspecified"
          },
          {
            "code": "I37.0",
            "display": "Nonrheumatic pulmonary valve stenosis"
          },
          {
            "code": "I37.1",
            "display": "Nonrheumatic pulmonary valve insufficiency"
          },
          {
            "code": "I37.2",
            "display": "Nonrheumatic pulmonary valve stenosis with insufficiency"
          },
          {
            "code": "I37.8",
            "display": "Other nonrheumatic pulmonary valve disorders"
          },
          {
            "code": "I37.9",
            "display": "Nonrheumatic pulmonary valve disorder, unspecified"
          },
          {
            "code": "I38",
            "display": "Endocarditis, valve unspecified"
          },
          {
            "code": "I39",
            "display": "Endocarditis and heart valve disorders in diseases classified elsewhere"
          },
          {
            "code": "I40.0",
            "display": "Infective myocarditis"
          },
          {
            "code": "I40.1",
            "display": "Isolated myocarditis"
          },
          {
            "code": "I40.8",
            "display": "Other acute myocarditis"
          },
          {
            "code": "I40.9",
            "display": "Acute myocarditis, unspecified"
          },
          {
            "code": "I41",
            "display": "Myocarditis in diseases classified elsewhere"
          },
          {
            "code": "I42.0",
            "display": "Dilated cardiomyopathy"
          },
          {
            "code": "I42.1",
            "display": "Obstructive hypertrophic cardiomyopathy"
          },
          {
            "code": "I42.2",
            "display": "Other hypertrophic cardiomyopathy"
          },
          {
            "code": "I42.3",
            "display": "Endomyocardial (eosinophilic) disease"
          },
          {
            "code": "I42.4",
            "display": "Endocardial fibroelastosis"
          },
          {
            "code": "I42.5",
            "display": "Other restrictive cardiomyopathy"
          },
          {
            "code": "I42.7",
            "display": "Cardiomyopathy due to drug and external agent"
          },
          {
            "code": "I42.8",
            "display": "Other cardiomyopathies"
          },
          {
            "code": "I42.9",
            "display": "Cardiomyopathy, unspecified"
          },
          {
            "code": "I43",
            "display": "Cardiomyopathy in diseases classified elsewhere"
          },
          {
            "code": "I44.0",
            "display": "Atrioventricular block, first degree"
          },
          {
            "code": "I44.1",
            "display": "Atrioventricular block, second degree"
          },
          {
            "code": "I44.2",
            "display": "Atrioventricular block, complete"
          },
          {
            "code": "I44.30",
            "display": "Unspecified atrioventricular block"
          },
          {
            "code": "I44.39",
            "display": "Other atrioventricular block"
          },
          {
            "code": "I44.4",
            "display": "Left anterior fascicular block"
          },
          {
            "code": "I44.5",
            "display": "Left posterior fascicular block"
          },
          {
            "code": "I44.60",
            "display": "Unspecified fascicular block"
          },
          {
            "code": "I44.69",
            "display": "Other fascicular block"
          },
          {
            "code": "I44.7",
            "display": "Left bundle-branch block, unspecified"
          },
          {
            "code": "I45.0",
            "display": "Right fascicular block"
          },
          {
            "code": "I45.10",
            "display": "Unspecified right bundle-branch block"
          },
          {
            "code": "I45.19",
            "display": "Other right bundle-branch block"
          },
          {
            "code": "I45.2",
            "display": "Bifascicular block"
          },
          {
            "code": "I45.3",
            "display": "Trifascicular block"
          },
          {
            "code": "I45.4",
            "display": "Nonspecific intraventricular block"
          },
          {
            "code": "I45.5",
            "display": "Other specified heart block"
          },
          {
            "code": "I45.6",
            "display": "Pre-excitation syndrome"
          },
          {
            "code": "I45.81",
            "display": "Long QT syndrome"
          },
          {
            "code": "I45.89",
            "display": "Other specified conduction disorders"
          },
          {
            "code": "I45.9",
            "display": "Conduction disorder, unspecified"
          },
          {
            "code": "I46.2",
            "display": "Cardiac arrest due to underlying cardiac condition"
          },
          {
            "code": "I46.8",
            "display": "Cardiac arrest due to other underlying condition"
          },
          {
            "code": "I46.9",
            "display": "Cardiac arrest, cause unspecified"
          },
          {
            "code": "I47.0",
            "display": "Re-entry ventricular arrhythmia"
          },
          {
            "code": "I47.1",
            "display": "Supraventricular tachycardia"
          },
          {
            "code": "I47.2",
            "display": "Ventricular tachycardia"
          },
          {
            "code": "I47.9",
            "display": "Paroxysmal tachycardia, unspecified"
          },
          {
            "code": "I48.0",
            "display": "Paroxysmal atrial fibrillation"
          },
          {
            "code": "I48.1",
            "display": "Persistent atrial fibrillation"
          },
          {
            "code": "I48.2",
            "display": "Chronic atrial fibrillation"
          },
          {
            "code": "I48.3",
            "display": "Typical atrial flutter"
          },
          {
            "code": "I48.4",
            "display": "Atypical atrial flutter"
          },
          {
            "code": "I48.91",
            "display": "Unspecified atrial fibrillation"
          },
          {
            "code": "I48.92",
            "display": "Unspecified atrial flutter"
          },
          {
            "code": "I49.01",
            "display": "Ventricular fibrillation"
          },
          {
            "code": "I49.02",
            "display": "Ventricular flutter"
          },
          {
            "code": "I49.1",
            "display": "Atrial premature depolarization"
          },
          {
            "code": "I49.2",
            "display": "Junctional premature depolarization"
          },
          {
            "code": "I49.3",
            "display": "Ventricular premature depolarization"
          },
          {
            "code": "I49.40",
            "display": "Unspecified premature depolarization"
          },
          {
            "code": "I49.49",
            "display": "Other premature depolarization"
          },
          {
            "code": "I49.5",
            "display": "Sick sinus syndrome"
          },
          {
            "code": "I49.8",
            "display": "Other specified cardiac arrhythmias"
          },
          {
            "code": "I49.9",
            "display": "Cardiac arrhythmia, unspecified"
          },
          {
            "code": "I50.1",
            "display": "Left ventricular failure, unspecified"
          },
          {
            "code": "I50.20",
            "display": "Unspecified systolic (congestive) heart failure"
          },
          {
            "code": "I50.21",
            "display": "Acute systolic (congestive) heart failure"
          },
          {
            "code": "I50.22",
            "display": "Chronic systolic (congestive) heart failure"
          },
          {
            "code": "I50.23",
            "display": "Acute on chronic systolic (congestive) heart failure"
          },
          {
            "code": "I50.30",
            "display": "Unspecified diastolic (congestive) heart failure"
          },
          {
            "code": "I50.31",
            "display": "Acute diastolic (congestive) heart failure"
          },
          {
            "code": "I50.32",
            "display": "Chronic diastolic (congestive) heart failure"
          },
          {
            "code": "I50.33",
            "display": "Acute on chronic diastolic (congestive) heart failure"
          },
          {
            "code": "I50.40",
            "display": "Unspecified combined systolic (congestive) and diastolic (congestive) heart failure"
          },
          {
            "code": "I50.41",
            "display": "Acute combined systolic (congestive) and diastolic (congestive) heart failure"
          },
          {
            "code": "I50.42",
            "display": "Chronic combined systolic (congestive) and diastolic (congestive) heart failure"
          },
          {
            "code": "I50.43",
            "display": "Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure"
          },
          {
            "code": "I50.810",
            "display": "Right heart failure, unspecified"
          },
          {
            "code": "I50.811",
            "display": "Acute right heart failure"
          },
          {
            "code": "I50.812",
            "display": "Chronic right heart failure"
          },
          {
            "code": "I50.813",
            "display": "Acute on chronic right heart failure"
          },
          {
            "code": "I50.814",
            "display": "Right heart failure due to left heart failure"
          },
          {
            "code": "I50.82",
            "display": "Biventricular heart failure"
          },
          {
            "code": "I50.83",
            "display": "High output heart failure"
          },
          {
            "code": "I50.84",
            "display": "End stage heart failure"
          },
          {
            "code": "I50.89",
            "display": "Other heart failure"
          },
          {
            "code": "I50.9",
            "display": "Heart failure, unspecified"
          },
          {
            "code": "I51.0",
            "display": "Cardiac septal defect, acquired"
          },
          {
            "code": "I51.1",
            "display": "Rupture of chordae tendineae, not elsewhere classified"
          },
          {
            "code": "I51.2",
            "display": "Rupture of papillary muscle, not elsewhere classified"
          },
          {
            "code": "I51.3",
            "display": "Intracardiac thrombosis, not elsewhere classified"
          },
          {
            "code": "I51.4",
            "display": "Myocarditis, unspecified"
          },
          {
            "code": "I51.5",
            "display": "Myocardial degeneration"
          },
          {
            "code": "I51.7",
            "display": "Cardiomegaly"
          },
          {
            "code": "I51.81",
            "display": "Takotsubo syndrome"
          },
          {
            "code": "I51.89",
            "display": "Other ill-defined heart diseases"
          },
          {
            "code": "I51.9",
            "display": "Heart disease, unspecified"
          },
          {
            "code": "I52",
            "display": "Other heart disorders in diseases classified elsewhere"
          },
          {
            "code": "I60.00",
            "display": "Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation"
          },
          {
            "code": "I60.01",
            "display": "Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation"
          },
          {
            "code": "I60.02",
            "display": "Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation"
          },
          {
            "code": "I60.10",
            "display": "Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery"
          },
          {
            "code": "I60.11",
            "display": "Nontraumatic subarachnoid hemorrhage from right middle cerebral artery"
          },
          {
            "code": "I60.12",
            "display": "Nontraumatic subarachnoid hemorrhage from left middle cerebral artery"
          },
          {
            "code": "I60.2",
            "display": "Nontraumatic subarachnoid hemorrhage from anterior communicating artery"
          },
          {
            "code": "I60.30",
            "display": "Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery"
          },
          {
            "code": "I60.31",
            "display": "Nontraumatic subarachnoid hemorrhage from right posterior communicating artery"
          },
          {
            "code": "I60.32",
            "display": "Nontraumatic subarachnoid hemorrhage from left posterior communicating artery"
          },
          {
            "code": "I60.4",
            "display": "Nontraumatic subarachnoid hemorrhage from basilar artery"
          },
          {
            "code": "I60.50",
            "display": "Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery"
          },
          {
            "code": "I60.51",
            "display": "Nontraumatic subarachnoid hemorrhage from right vertebral artery"
          },
          {
            "code": "I60.52",
            "display": "Nontraumatic subarachnoid hemorrhage from left vertebral artery"
          },
          {
            "code": "I60.6",
            "display": "Nontraumatic subarachnoid hemorrhage from other intracranial arteries"
          },
          {
            "code": "I60.7",
            "display": "Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery"
          },
          {
            "code": "I60.8",
            "display": "Other nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I60.9",
            "display": "Nontraumatic subarachnoid hemorrhage, unspecified"
          },
          {
            "code": "I61.0",
            "display": "Nontraumatic intracerebral hemorrhage in hemisphere, subcortical"
          },
          {
            "code": "I61.1",
            "display": "Nontraumatic intracerebral hemorrhage in hemisphere, cortical"
          },
          {
            "code": "I61.2",
            "display": "Nontraumatic intracerebral hemorrhage in hemisphere, unspecified"
          },
          {
            "code": "I61.3",
            "display": "Nontraumatic intracerebral hemorrhage in brain stem"
          },
          {
            "code": "I61.4",
            "display": "Nontraumatic intracerebral hemorrhage in cerebellum"
          },
          {
            "code": "I61.5",
            "display": "Nontraumatic intracerebral hemorrhage, intraventricular"
          },
          {
            "code": "I61.6",
            "display": "Nontraumatic intracerebral hemorrhage, multiple localized"
          },
          {
            "code": "I61.8",
            "display": "Other nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I61.9",
            "display": "Nontraumatic intracerebral hemorrhage, unspecified"
          },
          {
            "code": "I62.00",
            "display": "Nontraumatic subdural hemorrhage, unspecified"
          },
          {
            "code": "I62.01",
            "display": "Nontraumatic acute subdural hemorrhage"
          },
          {
            "code": "I62.02",
            "display": "Nontraumatic subacute subdural hemorrhage"
          },
          {
            "code": "I62.03",
            "display": "Nontraumatic chronic subdural hemorrhage"
          },
          {
            "code": "I62.1",
            "display": "Nontraumatic extradural hemorrhage"
          },
          {
            "code": "I62.9",
            "display": "Nontraumatic intracranial hemorrhage, unspecified"
          },
          {
            "code": "I63.00",
            "display": "Cerebral infarction due to thrombosis of unspecified precerebral artery"
          },
          {
            "code": "I63.011",
            "display": "Cerebral infarction due to thrombosis of right vertebral artery"
          },
          {
            "code": "I63.012",
            "display": "Cerebral infarction due to thrombosis of left vertebral artery"
          },
          {
            "code": "I63.013",
            "display": "Cerebral infarction due to thrombosis of bilateral vertebral arteries"
          },
          {
            "code": "I63.019",
            "display": "Cerebral infarction due to thrombosis of unspecified vertebral artery"
          },
          {
            "code": "I63.02",
            "display": "Cerebral infarction due to thrombosis of basilar artery"
          },
          {
            "code": "I63.031",
            "display": "Cerebral infarction due to thrombosis of right carotid artery"
          },
          {
            "code": "I63.032",
            "display": "Cerebral infarction due to thrombosis of left carotid artery"
          },
          {
            "code": "I63.033",
            "display": "Cerebral infarction due to thrombosis of bilateral carotid arteries"
          },
          {
            "code": "I63.039",
            "display": "Cerebral infarction due to thrombosis of unspecified carotid artery"
          },
          {
            "code": "I63.09",
            "display": "Cerebral infarction due to thrombosis of other precerebral artery"
          },
          {
            "code": "I63.10",
            "display": "Cerebral infarction due to embolism of unspecified precerebral artery"
          },
          {
            "code": "I63.111",
            "display": "Cerebral infarction due to embolism of right vertebral artery"
          },
          {
            "code": "I63.112",
            "display": "Cerebral infarction due to embolism of left vertebral artery"
          },
          {
            "code": "I63.113",
            "display": "Cerebral infarction due to embolism of bilateral vertebral arteries"
          },
          {
            "code": "I63.119",
            "display": "Cerebral infarction due to embolism of unspecified vertebral artery"
          },
          {
            "code": "I63.12",
            "display": "Cerebral infarction due to embolism of basilar artery"
          },
          {
            "code": "I63.131",
            "display": "Cerebral infarction due to embolism of right carotid artery"
          },
          {
            "code": "I63.132",
            "display": "Cerebral infarction due to embolism of left carotid artery"
          },
          {
            "code": "I63.133",
            "display": "Cerebral infarction due to embolism of bilateral carotid arteries"
          },
          {
            "code": "I63.139",
            "display": "Cerebral infarction due to embolism of unspecified carotid artery"
          },
          {
            "code": "I63.19",
            "display": "Cerebral infarction due to embolism of other precerebral artery"
          },
          {
            "code": "I63.20",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries"
          },
          {
            "code": "I63.211",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery"
          },
          {
            "code": "I63.212",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery"
          },
          {
            "code": "I63.213",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries"
          },
          {
            "code": "I63.219",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery"
          },
          {
            "code": "I63.22",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of basilar artery"
          },
          {
            "code": "I63.231",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries"
          },
          {
            "code": "I63.232",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries"
          },
          {
            "code": "I63.233",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries"
          },
          {
            "code": "I63.239",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery"
          },
          {
            "code": "I63.29",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries"
          },
          {
            "code": "I63.30",
            "display": "Cerebral infarction due to thrombosis of unspecified cerebral artery"
          },
          {
            "code": "I63.311",
            "display": "Cerebral infarction due to thrombosis of right middle cerebral artery"
          },
          {
            "code": "I63.312",
            "display": "Cerebral infarction due to thrombosis of left middle cerebral artery"
          },
          {
            "code": "I63.313",
            "display": "Cerebral infarction due to thrombosis of bilateral middle cerebral arteries"
          },
          {
            "code": "I63.319",
            "display": "Cerebral infarction due to thrombosis of unspecified middle cerebral artery"
          },
          {
            "code": "I63.321",
            "display": "Cerebral infarction due to thrombosis of right anterior cerebral artery"
          },
          {
            "code": "I63.322",
            "display": "Cerebral infarction due to thrombosis of left anterior cerebral artery"
          },
          {
            "code": "I63.323",
            "display": "Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries"
          },
          {
            "code": "I63.329",
            "display": "Cerebral infarction due to thrombosis of unspecified anterior cerebral artery"
          },
          {
            "code": "I63.331",
            "display": "Cerebral infarction due to thrombosis of right posterior cerebral artery"
          },
          {
            "code": "I63.332",
            "display": "Cerebral infarction due to thrombosis of left posterior cerebral artery"
          },
          {
            "code": "I63.333",
            "display": "Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries"
          },
          {
            "code": "I63.339",
            "display": "Cerebral infarction due to thrombosis of unspecified posterior cerebral artery"
          },
          {
            "code": "I63.341",
            "display": "Cerebral infarction due to thrombosis of right cerebellar artery"
          },
          {
            "code": "I63.342",
            "display": "Cerebral infarction due to thrombosis of left cerebellar artery"
          },
          {
            "code": "I63.343",
            "display": "Cerebral infarction due to thrombosis of bilateral cerebellar arteries"
          },
          {
            "code": "I63.349",
            "display": "Cerebral infarction due to thrombosis of unspecified cerebellar artery"
          },
          {
            "code": "I63.39",
            "display": "Cerebral infarction due to thrombosis of other cerebral artery"
          },
          {
            "code": "I63.40",
            "display": "Cerebral infarction due to embolism of unspecified cerebral artery"
          },
          {
            "code": "I63.411",
            "display": "Cerebral infarction due to embolism of right middle cerebral artery"
          },
          {
            "code": "I63.412",
            "display": "Cerebral infarction due to embolism of left middle cerebral artery"
          },
          {
            "code": "I63.413",
            "display": "Cerebral infarction due to embolism of bilateral middle cerebral arteries"
          },
          {
            "code": "I63.419",
            "display": "Cerebral infarction due to embolism of unspecified middle cerebral artery"
          },
          {
            "code": "I63.421",
            "display": "Cerebral infarction due to embolism of right anterior cerebral artery"
          },
          {
            "code": "I63.422",
            "display": "Cerebral infarction due to embolism of left anterior cerebral artery"
          },
          {
            "code": "I63.423",
            "display": "Cerebral infarction due to embolism of bilateral anterior cerebral arteries"
          },
          {
            "code": "I63.429",
            "display": "Cerebral infarction due to embolism of unspecified anterior cerebral artery"
          },
          {
            "code": "I63.431",
            "display": "Cerebral infarction due to embolism of right posterior cerebral artery"
          },
          {
            "code": "I63.432",
            "display": "Cerebral infarction due to embolism of left posterior cerebral artery"
          },
          {
            "code": "I63.433",
            "display": "Cerebral infarction due to embolism of bilateral posterior cerebral arteries"
          },
          {
            "code": "I63.439",
            "display": "Cerebral infarction due to embolism of unspecified posterior cerebral artery"
          },
          {
            "code": "I63.441",
            "display": "Cerebral infarction due to embolism of right cerebellar artery"
          },
          {
            "code": "I63.442",
            "display": "Cerebral infarction due to embolism of left cerebellar artery"
          },
          {
            "code": "I63.443",
            "display": "Cerebral infarction due to embolism of bilateral cerebellar arteries"
          },
          {
            "code": "I63.449",
            "display": "Cerebral infarction due to embolism of unspecified cerebellar artery"
          },
          {
            "code": "I63.49",
            "display": "Cerebral infarction due to embolism of other cerebral artery"
          },
          {
            "code": "I63.50",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery"
          },
          {
            "code": "I63.511",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery"
          },
          {
            "code": "I63.512",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery"
          },
          {
            "code": "I63.513",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries"
          },
          {
            "code": "I63.519",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery"
          },
          {
            "code": "I63.521",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery"
          },
          {
            "code": "I63.522",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery"
          },
          {
            "code": "I63.523",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries"
          },
          {
            "code": "I63.529",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery"
          },
          {
            "code": "I63.531",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery"
          },
          {
            "code": "I63.532",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery"
          },
          {
            "code": "I63.533",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries"
          },
          {
            "code": "I63.539",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery"
          },
          {
            "code": "I63.541",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery"
          },
          {
            "code": "I63.542",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery"
          },
          {
            "code": "I63.543",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries"
          },
          {
            "code": "I63.549",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery"
          },
          {
            "code": "I63.59",
            "display": "Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery"
          },
          {
            "code": "I63.6",
            "display": "Cerebral infarction due to cerebral venous thrombosis, nonpyogenic"
          },
          {
            "code": "I63.8",
            "display": "Other cerebral infarction"
          },
          {
            "code": "I63.81",
            "display": "Other cerebral infarction due to occlusion or stenosis of small artery"
          },
          {
            "code": "I63.89",
            "display": "Other cerebral infarction"
          },
          {
            "code": "I63.9",
            "display": "Cerebral infarction, unspecified"
          },
          {
            "code": "I65.01",
            "display": "Occlusion and stenosis of right vertebral artery"
          },
          {
            "code": "I65.02",
            "display": "Occlusion and stenosis of left vertebral artery"
          },
          {
            "code": "I65.03",
            "display": "Occlusion and stenosis of bilateral vertebral arteries"
          },
          {
            "code": "I65.09",
            "display": "Occlusion and stenosis of unspecified vertebral artery"
          },
          {
            "code": "I65.1",
            "display": "Occlusion and stenosis of basilar artery"
          },
          {
            "code": "I65.21",
            "display": "Occlusion and stenosis of right carotid artery"
          },
          {
            "code": "I65.22",
            "display": "Occlusion and stenosis of left carotid artery"
          },
          {
            "code": "I65.23",
            "display": "Occlusion and stenosis of bilateral carotid arteries"
          },
          {
            "code": "I65.29",
            "display": "Occlusion and stenosis of unspecified carotid artery"
          },
          {
            "code": "I65.8",
            "display": "Occlusion and stenosis of other precerebral arteries"
          },
          {
            "code": "I65.9",
            "display": "Occlusion and stenosis of unspecified precerebral artery"
          },
          {
            "code": "I66.01",
            "display": "Occlusion and stenosis of right middle cerebral artery"
          },
          {
            "code": "I66.02",
            "display": "Occlusion and stenosis of left middle cerebral artery"
          },
          {
            "code": "I66.03",
            "display": "Occlusion and stenosis of bilateral middle cerebral arteries"
          },
          {
            "code": "I66.09",
            "display": "Occlusion and stenosis of unspecified middle cerebral artery"
          },
          {
            "code": "I66.11",
            "display": "Occlusion and stenosis of right anterior cerebral artery"
          },
          {
            "code": "I66.12",
            "display": "Occlusion and stenosis of left anterior cerebral artery"
          },
          {
            "code": "I66.13",
            "display": "Occlusion and stenosis of bilateral anterior cerebral arteries"
          },
          {
            "code": "I66.19",
            "display": "Occlusion and stenosis of unspecified anterior cerebral artery"
          },
          {
            "code": "I66.21",
            "display": "Occlusion and stenosis of right posterior cerebral artery"
          },
          {
            "code": "I66.22",
            "display": "Occlusion and stenosis of left posterior cerebral artery"
          },
          {
            "code": "I66.23",
            "display": "Occlusion and stenosis of bilateral posterior cerebral arteries"
          },
          {
            "code": "I66.29",
            "display": "Occlusion and stenosis of unspecified posterior cerebral artery"
          },
          {
            "code": "I66.3",
            "display": "Occlusion and stenosis of cerebellar arteries"
          },
          {
            "code": "I66.8",
            "display": "Occlusion and stenosis of other cerebral arteries"
          },
          {
            "code": "I66.9",
            "display": "Occlusion and stenosis of unspecified cerebral artery"
          },
          {
            "code": "I67.0",
            "display": "Dissection of cerebral arteries, nonruptured"
          },
          {
            "code": "I67.1",
            "display": "Cerebral aneurysm, nonruptured"
          },
          {
            "code": "I67.2",
            "display": "Cerebral atherosclerosis"
          },
          {
            "code": "I67.4",
            "display": "Hypertensive encephalopathy"
          },
          {
            "code": "I67.5",
            "display": "Moyamoya disease"
          },
          {
            "code": "I67.6",
            "display": "Nonpyogenic thrombosis of intracranial venous system"
          },
          {
            "code": "I67.7",
            "display": "Cerebral arteritis, not elsewhere classified"
          },
          {
            "code": "I67.81",
            "display": "Acute cerebrovascular insufficiency"
          },
          {
            "code": "I67.82",
            "display": "Cerebral ischemia"
          },
          {
            "code": "I67.83",
            "display": "Posterior reversible encephalopathy syndrome"
          },
          {
            "code": "I67.841",
            "display": "Reversible cerebrovascular vasoconstriction syndrome"
          },
          {
            "code": "I67.848",
            "display": "Other cerebrovascular vasospasm and vasoconstriction"
          },
          {
            "code": "I67.850",
            "display": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy"
          },
          {
            "code": "I67.858",
            "display": "Other hereditary cerebrovascular disease"
          },
          {
            "code": "I67.89",
            "display": "Other cerebrovascular disease"
          },
          {
            "code": "I67.9",
            "display": "Cerebrovascular disease, unspecified"
          },
          {
            "code": "I68.0",
            "display": "Cerebral amyloid angiopathy"
          },
          {
            "code": "I68.2",
            "display": "Cerebral arteritis in other diseases classified elsewhere"
          },
          {
            "code": "I68.8",
            "display": "Other cerebrovascular disorders in diseases classified elsewhere"
          },
          {
            "code": "I69.00",
            "display": "Unspecified sequelae of nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.01",
            "display": "Cognitive deficits following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.010",
            "display": "Attention and concentration deficit following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.011",
            "display": "Memory deficit following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.012",
            "display": "Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.013",
            "display": "Psychomotor deficit following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.014",
            "display": "Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.015",
            "display": "Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.018",
            "display": "Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.019",
            "display": "Unspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.020",
            "display": "Aphasia following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.021",
            "display": "Dysphasia following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.022",
            "display": "Dysarthria following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.023",
            "display": "Fluency disorder following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.028",
            "display": "Other speech and language deficits following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.031",
            "display": "Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.032",
            "display": "Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.033",
            "display": "Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.034",
            "display": "Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.039",
            "display": "Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.041",
            "display": "Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.042",
            "display": "Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.043",
            "display": "Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.044",
            "display": "Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.049",
            "display": "Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.051",
            "display": "Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.052",
            "display": "Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.053",
            "display": "Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.054",
            "display": "Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.059",
            "display": "Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.061",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.062",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.063",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.064",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.065",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral"
          },
          {
            "code": "I69.069",
            "display": "Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.090",
            "display": "Apraxia following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.091",
            "display": "Dysphagia following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.092",
            "display": "Facial weakness following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.093",
            "display": "Ataxia following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.098",
            "display": "Other sequelae following nontraumatic subarachnoid hemorrhage"
          },
          {
            "code": "I69.10",
            "display": "Unspecified sequelae of nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.11",
            "display": "Cognitive deficits following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.110",
            "display": "Attention and concentration deficit following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.111",
            "display": "Memory deficit following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.112",
            "display": "Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.113",
            "display": "Psychomotor deficit following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.114",
            "display": "Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.115",
            "display": "Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.118",
            "display": "Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.119",
            "display": "Unspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.120",
            "display": "Aphasia following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.121",
            "display": "Dysphasia following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.122",
            "display": "Dysarthria following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.123",
            "display": "Fluency disorder following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.128",
            "display": "Other speech and language deficits following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.131",
            "display": "Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.132",
            "display": "Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.133",
            "display": "Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.134",
            "display": "Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.139",
            "display": "Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.141",
            "display": "Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.142",
            "display": "Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.143",
            "display": "Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.144",
            "display": "Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.149",
            "display": "Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.151",
            "display": "Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.152",
            "display": "Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.153",
            "display": "Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.154",
            "display": "Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.159",
            "display": "Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.161",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.162",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.163",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.164",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.165",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral"
          },
          {
            "code": "I69.169",
            "display": "Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.190",
            "display": "Apraxia following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.191",
            "display": "Dysphagia following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.192",
            "display": "Facial weakness following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.193",
            "display": "Ataxia following nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.198",
            "display": "Other sequelae of nontraumatic intracerebral hemorrhage"
          },
          {
            "code": "I69.20",
            "display": "Unspecified sequelae of other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.21",
            "display": "Cognitive deficits following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.210",
            "display": "Attention and concentration deficit following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.211",
            "display": "Memory deficit following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.212",
            "display": "Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.213",
            "display": "Psychomotor deficit following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.214",
            "display": "Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.215",
            "display": "Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.218",
            "display": "Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.219",
            "display": "Unspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.220",
            "display": "Aphasia following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.221",
            "display": "Dysphasia following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.222",
            "display": "Dysarthria following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.223",
            "display": "Fluency disorder following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.228",
            "display": "Other speech and language deficits following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.231",
            "display": "Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.232",
            "display": "Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.233",
            "display": "Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.234",
            "display": "Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.239",
            "display": "Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.241",
            "display": "Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.242",
            "display": "Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.243",
            "display": "Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.244",
            "display": "Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.249",
            "display": "Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.251",
            "display": "Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.252",
            "display": "Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.253",
            "display": "Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.254",
            "display": "Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.259",
            "display": "Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.261",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side"
          },
          {
            "code": "I69.262",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side"
          },
          {
            "code": "I69.263",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side"
          },
          {
            "code": "I69.264",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side"
          },
          {
            "code": "I69.265",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral"
          },
          {
            "code": "I69.269",
            "display": "Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side"
          },
          {
            "code": "I69.290",
            "display": "Apraxia following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.291",
            "display": "Dysphagia following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.292",
            "display": "Facial weakness following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.293",
            "display": "Ataxia following other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.298",
            "display": "Other sequelae of other nontraumatic intracranial hemorrhage"
          },
          {
            "code": "I69.30",
            "display": "Unspecified sequelae of cerebral infarction"
          },
          {
            "code": "I69.31",
            "display": "Cognitive deficits following cerebral infarction"
          },
          {
            "code": "I69.310",
            "display": "Attention and concentration deficit following cerebral infarction"
          },
          {
            "code": "I69.311",
            "display": "Memory deficit following cerebral infarction"
          },
          {
            "code": "I69.312",
            "display": "Visuospatial deficit and spatial neglect following cerebral infarction"
          },
          {
            "code": "I69.313",
            "display": "Psychomotor deficit following cerebral infarction"
          },
          {
            "code": "I69.314",
            "display": "Frontal lobe and executive function deficit following cerebral infarction"
          },
          {
            "code": "I69.315",
            "display": "Cognitive social or emotional deficit following cerebral infarction"
          },
          {
            "code": "I69.318",
            "display": "Other symptoms and signs involving cognitive functions following cerebral infarction"
          },
          {
            "code": "I69.319",
            "display": "Unspecified symptoms and signs involving cognitive functions following cerebral infarction"
          },
          {
            "code": "I69.320",
            "display": "Aphasia following cerebral infarction"
          },
          {
            "code": "I69.321",
            "display": "Dysphasia following cerebral infarction"
          },
          {
            "code": "I69.322",
            "display": "Dysarthria following cerebral infarction"
          },
          {
            "code": "I69.323",
            "display": "Fluency disorder following cerebral infarction"
          },
          {
            "code": "I69.328",
            "display": "Other speech and language deficits following cerebral infarction"
          },
          {
            "code": "I69.331",
            "display": "Monoplegia of upper limb following cerebral infarction affecting right dominant side"
          },
          {
            "code": "I69.332",
            "display": "Monoplegia of upper limb following cerebral infarction affecting left dominant side"
          },
          {
            "code": "I69.333",
            "display": "Monoplegia of upper limb following cerebral infarction affecting right non-dominant side"
          },
          {
            "code": "I69.334",
            "display": "Monoplegia of upper limb following cerebral infarction affecting left non-dominant side"
          },
          {
            "code": "I69.339",
            "display": "Monoplegia of upper limb following cerebral infarction affecting unspecified side"
          },
          {
            "code": "I69.341",
            "display": "Monoplegia of lower limb following cerebral infarction affecting right dominant side"
          },
          {
            "code": "I69.342",
            "display": "Monoplegia of lower limb following cerebral infarction affecting left dominant side"
          },
          {
            "code": "I69.343",
            "display": "Monoplegia of lower limb following cerebral infarction affecting right non-dominant side"
          },
          {
            "code": "I69.344",
            "display": "Monoplegia of lower limb following cerebral infarction affecting left non-dominant side"
          },
          {
            "code": "I69.349",
            "display": "Monoplegia of lower limb following cerebral infarction affecting unspecified side"
          },
          {
            "code": "I69.351",
            "display": "Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side"
          },
          {
            "code": "I69.352",
            "display": "Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side"
          },
          {
            "code": "I69.353",
            "display": "Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side"
          },
          {
            "code": "I69.354",
            "display": "Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side"
          },
          {
            "code": "I69.359",
            "display": "Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side"
          },
          {
            "code": "I69.361",
            "display": "Other paralytic syndrome following cerebral infarction affecting right dominant side"
          },
          {
            "code": "I69.362",
            "display": "Other paralytic syndrome following cerebral infarction affecting left dominant side"
          },
          {
            "code": "I69.363",
            "display": "Other paralytic syndrome following cerebral infarction affecting right non-dominant side"
          },
          {
            "code": "I69.364",
            "display": "Other paralytic syndrome following cerebral infarction affecting left non-dominant side"
          },
          {
            "code": "I69.365",
            "display": "Other paralytic syndrome following cerebral infarction, bilateral"
          },
          {
            "code": "I69.369",
            "display": "Other paralytic syndrome following cerebral infarction affecting unspecified side"
          },
          {
            "code": "I69.390",
            "display": "Apraxia following cerebral infarction"
          },
          {
            "code": "I69.391",
            "display": "Dysphagia following cerebral infarction"
          },
          {
            "code": "I69.392",
            "display": "Facial weakness following cerebral infarction"
          },
          {
            "code": "I69.393",
            "display": "Ataxia following cerebral infarction"
          },
          {
            "code": "I69.398",
            "display": "Other sequelae of cerebral infarction"
          },
          {
            "code": "I69.80",
            "display": "Unspecified sequelae of other cerebrovascular disease"
          },
          {
            "code": "I69.81",
            "display": "Cognitive deficits following other cerebrovascular disease"
          },
          {
            "code": "I69.810",
            "display": "Attention and concentration deficit following other cerebrovascular disease"
          },
          {
            "code": "I69.811",
            "display": "Memory deficit following other cerebrovascular disease"
          },
          {
            "code": "I69.812",
            "display": "Visuospatial deficit and spatial neglect following other cerebrovascular disease"
          },
          {
            "code": "I69.813",
            "display": "Psychomotor deficit following other cerebrovascular disease"
          },
          {
            "code": "I69.814",
            "display": "Frontal lobe and executive function deficit following other cerebrovascular disease"
          },
          {
            "code": "I69.815",
            "display": "Cognitive social or emotional deficit following other cerebrovascular disease"
          },
          {
            "code": "I69.818",
            "display": "Other symptoms and signs involving cognitive functions following other cerebrovascular disease"
          },
          {
            "code": "I69.819",
            "display": "Unspecified symptoms and signs involving cognitive functions following other cerebrovascular disease"
          },
          {
            "code": "I69.820",
            "display": "Aphasia following other cerebrovascular disease"
          },
          {
            "code": "I69.821",
            "display": "Dysphasia following other cerebrovascular disease"
          },
          {
            "code": "I69.822",
            "display": "Dysarthria following other cerebrovascular disease"
          },
          {
            "code": "I69.823",
            "display": "Fluency disorder following other cerebrovascular disease"
          },
          {
            "code": "I69.828",
            "display": "Other speech and language deficits following other cerebrovascular disease"
          },
          {
            "code": "I69.831",
            "display": "Monoplegia of upper limb following other cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.832",
            "display": "Monoplegia of upper limb following other cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.833",
            "display": "Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.834",
            "display": "Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.839",
            "display": "Monoplegia of upper limb following other cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.841",
            "display": "Monoplegia of lower limb following other cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.842",
            "display": "Monoplegia of lower limb following other cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.843",
            "display": "Monoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.844",
            "display": "Monoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.849",
            "display": "Monoplegia of lower limb following other cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.851",
            "display": "Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.852",
            "display": "Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.853",
            "display": "Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.854",
            "display": "Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.859",
            "display": "Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.861",
            "display": "Other paralytic syndrome following other cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.862",
            "display": "Other paralytic syndrome following other cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.863",
            "display": "Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.864",
            "display": "Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.865",
            "display": "Other paralytic syndrome following other cerebrovascular disease, bilateral"
          },
          {
            "code": "I69.869",
            "display": "Other paralytic syndrome following other cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.890",
            "display": "Apraxia following other cerebrovascular disease"
          },
          {
            "code": "I69.891",
            "display": "Dysphagia following other cerebrovascular disease"
          },
          {
            "code": "I69.892",
            "display": "Facial weakness following other cerebrovascular disease"
          },
          {
            "code": "I69.893",
            "display": "Ataxia following other cerebrovascular disease"
          },
          {
            "code": "I69.898",
            "display": "Other sequelae of other cerebrovascular disease"
          },
          {
            "code": "I69.90",
            "display": "Unspecified sequelae of unspecified cerebrovascular disease"
          },
          {
            "code": "I69.91",
            "display": "Cognitive deficits following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.910",
            "display": "Attention and concentration deficit following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.911",
            "display": "Memory deficit following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.912",
            "display": "Visuospatial deficit and spatial neglect following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.913",
            "display": "Psychomotor deficit following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.914",
            "display": "Frontal lobe and executive function deficit following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.915",
            "display": "Cognitive social or emotional deficit following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.918",
            "display": "Other symptoms and signs involving cognitive functions following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.919",
            "display": "Unspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.920",
            "display": "Aphasia following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.921",
            "display": "Dysphasia following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.922",
            "display": "Dysarthria following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.923",
            "display": "Fluency disorder following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.928",
            "display": "Other speech and language deficits following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.931",
            "display": "Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.932",
            "display": "Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.933",
            "display": "Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.934",
            "display": "Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.939",
            "display": "Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.941",
            "display": "Monoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.942",
            "display": "Monoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.943",
            "display": "Monoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.944",
            "display": "Monoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.949",
            "display": "Monoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.951",
            "display": "Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.952",
            "display": "Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.953",
            "display": "Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.954",
            "display": "Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.959",
            "display": "Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.961",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side"
          },
          {
            "code": "I69.962",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side"
          },
          {
            "code": "I69.963",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side"
          },
          {
            "code": "I69.964",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side"
          },
          {
            "code": "I69.965",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease, bilateral"
          },
          {
            "code": "I69.969",
            "display": "Other paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side"
          },
          {
            "code": "I69.990",
            "display": "Apraxia following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.991",
            "display": "Dysphagia following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.992",
            "display": "Facial weakness following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.993",
            "display": "Ataxia following unspecified cerebrovascular disease"
          },
          {
            "code": "I69.998",
            "display": "Other sequelae following unspecified cerebrovascular disease"
          },
          {
            "code": "I70.0",
            "display": "Atherosclerosis of aorta"
          },
          {
            "code": "I70.1",
            "display": "Atherosclerosis of renal artery"
          },
          {
            "code": "I70.201",
            "display": "Unspecified atherosclerosis of native arteries of extremities, right leg"
          },
          {
            "code": "I70.202",
            "display": "Unspecified atherosclerosis of native arteries of extremities, left leg"
          },
          {
            "code": "I70.203",
            "display": "Unspecified atherosclerosis of native arteries of extremities, bilateral legs"
          },
          {
            "code": "I70.208",
            "display": "Unspecified atherosclerosis of native arteries of extremities, other extremity"
          },
          {
            "code": "I70.209",
            "display": "Unspecified atherosclerosis of native arteries of extremities, unspecified extremity"
          },
          {
            "code": "I70.211",
            "display": "Atherosclerosis of native arteries of extremities with intermittent claudication, right leg"
          },
          {
            "code": "I70.212",
            "display": "Atherosclerosis of native arteries of extremities with intermittent claudication, left leg"
          },
          {
            "code": "I70.213",
            "display": "Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs"
          },
          {
            "code": "I70.218",
            "display": "Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity"
          },
          {
            "code": "I70.219",
            "display": "Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity"
          },
          {
            "code": "I70.221",
            "display": "Atherosclerosis of native arteries of extremities with rest pain, right leg"
          },
          {
            "code": "I70.222",
            "display": "Atherosclerosis of native arteries of extremities with rest pain, left leg"
          },
          {
            "code": "I70.223",
            "display": "Atherosclerosis of native arteries of extremities with rest pain, bilateral legs"
          },
          {
            "code": "I70.228",
            "display": "Atherosclerosis of native arteries of extremities with rest pain, other extremity"
          },
          {
            "code": "I70.229",
            "display": "Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity"
          },
          {
            "code": "I70.231",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of thigh"
          },
          {
            "code": "I70.232",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of calf"
          },
          {
            "code": "I70.233",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of ankle"
          },
          {
            "code": "I70.234",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot"
          },
          {
            "code": "I70.235",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of other part of foot"
          },
          {
            "code": "I70.238",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg"
          },
          {
            "code": "I70.239",
            "display": "Atherosclerosis of native arteries of right leg with ulceration of unspecified site"
          },
          {
            "code": "I70.241",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of thigh"
          },
          {
            "code": "I70.242",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of calf"
          },
          {
            "code": "I70.243",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of ankle"
          },
          {
            "code": "I70.244",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot"
          },
          {
            "code": "I70.245",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of other part of foot"
          },
          {
            "code": "I70.248",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg"
          },
          {
            "code": "I70.249",
            "display": "Atherosclerosis of native arteries of left leg with ulceration of unspecified site"
          },
          {
            "code": "I70.25",
            "display": "Atherosclerosis of native arteries of other extremities with ulceration"
          },
          {
            "code": "I70.261",
            "display": "Atherosclerosis of native arteries of extremities with gangrene, right leg"
          },
          {
            "code": "I70.262",
            "display": "Atherosclerosis of native arteries of extremities with gangrene, left leg"
          },
          {
            "code": "I70.263",
            "display": "Atherosclerosis of native arteries of extremities with gangrene, bilateral legs"
          },
          {
            "code": "I70.268",
            "display": "Atherosclerosis of native arteries of extremities with gangrene, other extremity"
          },
          {
            "code": "I70.269",
            "display": "Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity"
          },
          {
            "code": "I70.291",
            "display": "Other atherosclerosis of native arteries of extremities, right leg"
          },
          {
            "code": "I70.292",
            "display": "Other atherosclerosis of native arteries of extremities, left leg"
          },
          {
            "code": "I70.293",
            "display": "Other atherosclerosis of native arteries of extremities, bilateral legs"
          },
          {
            "code": "I70.298",
            "display": "Other atherosclerosis of native arteries of extremities, other extremity"
          },
          {
            "code": "I70.299",
            "display": "Other atherosclerosis of native arteries of extremities, unspecified extremity"
          },
          {
            "code": "I70.8",
            "display": "Atherosclerosis of other arteries"
          },
          {
            "code": "I70.90",
            "display": "Unspecified atherosclerosis"
          },
          {
            "code": "I70.91",
            "display": "Generalized atherosclerosis"
          },
          {
            "code": "I70.92",
            "display": "Chronic total occlusion of artery of the extremities"
          },
          {
            "code": "I71.00",
            "display": "Dissection of unspecified site of aorta"
          },
          {
            "code": "I71.01",
            "display": "Dissection of thoracic aorta"
          },
          {
            "code": "I71.02",
            "display": "Dissection of abdominal aorta"
          },
          {
            "code": "I71.03",
            "display": "Dissection of thoracoabdominal aorta"
          },
          {
            "code": "I71.1",
            "display": "Thoracic aortic aneurysm, ruptured"
          },
          {
            "code": "I71.2",
            "display": "Thoracic aortic aneurysm, without rupture"
          },
          {
            "code": "I71.3",
            "display": "Abdominal aortic aneurysm, ruptured"
          },
          {
            "code": "I71.4",
            "display": "Abdominal aortic aneurysm, without rupture"
          },
          {
            "code": "I71.5",
            "display": "Thoracoabdominal aortic aneurysm, ruptured"
          },
          {
            "code": "I71.6",
            "display": "Thoracoabdominal aortic aneurysm, without rupture"
          },
          {
            "code": "I71.8",
            "display": "Aortic aneurysm of unspecified site, ruptured"
          },
          {
            "code": "I71.9",
            "display": "Aortic aneurysm of unspecified site, without rupture"
          },
          {
            "code": "I72.0",
            "display": "Aneurysm of carotid artery"
          },
          {
            "code": "I72.1",
            "display": "Aneurysm of artery of upper extremity"
          },
          {
            "code": "I72.2",
            "display": "Aneurysm of renal artery"
          },
          {
            "code": "I72.3",
            "display": "Aneurysm of iliac artery"
          },
          {
            "code": "I72.4",
            "display": "Aneurysm of artery of lower extremity"
          },
          {
            "code": "I72.5",
            "display": "Aneurysm of other precerebral arteries"
          },
          {
            "code": "I72.6",
            "display": "Aneurysm of vertebral artery"
          },
          {
            "code": "I72.8",
            "display": "Aneurysm of other specified arteries"
          },
          {
            "code": "I72.9",
            "display": "Aneurysm of unspecified site"
          },
          {
            "code": "I73.00",
            "display": "Raynaud\u0027s syndrome without gangrene"
          },
          {
            "code": "I73.01",
            "display": "Raynaud\u0027s syndrome with gangrene"
          },
          {
            "code": "I73.1",
            "display": "Thromboangiitis obliterans [Buerger\u0027s disease]"
          },
          {
            "code": "I73.81",
            "display": "Erythromelalgia"
          },
          {
            "code": "I73.89",
            "display": "Other specified peripheral vascular diseases"
          },
          {
            "code": "I73.9",
            "display": "Peripheral vascular disease, unspecified"
          },
          {
            "code": "I74.01",
            "display": "Saddle embolus of abdominal aorta"
          },
          {
            "code": "I74.09",
            "display": "Other arterial embolism and thrombosis of abdominal aorta"
          },
          {
            "code": "I74.10",
            "display": "Embolism and thrombosis of unspecified parts of aorta"
          },
          {
            "code": "I74.11",
            "display": "Embolism and thrombosis of thoracic aorta"
          },
          {
            "code": "I74.19",
            "display": "Embolism and thrombosis of other parts of aorta"
          },
          {
            "code": "I74.2",
            "display": "Embolism and thrombosis of arteries of the upper extremities"
          },
          {
            "code": "I74.3",
            "display": "Embolism and thrombosis of arteries of the lower extremities"
          },
          {
            "code": "I74.4",
            "display": "Embolism and thrombosis of arteries of extremities, unspecified"
          },
          {
            "code": "I74.5",
            "display": "Embolism and thrombosis of iliac artery"
          },
          {
            "code": "I74.8",
            "display": "Embolism and thrombosis of other arteries"
          },
          {
            "code": "I74.9",
            "display": "Embolism and thrombosis of unspecified artery"
          },
          {
            "code": "I75.011",
            "display": "Atheroembolism of right upper extremity"
          },
          {
            "code": "I75.012",
            "display": "Atheroembolism of left upper extremity"
          },
          {
            "code": "I75.013",
            "display": "Atheroembolism of bilateral upper extremities"
          },
          {
            "code": "I75.019",
            "display": "Atheroembolism of unspecified upper extremity"
          },
          {
            "code": "I75.021",
            "display": "Atheroembolism of right lower extremity"
          },
          {
            "code": "I75.022",
            "display": "Atheroembolism of left lower extremity"
          },
          {
            "code": "I75.023",
            "display": "Atheroembolism of bilateral lower extremities"
          },
          {
            "code": "I75.029",
            "display": "Atheroembolism of unspecified lower extremity"
          },
          {
            "code": "I75.81",
            "display": "Atheroembolism of kidney"
          },
          {
            "code": "I75.89",
            "display": "Atheroembolism of other site"
          },
          {
            "code": "I77.0",
            "display": "Arteriovenous fistula, acquired"
          },
          {
            "code": "I77.1",
            "display": "Stricture of artery"
          },
          {
            "code": "I77.2",
            "display": "Rupture of artery"
          },
          {
            "code": "I77.3",
            "display": "Arterial fibromuscular dysplasia"
          },
          {
            "code": "I77.4",
            "display": "Celiac artery compression syndrome"
          },
          {
            "code": "I77.5",
            "display": "Necrosis of artery"
          },
          {
            "code": "I77.6",
            "display": "Arteritis, unspecified"
          },
          {
            "code": "I77.70",
            "display": "Dissection of unspecified artery"
          },
          {
            "code": "I77.71",
            "display": "Dissection of carotid artery"
          },
          {
            "code": "I77.72",
            "display": "Dissection of iliac artery"
          },
          {
            "code": "I77.73",
            "display": "Dissection of renal artery"
          },
          {
            "code": "I77.74",
            "display": "Dissection of vertebral artery"
          },
          {
            "code": "I77.75",
            "display": "Dissection of other precerebral arteries"
          },
          {
            "code": "I77.76",
            "display": "Dissection of artery of upper extremity"
          },
          {
            "code": "I77.77",
            "display": "Dissection of artery of lower extremity"
          },
          {
            "code": "I77.79",
            "display": "Dissection of other specified artery"
          },
          {
            "code": "I77.810",
            "display": "Thoracic aortic ectasia"
          },
          {
            "code": "I77.811",
            "display": "Abdominal aortic ectasia"
          },
          {
            "code": "I77.812",
            "display": "Thoracoabdominal aortic ectasia"
          },
          {
            "code": "I77.819",
            "display": "Aortic ectasia, unspecified site"
          },
          {
            "code": "I77.89",
            "display": "Other specified disorders of arteries and arterioles"
          },
          {
            "code": "I77.9",
            "display": "Disorder of arteries and arterioles, unspecified"
          },
          {
            "code": "I78.0",
            "display": "Hereditary hemorrhagic telangiectasia"
          },
          {
            "code": "I78.1",
            "display": "Nevus, non-neoplastic"
          },
          {
            "code": "I78.8",
            "display": "Other diseases of capillaries"
          },
          {
            "code": "I78.9",
            "display": "Disease of capillaries, unspecified"
          },
          {
            "code": "I79.0",
            "display": "Aneurysm of aorta in diseases classified elsewhere"
          },
          {
            "code": "I79.1",
            "display": "Aortitis in diseases classified elsewhere"
          },
          {
            "code": "I79.8",
            "display": "Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere"
          },
          {
            "code": "I80.00",
            "display": "Phlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity"
          },
          {
            "code": "I80.01",
            "display": "Phlebitis and thrombophlebitis of superficial vessels of right lower extremity"
          },
          {
            "code": "I80.02",
            "display": "Phlebitis and thrombophlebitis of superficial vessels of left lower extremity"
          },
          {
            "code": "I80.03",
            "display": "Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral"
          },
          {
            "code": "I80.10",
            "display": "Phlebitis and thrombophlebitis of unspecified femoral vein"
          },
          {
            "code": "I80.11",
            "display": "Phlebitis and thrombophlebitis of right femoral vein"
          },
          {
            "code": "I80.12",
            "display": "Phlebitis and thrombophlebitis of left femoral vein"
          },
          {
            "code": "I80.13",
            "display": "Phlebitis and thrombophlebitis of femoral vein, bilateral"
          },
          {
            "code": "I80.201",
            "display": "Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity"
          },
          {
            "code": "I80.202",
            "display": "Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity"
          },
          {
            "code": "I80.203",
            "display": "Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral"
          },
          {
            "code": "I80.209",
            "display": "Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity"
          },
          {
            "code": "I80.211",
            "display": "Phlebitis and thrombophlebitis of right iliac vein"
          },
          {
            "code": "I80.212",
            "display": "Phlebitis and thrombophlebitis of left iliac vein"
          },
          {
            "code": "I80.213",
            "display": "Phlebitis and thrombophlebitis of iliac vein, bilateral"
          },
          {
            "code": "I80.219",
            "display": "Phlebitis and thrombophlebitis of unspecified iliac vein"
          },
          {
            "code": "I80.221",
            "display": "Phlebitis and thrombophlebitis of right popliteal vein"
          },
          {
            "code": "I80.222",
            "display": "Phlebitis and thrombophlebitis of left popliteal vein"
          },
          {
            "code": "I80.223",
            "display": "Phlebitis and thrombophlebitis of popliteal vein, bilateral"
          },
          {
            "code": "I80.229",
            "display": "Phlebitis and thrombophlebitis of unspecified popliteal vein"
          },
          {
            "code": "I80.231",
            "display": "Phlebitis and thrombophlebitis of right tibial vein"
          },
          {
            "code": "I80.232",
            "display": "Phlebitis and thrombophlebitis of left tibial vein"
          },
          {
            "code": "I80.233",
            "display": "Phlebitis and thrombophlebitis of tibial vein, bilateral"
          },
          {
            "code": "I80.239",
            "display": "Phlebitis and thrombophlebitis of unspecified tibial vein"
          },
          {
            "code": "I80.291",
            "display": "Phlebitis and thrombophlebitis of other deep vessels of right lower extremity"
          },
          {
            "code": "I80.292",
            "display": "Phlebitis and thrombophlebitis of other deep vessels of left lower extremity"
          },
          {
            "code": "I80.293",
            "display": "Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral"
          },
          {
            "code": "I80.299",
            "display": "Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity"
          },
          {
            "code": "I80.3",
            "display": "Phlebitis and thrombophlebitis of lower extremities, unspecified"
          },
          {
            "code": "I80.8",
            "display": "Phlebitis and thrombophlebitis of other sites"
          },
          {
            "code": "I80.9",
            "display": "Phlebitis and thrombophlebitis of unspecified site"
          },
          {
            "code": "I81",
            "display": "Portal vein thrombosis"
          },
          {
            "code": "I82.0",
            "display": "Budd-Chiari syndrome"
          },
          {
            "code": "I82.1",
            "display": "Thrombophlebitis migrans"
          },
          {
            "code": "I82.210",
            "display": "Acute embolism and thrombosis of superior vena cava"
          },
          {
            "code": "I82.211",
            "display": "Chronic embolism and thrombosis of superior vena cava"
          },
          {
            "code": "I82.220",
            "display": "Acute embolism and thrombosis of inferior vena cava"
          },
          {
            "code": "I82.221",
            "display": "Chronic embolism and thrombosis of inferior vena cava"
          },
          {
            "code": "I82.290",
            "display": "Acute embolism and thrombosis of other thoracic veins"
          },
          {
            "code": "I82.291",
            "display": "Chronic embolism and thrombosis of other thoracic veins"
          },
          {
            "code": "I82.3",
            "display": "Embolism and thrombosis of renal vein"
          },
          {
            "code": "I82.401",
            "display": "Acute embolism and thrombosis of unspecified deep veins of right lower extremity"
          },
          {
            "code": "I82.402",
            "display": "Acute embolism and thrombosis of unspecified deep veins of left lower extremity"
          },
          {
            "code": "I82.403",
            "display": "Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral"
          },
          {
            "code": "I82.409",
            "display": "Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity"
          },
          {
            "code": "I82.411",
            "display": "Acute embolism and thrombosis of right femoral vein"
          },
          {
            "code": "I82.412",
            "display": "Acute embolism and thrombosis of left femoral vein"
          },
          {
            "code": "I82.413",
            "display": "Acute embolism and thrombosis of femoral vein, bilateral"
          },
          {
            "code": "I82.419",
            "display": "Acute embolism and thrombosis of unspecified femoral vein"
          },
          {
            "code": "I82.421",
            "display": "Acute embolism and thrombosis of right iliac vein"
          },
          {
            "code": "I82.422",
            "display": "Acute embolism and thrombosis of left iliac vein"
          },
          {
            "code": "I82.423",
            "display": "Acute embolism and thrombosis of iliac vein, bilateral"
          },
          {
            "code": "I82.429",
            "display": "Acute embolism and thrombosis of unspecified iliac vein"
          },
          {
            "code": "I82.431",
            "display": "Acute embolism and thrombosis of right popliteal vein"
          },
          {
            "code": "I82.432",
            "display": "Acute embolism and thrombosis of left popliteal vein"
          },
          {
            "code": "I82.433",
            "display": "Acute embolism and thrombosis of popliteal vein, bilateral"
          },
          {
            "code": "I82.439",
            "display": "Acute embolism and thrombosis of unspecified popliteal vein"
          },
          {
            "code": "I82.441",
            "display": "Acute embolism and thrombosis of right tibial vein"
          },
          {
            "code": "I82.442",
            "display": "Acute embolism and thrombosis of left tibial vein"
          },
          {
            "code": "I82.443",
            "display": "Acute embolism and thrombosis of tibial vein, bilateral"
          },
          {
            "code": "I82.449",
            "display": "Acute embolism and thrombosis of unspecified tibial vein"
          },
          {
            "code": "I82.491",
            "display": "Acute embolism and thrombosis of other specified deep vein of right lower extremity"
          },
          {
            "code": "I82.492",
            "display": "Acute embolism and thrombosis of other specified deep vein of left lower extremity"
          },
          {
            "code": "I82.493",
            "display": "Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral"
          },
          {
            "code": "I82.499",
            "display": "Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity"
          },
          {
            "code": "I82.4Y1",
            "display": "Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity"
          },
          {
            "code": "I82.4Y2",
            "display": "Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity"
          },
          {
            "code": "I82.4Y3",
            "display": "Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral"
          },
          {
            "code": "I82.4Y9",
            "display": "Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity"
          },
          {
            "code": "I82.4Z1",
            "display": "Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity"
          },
          {
            "code": "I82.4Z2",
            "display": "Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity"
          },
          {
            "code": "I82.4Z3",
            "display": "Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral"
          },
          {
            "code": "I82.4Z9",
            "display": "Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity"
          },
          {
            "code": "I82.501",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of right lower extremity"
          },
          {
            "code": "I82.502",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of left lower extremity"
          },
          {
            "code": "I82.503",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral"
          },
          {
            "code": "I82.509",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity"
          },
          {
            "code": "I82.511",
            "display": "Chronic embolism and thrombosis of right femoral vein"
          },
          {
            "code": "I82.512",
            "display": "Chronic embolism and thrombosis of left femoral vein"
          },
          {
            "code": "I82.513",
            "display": "Chronic embolism and thrombosis of femoral vein, bilateral"
          },
          {
            "code": "I82.519",
            "display": "Chronic embolism and thrombosis of unspecified femoral vein"
          },
          {
            "code": "I82.521",
            "display": "Chronic embolism and thrombosis of right iliac vein"
          },
          {
            "code": "I82.522",
            "display": "Chronic embolism and thrombosis of left iliac vein"
          },
          {
            "code": "I82.523",
            "display": "Chronic embolism and thrombosis of iliac vein, bilateral"
          },
          {
            "code": "I82.529",
            "display": "Chronic embolism and thrombosis of unspecified iliac vein"
          },
          {
            "code": "I82.531",
            "display": "Chronic embolism and thrombosis of right popliteal vein"
          },
          {
            "code": "I82.532",
            "display": "Chronic embolism and thrombosis of left popliteal vein"
          },
          {
            "code": "I82.533",
            "display": "Chronic embolism and thrombosis of popliteal vein, bilateral"
          },
          {
            "code": "I82.539",
            "display": "Chronic embolism and thrombosis of unspecified popliteal vein"
          },
          {
            "code": "I82.541",
            "display": "Chronic embolism and thrombosis of right tibial vein"
          },
          {
            "code": "I82.542",
            "display": "Chronic embolism and thrombosis of left tibial vein"
          },
          {
            "code": "I82.543",
            "display": "Chronic embolism and thrombosis of tibial vein, bilateral"
          },
          {
            "code": "I82.549",
            "display": "Chronic embolism and thrombosis of unspecified tibial vein"
          },
          {
            "code": "I82.591",
            "display": "Chronic embolism and thrombosis of other specified deep vein of right lower extremity"
          },
          {
            "code": "I82.592",
            "display": "Chronic embolism and thrombosis of other specified deep vein of left lower extremity"
          },
          {
            "code": "I82.593",
            "display": "Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral"
          },
          {
            "code": "I82.599",
            "display": "Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity"
          },
          {
            "code": "I82.5Y1",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity"
          },
          {
            "code": "I82.5Y2",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity"
          },
          {
            "code": "I82.5Y3",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral"
          },
          {
            "code": "I82.5Y9",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity"
          },
          {
            "code": "I82.5Z1",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity"
          },
          {
            "code": "I82.5Z2",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity"
          },
          {
            "code": "I82.5Z3",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral"
          },
          {
            "code": "I82.5Z9",
            "display": "Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity"
          },
          {
            "code": "I82.601",
            "display": "Acute embolism and thrombosis of unspecified veins of right upper extremity"
          },
          {
            "code": "I82.602",
            "display": "Acute embolism and thrombosis of unspecified veins of left upper extremity"
          },
          {
            "code": "I82.603",
            "display": "Acute embolism and thrombosis of unspecified veins of upper extremity, bilateral"
          },
          {
            "code": "I82.609",
            "display": "Acute embolism and thrombosis of unspecified veins of unspecified upper extremity"
          },
          {
            "code": "I82.611",
            "display": "Acute embolism and thrombosis of superficial veins of right upper extremity"
          },
          {
            "code": "I82.612",
            "display": "Acute embolism and thrombosis of superficial veins of left upper extremity"
          },
          {
            "code": "I82.613",
            "display": "Acute embolism and thrombosis of superficial veins of upper extremity, bilateral"
          },
          {
            "code": "I82.619",
            "display": "Acute embolism and thrombosis of superficial veins of unspecified upper extremity"
          },
          {
            "code": "I82.621",
            "display": "Acute embolism and thrombosis of deep veins of right upper extremity"
          },
          {
            "code": "I82.622",
            "display": "Acute embolism and thrombosis of deep veins of left upper extremity"
          },
          {
            "code": "I82.623",
            "display": "Acute embolism and thrombosis of deep veins of upper extremity, bilateral"
          },
          {
            "code": "I82.629",
            "display": "Acute embolism and thrombosis of deep veins of unspecified upper extremity"
          },
          {
            "code": "I82.701",
            "display": "Chronic embolism and thrombosis of unspecified veins of right upper extremity"
          },
          {
            "code": "I82.702",
            "display": "Chronic embolism and thrombosis of unspecified veins of left upper extremity"
          },
          {
            "code": "I82.703",
            "display": "Chronic embolism and thrombosis of unspecified veins of upper extremity, bilateral"
          },
          {
            "code": "I82.709",
            "display": "Chronic embolism and thrombosis of unspecified veins of unspecified upper extremity"
          },
          {
            "code": "I82.711",
            "display": "Chronic embolism and thrombosis of superficial veins of right upper extremity"
          },
          {
            "code": "I82.712",
            "display": "Chronic embolism and thrombosis of superficial veins of left upper extremity"
          },
          {
            "code": "I82.713",
            "display": "Chronic embolism and thrombosis of superficial veins of upper extremity, bilateral"
          },
          {
            "code": "I82.719",
            "display": "Chronic embolism and thrombosis of superficial veins of unspecified upper extremity"
          },
          {
            "code": "I82.721",
            "display": "Chronic embolism and thrombosis of deep veins of right upper extremity"
          },
          {
            "code": "I82.722",
            "display": "Chronic embolism and thrombosis of deep veins of left upper extremity"
          },
          {
            "code": "I82.723",
            "display": "Chronic embolism and thrombosis of deep veins of upper extremity, bilateral"
          },
          {
            "code": "I82.729",
            "display": "Chronic embolism and thrombosis of deep veins of unspecified upper extremity"
          },
          {
            "code": "I82.811",
            "display": "Embolism and thrombosis of superficial veins of right lower extremity"
          },
          {
            "code": "I82.812",
            "display": "Embolism and thrombosis of superficial veins of left lower extremity"
          },
          {
            "code": "I82.813",
            "display": "Embolism and thrombosis of superficial veins of lower extremities, bilateral"
          },
          {
            "code": "I82.819",
            "display": "Embolism and thrombosis of superficial veins of unspecified lower extremity"
          },
          {
            "code": "I82.890",
            "display": "Acute embolism and thrombosis of other specified veins"
          },
          {
            "code": "I82.891",
            "display": "Chronic embolism and thrombosis of other specified veins"
          },
          {
            "code": "I82.90",
            "display": "Acute embolism and thrombosis of unspecified vein"
          },
          {
            "code": "I82.91",
            "display": "Chronic embolism and thrombosis of unspecified vein"
          },
          {
            "code": "I82.A11",
            "display": "Acute embolism and thrombosis of right axillary vein"
          },
          {
            "code": "I82.A12",
            "display": "Acute embolism and thrombosis of left axillary vein"
          },
          {
            "code": "I82.A13",
            "display": "Acute embolism and thrombosis of axillary vein, bilateral"
          },
          {
            "code": "I82.A19",
            "display": "Acute embolism and thrombosis of unspecified axillary vein"
          },
          {
            "code": "I82.A21",
            "display": "Chronic embolism and thrombosis of right axillary vein"
          },
          {
            "code": "I82.A22",
            "display": "Chronic embolism and thrombosis of left axillary vein"
          },
          {
            "code": "I82.A23",
            "display": "Chronic embolism and thrombosis of axillary vein, bilateral"
          },
          {
            "code": "I82.A29",
            "display": "Chronic embolism and thrombosis of unspecified axillary vein"
          },
          {
            "code": "I82.B11",
            "display": "Acute embolism and thrombosis of right subclavian vein"
          },
          {
            "code": "I82.B12",
            "display": "Acute embolism and thrombosis of left subclavian vein"
          },
          {
            "code": "I82.B13",
            "display": "Acute embolism and thrombosis of subclavian vein, bilateral"
          },
          {
            "code": "I82.B19",
            "display": "Acute embolism and thrombosis of unspecified subclavian vein"
          },
          {
            "code": "I82.B21",
            "display": "Chronic embolism and thrombosis of right subclavian vein"
          },
          {
            "code": "I82.B22",
            "display": "Chronic embolism and thrombosis of left subclavian vein"
          },
          {
            "code": "I82.B23",
            "display": "Chronic embolism and thrombosis of subclavian vein, bilateral"
          },
          {
            "code": "I82.B29",
            "display": "Chronic embolism and thrombosis of unspecified subclavian vein"
          },
          {
            "code": "I82.C11",
            "display": "Acute embolism and thrombosis of right internal jugular vein"
          },
          {
            "code": "I82.C12",
            "display": "Acute embolism and thrombosis of left internal jugular vein"
          },
          {
            "code": "I82.C13",
            "display": "Acute embolism and thrombosis of internal jugular vein, bilateral"
          },
          {
            "code": "I82.C19",
            "display": "Acute embolism and thrombosis of unspecified internal jugular vein"
          },
          {
            "code": "I82.C21",
            "display": "Chronic embolism and thrombosis of right internal jugular vein"
          },
          {
            "code": "I82.C22",
            "display": "Chronic embolism and thrombosis of left internal jugular vein"
          },
          {
            "code": "I82.C23",
            "display": "Chronic embolism and thrombosis of internal jugular vein, bilateral"
          },
          {
            "code": "I82.C29",
            "display": "Chronic embolism and thrombosis of unspecified internal jugular vein"
          },
          {
            "code": "I83.001",
            "display": "Varicose veins of unspecified lower extremity with ulcer of thigh"
          },
          {
            "code": "I83.002",
            "display": "Varicose veins of unspecified lower extremity with ulcer of calf"
          },
          {
            "code": "I83.003",
            "display": "Varicose veins of unspecified lower extremity with ulcer of ankle"
          },
          {
            "code": "I83.004",
            "display": "Varicose veins of unspecified lower extremity with ulcer of heel and midfoot"
          },
          {
            "code": "I83.005",
            "display": "Varicose veins of unspecified lower extremity with ulcer other part of foot"
          },
          {
            "code": "I83.008",
            "display": "Varicose veins of unspecified lower extremity with ulcer other part of lower leg"
          },
          {
            "code": "I83.009",
            "display": "Varicose veins of unspecified lower extremity with ulcer of unspecified site"
          },
          {
            "code": "I83.011",
            "display": "Varicose veins of right lower extremity with ulcer of thigh"
          },
          {
            "code": "I83.012",
            "display": "Varicose veins of right lower extremity with ulcer of calf"
          },
          {
            "code": "I83.013",
            "display": "Varicose veins of right lower extremity with ulcer of ankle"
          },
          {
            "code": "I83.014",
            "display": "Varicose veins of right lower extremity with ulcer of heel and midfoot"
          },
          {
            "code": "I83.015",
            "display": "Varicose veins of right lower extremity with ulcer other part of foot"
          },
          {
            "code": "I83.018",
            "display": "Varicose veins of right lower extremity with ulcer other part of lower leg"
          },
          {
            "code": "I83.019",
            "display": "Varicose veins of right lower extremity with ulcer of unspecified site"
          },
          {
            "code": "I83.021",
            "display": "Varicose veins of left lower extremity with ulcer of thigh"
          },
          {
            "code": "I83.022",
            "display": "Varicose veins of left lower extremity with ulcer of calf"
          },
          {
            "code": "I83.023",
            "display": "Varicose veins of left lower extremity with ulcer of ankle"
          },
          {
            "code": "I83.024",
            "display": "Varicose veins of left lower extremity with ulcer of heel and midfoot"
          },
          {
            "code": "I83.025",
            "display": "Varicose veins of left lower extremity with ulcer other part of foot"
          },
          {
            "code": "I83.028",
            "display": "Varicose veins of left lower extremity with ulcer other part of lower leg"
          },
          {
            "code": "I83.029",
            "display": "Varicose veins of left lower extremity with ulcer of unspecified site"
          },
          {
            "code": "I83.10",
            "display": "Varicose veins of unspecified lower extremity with inflammation"
          },
          {
            "code": "I83.11",
            "display": "Varicose veins of right lower extremity with inflammation"
          },
          {
            "code": "I83.12",
            "display": "Varicose veins of left lower extremity with inflammation"
          },
          {
            "code": "I83.201",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of thigh and inflammation"
          },
          {
            "code": "I83.202",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of calf and inflammation"
          },
          {
            "code": "I83.203",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of ankle and inflammation"
          },
          {
            "code": "I83.204",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation"
          },
          {
            "code": "I83.205",
            "display": "Varicose veins of unspecified lower extremity with both ulcer other part of foot and inflammation"
          },
          {
            "code": "I83.208",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation"
          },
          {
            "code": "I83.209",
            "display": "Varicose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation"
          },
          {
            "code": "I83.211",
            "display": "Varicose veins of right lower extremity with both ulcer of thigh and inflammation"
          },
          {
            "code": "I83.212",
            "display": "Varicose veins of right lower extremity with both ulcer of calf and inflammation"
          },
          {
            "code": "I83.213",
            "display": "Varicose veins of right lower extremity with both ulcer of ankle and inflammation"
          },
          {
            "code": "I83.214",
            "display": "Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation"
          },
          {
            "code": "I83.215",
            "display": "Varicose veins of right lower extremity with both ulcer other part of foot and inflammation"
          },
          {
            "code": "I83.218",
            "display": "Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation"
          },
          {
            "code": "I83.219",
            "display": "Varicose veins of right lower extremity with both ulcer of unspecified site and inflammation"
          },
          {
            "code": "I83.221",
            "display": "Varicose veins of left lower extremity with both ulcer of thigh and inflammation"
          },
          {
            "code": "I83.222",
            "display": "Varicose veins of left lower extremity with both ulcer of calf and inflammation"
          },
          {
            "code": "I83.223",
            "display": "Varicose veins of left lower extremity with both ulcer of ankle and inflammation"
          },
          {
            "code": "I83.224",
            "display": "Varicose veins of left lower extremity with both ulcer of heel and midfoot and inflammation"
          },
          {
            "code": "I83.225",
            "display": "Varicose veins of left lower extremity with both ulcer other part of foot and inflammation"
          },
          {
            "code": "I83.228",
            "display": "Varicose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation"
          },
          {
            "code": "I83.229",
            "display": "Varicose veins of left lower extremity with both ulcer of unspecified site and inflammation"
          },
          {
            "code": "I83.811",
            "display": "Varicose veins of right lower extremity with pain"
          },
          {
            "code": "I83.812",
            "display": "Varicose veins of left lower extremity with pain"
          },
          {
            "code": "I83.813",
            "display": "Varicose veins of bilateral lower extremities with pain"
          },
          {
            "code": "I83.819",
            "display": "Varicose veins of unspecified lower extremity with pain"
          },
          {
            "code": "I83.891",
            "display": "Varicose veins of right lower extremity with other complications"
          },
          {
            "code": "I83.892",
            "display": "Varicose veins of left lower extremity with other complications"
          },
          {
            "code": "I83.893",
            "display": "Varicose veins of bilateral lower extremities with other complications"
          },
          {
            "code": "I83.899",
            "display": "Varicose veins of unspecified lower extremity with other complications"
          },
          {
            "code": "I83.90",
            "display": "Asymptomatic varicose veins of unspecified lower extremity"
          },
          {
            "code": "I83.91",
            "display": "Asymptomatic varicose veins of right lower extremity"
          },
          {
            "code": "I83.92",
            "display": "Asymptomatic varicose veins of left lower extremity"
          },
          {
            "code": "I83.93",
            "display": "Asymptomatic varicose veins of bilateral lower extremities"
          },
          {
            "code": "I86.0",
            "display": "Sublingual varices"
          },
          {
            "code": "I86.1",
            "display": "Scrotal varices"
          },
          {
            "code": "I86.2",
            "display": "Pelvic varices"
          },
          {
            "code": "I86.3",
            "display": "Vulval varices"
          },
          {
            "code": "I86.4",
            "display": "Gastric varices"
          },
          {
            "code": "I86.8",
            "display": "Varicose veins of other specified sites"
          },
          {
            "code": "I87.001",
            "display": "Postthrombotic syndrome without complications of right lower extremity"
          },
          {
            "code": "I87.002",
            "display": "Postthrombotic syndrome without complications of left lower extremity"
          },
          {
            "code": "I87.003",
            "display": "Postthrombotic syndrome without complications of bilateral lower extremity"
          },
          {
            "code": "I87.009",
            "display": "Postthrombotic syndrome without complications of unspecified extremity"
          },
          {
            "code": "I87.011",
            "display": "Postthrombotic syndrome with ulcer of right lower extremity"
          },
          {
            "code": "I87.012",
            "display": "Postthrombotic syndrome with ulcer of left lower extremity"
          },
          {
            "code": "I87.013",
            "display": "Postthrombotic syndrome with ulcer of bilateral lower extremity"
          },
          {
            "code": "I87.019",
            "display": "Postthrombotic syndrome with ulcer of unspecified lower extremity"
          },
          {
            "code": "I87.021",
            "display": "Postthrombotic syndrome with inflammation of right lower extremity"
          },
          {
            "code": "I87.022",
            "display": "Postthrombotic syndrome with inflammation of left lower extremity"
          },
          {
            "code": "I87.023",
            "display": "Postthrombotic syndrome with inflammation of bilateral lower extremity"
          },
          {
            "code": "I87.029",
            "display": "Postthrombotic syndrome with inflammation of unspecified lower extremity"
          },
          {
            "code": "I87.031",
            "display": "Postthrombotic syndrome with ulcer and inflammation of right lower extremity"
          },
          {
            "code": "I87.032",
            "display": "Postthrombotic syndrome with ulcer and inflammation of left lower extremity"
          },
          {
            "code": "I87.033",
            "display": "Postthrombotic syndrome with ulcer and inflammation of bilateral lower extremity"
          },
          {
            "code": "I87.039",
            "display": "Postthrombotic syndrome with ulcer and inflammation of unspecified lower extremity"
          },
          {
            "code": "I87.091",
            "display": "Postthrombotic syndrome with other complications of right lower extremity"
          },
          {
            "code": "I87.092",
            "display": "Postthrombotic syndrome with other complications of left lower extremity"
          },
          {
            "code": "I87.093",
            "display": "Postthrombotic syndrome with other complications of bilateral lower extremity"
          },
          {
            "code": "I87.099",
            "display": "Postthrombotic syndrome with other complications of unspecified lower extremity"
          },
          {
            "code": "I87.1",
            "display": "Compression of vein"
          },
          {
            "code": "I87.2",
            "display": "Venous insufficiency (chronic) (peripheral)"
          },
          {
            "code": "I87.301",
            "display": "Chronic venous hypertension (idiopathic) without complications of right lower extremity"
          },
          {
            "code": "I87.302",
            "display": "Chronic venous hypertension (idiopathic) without complications of left lower extremity"
          },
          {
            "code": "I87.303",
            "display": "Chronic venous hypertension (idiopathic) without complications of bilateral lower extremity"
          },
          {
            "code": "I87.309",
            "display": "Chronic venous hypertension (idiopathic) without complications of unspecified lower extremity"
          },
          {
            "code": "I87.311",
            "display": "Chronic venous hypertension (idiopathic) with ulcer of right lower extremity"
          },
          {
            "code": "I87.312",
            "display": "Chronic venous hypertension (idiopathic) with ulcer of left lower extremity"
          },
          {
            "code": "I87.313",
            "display": "Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity"
          },
          {
            "code": "I87.319",
            "display": "Chronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity"
          },
          {
            "code": "I87.321",
            "display": "Chronic venous hypertension (idiopathic) with inflammation of right lower extremity"
          },
          {
            "code": "I87.322",
            "display": "Chronic venous hypertension (idiopathic) with inflammation of left lower extremity"
          },
          {
            "code": "I87.323",
            "display": "Chronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity"
          },
          {
            "code": "I87.329",
            "display": "Chronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity"
          },
          {
            "code": "I87.331",
            "display": "Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity"
          },
          {
            "code": "I87.332",
            "display": "Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity"
          },
          {
            "code": "I87.333",
            "display": "Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity"
          },
          {
            "code": "I87.339",
            "display": "Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity"
          },
          {
            "code": "I87.391",
            "display": "Chronic venous hypertension (idiopathic) with other complications of right lower extremity"
          },
          {
            "code": "I87.392",
            "display": "Chronic venous hypertension (idiopathic) with other complications of left lower extremity"
          },
          {
            "code": "I87.393",
            "display": "Chronic venous hypertension (idiopathic) with other complications of bilateral lower extremity"
          },
          {
            "code": "I87.399",
            "display": "Chronic venous hypertension (idiopathic) with other complications of unspecified lower extremity"
          },
          {
            "code": "I87.8",
            "display": "Other specified disorders of veins"
          },
          {
            "code": "I87.9",
            "display": "Disorder of vein, unspecified"
          },
          {
            "code": "I88.0",
            "display": "Nonspecific mesenteric lymphadenitis"
          },
          {
            "code": "I88.1",
            "display": "Chronic lymphadenitis, except mesenteric"
          },
          {
            "code": "I88.8",
            "display": "Other nonspecific lymphadenitis"
          },
          {
            "code": "I88.9",
            "display": "Nonspecific lymphadenitis, unspecified"
          },
          {
            "code": "I89.0",
            "display": "Lymphedema, not elsewhere classified"
          },
          {
            "code": "I89.1",
            "display": "Lymphangitis"
          },
          {
            "code": "I89.8",
            "display": "Other specified noninfective disorders of lymphatic vessels and lymph nodes"
          },
          {
            "code": "I89.9",
            "display": "Noninfective disorder of lymphatic vessels and lymph nodes, unspecified"
          },
          {
            "code": "I95.0",
            "display": "Idiopathic hypotension"
          },
          {
            "code": "I95.1",
            "display": "Orthostatic hypotension"
          },
          {
            "code": "I95.89",
            "display": "Other hypotension"
          },
          {
            "code": "I95.9",
            "display": "Hypotension, unspecified"
          },
          {
            "code": "I96",
            "display": "Gangrene, not elsewhere classified"
          },
          {
            "code": "I99.8",
            "display": "Other disorder of circulatory system"
          },
          {
            "code": "I99.9",
            "display": "Unspecified disorder of circulatory system"
          },
          {
            "code": "J10.82",
            "display": "Influenza due to other identified influenza virus with myocarditis"
          },
          {
            "code": "J30.5",
            "display": "Allergic rhinitis due to food"
          },
          {
            "code": "J85.0",
            "display": "Gangrene and necrosis of lung"
          },
          {
            "code": "J91.0",
            "display": "Malignant pleural effusion"
          },
          {
            "code": "K31.7",
            "display": "Polyp of stomach and duodenum"
          },
          {
            "code": "K52.2",
            "display": "Allergic and dietetic gastroenteritis and colitis"
          },
          {
            "code": "K52.21",
            "display": "Food protein-induced enterocolitis syndrome"
          },
          {
            "code": "K52.22",
            "display": "Food protein-induced enteropathy"
          },
          {
            "code": "K52.29",
            "display": "Other allergic and dietetic gastroenteritis and colitis"
          },
          {
            "code": "K55.0",
            "display": "Acute vascular disorders of intestine"
          },
          {
            "code": "K55.011",
            "display": "Focal (segmental) acute (reversible) ischemia of small intestine"
          },
          {
            "code": "K55.012",
            "display": "Diffuse acute (reversible) ischemia of small intestine"
          },
          {
            "code": "K55.019",
            "display": "Acute (reversible) ischemia of small intestine, extent unspecified"
          },
          {
            "code": "K55.021",
            "display": "Focal (segmental) acute infarction of small intestine"
          },
          {
            "code": "K55.022",
            "display": "Diffuse acute infarction of small intestine"
          },
          {
            "code": "K55.029",
            "display": "Acute infarction of small intestine, extent unspecified"
          },
          {
            "code": "K55.031",
            "display": "Focal (segmental) acute (reversible) ischemia of large intestine"
          },
          {
            "code": "K55.032",
            "display": "Diffuse acute (reversible) ischemia of large intestine"
          },
          {
            "code": "K55.039",
            "display": "Acute (reversible) ischemia of large intestine, extent unspecified"
          },
          {
            "code": "K55.041",
            "display": "Focal (segmental) acute infarction of large intestine"
          },
          {
            "code": "K55.042",
            "display": "Diffuse acute infarction of large intestine"
          },
          {
            "code": "K55.049",
            "display": "Acute infarction of large intestine, extent unspecified"
          },
          {
            "code": "K55.051",
            "display": "Focal (segmental) acute (reversible) ischemia of intestine, part unspecified"
          },
          {
            "code": "K55.052",
            "display": "Diffuse acute (reversible) ischemia of intestine, part unspecified"
          },
          {
            "code": "K55.059",
            "display": "Acute (reversible) ischemia of intestine, part and extent unspecified"
          },
          {
            "code": "K55.061",
            "display": "Focal (segmental) acute infarction of intestine, part unspecified"
          },
          {
            "code": "K55.062",
            "display": "Diffuse acute infarction of intestine, part unspecified"
          },
          {
            "code": "K55.069",
            "display": "Acute infarction of intestine, part and extent unspecified"
          },
          {
            "code": "K55.1",
            "display": "Chronic vascular disorders of intestine"
          },
          {
            "code": "K55.8",
            "display": "Other vascular disorders of intestine"
          },
          {
            "code": "K55.9",
            "display": "Vascular disorder of intestine, unspecified"
          },
          {
            "code": "K63.5",
            "display": "Polyp of colon"
          },
          {
            "code": "K64.0",
            "display": "First degree hemorrhoids"
          },
          {
            "code": "K64.1",
            "display": "Second degree hemorrhoids"
          },
          {
            "code": "K64.2",
            "display": "Third degree hemorrhoids"
          },
          {
            "code": "K64.3",
            "display": "Fourth degree hemorrhoids"
          },
          {
            "code": "K64.4",
            "display": "Residual hemorrhoidal skin tags"
          },
          {
            "code": "K64.5",
            "display": "Perianal venous thrombosis"
          },
          {
            "code": "K64.8",
            "display": "Other hemorrhoids"
          },
          {
            "code": "K64.9",
            "display": "Unspecified hemorrhoids"
          },
          {
            "code": "K90.41",
            "display": "Non-celiac gluten sensitivity"
          },
          {
            "code": "L04.0",
            "display": "Acute lymphadenitis of face, head and neck"
          },
          {
            "code": "L04.1",
            "display": "Acute lymphadenitis of trunk"
          },
          {
            "code": "L04.2",
            "display": "Acute lymphadenitis of upper limb"
          },
          {
            "code": "L04.3",
            "display": "Acute lymphadenitis of lower limb"
          },
          {
            "code": "L04.8",
            "display": "Acute lymphadenitis of other sites"
          },
          {
            "code": "L04.9",
            "display": "Acute lymphadenitis, unspecified"
          },
          {
            "code": "L20.0",
            "display": "Besnier\u0027s prurigo"
          },
          {
            "code": "L20.81",
            "display": "Atopic neurodermatitis"
          },
          {
            "code": "L20.82",
            "display": "Flexural eczema"
          },
          {
            "code": "L20.83",
            "display": "Infantile (acute) (chronic) eczema"
          },
          {
            "code": "L20.84",
            "display": "Intrinsic (allergic) eczema"
          },
          {
            "code": "L20.89",
            "display": "Other atopic dermatitis"
          },
          {
            "code": "L20.9",
            "display": "Atopic dermatitis, unspecified"
          },
          {
            "code": "L22",
            "display": "Diaper dermatitis"
          },
          {
            "code": "L23.0",
            "display": "Allergic contact dermatitis due to metals"
          },
          {
            "code": "L23.1",
            "display": "Allergic contact dermatitis due to adhesives"
          },
          {
            "code": "L23.2",
            "display": "Allergic contact dermatitis due to cosmetics"
          },
          {
            "code": "L23.3",
            "display": "Allergic contact dermatitis due to drugs in contact with skin"
          },
          {
            "code": "L23.4",
            "display": "Allergic contact dermatitis due to dyes"
          },
          {
            "code": "L23.5",
            "display": "Allergic contact dermatitis due to other chemical products"
          },
          {
            "code": "L23.6",
            "display": "Allergic contact dermatitis due to food in contact with the skin"
          },
          {
            "code": "L23.7",
            "display": "Allergic contact dermatitis due to plants, except food"
          },
          {
            "code": "L23.81",
            "display": "Allergic contact dermatitis due to animal (cat) (dog) dander"
          },
          {
            "code": "L23.89",
            "display": "Allergic contact dermatitis due to other agents"
          },
          {
            "code": "L23.9",
            "display": "Allergic contact dermatitis, unspecified cause"
          },
          {
            "code": "L24.0",
            "display": "Irritant contact dermatitis due to detergents"
          },
          {
            "code": "L24.1",
            "display": "Irritant contact dermatitis due to oils and greases"
          },
          {
            "code": "L24.2",
            "display": "Irritant contact dermatitis due to solvents"
          },
          {
            "code": "L24.3",
            "display": "Irritant contact dermatitis due to cosmetics"
          },
          {
            "code": "L24.4",
            "display": "Irritant contact dermatitis due to drugs in contact with skin"
          },
          {
            "code": "L24.5",
            "display": "Irritant contact dermatitis due to other chemical products"
          },
          {
            "code": "L24.6",
            "display": "Irritant contact dermatitis due to food in contact with skin"
          },
          {
            "code": "L24.7",
            "display": "Irritant contact dermatitis due to plants, except food"
          },
          {
            "code": "L24.81",
            "display": "Irritant contact dermatitis due to metals"
          },
          {
            "code": "L24.89",
            "display": "Irritant contact dermatitis due to other agents"
          },
          {
            "code": "L24.9",
            "display": "Irritant contact dermatitis, unspecified cause"
          },
          {
            "code": "L25.0",
            "display": "Unspecified contact dermatitis due to cosmetics"
          },
          {
            "code": "L25.1",
            "display": "Unspecified contact dermatitis due to drugs in contact with skin"
          },
          {
            "code": "L25.2",
            "display": "Unspecified contact dermatitis due to dyes"
          },
          {
            "code": "L25.3",
            "display": "Unspecified contact dermatitis due to other chemical products"
          },
          {
            "code": "L25.4",
            "display": "Unspecified contact dermatitis due to food in contact with skin"
          },
          {
            "code": "L25.5",
            "display": "Unspecified contact dermatitis due to plants, except food"
          },
          {
            "code": "L25.8",
            "display": "Unspecified contact dermatitis due to other agents"
          },
          {
            "code": "L25.9",
            "display": "Unspecified contact dermatitis, unspecified cause"
          },
          {
            "code": "L27.0",
            "display": "Generalized skin eruption due to drugs and medicaments taken internally"
          },
          {
            "code": "L27.1",
            "display": "Localized skin eruption due to drugs and medicaments taken internally"
          },
          {
            "code": "L27.2",
            "display": "Dermatitis due to ingested food"
          },
          {
            "code": "L27.8",
            "display": "Dermatitis due to other substances taken internally"
          },
          {
            "code": "L27.9",
            "display": "Dermatitis due to unspecified substance taken internally"
          },
          {
            "code": "L30.0",
            "display": "Nummular dermatitis"
          },
          {
            "code": "L30.2",
            "display": "Cutaneous autosensitization"
          },
          {
            "code": "L30.8",
            "display": "Other specified dermatitis"
          },
          {
            "code": "L30.9",
            "display": "Dermatitis, unspecified"
          },
          {
            "code": "L50.0",
            "display": "Allergic urticaria"
          },
          {
            "code": "L50.1",
            "display": "Idiopathic urticaria"
          },
          {
            "code": "L50.2",
            "display": "Urticaria due to cold and heat"
          },
          {
            "code": "L50.3",
            "display": "Dermatographic urticaria"
          },
          {
            "code": "L50.4",
            "display": "Vibratory urticaria"
          },
          {
            "code": "L50.5",
            "display": "Cholinergic urticaria"
          },
          {
            "code": "L50.6",
            "display": "Contact urticaria"
          },
          {
            "code": "L50.8",
            "display": "Other urticaria"
          },
          {
            "code": "L50.9",
            "display": "Urticaria, unspecified"
          },
          {
            "code": "L56.0",
            "display": "Drug phototoxic response"
          },
          {
            "code": "L56.1",
            "display": "Drug photoallergic response"
          },
          {
            "code": "L56.2",
            "display": "Photocontact dermatitis [berloque dermatitis]"
          },
          {
            "code": "L56.3",
            "display": "Solar urticaria"
          },
          {
            "code": "L56.4",
            "display": "Polymorphous light eruption"
          },
          {
            "code": "L56.8",
            "display": "Other specified acute skin changes due to ultraviolet radiation"
          },
          {
            "code": "L56.9",
            "display": "Acute skin change due to ultraviolet radiation, unspecified"
          },
          {
            "code": "L57.8",
            "display": "Other skin changes due to chronic exposure to nonionizing radiation"
          },
          {
            "code": "L57.9",
            "display": "Skin changes due to chronic exposure to nonionizing radiation, unspecified"
          },
          {
            "code": "L58.0",
            "display": "Acute radiodermatitis"
          },
          {
            "code": "L58.1",
            "display": "Chronic radiodermatitis"
          },
          {
            "code": "L58.9",
            "display": "Radiodermatitis, unspecified"
          },
          {
            "code": "L59.0",
            "display": "Erythema ab igne [dermatitis ab igne]"
          },
          {
            "code": "L59.8",
            "display": "Other specified disorders of the skin and subcutaneous tissue related to radiation"
          },
          {
            "code": "L59.9",
            "display": "Disorder of the skin and subcutaneous tissue related to radiation, unspecified"
          },
          {
            "code": "M31.0",
            "display": "Hypersensitivity angiitis"
          },
          {
            "code": "N26.2",
            "display": "Page kidney"
          },
          {
            "code": "R00.0",
            "display": "Tachycardia, unspecified"
          },
          {
            "code": "R00.1",
            "display": "Bradycardia, unspecified"
          },
          {
            "code": "R00.2",
            "display": "Palpitations"
          },
          {
            "code": "R00.8",
            "display": "Other abnormalities of heart beat"
          },
          {
            "code": "R00.9",
            "display": "Unspecified abnormalities of heart beat"
          },
          {
            "code": "R01.0",
            "display": "Benign and innocent cardiac murmurs"
          },
          {
            "code": "R01.1",
            "display": "Cardiac murmur, unspecified"
          },
          {
            "code": "R01.2",
            "display": "Other cardiac sounds"
          },
          {
            "code": "R03.0",
            "display": "Elevated blood-pressure reading, without diagnosis of hypertension"
          },
          {
            "code": "R03.1",
            "display": "Nonspecific low blood-pressure reading"
          },
          {
            "code": "R07.2",
            "display": "Precordial pain"
          },
          {
            "code": "R07.82",
            "display": "Intercostal pain"
          },
          {
            "code": "R07.89",
            "display": "Other chest pain"
          },
          {
            "code": "R07.9",
            "display": "Chest pain, unspecified"
          },
          {
            "code": "R09.89",
            "display": "Other specified symptoms and signs involving the circulatory and respiratory systems"
          },
          {
            "code": "R10.0",
            "display": "Acute abdomen"
          },
          {
            "code": "R10.10",
            "display": "Upper abdominal pain, unspecified"
          },
          {
            "code": "R10.11",
            "display": "Right upper quadrant pain"
          },
          {
            "code": "R10.12",
            "display": "Left upper quadrant pain"
          },
          {
            "code": "R10.13",
            "display": "Epigastric pain"
          },
          {
            "code": "R10.2",
            "display": "Pelvic and perineal pain"
          },
          {
            "code": "R10.30",
            "display": "Lower abdominal pain, unspecified"
          },
          {
            "code": "R10.31",
            "display": "Right lower quadrant pain"
          },
          {
            "code": "R10.32",
            "display": "Left lower quadrant pain"
          },
          {
            "code": "R10.33",
            "display": "Periumbilical pain"
          },
          {
            "code": "R10.811",
            "display": "Right upper quadrant abdominal tenderness"
          },
          {
            "code": "R10.812",
            "display": "Left upper quadrant abdominal tenderness"
          },
          {
            "code": "R10.813",
            "display": "Right lower quadrant abdominal tenderness"
          },
          {
            "code": "R10.814",
            "display": "Left lower quadrant abdominal tenderness"
          },
          {
            "code": "R10.815",
            "display": "Periumbilic abdominal tenderness"
          },
          {
            "code": "R10.816",
            "display": "Epigastric abdominal tenderness"
          },
          {
            "code": "R10.817",
            "display": "Generalized abdominal tenderness"
          },
          {
            "code": "R10.819",
            "display": "Abdominal tenderness, unspecified site"
          },
          {
            "code": "R10.821",
            "display": "Right upper quadrant rebound abdominal tenderness"
          },
          {
            "code": "R10.822",
            "display": "Left upper quadrant rebound abdominal tenderness"
          },
          {
            "code": "R10.823",
            "display": "Right lower quadrant rebound abdominal tenderness"
          },
          {
            "code": "R10.824",
            "display": "Left lower quadrant rebound abdominal tenderness"
          },
          {
            "code": "R10.825",
            "display": "Periumbilic rebound abdominal tenderness"
          },
          {
            "code": "R10.826",
            "display": "Epigastric rebound abdominal tenderness"
          },
          {
            "code": "R10.827",
            "display": "Generalized rebound abdominal tenderness"
          },
          {
            "code": "R10.829",
            "display": "Rebound abdominal tenderness, unspecified site"
          },
          {
            "code": "R10.84",
            "display": "Generalized abdominal pain"
          },
          {
            "code": "R10.9",
            "display": "Unspecified abdominal pain"
          },
          {
            "code": "R11.0",
            "display": "Nausea"
          },
          {
            "code": "R11.10",
            "display": "Vomiting, unspecified"
          },
          {
            "code": "R11.11",
            "display": "Vomiting without nausea"
          },
          {
            "code": "R11.12",
            "display": "Projectile vomiting"
          },
          {
            "code": "R11.14",
            "display": "Bilious vomiting"
          },
          {
            "code": "R11.2",
            "display": "Nausea with vomiting, unspecified"
          },
          {
            "code": "R18.0",
            "display": "Malignant ascites"
          },
          {
            "code": "R29.700",
            "display": "NIHSS score 0"
          },
          {
            "code": "R29.701",
            "display": "NIHSS score 1"
          },
          {
            "code": "R29.702",
            "display": "NIHSS score 2"
          },
          {
            "code": "R29.703",
            "display": "NIHSS score 3"
          },
          {
            "code": "R29.704",
            "display": "NIHSS score 4"
          },
          {
            "code": "R29.705",
            "display": "NIHSS score 5"
          },
          {
            "code": "R29.706",
            "display": "NIHSS score 6"
          },
          {
            "code": "R29.707",
            "display": "NIHSS score 7"
          },
          {
            "code": "R29.708",
            "display": "NIHSS score 8"
          },
          {
            "code": "R29.709",
            "display": "NIHSS score 9"
          },
          {
            "code": "R29.710",
            "display": "NIHSS score 10"
          },
          {
            "code": "R29.711",
            "display": "NIHSS score 11"
          },
          {
            "code": "R29.712",
            "display": "NIHSS score 12"
          },
          {
            "code": "R29.713",
            "display": "NIHSS score 13"
          },
          {
            "code": "R29.714",
            "display": "NIHSS score 14"
          },
          {
            "code": "R29.715",
            "display": "NIHSS score 15"
          },
          {
            "code": "R29.716",
            "display": "NIHSS score 16"
          },
          {
            "code": "R29.717",
            "display": "NIHSS score 17"
          },
          {
            "code": "R29.718",
            "display": "NIHSS score 18"
          },
          {
            "code": "R29.719",
            "display": "NIHSS score 19"
          },
          {
            "code": "R29.720",
            "display": "NIHSS score 20"
          },
          {
            "code": "R29.721",
            "display": "NIHSS score 21"
          },
          {
            "code": "R29.722",
            "display": "NIHSS score 22"
          },
          {
            "code": "R29.723",
            "display": "NIHSS score 23"
          },
          {
            "code": "R29.724",
            "display": "NIHSS score 24"
          },
          {
            "code": "R29.725",
            "display": "NIHSS score 25"
          },
          {
            "code": "R29.726",
            "display": "NIHSS score 26"
          },
          {
            "code": "R29.727",
            "display": "NIHSS score 27"
          },
          {
            "code": "R29.728",
            "display": "NIHSS score 28"
          },
          {
            "code": "R29.729",
            "display": "NIHSS score 29"
          },
          {
            "code": "R29.730",
            "display": "NIHSS score 30"
          },
          {
            "code": "R29.731",
            "display": "NIHSS score 31"
          },
          {
            "code": "R29.732",
            "display": "NIHSS score 32"
          },
          {
            "code": "R29.733",
            "display": "NIHSS score 33"
          },
          {
            "code": "R29.734",
            "display": "NIHSS score 34"
          },
          {
            "code": "R29.735",
            "display": "NIHSS score 35"
          },
          {
            "code": "R29.736",
            "display": "NIHSS score 36"
          },
          {
            "code": "R29.737",
            "display": "NIHSS score 37"
          },
          {
            "code": "R29.738",
            "display": "NIHSS score 38"
          },
          {
            "code": "R29.739",
            "display": "NIHSS score 39"
          },
          {
            "code": "R29.740",
            "display": "NIHSS score 40"
          },
          {
            "code": "R29.741",
            "display": "NIHSS score 41"
          },
          {
            "code": "R29.742",
            "display": "NIHSS score 42"
          },
          {
            "code": "R50.81",
            "display": "Fever presenting with conditions classified elsewhere"
          },
          {
            "code": "R50.9",
            "display": "Fever, unspecified"
          },
          {
            "code": "R53.0",
            "display": "Neoplastic (malignant) related fatigue"
          },
          {
            "code": "R53.1",
            "display": "Weakness"
          },
          {
            "code": "R53.81",
            "display": "Other malaise"
          },
          {
            "code": "R53.82",
            "display": "Chronic fatigue, unspecified"
          },
          {
            "code": "R53.83",
            "display": "Other fatigue"
          },
          {
            "code": "R55",
            "display": "Syncope and collapse"
          },
          {
            "code": "R57.0",
            "display": "Cardiogenic shock"
          },
          {
            "code": "R57.1",
            "display": "Hypovolemic shock"
          },
          {
            "code": "R57.8",
            "display": "Other shock"
          },
          {
            "code": "R57.9",
            "display": "Shock, unspecified"
          },
          {
            "code": "R58",
            "display": "Hemorrhage, not elsewhere classified"
          },
          {
            "code": "R59.0",
            "display": "Localized enlarged lymph nodes"
          },
          {
            "code": "R59.1",
            "display": "Generalized enlarged lymph nodes"
          },
          {
            "code": "R59.9",
            "display": "Enlarged lymph nodes, unspecified"
          },
          {
            "code": "R65.21",
            "display": "Severe sepsis with septic shock"
          },
          {
            "code": "R78.71",
            "display": "Abnormal lead level in blood"
          },
          {
            "code": "R78.79",
            "display": "Finding of abnormal level of heavy metals in blood"
          },
          {
            "code": "R78.89",
            "display": "Finding of other specified substances, not normally found in blood"
          },
          {
            "code": "R78.9",
            "display": "Finding of unspecified substance, not normally found in blood"
          },
          {
            "code": "R79.0",
            "display": "Abnormal level of blood mineral"
          },
          {
            "code": "R79.1",
            "display": "Abnormal coagulation profile"
          },
          {
            "code": "R79.81",
            "display": "Abnormal blood-gas level"
          },
          {
            "code": "R79.82",
            "display": "Elevated C-reactive protein (CRP)"
          },
          {
            "code": "R79.89",
            "display": "Other specified abnormal findings of blood chemistry"
          },
          {
            "code": "R79.9",
            "display": "Abnormal finding of blood chemistry, unspecified"
          },
          {
            "code": "R83.0",
            "display": "Abnormal level of enzymes in cerebrospinal fluid"
          },
          {
            "code": "R83.1",
            "display": "Abnormal level of hormones in cerebrospinal fluid"
          },
          {
            "code": "R83.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid"
          },
          {
            "code": "R83.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid"
          },
          {
            "code": "R83.4",
            "display": "Abnormal immunological findings in cerebrospinal fluid"
          },
          {
            "code": "R83.5",
            "display": "Abnormal microbiological findings in cerebrospinal fluid"
          },
          {
            "code": "R83.6",
            "display": "Abnormal cytological findings in cerebrospinal fluid"
          },
          {
            "code": "R83.8",
            "display": "Other abnormal findings in cerebrospinal fluid"
          },
          {
            "code": "R83.9",
            "display": "Unspecified abnormal finding in cerebrospinal fluid"
          },
          {
            "code": "R84.0",
            "display": "Abnormal level of enzymes in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.1",
            "display": "Abnormal level of hormones in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.4",
            "display": "Abnormal immunological findings in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.5",
            "display": "Abnormal microbiological findings in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.6",
            "display": "Abnormal cytological findings in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.7",
            "display": "Abnormal histological findings in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.8",
            "display": "Other abnormal findings in specimens from respiratory organs and thorax"
          },
          {
            "code": "R84.9",
            "display": "Unspecified abnormal finding in specimens from respiratory organs and thorax"
          },
          {
            "code": "R85.0",
            "display": "Abnormal level of enzymes in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.1",
            "display": "Abnormal level of hormones in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.4",
            "display": "Abnormal immunological findings in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.5",
            "display": "Abnormal microbiological findings in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.610",
            "display": "Atypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US)"
          },
          {
            "code": "R85.611",
            "display": "Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H)"
          },
          {
            "code": "R85.612",
            "display": "Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)"
          },
          {
            "code": "R85.613",
            "display": "High grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL)"
          },
          {
            "code": "R85.614",
            "display": "Cytologic evidence of malignancy on smear of anus"
          },
          {
            "code": "R85.615",
            "display": "Unsatisfactory cytologic smear of anus"
          },
          {
            "code": "R85.616",
            "display": "Satisfactory anal smear but lacking transformation zone"
          },
          {
            "code": "R85.618",
            "display": "Other abnormal cytological findings on specimens from anus"
          },
          {
            "code": "R85.619",
            "display": "Unspecified abnormal cytological findings in specimens from anus"
          },
          {
            "code": "R85.69",
            "display": "Abnormal cytological findings in specimens from other digestive organs and abdominal cavity"
          },
          {
            "code": "R85.7",
            "display": "Abnormal histological findings in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.89",
            "display": "Other abnormal findings in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R85.9",
            "display": "Unspecified abnormal finding in specimens from digestive organs and abdominal cavity"
          },
          {
            "code": "R86.0",
            "display": "Abnormal level of enzymes in specimens from male genital organs"
          },
          {
            "code": "R86.1",
            "display": "Abnormal level of hormones in specimens from male genital organs"
          },
          {
            "code": "R86.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs"
          },
          {
            "code": "R86.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs"
          },
          {
            "code": "R86.4",
            "display": "Abnormal immunological findings in specimens from male genital organs"
          },
          {
            "code": "R86.5",
            "display": "Abnormal microbiological findings in specimens from male genital organs"
          },
          {
            "code": "R86.6",
            "display": "Abnormal cytological findings in specimens from male genital organs"
          },
          {
            "code": "R86.7",
            "display": "Abnormal histological findings in specimens from male genital organs"
          },
          {
            "code": "R86.8",
            "display": "Other abnormal findings in specimens from male genital organs"
          },
          {
            "code": "R86.9",
            "display": "Unspecified abnormal finding in specimens from male genital organs"
          },
          {
            "code": "R87.0",
            "display": "Abnormal level of enzymes in specimens from female genital organs"
          },
          {
            "code": "R87.1",
            "display": "Abnormal level of hormones in specimens from female genital organs"
          },
          {
            "code": "R87.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs"
          },
          {
            "code": "R87.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs"
          },
          {
            "code": "R87.4",
            "display": "Abnormal immunological findings in specimens from female genital organs"
          },
          {
            "code": "R87.5",
            "display": "Abnormal microbiological findings in specimens from female genital organs"
          },
          {
            "code": "R87.610",
            "display": "Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)"
          },
          {
            "code": "R87.611",
            "display": "Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)"
          },
          {
            "code": "R87.612",
            "display": "Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)"
          },
          {
            "code": "R87.613",
            "display": "High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)"
          },
          {
            "code": "R87.614",
            "display": "Cytologic evidence of malignancy on smear of cervix"
          },
          {
            "code": "R87.615",
            "display": "Unsatisfactory cytologic smear of cervix"
          },
          {
            "code": "R87.616",
            "display": "Satisfactory cervical smear but lacking transformation zone"
          },
          {
            "code": "R87.618",
            "display": "Other abnormal cytological findings on specimens from cervix uteri"
          },
          {
            "code": "R87.619",
            "display": "Unspecified abnormal cytological findings in specimens from cervix uteri"
          },
          {
            "code": "R87.620",
            "display": "Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)"
          },
          {
            "code": "R87.621",
            "display": "Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)"
          },
          {
            "code": "R87.622",
            "display": "Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)"
          },
          {
            "code": "R87.623",
            "display": "High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)"
          },
          {
            "code": "R87.624",
            "display": "Cytologic evidence of malignancy on smear of vagina"
          },
          {
            "code": "R87.625",
            "display": "Unsatisfactory cytologic smear of vagina"
          },
          {
            "code": "R87.628",
            "display": "Other abnormal cytological findings on specimens from vagina"
          },
          {
            "code": "R87.629",
            "display": "Unspecified abnormal cytological findings in specimens from vagina"
          },
          {
            "code": "R87.69",
            "display": "Abnormal cytological findings in specimens from other female genital organs"
          },
          {
            "code": "R87.7",
            "display": "Abnormal histological findings in specimens from female genital organs"
          },
          {
            "code": "R87.89",
            "display": "Other abnormal findings in specimens from female genital organs"
          },
          {
            "code": "R87.9",
            "display": "Unspecified abnormal finding in specimens from female genital organs"
          },
          {
            "code": "R88.8",
            "display": "Abnormal findings in other body fluids and substances"
          },
          {
            "code": "R89.0",
            "display": "Abnormal level of enzymes in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.1",
            "display": "Abnormal level of hormones in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.2",
            "display": "Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.3",
            "display": "Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.4",
            "display": "Abnormal immunological findings in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.5",
            "display": "Abnormal microbiological findings in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.6",
            "display": "Abnormal cytological findings in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.7",
            "display": "Abnormal histological findings in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.8",
            "display": "Other abnormal findings in specimens from other organs, systems and tissues"
          },
          {
            "code": "R89.9",
            "display": "Unspecified abnormal finding in specimens from other organs, systems and tissues"
          },
          {
            "code": "R90.81",
            "display": "Abnormal echoencephalogram"
          },
          {
            "code": "R90.89",
            "display": "Other abnormal findings on diagnostic imaging of central nervous system"
          },
          {
            "code": "R92.2",
            "display": "Inconclusive mammogram"
          },
          {
            "code": "R92.8",
            "display": "Other abnormal and inconclusive findings on diagnostic imaging of breast"
          },
          {
            "code": "R93.0",
            "display": "Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified"
          },
          {
            "code": "R93.1",
            "display": "Abnormal findings on diagnostic imaging of heart and coronary circulation"
          },
          {
            "code": "R93.2",
            "display": "Abnormal findings on diagnostic imaging of liver and biliary tract"
          },
          {
            "code": "R93.3",
            "display": "Abnormal findings on diagnostic imaging of other parts of digestive tract"
          },
          {
            "code": "R93.4",
            "display": "Abnormal findings on diagnostic imaging of urinary organs"
          },
          {
            "code": "R93.41",
            "display": "Abnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder"
          },
          {
            "code": "R93.421",
            "display": "Abnormal radiologic findings on diagnostic imaging of right kidney"
          },
          {
            "code": "R93.422",
            "display": "Abnormal radiologic findings on diagnostic imaging of left kidney"
          },
          {
            "code": "R93.429",
            "display": "Abnormal radiologic findings on diagnostic imaging of unspecified kidney"
          },
          {
            "code": "R93.49",
            "display": "Abnormal radiologic findings on diagnostic imaging of other urinary organs"
          },
          {
            "code": "R93.5",
            "display": "Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum"
          },
          {
            "code": "R93.6",
            "display": "Abnormal findings on diagnostic imaging of limbs"
          },
          {
            "code": "R93.7",
            "display": "Abnormal findings on diagnostic imaging of other parts of musculoskeletal system"
          },
          {
            "code": "R93.8",
            "display": "Abnormal findings on diagnostic imaging of other specified body structures"
          },
          {
            "code": "R93.811",
            "display": "Abnormal radiologic findings on diagnostic imaging of right testicle"
          },
          {
            "code": "R93.812",
            "display": "Abnormal radiologic findings on diagnostic imaging of left testicle"
          },
          {
            "code": "R93.813",
            "display": "Abnormal radiologic findings on diagnostic imaging of testicles, bilateral"
          },
          {
            "code": "R93.819",
            "display": "Abnormal radiologic findings on diagnostic imaging of unspecified testicle"
          },
          {
            "code": "R93.89",
            "display": "Abnormal findings on diagnostic imaging of other specified body structures"
          },
          {
            "code": "R93.9",
            "display": "Diagnostic imaging inconclusive due to excess body fat of patient"
          },
          {
            "code": "R94.01",
            "display": "Abnormal electroencephalogram [EEG]"
          },
          {
            "code": "R94.02",
            "display": "Abnormal brain scan"
          },
          {
            "code": "R94.09",
            "display": "Abnormal results of other function studies of central nervous system"
          },
          {
            "code": "R94.110",
            "display": "Abnormal electro-oculogram [EOG]"
          },
          {
            "code": "R94.111",
            "display": "Abnormal electroretinogram [ERG]"
          },
          {
            "code": "R94.112",
            "display": "Abnormal visually evoked potential [VEP]"
          },
          {
            "code": "R94.113",
            "display": "Abnormal oculomotor study"
          },
          {
            "code": "R94.118",
            "display": "Abnormal results of other function studies of eye"
          },
          {
            "code": "R94.120",
            "display": "Abnormal auditory function study"
          },
          {
            "code": "R94.121",
            "display": "Abnormal vestibular function study"
          },
          {
            "code": "R94.128",
            "display": "Abnormal results of other function studies of ear and other special senses"
          },
          {
            "code": "R94.130",
            "display": "Abnormal response to nerve stimulation, unspecified"
          },
          {
            "code": "R94.131",
            "display": "Abnormal electromyogram [EMG]"
          },
          {
            "code": "R94.138",
            "display": "Abnormal results of other function studies of peripheral nervous system"
          },
          {
            "code": "R94.2",
            "display": "Abnormal results of pulmonary function studies"
          },
          {
            "code": "R94.30",
            "display": "Abnormal result of cardiovascular function study, unspecified"
          },
          {
            "code": "R94.31",
            "display": "Abnormal electrocardiogram [ECG] [EKG]"
          },
          {
            "code": "R94.39",
            "display": "Abnormal result of other cardiovascular function study"
          },
          {
            "code": "R94.4",
            "display": "Abnormal results of kidney function studies"
          },
          {
            "code": "R94.5",
            "display": "Abnormal results of liver function studies"
          },
          {
            "code": "R94.6",
            "display": "Abnormal results of thyroid function studies"
          },
          {
            "code": "R94.7",
            "display": "Abnormal results of other endocrine function studies"
          },
          {
            "code": "R94.8",
            "display": "Abnormal results of function studies of other organs and systems"
          },
          {
            "code": "R97.0",
            "display": "Elevated carcinoembryonic antigen [CEA]"
          },
          {
            "code": "R97.1",
            "display": "Elevated cancer antigen 125 [CA 125]"
          },
          {
            "code": "R97.2",
            "display": "Elevated prostate specific antigen [PSA]"
          },
          {
            "code": "R97.20",
            "display": "Elevated prostate specific antigen [PSA]"
          },
          {
            "code": "R97.21",
            "display": "Rising PSA following treatment for malignant neoplasm of prostate"
          },
          {
            "code": "R97.8",
            "display": "Other abnormal tumor markers"
          },
          {
            "code": "T78.00XA",
            "display": "Anaphylactic reaction due to unspecified food, initial encounter"
          },
          {
            "code": "T78.00XD",
            "display": "Anaphylactic reaction due to unspecified food, subsequent encounter"
          },
          {
            "code": "T78.00XS",
            "display": "Anaphylactic reaction due to unspecified food, sequela"
          },
          {
            "code": "T78.01XA",
            "display": "Anaphylactic reaction due to peanuts, initial encounter"
          },
          {
            "code": "T78.01XD",
            "display": "Anaphylactic reaction due to peanuts, subsequent encounter"
          },
          {
            "code": "T78.01XS",
            "display": "Anaphylactic reaction due to peanuts, sequela"
          },
          {
            "code": "T78.02XA",
            "display": "Anaphylactic reaction due to shellfish (crustaceans), initial encounter"
          },
          {
            "code": "T78.02XD",
            "display": "Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter"
          },
          {
            "code": "T78.02XS",
            "display": "Anaphylactic reaction due to shellfish (crustaceans), sequela"
          },
          {
            "code": "T78.03XA",
            "display": "Anaphylactic reaction due to other fish, initial encounter"
          },
          {
            "code": "T78.03XD",
            "display": "Anaphylactic reaction due to other fish, subsequent encounter"
          },
          {
            "code": "T78.03XS",
            "display": "Anaphylactic reaction due to other fish, sequela"
          },
          {
            "code": "T78.04XA",
            "display": "Anaphylactic reaction due to fruits and vegetables, initial encounter"
          },
          {
            "code": "T78.04XD",
            "display": "Anaphylactic reaction due to fruits and vegetables, subsequent encounter"
          },
          {
            "code": "T78.04XS",
            "display": "Anaphylactic reaction due to fruits and vegetables, sequela"
          },
          {
            "code": "T78.05XA",
            "display": "Anaphylactic reaction due to tree nuts and seeds, initial encounter"
          },
          {
            "code": "T78.05XD",
            "display": "Anaphylactic reaction due to tree nuts and seeds, subsequent encounter"
          },
          {
            "code": "T78.05XS",
            "display": "Anaphylactic reaction due to tree nuts and seeds, sequela"
          },
          {
            "code": "T78.06XA",
            "display": "Anaphylactic reaction due to food additives, initial encounter"
          },
          {
            "code": "T78.06XD",
            "display": "Anaphylactic reaction due to food additives, subsequent encounter"
          },
          {
            "code": "T78.06XS",
            "display": "Anaphylactic reaction due to food additives, sequela"
          },
          {
            "code": "T78.07XA",
            "display": "Anaphylactic reaction due to milk and dairy products, initial encounter"
          },
          {
            "code": "T78.07XD",
            "display": "Anaphylactic reaction due to milk and dairy products, subsequent encounter"
          },
          {
            "code": "T78.07XS",
            "display": "Anaphylactic reaction due to milk and dairy products, sequela"
          },
          {
            "code": "T78.08XA",
            "display": "Anaphylactic reaction due to eggs, initial encounter"
          },
          {
            "code": "T78.08XD",
            "display": "Anaphylactic reaction due to eggs, subsequent encounter"
          },
          {
            "code": "T78.08XS",
            "display": "Anaphylactic reaction due to eggs, sequela"
          },
          {
            "code": "T78.09XA",
            "display": "Anaphylactic reaction due to other food products, initial encounter"
          },
          {
            "code": "T78.09XD",
            "display": "Anaphylactic reaction due to other food products, subsequent encounter"
          },
          {
            "code": "T78.09XS",
            "display": "Anaphylactic reaction due to other food products, sequela"
          },
          {
            "code": "T78.1XXA",
            "display": "Other adverse food reactions, not elsewhere classified, initial encounter"
          },
          {
            "code": "T78.1XXD",
            "display": "Other adverse food reactions, not elsewhere classified, subsequent encounter"
          },
          {
            "code": "T78.1XXS",
            "display": "Other adverse food reactions, not elsewhere classified, sequela"
          },
          {
            "code": "T78.2XXA",
            "display": "Anaphylactic shock, unspecified, initial encounter"
          },
          {
            "code": "T78.40XA",
            "display": "Allergy, unspecified, initial encounter"
          },
          {
            "code": "T78.49XA",
            "display": "Other allergy, initial encounter"
          },
          {
            "code": "Z00.00",
            "display": "Encounter for general adult medical examination without abnormal findings"
          },
          {
            "code": "Z00.01",
            "display": "Encounter for general adult medical examination with abnormal findings"
          },
          {
            "code": "Z00.110",
            "display": "Health examination for newborn under 8 days old"
          },
          {
            "code": "Z00.111",
            "display": "Health examination for newborn 8 to 28 days old"
          },
          {
            "code": "Z00.121",
            "display": "Encounter for routine child health examination with abnormal findings"
          },
          {
            "code": "Z00.129",
            "display": "Encounter for routine child health examination without abnormal findings"
          },
          {
            "code": "Z00.2",
            "display": "Encounter for examination for period of rapid growth in childhood"
          },
          {
            "code": "Z00.3",
            "display": "Encounter for examination for adolescent development state"
          },
          {
            "code": "Z00.5",
            "display": "Encounter for examination of potential donor of organ and tissue"
          },
          {
            "code": "Z00.6",
            "display": "Encounter for examination for normal comparison and control in clinical research program"
          },
          {
            "code": "Z00.70",
            "display": "Encounter for examination for period of delayed growth in childhood without abnormal findings"
          },
          {
            "code": "Z00.71",
            "display": "Encounter for examination for period of delayed growth in childhood with abnormal findings"
          },
          {
            "code": "Z00.8",
            "display": "Encounter for other general examination"
          },
          {
            "code": "Z01.00",
            "display": "Encounter for examination of eyes and vision without abnormal findings"
          },
          {
            "code": "Z01.01",
            "display": "Encounter for examination of eyes and vision with abnormal findings"
          },
          {
            "code": "Z01.10",
            "display": "Encounter for examination of ears and hearing without abnormal findings"
          },
          {
            "code": "Z01.110",
            "display": "Encounter for hearing examination following failed hearing screening"
          },
          {
            "code": "Z01.118",
            "display": "Encounter for examination of ears and hearing with other abnormal findings"
          },
          {
            "code": "Z01.12",
            "display": "Encounter for hearing conservation and treatment"
          },
          {
            "code": "Z01.20",
            "display": "Encounter for dental examination and cleaning without abnormal findings"
          },
          {
            "code": "Z01.21",
            "display": "Encounter for dental examination and cleaning with abnormal findings"
          },
          {
            "code": "Z01.30",
            "display": "Encounter for examination of blood pressure without abnormal findings"
          },
          {
            "code": "Z01.31",
            "display": "Encounter for examination of blood pressure with abnormal findings"
          },
          {
            "code": "Z01.411",
            "display": "Encounter for gynecological examination (general) (routine) with abnormal findings"
          },
          {
            "code": "Z01.419",
            "display": "Encounter for gynecological examination (general) (routine) without abnormal findings"
          },
          {
            "code": "Z01.42",
            "display": "Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear"
          },
          {
            "code": "Z01.810",
            "display": "Encounter for preprocedural cardiovascular examination"
          },
          {
            "code": "Z01.811",
            "display": "Encounter for preprocedural respiratory examination"
          },
          {
            "code": "Z01.812",
            "display": "Encounter for preprocedural laboratory examination"
          },
          {
            "code": "Z01.818",
            "display": "Encounter for other preprocedural examination"
          },
          {
            "code": "Z01.82",
            "display": "Encounter for allergy testing"
          },
          {
            "code": "Z01.83",
            "display": "Encounter for blood typing"
          },
          {
            "code": "Z01.84",
            "display": "Encounter for antibody response examination"
          },
          {
            "code": "Z01.89",
            "display": "Encounter for other specified special examinations"
          },
          {
            "code": "Z02.0",
            "display": "Encounter for examination for admission to educational institution"
          },
          {
            "code": "Z02.1",
            "display": "Encounter for pre-employment examination"
          },
          {
            "code": "Z02.2",
            "display": "Encounter for examination for admission to residential institution"
          },
          {
            "code": "Z02.3",
            "display": "Encounter for examination for recruitment to armed forces"
          },
          {
            "code": "Z02.4",
            "display": "Encounter for examination for driving license"
          },
          {
            "code": "Z02.5",
            "display": "Encounter for examination for participation in sport"
          },
          {
            "code": "Z02.6",
            "display": "Encounter for examination for insurance purposes"
          },
          {
            "code": "Z02.71",
            "display": "Encounter for disability determination"
          },
          {
            "code": "Z02.79",
            "display": "Encounter for issue of other medical certificate"
          },
          {
            "code": "Z02.81",
            "display": "Encounter for paternity testing"
          },
          {
            "code": "Z02.82",
            "display": "Encounter for adoption services"
          },
          {
            "code": "Z02.83",
            "display": "Encounter for blood-alcohol and blood-drug test"
          },
          {
            "code": "Z02.89",
            "display": "Encounter for other administrative examinations"
          },
          {
            "code": "Z02.9",
            "display": "Encounter for administrative examinations, unspecified"
          },
          {
            "code": "Z03.6",
            "display": "Encounter for observation for suspected toxic effect from ingested substance ruled out"
          },
          {
            "code": "Z03.71",
            "display": "Encounter for suspected problem with amniotic cavity and membrane ruled out"
          },
          {
            "code": "Z03.72",
            "display": "Encounter for suspected placental problem ruled out"
          },
          {
            "code": "Z03.73",
            "display": "Encounter for suspected fetal anomaly ruled out"
          },
          {
            "code": "Z03.74",
            "display": "Encounter for suspected problem with fetal growth ruled out"
          },
          {
            "code": "Z03.75",
            "display": "Encounter for suspected cervical shortening ruled out"
          },
          {
            "code": "Z03.79",
            "display": "Encounter for other suspected maternal and fetal conditions ruled out"
          },
          {
            "code": "Z03.89",
            "display": "Encounter for observation for other suspected diseases and conditions ruled out"
          },
          {
            "code": "Z04.41",
            "display": "Encounter for examination and observation following alleged adult rape"
          },
          {
            "code": "Z04.42",
            "display": "Encounter for examination and observation following alleged child rape"
          },
          {
            "code": "Z04.71",
            "display": "Encounter for examination and observation following alleged adult physical abuse"
          },
          {
            "code": "Z04.72",
            "display": "Encounter for examination and observation following alleged child physical abuse"
          },
          {
            "code": "Z04.8",
            "display": "Encounter for examination and observation for other specified reasons"
          },
          {
            "code": "Z04.81",
            "display": "Encounter for examination and observation of victim following forced sexual exploitation"
          },
          {
            "code": "Z04.82",
            "display": "Encounter for examination and observation of victim following forced labor exploitation"
          },
          {
            "code": "Z04.89",
            "display": "Encounter for examination and observation for other specified reasons"
          },
          {
            "code": "Z04.9",
            "display": "Encounter for examination and observation for unspecified reason"
          },
          {
            "code": "Z05.0",
            "display": "Observation and evaluation of newborn for suspected cardiac condition ruled out"
          },
          {
            "code": "Z05.2",
            "display": "Observation and evaluation of newborn for suspected neurological condition ruled out"
          },
          {
            "code": "Z05.3",
            "display": "Observation and evaluation of newborn for suspected respiratory condition ruled out"
          },
          {
            "code": "Z05.41",
            "display": "Observation and evaluation of newborn for suspected genetic condition ruled out"
          },
          {
            "code": "Z05.42",
            "display": "Observation and evaluation of newborn for suspected metabolic condition ruled out"
          },
          {
            "code": "Z05.43",
            "display": "Observation and evaluation of newborn for suspected immunologic condition ruled out"
          },
          {
            "code": "Z05.5",
            "display": "Observation and evaluation of newborn for suspected gastrointestinal condition ruled out"
          },
          {
            "code": "Z05.6",
            "display": "Observation and evaluation of newborn for suspected genitourinary condition ruled out"
          },
          {
            "code": "Z05.71",
            "display": "Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out"
          },
          {
            "code": "Z05.72",
            "display": "Observation and evaluation of newborn for suspected musculoskeletal condition ruled out"
          },
          {
            "code": "Z05.73",
            "display": "Observation and evaluation of newborn for suspected connective tissue condition ruled out"
          },
          {
            "code": "Z05.8",
            "display": "Observation and evaluation of newborn for other specified suspected condition ruled out"
          },
          {
            "code": "Z05.9",
            "display": "Observation and evaluation of newborn for unspecified suspected condition ruled out"
          },
          {
            "code": "Z08",
            "display": "Encounter for follow-up examination after completed treatment for malignant neoplasm"
          },
          {
            "code": "Z09",
            "display": "Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm"
          },
          {
            "code": "Z12.0",
            "display": "Encounter for screening for malignant neoplasm of stomach"
          },
          {
            "code": "Z12.10",
            "display": "Encounter for screening for malignant neoplasm of intestinal tract, unspecified"
          },
          {
            "code": "Z12.11",
            "display": "Encounter for screening for malignant neoplasm of colon"
          },
          {
            "code": "Z12.12",
            "display": "Encounter for screening for malignant neoplasm of rectum"
          },
          {
            "code": "Z12.13",
            "display": "Encounter for screening for malignant neoplasm of small intestine"
          },
          {
            "code": "Z12.2",
            "display": "Encounter for screening for malignant neoplasm of respiratory organs"
          },
          {
            "code": "Z12.31",
            "display": "Encounter for screening mammogram for malignant neoplasm of breast"
          },
          {
            "code": "Z12.39",
            "display": "Encounter for other screening for malignant neoplasm of breast"
          },
          {
            "code": "Z12.4",
            "display": "Encounter for screening for malignant neoplasm of cervix"
          },
          {
            "code": "Z12.5",
            "display": "Encounter for screening for malignant neoplasm of prostate"
          },
          {
            "code": "Z12.6",
            "display": "Encounter for screening for malignant neoplasm of bladder"
          },
          {
            "code": "Z12.71",
            "display": "Encounter for screening for malignant neoplasm of testis"
          },
          {
            "code": "Z12.72",
            "display": "Encounter for screening for malignant neoplasm of vagina"
          },
          {
            "code": "Z12.73",
            "display": "Encounter for screening for malignant neoplasm of ovary"
          },
          {
            "code": "Z12.79",
            "display": "Encounter for screening for malignant neoplasm of other genitourinary organs"
          },
          {
            "code": "Z12.81",
            "display": "Encounter for screening for malignant neoplasm of oral cavity"
          },
          {
            "code": "Z12.82",
            "display": "Encounter for screening for malignant neoplasm of nervous system"
          },
          {
            "code": "Z12.83",
            "display": "Encounter for screening for malignant neoplasm of skin"
          },
          {
            "code": "Z12.89",
            "display": "Encounter for screening for malignant neoplasm of other sites"
          },
          {
            "code": "Z12.9",
            "display": "Encounter for screening for malignant neoplasm, site unspecified"
          },
          {
            "code": "Z13.0",
            "display": "Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism"
          },
          {
            "code": "Z13.1",
            "display": "Encounter for screening for diabetes mellitus"
          },
          {
            "code": "Z13.21",
            "display": "Encounter for screening for nutritional disorder"
          },
          {
            "code": "Z13.220",
            "display": "Encounter for screening for lipoid disorders"
          },
          {
            "code": "Z13.228",
            "display": "Encounter for screening for other metabolic disorders"
          },
          {
            "code": "Z13.29",
            "display": "Encounter for screening for other suspected endocrine disorder"
          },
          {
            "code": "Z13.5",
            "display": "Encounter for screening for eye and ear disorders"
          },
          {
            "code": "Z13.6",
            "display": "Encounter for screening for cardiovascular disorders"
          },
          {
            "code": "Z13.71",
            "display": "Encounter for nonprocreative screening for genetic disease carrier status"
          },
          {
            "code": "Z13.79",
            "display": "Encounter for other screening for genetic and chromosomal anomalies"
          },
          {
            "code": "Z13.810",
            "display": "Encounter for screening for upper gastrointestinal disorder"
          },
          {
            "code": "Z13.811",
            "display": "Encounter for screening for lower gastrointestinal disorder"
          },
          {
            "code": "Z13.818",
            "display": "Encounter for screening for other digestive system disorders"
          },
          {
            "code": "Z13.820",
            "display": "Encounter for screening for osteoporosis"
          },
          {
            "code": "Z13.828",
            "display": "Encounter for screening for other musculoskeletal disorder"
          },
          {
            "code": "Z13.83",
            "display": "Encounter for screening for respiratory disorder NEC"
          },
          {
            "code": "Z13.84",
            "display": "Encounter for screening for dental disorders"
          },
          {
            "code": "Z13.850",
            "display": "Encounter for screening for traumatic brain injury"
          },
          {
            "code": "Z13.858",
            "display": "Encounter for screening for other nervous system disorders"
          },
          {
            "code": "Z13.88",
            "display": "Encounter for screening for disorder due to exposure to contaminants"
          },
          {
            "code": "Z13.89",
            "display": "Encounter for screening for other disorder"
          },
          {
            "code": "Z13.9",
            "display": "Encounter for screening, unspecified"
          },
          {
            "code": "Z32.00",
            "display": "Encounter for pregnancy test, result unknown"
          },
          {
            "code": "Z32.02",
            "display": "Encounter for pregnancy test, result negative"
          },
          {
            "code": "Z32.2",
            "display": "Encounter for childbirth instruction"
          },
          {
            "code": "Z32.3",
            "display": "Encounter for childcare instruction"
          },
          {
            "code": "Z36",
            "display": "Encounter for antenatal screening of mother"
          },
          {
            "code": "Z36.0",
            "display": "Encounter for antenatal screening for chromosomal anomalies"
          },
          {
            "code": "Z36.1",
            "display": "Encounter for antenatal screening for raised alphafetoprotein level"
          },
          {
            "code": "Z36.2",
            "display": "Encounter for other antenatal screening follow-up"
          },
          {
            "code": "Z36.3",
            "display": "Encounter for antenatal screening for malformations"
          },
          {
            "code": "Z36.4",
            "display": "Encounter for antenatal screening for fetal growth retardation"
          },
          {
            "code": "Z36.5",
            "display": "Encounter for antenatal screening for isoimmunization"
          },
          {
            "code": "Z36.81",
            "display": "Encounter for antenatal screening for hydrops fetalis"
          },
          {
            "code": "Z36.82",
            "display": "Encounter for antenatal screening for nuchal translucency"
          },
          {
            "code": "Z36.83",
            "display": "Encounter for fetal screening for congenital cardiac abnormalities"
          },
          {
            "code": "Z36.84",
            "display": "Encounter for antenatal screening for fetal lung maturity"
          },
          {
            "code": "Z36.85",
            "display": "Encounter for antenatal screening for Streptococcus B"
          },
          {
            "code": "Z36.86",
            "display": "Encounter for antenatal screening for cervical length"
          },
          {
            "code": "Z36.87",
            "display": "Encounter for antenatal screening for uncertain dates"
          },
          {
            "code": "Z36.88",
            "display": "Encounter for antenatal screening for fetal macrosomia"
          },
          {
            "code": "Z36.89",
            "display": "Encounter for other specified antenatal screening"
          },
          {
            "code": "Z36.8A",
            "display": "Encounter for antenatal screening for other genetic defects"
          },
          {
            "code": "Z36.9",
            "display": "Encounter for antenatal screening, unspecified"
          },
          {
            "code": "Z42.1",
            "display": "Encounter for breast reconstruction following mastectomy"
          },
          {
            "code": "Z42.8",
            "display": "Encounter for other plastic and reconstructive surgery following medical procedure or healed injury"
          },
          {
            "code": "Z43.8",
            "display": "Encounter for attention to other artificial openings"
          },
          {
            "code": "Z43.9",
            "display": "Encounter for attention to unspecified artificial opening"
          },
          {
            "code": "Z44.001",
            "display": "Encounter for fitting and adjustment of unspecified right artificial arm"
          },
          {
            "code": "Z44.002",
            "display": "Encounter for fitting and adjustment of unspecified left artificial arm"
          },
          {
            "code": "Z44.009",
            "display": "Encounter for fitting and adjustment of unspecified artificial arm, unspecified arm"
          },
          {
            "code": "Z44.011",
            "display": "Encounter for fitting and adjustment of complete right artificial arm"
          },
          {
            "code": "Z44.012",
            "display": "Encounter for fitting and adjustment of complete left artificial arm"
          },
          {
            "code": "Z44.019",
            "display": "Encounter for fitting and adjustment of complete artificial arm, unspecified arm"
          },
          {
            "code": "Z44.021",
            "display": "Encounter for fitting and adjustment of partial artificial right arm"
          },
          {
            "code": "Z44.022",
            "display": "Encounter for fitting and adjustment of partial artificial left arm"
          },
          {
            "code": "Z44.029",
            "display": "Encounter for fitting and adjustment of partial artificial arm, unspecified arm"
          },
          {
            "code": "Z44.101",
            "display": "Encounter for fitting and adjustment of unspecified right artificial leg"
          },
          {
            "code": "Z44.102",
            "display": "Encounter for fitting and adjustment of unspecified left artificial leg"
          },
          {
            "code": "Z44.109",
            "display": "Encounter for fitting and adjustment of unspecified artificial leg, unspecified leg"
          },
          {
            "code": "Z44.111",
            "display": "Encounter for fitting and adjustment of complete right artificial leg"
          },
          {
            "code": "Z44.112",
            "display": "Encounter for fitting and adjustment of complete left artificial leg"
          },
          {
            "code": "Z44.119",
            "display": "Encounter for fitting and adjustment of complete artificial leg, unspecified leg"
          },
          {
            "code": "Z44.121",
            "display": "Encounter for fitting and adjustment of partial artificial right leg"
          },
          {
            "code": "Z44.122",
            "display": "Encounter for fitting and adjustment of partial artificial left leg"
          },
          {
            "code": "Z44.129",
            "display": "Encounter for fitting and adjustment of partial artificial leg, unspecified leg"
          },
          {
            "code": "Z44.30",
            "display": "Encounter for fitting and adjustment of external breast prosthesis, unspecified breast"
          },
          {
            "code": "Z44.31",
            "display": "Encounter for fitting and adjustment of external right breast prosthesis"
          },
          {
            "code": "Z44.32",
            "display": "Encounter for fitting and adjustment of external left breast prosthesis"
          },
          {
            "code": "Z44.8",
            "display": "Encounter for fitting and adjustment of other external prosthetic devices"
          },
          {
            "code": "Z44.9",
            "display": "Encounter for fitting and adjustment of unspecified external prosthetic device"
          },
          {
            "code": "Z45.010",
            "display": "Encounter for checking and testing of cardiac pacemaker pulse generator [battery]"
          },
          {
            "code": "Z45.018",
            "display": "Encounter for adjustment and management of other part of cardiac pacemaker"
          },
          {
            "code": "Z45.02",
            "display": "Encounter for adjustment and management of automatic implantable cardiac defibrillator"
          },
          {
            "code": "Z45.09",
            "display": "Encounter for adjustment and management of other cardiac device"
          },
          {
            "code": "Z45.1",
            "display": "Encounter for adjustment and management of infusion pump"
          },
          {
            "code": "Z45.2",
            "display": "Encounter for adjustment and management of vascular access device"
          },
          {
            "code": "Z45.31",
            "display": "Encounter for adjustment and management of implanted visual substitution device"
          },
          {
            "code": "Z45.320",
            "display": "Encounter for adjustment and management of bone conduction device"
          },
          {
            "code": "Z45.321",
            "display": "Encounter for adjustment and management of cochlear device"
          },
          {
            "code": "Z45.328",
            "display": "Encounter for adjustment and management of other implanted hearing device"
          },
          {
            "code": "Z45.41",
            "display": "Encounter for adjustment and management of cerebrospinal fluid drainage device"
          },
          {
            "code": "Z45.42",
            "display": "Encounter for adjustment and management of neurostimulator"
          },
          {
            "code": "Z45.49",
            "display": "Encounter for adjustment and management of other implanted nervous system device"
          },
          {
            "code": "Z45.811",
            "display": "Encounter for adjustment or removal of right breast implant"
          },
          {
            "code": "Z45.812",
            "display": "Encounter for adjustment or removal of left breast implant"
          },
          {
            "code": "Z45.819",
            "display": "Encounter for adjustment or removal of unspecified breast implant"
          },
          {
            "code": "Z45.82",
            "display": "Encounter for adjustment or removal of myringotomy device (stent) (tube)"
          },
          {
            "code": "Z45.89",
            "display": "Encounter for adjustment and management of other implanted devices"
          },
          {
            "code": "Z45.9",
            "display": "Encounter for adjustment and management of unspecified implanted device"
          },
          {
            "code": "Z46.82",
            "display": "Encounter for fitting and adjustment of non-vascular catheter"
          },
          {
            "code": "Z46.89",
            "display": "Encounter for fitting and adjustment of other specified devices"
          },
          {
            "code": "Z46.9",
            "display": "Encounter for fitting and adjustment of unspecified device"
          },
          {
            "code": "Z47.1",
            "display": "Aftercare following joint replacement surgery"
          },
          {
            "code": "Z47.2",
            "display": "Encounter for removal of internal fixation device"
          },
          {
            "code": "Z47.31",
            "display": "Aftercare following explantation of shoulder joint prosthesis"
          },
          {
            "code": "Z47.32",
            "display": "Aftercare following explantation of hip joint prosthesis"
          },
          {
            "code": "Z47.33",
            "display": "Aftercare following explantation of knee joint prosthesis"
          },
          {
            "code": "Z47.81",
            "display": "Encounter for orthopedic aftercare following surgical amputation"
          },
          {
            "code": "Z47.82",
            "display": "Encounter for orthopedic aftercare following scoliosis surgery"
          },
          {
            "code": "Z47.89",
            "display": "Encounter for other orthopedic aftercare"
          },
          {
            "code": "Z48.00",
            "display": "Encounter for change or removal of nonsurgical wound dressing"
          },
          {
            "code": "Z48.01",
            "display": "Encounter for change or removal of surgical wound dressing"
          },
          {
            "code": "Z48.02",
            "display": "Encounter for removal of sutures"
          },
          {
            "code": "Z48.03",
            "display": "Encounter for change or removal of drains"
          },
          {
            "code": "Z48.1",
            "display": "Encounter for planned postprocedural wound closure"
          },
          {
            "code": "Z48.21",
            "display": "Encounter for aftercare following heart transplant"
          },
          {
            "code": "Z48.22",
            "display": "Encounter for aftercare following kidney transplant"
          },
          {
            "code": "Z48.23",
            "display": "Encounter for aftercare following liver transplant"
          },
          {
            "code": "Z48.24",
            "display": "Encounter for aftercare following lung transplant"
          },
          {
            "code": "Z48.280",
            "display": "Encounter for aftercare following heart-lung transplant"
          },
          {
            "code": "Z48.288",
            "display": "Encounter for aftercare following multiple organ transplant"
          },
          {
            "code": "Z48.290",
            "display": "Encounter for aftercare following bone marrow transplant"
          },
          {
            "code": "Z48.298",
            "display": "Encounter for aftercare following other organ transplant"
          },
          {
            "code": "Z48.3",
            "display": "Aftercare following surgery for neoplasm"
          },
          {
            "code": "Z48.810",
            "display": "Encounter for surgical aftercare following surgery on the sense organs"
          },
          {
            "code": "Z48.811",
            "display": "Encounter for surgical aftercare following surgery on the nervous system"
          },
          {
            "code": "Z48.812",
            "display": "Encounter for surgical aftercare following surgery on the circulatory system"
          },
          {
            "code": "Z48.813",
            "display": "Encounter for surgical aftercare following surgery on the respiratory system"
          },
          {
            "code": "Z48.814",
            "display": "Encounter for surgical aftercare following surgery on the teeth or oral cavity"
          },
          {
            "code": "Z48.815",
            "display": "Encounter for surgical aftercare following surgery on the digestive system"
          },
          {
            "code": "Z48.816",
            "display": "Encounter for surgical aftercare following surgery on the genitourinary system"
          },
          {
            "code": "Z48.817",
            "display": "Encounter for surgical aftercare following surgery on the skin and subcutaneous tissue"
          },
          {
            "code": "Z48.89",
            "display": "Encounter for other specified surgical aftercare"
          },
          {
            "code": "Z51.0",
            "display": "Encounter for antineoplastic radiation therapy"
          },
          {
            "code": "Z51.11",
            "display": "Encounter for antineoplastic chemotherapy"
          },
          {
            "code": "Z51.12",
            "display": "Encounter for antineoplastic immunotherapy"
          },
          {
            "code": "Z51.5",
            "display": "Encounter for palliative care"
          },
          {
            "code": "Z51.6",
            "display": "Encounter for desensitization to allergens"
          },
          {
            "code": "Z51.81",
            "display": "Encounter for therapeutic drug level monitoring"
          },
          {
            "code": "Z51.89",
            "display": "Encounter for other specified aftercare"
          },
          {
            "code": "Z55.0",
            "display": "Illiteracy and low-level literacy"
          },
          {
            "code": "Z55.1",
            "display": "Schooling unavailable and unattainable"
          },
          {
            "code": "Z55.2",
            "display": "Failed school examinations"
          },
          {
            "code": "Z55.3",
            "display": "Underachievement in school"
          },
          {
            "code": "Z55.4",
            "display": "Educational maladjustment and discord with teachers and classmates"
          },
          {
            "code": "Z55.8",
            "display": "Other problems related to education and literacy"
          },
          {
            "code": "Z55.9",
            "display": "Problems related to education and literacy, unspecified"
          },
          {
            "code": "Z56.0",
            "display": "Unemployment, unspecified"
          },
          {
            "code": "Z56.1",
            "display": "Change of job"
          },
          {
            "code": "Z56.2",
            "display": "Threat of job loss"
          },
          {
            "code": "Z56.3",
            "display": "Stressful work schedule"
          },
          {
            "code": "Z56.4",
            "display": "Discord with boss and workmates"
          },
          {
            "code": "Z56.5",
            "display": "Uncongenial work environment"
          },
          {
            "code": "Z56.6",
            "display": "Other physical and mental strain related to work"
          },
          {
            "code": "Z56.81",
            "display": "Sexual harassment on the job"
          },
          {
            "code": "Z56.82",
            "display": "Military deployment status"
          },
          {
            "code": "Z56.89",
            "display": "Other problems related to employment"
          },
          {
            "code": "Z56.9",
            "display": "Unspecified problems related to employment"
          },
          {
            "code": "Z57.0",
            "display": "Occupational exposure to noise"
          },
          {
            "code": "Z57.1",
            "display": "Occupational exposure to radiation"
          },
          {
            "code": "Z57.2",
            "display": "Occupational exposure to dust"
          },
          {
            "code": "Z57.31",
            "display": "Occupational exposure to environmental tobacco smoke"
          },
          {
            "code": "Z57.39",
            "display": "Occupational exposure to other air contaminants"
          },
          {
            "code": "Z57.4",
            "display": "Occupational exposure to toxic agents in agriculture"
          },
          {
            "code": "Z57.5",
            "display": "Occupational exposure to toxic agents in other industries"
          },
          {
            "code": "Z57.6",
            "display": "Occupational exposure to extreme temperature"
          },
          {
            "code": "Z57.7",
            "display": "Occupational exposure to vibration"
          },
          {
            "code": "Z57.8",
            "display": "Occupational exposure to other risk factors"
          },
          {
            "code": "Z57.9",
            "display": "Occupational exposure to unspecified risk factor"
          },
          {
            "code": "Z59.0",
            "display": "Homelessness"
          },
          {
            "code": "Z59.1",
            "display": "Inadequate housing"
          },
          {
            "code": "Z59.2",
            "display": "Discord with neighbors, lodgers and landlord"
          },
          {
            "code": "Z59.3",
            "display": "Problems related to living in residential institution"
          },
          {
            "code": "Z59.4",
            "display": "Lack of adequate food and safe drinking water"
          },
          {
            "code": "Z59.5",
            "display": "Extreme poverty"
          },
          {
            "code": "Z59.6",
            "display": "Low income"
          },
          {
            "code": "Z59.7",
            "display": "Insufficient social insurance and welfare support"
          },
          {
            "code": "Z59.8",
            "display": "Other problems related to housing and economic circumstances"
          },
          {
            "code": "Z59.9",
            "display": "Problem related to housing and economic circumstances, unspecified"
          },
          {
            "code": "Z60.0",
            "display": "Problems of adjustment to life-cycle transitions"
          },
          {
            "code": "Z60.2",
            "display": "Problems related to living alone"
          },
          {
            "code": "Z60.3",
            "display": "Acculturation difficulty"
          },
          {
            "code": "Z60.4",
            "display": "Social exclusion and rejection"
          },
          {
            "code": "Z60.5",
            "display": "Target of (perceived) adverse discrimination and persecution"
          },
          {
            "code": "Z60.8",
            "display": "Other problems related to social environment"
          },
          {
            "code": "Z60.9",
            "display": "Problem related to social environment, unspecified"
          },
          {
            "code": "Z62.0",
            "display": "Inadequate parental supervision and control"
          },
          {
            "code": "Z62.1",
            "display": "Parental overprotection"
          },
          {
            "code": "Z62.21",
            "display": "Child in welfare custody"
          },
          {
            "code": "Z62.22",
            "display": "Institutional upbringing"
          },
          {
            "code": "Z62.29",
            "display": "Other upbringing away from parents"
          },
          {
            "code": "Z62.3",
            "display": "Hostility towards and scapegoating of child"
          },
          {
            "code": "Z62.6",
            "display": "Inappropriate (excessive) parental pressure"
          },
          {
            "code": "Z62.810",
            "display": "Personal history of physical and sexual abuse in childhood"
          },
          {
            "code": "Z62.811",
            "display": "Personal history of psychological abuse in childhood"
          },
          {
            "code": "Z62.812",
            "display": "Personal history of neglect in childhood"
          },
          {
            "code": "Z62.813",
            "display": "Personal history of forced labor or sexual exploitation in childhood"
          },
          {
            "code": "Z62.819",
            "display": "Personal history of unspecified abuse in childhood"
          },
          {
            "code": "Z62.820",
            "display": "Parent-biological child conflict"
          },
          {
            "code": "Z62.821",
            "display": "Parent-adopted child conflict"
          },
          {
            "code": "Z62.822",
            "display": "Parent-foster child conflict"
          },
          {
            "code": "Z62.890",
            "display": "Parent-child estrangement NEC"
          },
          {
            "code": "Z62.891",
            "display": "Sibling rivalry"
          },
          {
            "code": "Z62.898",
            "display": "Other specified problems related to upbringing"
          },
          {
            "code": "Z62.9",
            "display": "Problem related to upbringing, unspecified"
          },
          {
            "code": "Z63.0",
            "display": "Problems in relationship with spouse or partner"
          },
          {
            "code": "Z63.1",
            "display": "Problems in relationship with in-laws"
          },
          {
            "code": "Z63.31",
            "display": "Absence of family member due to military deployment"
          },
          {
            "code": "Z63.32",
            "display": "Other absence of family member"
          },
          {
            "code": "Z63.4",
            "display": "Disappearance and death of family member"
          },
          {
            "code": "Z63.5",
            "display": "Disruption of family by separation and divorce"
          },
          {
            "code": "Z63.6",
            "display": "Dependent relative needing care at home"
          },
          {
            "code": "Z63.71",
            "display": "Stress on family due to return of family member from military deployment"
          },
          {
            "code": "Z63.72",
            "display": "Alcoholism and drug addiction in family"
          },
          {
            "code": "Z63.79",
            "display": "Other stressful life events affecting family and household"
          },
          {
            "code": "Z63.8",
            "display": "Other specified problems related to primary support group"
          },
          {
            "code": "Z63.9",
            "display": "Problem related to primary support group, unspecified"
          },
          {
            "code": "Z64.0",
            "display": "Problems related to unwanted pregnancy"
          },
          {
            "code": "Z64.1",
            "display": "Problems related to multiparity"
          },
          {
            "code": "Z64.4",
            "display": "Discord with counselors"
          },
          {
            "code": "Z65.0",
            "display": "Conviction in civil and criminal proceedings without imprisonment"
          },
          {
            "code": "Z65.1",
            "display": "Imprisonment and other incarceration"
          },
          {
            "code": "Z65.2",
            "display": "Problems related to release from prison"
          },
          {
            "code": "Z65.3",
            "display": "Problems related to other legal circumstances"
          },
          {
            "code": "Z65.4",
            "display": "Victim of crime and terrorism"
          },
          {
            "code": "Z65.5",
            "display": "Exposure to disaster, war and other hostilities"
          },
          {
            "code": "Z65.8",
            "display": "Other specified problems related to psychosocial circumstances"
          },
          {
            "code": "Z65.9",
            "display": "Problem related to unspecified psychosocial circumstances"
          },
          {
            "code": "Z69.010",
            "display": "Encounter for mental health services for victim of parental child abuse"
          },
          {
            "code": "Z69.011",
            "display": "Encounter for mental health services for perpetrator of parental child abuse"
          },
          {
            "code": "Z69.020",
            "display": "Encounter for mental health services for victim of non-parental child abuse"
          },
          {
            "code": "Z69.021",
            "display": "Encounter for mental health services for perpetrator of non-parental child abuse"
          },
          {
            "code": "Z69.11",
            "display": "Encounter for mental health services for victim of spousal or partner abuse"
          },
          {
            "code": "Z69.12",
            "display": "Encounter for mental health services for perpetrator of spousal or partner abuse"
          },
          {
            "code": "Z69.81",
            "display": "Encounter for mental health services for victim of other abuse"
          },
          {
            "code": "Z69.82",
            "display": "Encounter for mental health services for perpetrator of other abuse"
          },
          {
            "code": "Z70.0",
            "display": "Counseling related to sexual attitude"
          },
          {
            "code": "Z70.1",
            "display": "Counseling related to patient\u0027s sexual behavior and orientation"
          },
          {
            "code": "Z70.2",
            "display": "Counseling related to sexual behavior and orientation of third party"
          },
          {
            "code": "Z70.3",
            "display": "Counseling related to combined concerns regarding sexual attitude, behavior and orientation"
          },
          {
            "code": "Z70.8",
            "display": "Other sex counseling"
          },
          {
            "code": "Z70.9",
            "display": "Sex counseling, unspecified"
          },
          {
            "code": "Z71.0",
            "display": "Person encountering health services to consult on behalf of another person"
          },
          {
            "code": "Z71.1",
            "display": "Person with feared health complaint in whom no diagnosis is made"
          },
          {
            "code": "Z71.2",
            "display": "Person consulting for explanation of examination or test findings"
          },
          {
            "code": "Z71.3",
            "display": "Dietary counseling and surveillance"
          },
          {
            "code": "Z71.41",
            "display": "Alcohol abuse counseling and surveillance of alcoholic"
          },
          {
            "code": "Z71.42",
            "display": "Counseling for family member of alcoholic"
          },
          {
            "code": "Z71.51",
            "display": "Drug abuse counseling and surveillance of drug abuser"
          },
          {
            "code": "Z71.52",
            "display": "Counseling for family member of drug abuser"
          },
          {
            "code": "Z71.6",
            "display": "Tobacco abuse counseling"
          },
          {
            "code": "Z71.7",
            "display": "Human immunodeficiency virus [HIV] counseling"
          },
          {
            "code": "Z71.81",
            "display": "Spiritual or religious counseling"
          },
          {
            "code": "Z71.82",
            "display": "Exercise counseling"
          },
          {
            "code": "Z71.83",
            "display": "Encounter for nonprocreative genetic counseling"
          },
          {
            "code": "Z71.89",
            "display": "Other specified counseling"
          },
          {
            "code": "Z71.9",
            "display": "Counseling, unspecified"
          },
          {
            "code": "Z73.0",
            "display": "Burn-out"
          },
          {
            "code": "Z73.1",
            "display": "Type A behavior pattern"
          },
          {
            "code": "Z73.2",
            "display": "Lack of relaxation and leisure"
          },
          {
            "code": "Z73.3",
            "display": "Stress, not elsewhere classified"
          },
          {
            "code": "Z73.4",
            "display": "Inadequate social skills, not elsewhere classified"
          },
          {
            "code": "Z73.5",
            "display": "Social role conflict, not elsewhere classified"
          },
          {
            "code": "Z73.6",
            "display": "Limitation of activities due to disability"
          },
          {
            "code": "Z73.810",
            "display": "Behavioral insomnia of childhood, sleep-onset association type"
          },
          {
            "code": "Z73.811",
            "display": "Behavioral insomnia of childhood, limit setting type"
          },
          {
            "code": "Z73.812",
            "display": "Behavioral insomnia of childhood, combined type"
          },
          {
            "code": "Z73.819",
            "display": "Behavioral insomnia of childhood, unspecified type"
          },
          {
            "code": "Z73.89",
            "display": "Other problems related to life management difficulty"
          },
          {
            "code": "Z73.9",
            "display": "Problem related to life management difficulty, unspecified"
          },
          {
            "code": "Z74.01",
            "display": "Bed confinement status"
          },
          {
            "code": "Z74.09",
            "display": "Other reduced mobility"
          },
          {
            "code": "Z74.1",
            "display": "Need for assistance with personal care"
          },
          {
            "code": "Z74.2",
            "display": "Need for assistance at home and no other household member able to render care"
          },
          {
            "code": "Z74.3",
            "display": "Need for continuous supervision"
          },
          {
            "code": "Z74.8",
            "display": "Other problems related to care provider dependency"
          },
          {
            "code": "Z74.9",
            "display": "Problem related to care provider dependency, unspecified"
          },
          {
            "code": "Z75.0",
            "display": "Medical services not available in home"
          },
          {
            "code": "Z75.1",
            "display": "Person awaiting admission to adequate facility elsewhere"
          },
          {
            "code": "Z75.2",
            "display": "Other waiting period for investigation and treatment"
          },
          {
            "code": "Z75.3",
            "display": "Unavailability and inaccessibility of health-care facilities"
          },
          {
            "code": "Z75.4",
            "display": "Unavailability and inaccessibility of other helping agencies"
          },
          {
            "code": "Z75.5",
            "display": "Holiday relief care"
          },
          {
            "code": "Z75.8",
            "display": "Other problems related to medical facilities and other health care"
          },
          {
            "code": "Z75.9",
            "display": "Unspecified problem related to medical facilities and other health care"
          },
          {
            "code": "Z76.0",
            "display": "Encounter for issue of repeat prescription"
          },
          {
            "code": "Z76.1",
            "display": "Encounter for health supervision and care of foundling"
          },
          {
            "code": "Z76.2",
            "display": "Encounter for health supervision and care of other healthy infant and child"
          },
          {
            "code": "Z76.3",
            "display": "Healthy person accompanying sick person"
          },
          {
            "code": "Z76.4",
            "display": "Other boarder to healthcare facility"
          },
          {
            "code": "Z76.5",
            "display": "Malingerer [conscious simulation]"
          },
          {
            "code": "Z76.81",
            "display": "Expectant parent(s) prebirth pediatrician visit"
          },
          {
            "code": "Z76.89",
            "display": "Persons encountering health services in other specified circumstances"
          },
          {
            "code": "Z79.01",
            "display": "Long term (current) use of anticoagulants"
          },
          {
            "code": "Z79.02",
            "display": "Long term (current) use of antithrombotics/antiplatelets"
          },
          {
            "code": "Z79.1",
            "display": "Long term (current) use of non-steroidal anti-inflammatories (NSAID)"
          },
          {
            "code": "Z79.2",
            "display": "Long term (current) use of antibiotics"
          },
          {
            "code": "Z79.3",
            "display": "Long term (current) use of hormonal contraceptives"
          },
          {
            "code": "Z79.4",
            "display": "Long term (current) use of insulin"
          },
          {
            "code": "Z79.51",
            "display": "Long term (current) use of inhaled steroids"
          },
          {
            "code": "Z79.52",
            "display": "Long term (current) use of systemic steroids"
          },
          {
            "code": "Z79.810",
            "display": "Long term (current) use of selective estrogen receptor modulators (SERMs)"
          },
          {
            "code": "Z79.811",
            "display": "Long term (current) use of aromatase inhibitors"
          },
          {
            "code": "Z79.818",
            "display": "Long term (current) use of other agents affecting estrogen receptors and estrogen levels"
          },
          {
            "code": "Z79.82",
            "display": "Long term (current) use of aspirin"
          },
          {
            "code": "Z79.83",
            "display": "Long term (current) use of bisphosphonates"
          },
          {
            "code": "Z79.84",
            "display": "Long term (current) use of oral hypoglycemic drugs"
          },
          {
            "code": "Z79.891",
            "display": "Long term (current) use of opiate analgesic"
          },
          {
            "code": "Z79.899",
            "display": "Other long term (current) drug therapy"
          },
          {
            "code": "Z85.00",
            "display": "Personal history of malignant neoplasm of unspecified digestive organ"
          },
          {
            "code": "Z85.01",
            "display": "Personal history of malignant neoplasm of esophagus"
          },
          {
            "code": "Z85.020",
            "display": "Personal history of malignant carcinoid tumor of stomach"
          },
          {
            "code": "Z85.028",
            "display": "Personal history of other malignant neoplasm of stomach"
          },
          {
            "code": "Z85.030",
            "display": "Personal history of malignant carcinoid tumor of large intestine"
          },
          {
            "code": "Z85.038",
            "display": "Personal history of other malignant neoplasm of large intestine"
          },
          {
            "code": "Z85.040",
            "display": "Personal history of malignant carcinoid tumor of rectum"
          },
          {
            "code": "Z85.048",
            "display": "Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus"
          },
          {
            "code": "Z85.05",
            "display": "Personal history of malignant neoplasm of liver"
          },
          {
            "code": "Z85.060",
            "display": "Personal history of malignant carcinoid tumor of small intestine"
          },
          {
            "code": "Z85.068",
            "display": "Personal history of other malignant neoplasm of small intestine"
          },
          {
            "code": "Z85.07",
            "display": "Personal history of malignant neoplasm of pancreas"
          },
          {
            "code": "Z85.09",
            "display": "Personal history of malignant neoplasm of other digestive organs"
          },
          {
            "code": "Z85.110",
            "display": "Personal history of malignant carcinoid tumor of bronchus and lung"
          },
          {
            "code": "Z85.118",
            "display": "Personal history of other malignant neoplasm of bronchus and lung"
          },
          {
            "code": "Z85.12",
            "display": "Personal history of malignant neoplasm of trachea"
          },
          {
            "code": "Z85.20",
            "display": "Personal history of malignant neoplasm of unspecified respiratory organ"
          },
          {
            "code": "Z85.21",
            "display": "Personal history of malignant neoplasm of larynx"
          },
          {
            "code": "Z85.22",
            "display": "Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses"
          },
          {
            "code": "Z85.230",
            "display": "Personal history of malignant carcinoid tumor of thymus"
          },
          {
            "code": "Z85.238",
            "display": "Personal history of other malignant neoplasm of thymus"
          },
          {
            "code": "Z85.29",
            "display": "Personal history of malignant neoplasm of other respiratory and intrathoracic organs"
          },
          {
            "code": "Z85.3",
            "display": "Personal history of malignant neoplasm of breast"
          },
          {
            "code": "Z85.40",
            "display": "Personal history of malignant neoplasm of unspecified female genital organ"
          },
          {
            "code": "Z85.41",
            "display": "Personal history of malignant neoplasm of cervix uteri"
          },
          {
            "code": "Z85.42",
            "display": "Personal history of malignant neoplasm of other parts of uterus"
          },
          {
            "code": "Z85.43",
            "display": "Personal history of malignant neoplasm of ovary"
          },
          {
            "code": "Z85.44",
            "display": "Personal history of malignant neoplasm of other female genital organs"
          },
          {
            "code": "Z85.45",
            "display": "Personal history of malignant neoplasm of unspecified male genital organ"
          },
          {
            "code": "Z85.46",
            "display": "Personal history of malignant neoplasm of prostate"
          },
          {
            "code": "Z85.47",
            "display": "Personal history of malignant neoplasm of testis"
          },
          {
            "code": "Z85.48",
            "display": "Personal history of malignant neoplasm of epididymis"
          },
          {
            "code": "Z85.49",
            "display": "Personal history of malignant neoplasm of other male genital organs"
          },
          {
            "code": "Z85.50",
            "display": "Personal history of malignant neoplasm of unspecified urinary tract organ"
          },
          {
            "code": "Z85.51",
            "display": "Personal history of malignant neoplasm of bladder"
          },
          {
            "code": "Z85.520",
            "display": "Personal history of malignant carcinoid tumor of kidney"
          },
          {
            "code": "Z85.528",
            "display": "Personal history of other malignant neoplasm of kidney"
          },
          {
            "code": "Z85.53",
            "display": "Personal history of malignant neoplasm of renal pelvis"
          },
          {
            "code": "Z85.54",
            "display": "Personal history of malignant neoplasm of ureter"
          },
          {
            "code": "Z85.59",
            "display": "Personal history of malignant neoplasm of other urinary tract organ"
          },
          {
            "code": "Z85.6",
            "display": "Personal history of leukemia"
          },
          {
            "code": "Z85.71",
            "display": "Personal history of Hodgkin lymphoma"
          },
          {
            "code": "Z85.72",
            "display": "Personal history of non-Hodgkin lymphomas"
          },
          {
            "code": "Z85.79",
            "display": "Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues"
          },
          {
            "code": "Z85.810",
            "display": "Personal history of malignant neoplasm of tongue"
          },
          {
            "code": "Z85.818",
            "display": "Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx"
          },
          {
            "code": "Z85.819",
            "display": "Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx"
          },
          {
            "code": "Z85.820",
            "display": "Personal history of malignant melanoma of skin"
          },
          {
            "code": "Z85.821",
            "display": "Personal history of Merkel cell carcinoma"
          },
          {
            "code": "Z85.828",
            "display": "Personal history of other malignant neoplasm of skin"
          },
          {
            "code": "Z85.830",
            "display": "Personal history of malignant neoplasm of bone"
          },
          {
            "code": "Z85.831",
            "display": "Personal history of malignant neoplasm of soft tissue"
          },
          {
            "code": "Z85.840",
            "display": "Personal history of malignant neoplasm of eye"
          },
          {
            "code": "Z85.841",
            "display": "Personal history of malignant neoplasm of brain"
          },
          {
            "code": "Z85.848",
            "display": "Personal history of malignant neoplasm of other parts of nervous tissue"
          },
          {
            "code": "Z85.850",
            "display": "Personal history of malignant neoplasm of thyroid"
          },
          {
            "code": "Z85.858",
            "display": "Personal history of malignant neoplasm of other endocrine glands"
          },
          {
            "code": "Z85.89",
            "display": "Personal history of malignant neoplasm of other organs and systems"
          },
          {
            "code": "Z85.9",
            "display": "Personal history of malignant neoplasm, unspecified"
          },
          {
            "code": "Z86.000",
            "display": "Personal history of in-situ neoplasm of breast"
          },
          {
            "code": "Z86.001",
            "display": "Personal history of in-situ neoplasm of cervix uteri"
          },
          {
            "code": "Z86.008",
            "display": "Personal history of in-situ neoplasm of other site"
          },
          {
            "code": "Z86.010",
            "display": "Personal history of colonic polyps"
          },
          {
            "code": "Z86.012",
            "display": "Personal history of benign carcinoid tumor"
          },
          {
            "code": "Z86.018",
            "display": "Personal history of other benign neoplasm"
          },
          {
            "code": "Z86.03",
            "display": "Personal history of neoplasm of uncertain behavior"
          },
          {
            "code": "Z86.711",
            "display": "Personal history of pulmonary embolism"
          },
          {
            "code": "Z86.718",
            "display": "Personal history of other venous thrombosis and embolism"
          },
          {
            "code": "Z86.72",
            "display": "Personal history of thrombophlebitis"
          },
          {
            "code": "Z86.73",
            "display": "Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits"
          },
          {
            "code": "Z86.74",
            "display": "Personal history of sudden cardiac arrest"
          },
          {
            "code": "Z86.79",
            "display": "Personal history of other diseases of the circulatory system"
          },
          {
            "code": "Z87.892",
            "display": "Personal history of anaphylaxis"
          },
          {
            "code": "Z88.0",
            "display": "Allergy status to penicillin"
          },
          {
            "code": "Z88.1",
            "display": "Allergy status to other antibiotic agents status"
          },
          {
            "code": "Z88.2",
            "display": "Allergy status to sulfonamides status"
          },
          {
            "code": "Z88.3",
            "display": "Allergy status to other anti-infective agents status"
          },
          {
            "code": "Z88.4",
            "display": "Allergy status to anesthetic agent status"
          },
          {
            "code": "Z88.5",
            "display": "Allergy status to narcotic agent status"
          },
          {
            "code": "Z88.6",
            "display": "Allergy status to analgesic agent status"
          },
          {
            "code": "Z88.7",
            "display": "Allergy status to serum and vaccine status"
          },
          {
            "code": "Z88.8",
            "display": "Allergy status to other drugs, medicaments and biological substances status"
          },
          {
            "code": "Z88.9",
            "display": "Allergy status to unspecified drugs, medicaments and biological substances status"
          },
          {
            "code": "Z91.010",
            "display": "Allergy to peanuts"
          },
          {
            "code": "Z91.011",
            "display": "Allergy to milk products"
          },
          {
            "code": "Z91.012",
            "display": "Allergy to eggs"
          },
          {
            "code": "Z91.013",
            "display": "Allergy to seafood"
          },
          {
            "code": "Z91.018",
            "display": "Allergy to other foods"
          },
          {
            "code": "Z91.02",
            "display": "Food additives allergy status"
          },
          {
            "code": "Z91.030",
            "display": "Bee allergy status"
          },
          {
            "code": "Z91.038",
            "display": "Other insect allergy status"
          },
          {
            "code": "Z91.040",
            "display": "Latex allergy status"
          },
          {
            "code": "Z91.041",
            "display": "Radiographic dye allergy status"
          },
          {
            "code": "Z91.048",
            "display": "Other nonmedicinal substance allergy status"
          },
          {
            "code": "Z91.09",
            "display": "Other allergy status, other than to drugs and biological substances"
          },
          {
            "code": "Z94.1",
            "display": "Heart transplant status"
          },
          {
            "code": "Z94.3",
            "display": "Heart and lungs transplant status"
          },
          {
            "code": "Z95.0",
            "display": "Presence of cardiac pacemaker"
          },
          {
            "code": "Z95.1",
            "display": "Presence of aortocoronary bypass graft"
          },
          {
            "code": "Z95.2",
            "display": "Presence of prosthetic heart valve"
          },
          {
            "code": "Z95.3",
            "display": "Presence of xenogenic heart valve"
          },
          {
            "code": "Z95.4",
            "display": "Presence of other heart-valve replacement"
          },
          {
            "code": "Z95.5",
            "display": "Presence of coronary angioplasty implant and graft"
          },
          {
            "code": "Z95.810",
            "display": "Presence of automatic (implantable) cardiac defibrillator"
          },
          {
            "code": "Z95.811",
            "display": "Presence of heart assist device"
          },
          {
            "code": "Z95.812",
            "display": "Presence of fully implantable artificial heart"
          },
          {
            "code": "Z95.818",
            "display": "Presence of other cardiac implants and grafts"
          },
          {
            "code": "Z95.820",
            "display": "Peripheral vascular angioplasty status with implants and grafts"
          },
          {
            "code": "Z95.828",
            "display": "Presence of other vascular implants and grafts"
          },
          {
            "code": "Z95.9",
            "display": "Presence of cardiac and vascular implant and graft, unspecified"
          },
          {
            "code": "Z98.61",
            "display": "Coronary angioplasty status"
          },
          {
            "code": "Z98.62",
            "display": "Peripheral vascular angioplasty status"
          }
        ]
      }
    ]
  }
}